data_2equ_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2equ _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -155.54 158.12 37.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.596 1.558 . . . . 0.0 111.419 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.81 127.53 32.67 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.952 -0.468 . . . . 0.0 110.887 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.66 -11.64 64.67 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.667 1.603 . . . . 0.0 114.68 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.11 134.72 51.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.3 1.55 . . . . 0.0 111.902 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.51 138.05 37.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.329 0.652 . . . . 0.0 111.003 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.1 m -146.29 176.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.193 1.797 . . . . 0.0 111.22 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.1 mt -112.87 144.94 41.57 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.05 1.34 . . . . 0.0 108.475 168.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.17 146.5 31.79 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.239 0.543 . . . . 0.0 111.673 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -74.15 140.43 45.18 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 109.438 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -121.71 -162.98 1.02 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.347 1.059 . . . . 0.0 111.472 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.9 m -55.25 -35.14 64.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.365 -0.834 . . . . 0.0 111.197 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.61 135.46 33.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.398 1.479 . . . . 0.0 109.35 167.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.2 m -65.32 -21.4 66.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -63.6 145.56 55.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.207 1.003 . . . . 0.0 111.557 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -79.46 151.78 30.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.099 0.56 . . . . 0.0 110.848 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.64 154.23 65.99 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.043 1.337 . . . . 0.0 111.648 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 130.43 23.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.04 2.493 . . . . 0.0 111.355 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.89 -179.65 6.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.983 1.713 . . . . 0.0 110.539 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -143.3 152.82 42.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.48 1.112 . . . . 0.0 111.486 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -75.54 128.96 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.409 1.083 . . . . 0.0 109.606 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -98.54 -33.59 10.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.55 1.14 . . . . 0.0 112.185 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.43 35.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.799 1.24 . . . . 0.0 112.194 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 125.615 1.566 . . . . 0.0 109.128 -176.397 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 C--O 1.236 0.364 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -76.25 133.63 40.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.03 152.49 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.848 1.259 . . . . 0.0 111.633 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -122.99 134.34 54.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.362 1.465 . . . . 0.0 110.313 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.11 164.52 13.23 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.0 111.62 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -55.49 -27.44 48.49 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 114.371 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.29 -22.31 63.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.157 1.383 . . . . 0.0 113.712 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.5 28.36 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.987 1.756 . . . . 0.0 113.937 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.97 145.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.411 1.485 . . . . 0.0 112.585 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.5 mt -128.56 130.47 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.603 1.561 . . . . 0.0 109.481 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -142.14 173.83 11.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.216 1.807 . . . . 0.0 111.063 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -120.57 139.1 53.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.971 1.309 . . . . 0.0 110.363 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.7 mt -140.81 167.45 22.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.449 1.5 . . . . 0.0 111.659 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.61 156.55 19.44 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.173 0.989 . . . . 0.0 110.114 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -28.8 13.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 96.7 mtp -67.05 -10.43 49.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.362 1.465 . . . . 0.0 113.88 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -117.54 8.82 13.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.381 1.472 . . . . 0.0 113.572 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.7 mt -128.43 144.64 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.15 1.78 . . . . 0.0 109.215 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -138.92 150.32 45.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 0.0 111.063 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.38 132.16 45.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 CA--C 1.55 0.947 0 O-C-N 121.784 -0.572 . . . . 0.0 111.779 176.053 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -138.0 148.07 44.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 113.166 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.24 132.59 54.48 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.57 -0.706 . . . . 0.0 111.723 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.77 6.15 66.32 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.73 141.47 48.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.185 1.492 . . . . 0.0 111.839 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 132.27 38.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.005 0.922 . . . . 0.0 111.669 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.16 175.62 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.506 1.522 . . . . 0.0 111.918 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.3 151.63 35.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.406 1.483 . . . . 0.0 108.971 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.67 154.82 36.06 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.207 -0.933 . . . . 0.0 112.255 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -72.01 156.85 38.78 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.022 1.329 . . . . 0.0 110.236 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -136.91 -150.09 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.53 0.732 . . . . 0.0 112.274 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.2 p -62.54 -3.0 1.23 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.792 1.637 . . . . 0.0 114.735 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -129.24 161.76 29.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.811 2.045 . . . . 0.0 110.543 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.6 -21.69 66.78 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.33 147.05 53.87 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.315 1.446 . . . . 0.0 112.259 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -86.55 152.76 22.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.111 0.564 . . . . 0.0 109.622 167.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -139.76 152.15 67.6 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.462 1.105 . . . . 0.0 111.805 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.61 137.33 38.72 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.302 2.668 . . . . 0.0 112.319 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.81 176.83 10.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.274 1.43 . . . . 0.0 111.715 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -135.25 139.94 44.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.954 1.702 . . . . 0.0 109.578 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.0 mm -61.49 134.78 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.501 0.721 . . . . 0.0 110.251 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -106.75 -29.99 9.22 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.214 1.806 . . . . 0.0 112.106 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 148.18 27.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.989 0.916 . . . . 0.0 113.154 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 127.709 2.404 . . . . 0.0 108.246 176.938 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.4 m -111.93 140.17 46.82 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.736 -0.602 . . . . 0.0 109.561 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.67 151.77 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.763 1.225 . . . . 0.0 112.207 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -112.72 124.07 51.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.84 1.656 . . . . 0.0 108.87 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.72 163.58 27.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.561 0.745 . . . . 0.0 112.24 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -54.17 -29.75 46.84 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.652 1.181 . . . . 0.0 114.008 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.72 -21.09 62.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.478 1.511 . . . . 0.0 113.794 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -17.25 37.02 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.844 1.688 . . . . 0.0 114.419 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.28 148.96 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.982 1.313 . . . . 0.0 112.218 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -128.85 129.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.606 1.562 . . . . 0.0 109.834 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -145.63 177.37 8.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.038 2.135 . . . . 0.0 110.142 173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 28.0 p -125.52 148.16 48.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.366 1.066 . . . . 0.0 111.754 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.82 144.03 27.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 111.414 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.94 151.3 47.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.989 0.916 . . . . 0.0 111.076 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.53 12.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.9 tpp -66.59 -12.44 57.9 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.782 1.633 . . . . 0.0 113.744 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.0 15.0 15.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.713 1.605 . . . . 0.0 112.418 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.7 mt -127.64 151.36 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 127.013 2.125 . . . . 0.0 109.866 -171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -140.18 155.23 47.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.702 2.001 . . . . 0.0 111.497 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.43 24.2 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 0.0 111.657 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 123.921 0.888 . . . . 0.0 110.592 172.074 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.266 0.555 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.99 155.81 23.77 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.196 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.74 135.81 41.77 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.84 77.6 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.653 1.12 . . . . 0.0 114.88 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -65.65 131.93 47.56 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.119 1.46 . . . . 0.0 111.782 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.22 130.06 37.63 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.285 0.564 . . . . 0.0 110.159 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.61 177.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.229 1.812 . . . . 0.0 111.31 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.5 mt -114.26 133.8 55.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.387 1.475 . . . . 0.0 109.766 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.98 155.91 42.07 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -75.76 148.35 38.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.028 1.331 . . . . 0.0 111.555 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -144.92 -36.13 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -139.22 -28.67 0.78 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -148.81 178.41 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.768 1.627 . . . . 0.0 110.787 -169.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.5 m -61.53 -17.55 55.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -73.05 114.24 10.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 110.477 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -72.33 152.27 42.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.301 0.641 . . . . 0.0 110.092 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -129.97 156.2 79.46 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.909 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 139.29 37.26 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.603 2.202 . . . . 0.0 113.029 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.47 172.58 14.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.702 1.601 . . . . 0.0 111.404 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -119.92 141.48 49.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.852 1.661 . . . . 0.0 110.088 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -80.16 110.3 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.658 0.783 . . . . 0.0 109.833 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -83.03 -31.35 27.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.447 1.099 . . . . 0.0 113.106 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.16 163.97 37.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.929 1.292 . . . . 0.0 112.14 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 125.781 1.632 . . . . 0.0 109.676 -171.49 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.8 m -82.47 134.68 35.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.44 144.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.117 0.967 . . . . 0.0 112.257 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.36 110.19 16.66 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.598 1.559 . . . . 0.0 109.62 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 164.17 26.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.046 0.938 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -54.21 -26.34 27.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.73 -22.08 64.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.358 . . . . 0.0 113.874 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.76 -15.61 44.7 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.005 1.764 . . . . 0.0 114.083 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.43 148.23 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.655 1.582 . . . . 0.0 112.274 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.3 mt -129.92 127.59 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.147 1.379 . . . . 0.0 110.003 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -143.29 -171.05 3.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.276 2.231 . . . . 0.0 109.307 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.77 151.2 50.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.005 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.5 mt -142.15 160.22 40.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.11 1.764 . . . . 0.0 110.882 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -87.58 161.6 17.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 111.246 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.6 ptt85 -55.42 -20.9 13.62 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 169.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.87 -13.37 44.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.828 1.251 . . . . 0.0 113.97 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -128.28 10.9 6.35 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.376 1.47 . . . . 0.0 113.633 -171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.26 140.3 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.494 1.518 . . . . 0.0 110.039 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -141.18 152.79 44.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.172 1.789 . . . . 0.0 110.927 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.05 139.98 58.23 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.706 -0.621 . . . . 0.0 109.861 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 CA--C 1.55 0.968 0 O-C-N 121.716 -0.615 . . . . 0.0 111.553 175.303 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.36 157.55 24.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.626 1.57 . . . . 0.0 111.699 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.48 133.69 46.02 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.35 0.66 . . . . 0.0 110.793 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.8 3.05 58.47 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.608 1.099 . . . . 0.0 114.849 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.7 129.41 39.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.786 1.293 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -74.95 134.58 41.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.436 0.636 . . . . 0.0 110.778 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.89 179.43 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.501 1.921 . . . . 0.0 111.023 -169.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.75 146.59 43.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.336 1.454 . . . . 0.0 108.909 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.08 149.6 26.3 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.296 -0.877 . . . . 0.0 112.979 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -80.61 110.13 15.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.252 1.421 . . . . 0.0 110.348 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -85.71 -160.06 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.111 0.965 . . . . 0.0 112.063 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -56.4 -35.14 67.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.767 1.227 . . . . 0.0 112.458 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.75 153.42 22.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.808 1.243 . . . . 0.0 111.957 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 82.7 m -77.24 50.85 0.8 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -134.41 163.22 30.17 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.526 2.331 . . . . 0.0 110.607 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -121.96 70.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.395 1.478 . . . . 0.0 110.493 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -67.54 157.39 86.08 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.429 1.092 . . . . 0.0 112.442 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.22 138.58 47.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.808 2.338 . . . . 0.0 111.965 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.17 179.57 7.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.175 1.79 . . . . 0.0 110.619 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -142.55 152.76 42.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.633 1.173 . . . . 0.0 111.987 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 91.0 mt -83.33 113.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.259 1.024 . . . . 0.0 110.108 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -80.65 -33.44 35.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.668 1.187 . . . . 0.0 112.787 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.76 38.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.461 1.104 . . . . 0.0 112.546 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 126.111 1.764 . . . . 0.0 109.118 -174.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.5 m -86.93 135.76 33.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.722 0.809 . . . . 0.0 108.926 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.84 148.5 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -119.7 123.82 44.72 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 109.593 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.42 164.77 16.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 111.548 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -52.7 -28.45 21.91 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.98 -21.95 65.04 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.263 1.425 . . . . 0.0 113.733 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.44 -20.15 32.9 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.206 1.86 . . . . 0.0 114.068 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.48 145.95 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.856 1.662 . . . . 0.0 112.749 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.61 125.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.241 1.416 . . . . 0.0 109.892 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -142.62 -172.68 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.153 2.181 . . . . 0.0 109.636 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 32.1 p -130.3 154.5 47.56 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.381 -0.824 . . . . 0.0 112.261 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.4 157.95 44.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.025 1.73 . . . . 0.0 111.088 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -73.05 156.64 38.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.197 0.999 . . . . 0.0 110.447 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -54.54 -25.4 25.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.61 -19.56 58.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.355 1.862 . . . . 0.0 114.139 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -120.26 12.23 11.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.137 1.375 . . . . 0.0 113.394 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.38 142.28 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.01 1.724 . . . . 0.0 108.854 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -135.69 145.76 47.06 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.053 1.741 . . . . 0.0 110.254 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.52 139.27 58.46 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.028 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 CA--C 1.549 0.907 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.893 174.369 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 121.048 0.451 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 152.12 34.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.39 1.476 . . . . 0.0 111.706 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.38 141.29 57.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.012 0.525 . . . . 0.0 111.326 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.32 -9.36 73.39 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.17 1.367 . . . . 0.0 114.626 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.38 145.06 31.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.16 1.48 . . . . 0.0 111.974 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.87 143.78 25.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.53 1.132 . . . . 0.0 112.05 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.93 170.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.438 1.895 . . . . 0.0 111.008 -170.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -109.72 133.39 53.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.6 1.16 . . . . 0.0 108.889 169.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.21 153.28 38.54 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -74.66 150.38 39.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.138 1.375 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -140.23 -44.13 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -139.63 -21.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -171.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -142.76 -178.61 5.88 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.679 1.592 . . . . 0.0 110.721 -171.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.4 m -65.47 -14.07 60.18 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.816 -1.178 . . . . 0.0 113.768 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.89 133.58 43.13 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.8 1.24 . . . . 0.0 110.571 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -89.06 152.3 21.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.577 0.751 . . . . 0.0 109.255 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.47 155.84 79.34 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.118 1.367 . . . . 0.0 110.859 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.52 137.17 38.58 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.679 2.253 . . . . 0.0 112.732 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.41 174.6 12.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.818 1.647 . . . . 0.0 111.482 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -136.39 138.3 41.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 110.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.11 130.8 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.343 0.657 . . . . 0.0 109.586 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.84 -31.51 7.99 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.764 1.226 . . . . 0.0 112.53 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.5 33.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.092 1.757 . . . . 0.0 110.749 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 124.849 1.26 . . . . 0.0 110.521 -169.666 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -81.69 130.45 35.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.954 0.902 . . . . 0.0 108.612 172.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.62 142.43 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.434 1.094 . . . . 0.0 112.027 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.78 129.51 55.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.679 1.592 . . . . 0.0 109.473 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.22 168.01 11.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.951 0.9 . . . . 0.0 111.756 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.82 -27.05 27.21 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.069 1.348 . . . . 0.0 113.841 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 -17.99 37.33 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.123 1.821 . . . . 0.0 114.193 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.11 147.0 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.789 1.636 . . . . 0.0 112.439 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 129.53 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.691 1.596 . . . . 0.0 110.136 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -143.09 -166.72 2.37 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.142 2.177 . . . . 0.0 109.351 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.13 155.45 46.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.228 -0.92 . . . . 0.0 111.564 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.42 152.79 45.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.242 1.417 . . . . 0.0 110.753 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.27 153.38 42.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.303 1.041 . . . . 0.0 110.957 171.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.33 18.56 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 169.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 tpt -65.33 -13.98 59.75 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.44 1.896 . . . . 0.0 113.804 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -120.79 13.35 11.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.492 1.517 . . . . 0.0 113.603 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.9 mt -134.3 144.41 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.035 1.734 . . . . 0.0 109.455 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -136.61 149.32 47.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.063 2.145 . . . . 0.0 110.271 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 157.24 30.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.58 0.752 . . . . 0.0 111.229 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 CA--C 1.55 0.962 0 O-C-N 121.964 -0.46 . . . . 0.0 110.306 177.612 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.221 0.534 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.27 164.26 30.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 111.779 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.89 132.32 53.47 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.942 0.401 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.78 -4.52 85.71 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.087 1.327 . . . . 0.0 115.054 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.88 132.68 49.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.519 1.66 . . . . 0.0 111.776 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -77.81 133.82 38.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.621 0.769 . . . . 0.0 110.792 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.34 167.05 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.715 1.606 . . . . 0.0 111.171 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.17 140.7 29.73 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.26 160.08 44.01 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.717 -0.614 . . . . 0.0 112.225 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.52 145.52 26.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.827 1.251 . . . . 0.0 111.258 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.89 -48.02 0.5 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 m -140.27 -14.55 1.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -169.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -140.25 179.14 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.209 1.404 . . . . 0.0 111.6 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.6 m -73.13 -20.49 60.91 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.762 -0.587 . . . . 0.0 111.59 167.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -71.81 131.38 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.581 1.552 . . . . 0.0 110.357 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.76 161.91 24.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.895 0.478 . . . . 0.0 110.145 168.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -136.48 154.56 76.94 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.51 1.524 . . . . 0.0 110.529 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.49 139.44 37.72 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.101 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.5 173.5 12.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.127 1.771 . . . . 0.0 110.736 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -125.06 140.42 52.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.485 1.514 . . . . 0.0 109.533 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.53 121.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.323 0.649 . . . . 0.0 109.736 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -90.36 -33.97 15.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.284 1.034 . . . . 0.0 112.379 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.58 35.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.549 1.14 . . . . 0.0 112.702 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 126.797 2.039 . . . . 0.0 109.187 -172.194 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.8 m -77.37 135.9 38.39 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -143.02 151.53 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.564 1.146 . . . . 0.0 112.275 -171.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -122.31 112.86 18.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.949 1.7 . . . . 0.0 109.445 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -76.17 164.17 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 111.614 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -58.02 -21.79 46.82 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -69.96 -16.03 63.13 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.709 1.203 . . . . 0.0 114.032 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.52 -11.46 64.97 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.805 1.669 . . . . 0.0 114.542 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.51 148.19 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.095 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.6 mt -130.23 126.14 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.214 1.405 . . . . 0.0 110.099 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -144.6 -167.42 2.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.481 2.312 . . . . 0.0 109.249 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.34 153.98 49.05 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.26 -0.9 . . . . 0.0 112.067 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.1 mt -138.69 156.83 47.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 111.816 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.99 158.39 29.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.7 1.2 . . . . 0.0 110.569 169.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -57.74 -26.45 61.84 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -67.01 -11.63 57.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.146 1.378 . . . . 0.0 113.91 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -115.51 14.82 16.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.767 1.627 . . . . 0.0 112.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -134.25 145.79 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.47 1.908 . . . . 0.0 109.446 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -138.86 150.03 45.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.526 1.931 . . . . 0.0 111.36 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.42 144.52 48.12 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.006 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 CA--C 1.548 0.896 0 C-N-CA 124.134 0.974 . . . . 0.0 110.785 176.296 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -143.46 146.14 33.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 111.571 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.49 131.44 50.95 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 122.021 -0.425 . . . . 0.0 111.154 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.78 -13.5 52.82 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.531 1.538 . . . . 0.0 115.371 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.45 149.46 45.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.356 1.578 . . . . 0.0 111.488 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -90.21 143.94 26.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 112.127 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.72 164.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.599 1.96 . . . . 0.0 111.142 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -108.71 125.25 51.71 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.091 1.756 . . . . 0.0 109.208 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.37 152.72 41.93 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -92.33 72.25 5.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.75 1.62 . . . . 0.0 112.508 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CE3' ' CE1' ' A' ' 120' ' ' PHE . 50.8 t-105 -62.33 -37.13 84.45 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -155.25 -29.17 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -136.46 163.04 31.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.103 1.361 . . . . 0.0 111.792 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.53 -20.34 54.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.892 1.277 . . . . 0.0 114.418 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.67 96.44 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.308 1.043 . . . . 0.0 108.918 168.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -55.49 143.21 30.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.386 0.675 . . . . 0.0 111.419 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.89 150.87 56.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.955 1.302 . . . . 0.0 111.522 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.68 137.77 28.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.667 2.245 . . . . 0.0 112.193 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.99 167.18 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.008 1.723 . . . . 0.0 110.954 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.01 142.29 45.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.151 1.38 . . . . 0.0 109.996 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.83 120.61 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.91 0.884 . . . . 0.0 109.383 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -92.79 -31.47 15.02 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.124 0.969 . . . . 0.0 112.561 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.03 158.68 36.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.357 1.063 . . . . 0.0 112.446 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 126.564 1.946 . . . . 0.0 108.408 -177.555 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.1 0.476 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 m -72.4 134.8 45.6 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.52 0.728 . . . . 0.0 109.506 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.31 147.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.027 1.331 . . . . 0.0 111.751 -171.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.22 118.27 27.23 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.547 1.539 . . . . 0.0 109.954 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CE1' ' CE3' ' A' ' 97' ' ' TRP . 33.2 m-85 -85.91 172.05 11.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.709 1.203 . . . . 0.0 111.872 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -57.87 -21.75 44.55 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -70.78 -14.03 62.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.923 1.289 . . . . 0.0 114.12 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.61 -16.31 58.29 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.641 1.591 . . . . 0.0 114.883 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.47 148.56 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.689 1.596 . . . . 0.0 112.326 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.36 124.22 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.522 1.529 . . . . 0.0 110.368 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -142.57 -162.46 1.42 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.295 2.238 . . . . 0.0 108.888 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.6 p -135.52 155.29 50.74 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.134 -0.979 . . . . 0.0 112.492 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.25 149.97 40.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.314 1.446 . . . . 0.0 111.192 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -68.71 159.54 32.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.631 1.172 . . . . 0.0 111.329 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -58.27 -20.47 42.75 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 171.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.9 mmm -67.89 -12.91 61.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.915 1.286 . . . . 0.0 113.661 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.8 13.51 5.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 112.871 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.83 136.22 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.791 1.636 . . . . 0.0 109.422 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -140.53 157.61 45.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.063 1.745 . . . . 0.0 111.287 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 174.52 5.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.211 0.604 . . . . 0.0 111.0 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.866 0 O-C-N 121.201 -0.937 . . . . 0.0 111.318 169.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.8 142.71 30.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.928 1.291 . . . . 0.0 112.566 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 135.96 57.78 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.831 -0.543 . . . . 0.0 110.834 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.04 -12.88 69.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.105 1.336 . . . . 0.0 114.631 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -69.26 162.17 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.4 1.6 . . . . 0.0 112.375 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.41 142.79 32.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.833 0.853 . . . . 0.0 112.175 170.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.95 162.98 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.838 2.055 . . . . 0.0 110.806 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.8 137.43 32.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.55 152.06 33.58 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.522 0.601 . . . . 0.0 112.379 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -84.95 150.01 25.23 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.846 1.258 . . . . 0.0 111.519 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 t-105 -151.42 -39.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -132.73 -32.68 1.25 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.62 178.83 7.69 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.146 1.778 . . . . 0.0 110.528 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.2 m -61.17 -22.45 64.73 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 122.78 22.22 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.647 1.179 . . . . 0.0 111.096 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -70.64 155.69 40.42 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.009 0.924 . . . . 0.0 110.745 169.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.29 157.34 76.47 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.435 1.494 . . . . 0.0 110.579 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.44 135.08 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.135 1.89 . . . . 0.0 111.564 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.16 174.14 11.14 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.722 2.009 . . . . 0.0 110.145 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -127.34 134.99 49.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.528 1.531 . . . . 0.0 110.098 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.5 mt -72.31 121.95 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.02 0.528 . . . . 0.0 110.007 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -87.47 -37.45 16.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.526 1.131 . . . . 0.0 111.858 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.1 162.11 38.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.571 1.148 . . . . 0.0 113.002 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.885 1.674 . . . . 0.0 109.242 -175.979 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 m -73.64 131.34 41.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.92 149.76 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.467 1.107 . . . . 0.0 112.018 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.84 127.92 52.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.034 1.733 . . . . 0.0 109.368 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.46 168.18 11.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.659 0.784 . . . . 0.0 111.488 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -59.77 -20.43 56.6 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -73.22 -14.01 61.26 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.551 1.14 . . . . 0.0 113.994 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.94 -12.08 67.36 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.935 1.731 . . . . 0.0 114.53 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.9 149.18 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.643 1.577 . . . . 0.0 112.301 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.6 130.27 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.308 1.443 . . . . 0.0 110.263 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -145.81 -169.8 3.32 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.429 2.292 . . . . 0.0 109.661 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.59 151.33 50.32 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.816 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.3 mt -139.2 159.39 42.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.231 1.412 . . . . 0.0 112.21 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.98 155.62 23.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -53.98 -25.72 22.27 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.3 ttt -61.84 -20.56 63.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.788 1.635 . . . . 0.0 113.928 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -120.89 17.63 11.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.274 1.43 . . . . 0.0 112.913 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.28 145.53 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.053 2.141 . . . . 0.0 108.929 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 110.781 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.07 152.66 42.92 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 CA--C 1.547 0.856 0 O-C-N 121.499 -0.751 . . . . 0.0 112.397 176.062 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.44 165.15 28.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.313 1.845 . . . . 0.0 111.477 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.61 130.06 45.02 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.859 0.464 . . . . 0.0 110.668 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.48 88.27 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.907 1.241 . . . . 0.0 115.13 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.35 146.04 53.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.758 1.779 . . . . 0.0 112.256 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -95.37 131.12 41.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.044 1.338 . . . . 0.0 110.635 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.64 177.67 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.138 1.775 . . . . 0.0 111.666 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.3 140.33 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.449 1.1 . . . . 0.0 108.434 168.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.39 34.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.555 0.742 . . . . 0.0 111.798 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -77.67 129.12 35.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.903 1.281 . . . . 0.0 109.767 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -93.36 -160.35 0.75 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.551 0.741 . . . . 0.0 111.928 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 t -61.99 -28.5 69.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.167 -0.958 . . . . 0.0 112.222 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -76.87 155.45 32.89 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.043 1.337 . . . . 0.0 112.174 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.04 34.78 0.09 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.887 1.675 . . . . 0.0 114.262 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.46 145.47 40.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.58 1.952 . . . . 0.0 111.488 -172.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.41 148.51 25.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.499 1.119 . . . . 0.0 111.432 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.38 155.45 64.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.995 1.718 . . . . 0.0 111.185 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.62 134.44 32.84 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.023 2.482 . . . . 0.0 111.739 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.88 172.51 15.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.227 1.411 . . . . 0.0 111.933 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -134.1 130.86 38.02 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.537 1.535 . . . . 0.0 110.054 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.14 118.39 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.044 0.938 . . . . 0.0 110.536 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.5 -31.84 15.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.14 1.376 . . . . 0.0 112.474 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.65 160.67 38.27 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.716 1.206 . . . . 0.0 112.523 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.473 0.681 0 C-N-CA 126.017 1.727 . . . . 0.0 108.905 -177.373 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -98.88 134.7 41.38 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 108.982 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.91 140.73 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.34 1.056 . . . . 0.0 111.953 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -99.65 128.46 45.75 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.857 1.263 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.73 165.16 18.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.305 1.042 . . . . 0.0 112.444 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.31 -29.7 34.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.302 1.441 . . . . 0.0 114.266 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.94 -20.03 61.13 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 113.797 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.49 -20.88 31.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.104 1.811 . . . . 0.0 114.278 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 150.14 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.56 1.544 . . . . 0.0 112.457 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.61 126.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.283 1.433 . . . . 0.0 109.896 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -142.83 177.93 8.0 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.168 2.187 . . . . 0.0 110.036 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 29.1 p -121.95 154.05 37.68 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.134 0.974 . . . . 0.0 112.522 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.41 157.22 44.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.621 1.569 . . . . 0.0 112.059 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -72.2 158.59 35.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.087 1.355 . . . . 0.0 111.497 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -52.34 -39.14 60.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.293 1.437 . . . . 0.0 113.657 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.16 2.61 2.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.69 1.996 . . . . 0.0 114.238 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -122.91 13.33 9.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.888 1.675 . . . . 0.0 112.654 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -135.7 141.63 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.873 1.269 . . . . 0.0 110.025 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -138.12 152.28 48.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.509 1.924 . . . . 0.0 110.662 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.27 135.95 55.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.812 0.445 . . . . 0.0 110.416 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.864 172.052 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 121.162 0.506 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -144.46 151.61 39.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.648 1.579 . . . . 0.0 111.458 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.69 58.29 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.042 0.449 . . . . 0.0 110.927 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.13 -18.34 54.24 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 125.287 1.423 . . . . 0.0 114.384 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -72.02 147.28 47.0 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.591 1.196 . . . . 0.0 111.755 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 141.34 28.57 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 122.024 0.916 . . . . 0.0 112.148 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 166.87 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.826 2.05 . . . . 0.0 110.46 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.55 137.75 32.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.869 0.868 . . . . 0.0 109.037 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.31 153.37 38.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.527 -0.733 . . . . 0.0 112.488 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -82.77 148.03 28.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.795 1.238 . . . . 0.0 110.994 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -142.74 -42.51 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -134.55 -29.11 1.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -149.85 -161.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.348 1.459 . . . . 0.0 110.955 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.1 t -67.2 -32.24 73.18 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -63.78 153.27 37.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 0.0 112.582 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -101.27 157.43 16.79 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.263 1.025 . . . . 0.0 110.387 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -138.26 153.0 72.65 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.644 1.577 . . . . 0.0 110.092 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 137.79 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.518 2.145 . . . . 0.0 112.499 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.81 160.25 42.51 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.36 1.464 . . . . 0.0 111.842 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.14 127.79 54.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.553 1.941 . . . . 0.0 109.555 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.74 135.68 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.031 0.532 . . . . 0.0 109.686 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -115.78 -26.33 7.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.656 1.182 . . . . 0.0 113.008 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.0 153.41 30.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 111.377 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.591 1.556 . . . . 0.0 109.064 -174.008 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.6 m -110.29 135.76 50.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.872 0.869 . . . . 0.0 109.354 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.82 151.26 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.19 0.996 . . . . 0.0 112.669 -169.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -121.11 111.36 17.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 109.114 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.16 161.33 30.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.25 0.62 . . . . 0.0 111.806 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -55.15 -26.1 36.38 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.7 -21.88 64.39 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.135 1.374 . . . . 0.0 113.762 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.51 -12.95 36.08 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 126.183 1.849 . . . . 0.0 114.232 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.63 149.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.453 1.501 . . . . 0.0 112.407 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.6 mt -131.83 124.55 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.466 1.506 . . . . 0.0 109.952 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -144.17 -174.93 4.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.171 2.188 . . . . 0.0 109.883 170.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.1 p -125.17 151.35 45.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.723 1.209 . . . . 0.0 111.732 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.6 mt -143.18 152.54 41.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.815 1.646 . . . . 0.0 111.704 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -70.09 151.49 45.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.53 0.732 . . . . 0.0 109.338 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -57.88 -29.59 65.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.881 0.873 . . . . 0.0 113.121 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -59.31 -7.33 1.24 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.504 1.922 . . . . 0.0 114.488 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -115.97 10.72 15.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.079 1.752 . . . . 0.0 112.626 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.4 mt -131.53 143.73 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 109.625 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.16 152.6 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.155 2.182 . . . . 0.0 111.05 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.85 159.19 25.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.294 0.638 . . . . 0.0 111.712 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 CA--C 1.55 0.968 0 C-N-CA 123.706 0.802 . . . . 0.0 112.32 170.437 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.399 0.618 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.01 159.81 43.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.86 1.664 . . . . 0.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.55 37.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.692 0.397 . . . . 0.0 110.989 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.36 -10.72 72.82 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.474 1.511 . . . . 0.0 114.559 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.11 132.04 47.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.133 1.466 . . . . 0.0 111.61 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.65 143.4 33.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.34 169.5 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.855 1.662 . . . . 0.0 111.645 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.3 141.72 45.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.396 1.478 . . . . 0.0 108.325 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.99 151.32 30.16 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.51 -0.744 . . . . 0.0 112.886 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -81.4 113.22 19.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.938 1.295 . . . . 0.0 110.247 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -93.75 -159.7 0.71 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.347 1.059 . . . . 0.0 112.044 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 t -61.14 -12.17 11.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.538 1.135 . . . . 0.0 113.712 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.16 149.7 43.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.423 2.289 . . . . 0.0 110.055 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.34 -17.24 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -169.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.71 155.98 39.1 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.254 0.934 . . . . 0.0 111.682 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -101.52 80.92 2.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.195 1.398 . . . . 0.0 110.25 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -71.62 153.66 93.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.476 1.11 . . . . 0.0 112.085 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.75 137.78 33.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.132 2.555 . . . . 0.0 112.447 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.03 -178.32 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.568 1.547 . . . . 0.0 111.606 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -143.32 154.41 43.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.354 1.462 . . . . 0.0 111.255 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -82.6 133.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.157 0.983 . . . . 0.0 109.743 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -104.38 -30.16 10.27 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.446 1.499 . . . . 0.0 112.794 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.32 154.44 32.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.609 1.164 . . . . 0.0 112.301 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.044 1.738 . . . . 0.0 110.085 -172.47 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.7 m -68.4 135.84 52.38 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.62 150.1 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.694 1.197 . . . . 0.0 111.5 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -126.86 125.58 41.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.129 1.371 . . . . 0.0 110.233 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -87.95 162.29 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.013 0.925 . . . . 0.0 111.672 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -52.39 -29.44 24.18 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.0 -20.15 58.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.41 -22.91 8.2 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.694 1.616 . . . . 0.0 115.472 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.31 148.0 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.109 1.454 . . . . 0.0 113.176 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.5 mt -130.2 127.84 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.214 1.405 . . . . 0.0 110.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -143.7 -169.03 2.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.413 2.285 . . . . 0.0 109.436 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.5 p -127.77 150.81 49.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.413 1.085 . . . . 0.0 112.133 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -141.21 163.09 33.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 111.557 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -89.0 155.89 19.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.138 1.375 . . . . 0.0 110.715 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.99 -28.7 10.5 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.3 ttt -63.94 -12.83 40.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.942 1.697 . . . . 0.0 113.811 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -128.18 13.36 6.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.049 1.74 . . . . 0.0 113.354 -172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.6 mt -131.56 143.58 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.458 1.903 . . . . 0.0 109.148 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -137.21 149.89 47.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.637 1.975 . . . . 0.0 110.521 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 150.14 48.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.304 0.642 . . . . 0.0 111.094 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 123.464 0.706 . . . . 0.0 110.821 179.307 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.344 0.592 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -126.35 152.67 45.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.006 1.722 . . . . 0.0 111.795 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.9 137.85 54.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.173 0.589 . . . . 0.0 111.051 173.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.18 72.33 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.77 1.176 . . . . 0.0 114.886 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.51 142.45 28.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.738 1.269 . . . . 0.0 112.199 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.38 141.13 30.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.175 0.99 . . . . 0.0 111.849 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -146.39 170.16 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.185 1.794 . . . . 0.0 111.061 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.73 133.54 52.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.533 1.133 . . . . 0.0 107.998 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.42 159.04 44.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.4 -0.813 . . . . 0.0 112.526 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 139.61 35.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.211 1.004 . . . . 0.0 111.549 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -135.72 -29.24 1.05 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.2 m -142.41 -56.5 0.44 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.063 0.847 . . . . 0.0 112.19 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -119.28 176.97 5.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.015 1.326 . . . . 0.0 111.814 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.8 m -60.74 -20.74 61.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.44 128.02 33.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.655 1.182 . . . . 0.0 110.508 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -68.37 161.02 28.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.759 168.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.4 156.42 80.15 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.751 1.621 . . . . 0.0 110.37 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.57 135.52 36.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.407 2.071 . . . . 0.0 111.64 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.24 173.87 12.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.846 1.658 . . . . 0.0 111.093 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -144.15 133.12 22.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.6 117.86 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.991 0.917 . . . . 0.0 110.15 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -84.03 -37.28 22.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.087 1.355 . . . . 0.0 112.167 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.45 160.82 38.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.788 1.235 . . . . 0.0 112.347 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 125.799 1.64 . . . . 0.0 109.246 -174.912 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -97.89 126.1 43.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.843 0.857 . . . . 0.0 109.121 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.28 130.81 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.052 0.941 . . . . 0.0 112.449 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.77 140.87 29.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.08 1.352 . . . . 0.0 109.529 169.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.58 168.25 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 111.43 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -58.17 -22.88 53.28 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.53 -13.54 61.05 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.24 -14.12 63.92 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.0 1.762 . . . . 0.0 114.258 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.65 151.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.735 1.614 . . . . 0.0 112.182 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.32 129.93 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.504 1.521 . . . . 0.0 109.993 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -146.45 167.7 23.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.015 1.726 . . . . 0.0 111.515 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 79.0 m -82.65 145.43 29.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.935 0.494 . . . . 0.0 110.346 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 37.3 mt -139.25 157.15 46.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.541 1.536 . . . . 0.0 111.252 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -81.49 155.65 25.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.906 1.282 . . . . 0.0 111.268 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -56.37 -29.3 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.859 1.264 . . . . 0.0 113.365 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 21.9 ttt -59.0 -14.85 10.56 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.707 1.603 . . . . 0.0 114.157 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -130.35 16.19 5.51 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.306 1.842 . . . . 0.0 112.805 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.4 mt -132.43 143.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.676 1.99 . . . . 0.0 108.825 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -136.87 149.2 47.52 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.227 2.211 . . . . 0.0 110.07 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.12 155.83 38.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.172 0.589 . . . . 0.0 111.114 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 CA--C 1.547 0.85 0 O-C-N 121.949 -0.469 . . . . 0.0 111.824 171.251 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 121.498 0.666 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -122.89 128.08 49.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.624 1.57 . . . . 0.0 110.475 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.96 134.54 54.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.148 0.579 . . . . 0.0 111.528 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.23 -7.74 35.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.784 1.659 . . . . 0.0 115.178 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -79.12 146.82 32.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.776 1.288 . . . . 0.0 112.599 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.43 138.92 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.811 1.245 . . . . 0.0 111.807 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.6 174.23 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 127.174 2.19 . . . . 0.0 110.896 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.26 136.45 47.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.182 . . . . 0.0 107.98 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.41 31.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.597 -0.689 . . . . 0.0 112.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -72.97 142.68 47.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -146.72 -44.23 0.18 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 m -136.51 -16.7 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -147.97 -176.24 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.428 1.491 . . . . 0.0 111.228 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 77.3 m -67.89 -24.16 65.19 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.142 -0.974 . . . . 0.0 111.439 166.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -68.31 141.7 55.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.229 1.812 . . . . 0.0 111.953 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.47 163.87 22.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.563 0.745 . . . . 0.0 110.593 168.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -134.79 153.26 78.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.191 1.796 . . . . 0.0 110.669 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.57 135.1 25.56 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.683 2.256 . . . . 0.0 111.825 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.52 177.69 9.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.559 1.543 . . . . 0.0 110.581 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.92 151.71 51.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.133 0.973 . . . . 0.0 110.819 168.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.6 mt -81.14 113.68 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.675 0.79 . . . . 0.0 109.922 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -80.4 -32.83 37.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 112.747 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.77 36.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.064 0.946 . . . . 0.0 113.177 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 126.424 1.89 . . . . 0.0 108.609 -177.06 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.5 m -115.48 136.61 52.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.646 1.178 . . . . 0.0 108.392 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.5 m -135.95 156.15 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.899 . . . . 0.0 112.15 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -125.0 117.29 23.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.274 1.43 . . . . 0.0 109.473 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.71 165.39 22.88 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.119 0.968 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -54.0 -27.03 29.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.872 1.269 . . . . 0.0 114.367 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.94 -21.88 64.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.475 . . . . 0.0 113.863 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.14 56.78 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.668 1.604 . . . . 0.0 114.766 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.51 144.65 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.239 1.416 . . . . 0.0 112.179 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.78 109.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.038 1.335 . . . . 0.0 109.515 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -138.51 175.58 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.978 1.711 . . . . 0.0 111.644 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.56 155.6 18.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.326 1.05 . . . . 0.0 112.199 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.2 mt -144.77 156.91 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.11 156.32 38.8 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.417 1.087 . . . . 0.0 110.732 169.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -57.12 -24.83 56.87 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.05 -12.16 53.42 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.001 1.72 . . . . 0.0 114.126 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -120.86 12.04 11.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.727 1.611 . . . . 0.0 113.109 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -132.67 143.2 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.667 1.587 . . . . 0.0 109.565 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -134.72 147.29 50.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.765 2.026 . . . . 0.0 110.697 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.45 141.63 48.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.929 0.892 . . . . 0.0 110.959 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.663 0.785 . . . . 0.0 110.437 175.056 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 154.81 43.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.864 1.266 . . . . 0.0 112.428 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.52 130.23 43.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.367 0.667 . . . . 0.0 111.547 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.61 -8.71 68.81 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.463 1.506 . . . . 0.0 114.371 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.24 132.52 41.13 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.018 1.409 . . . . 0.0 112.5 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.45 135.65 37.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.425 1.09 . . . . 0.0 111.64 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.35 -176.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.418 2.287 . . . . 0.0 111.009 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -111.39 145.09 39.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.132 0.973 . . . . 0.0 109.247 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 150.43 35.41 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.443 0.64 . . . . 0.0 112.46 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -80.72 154.29 27.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.543 1.537 . . . . 0.0 110.638 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.39 -47.51 0.52 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -142.95 -29.36 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -138.58 -169.51 2.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.095 1.758 . . . . 0.0 110.301 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.0 p -62.17 -15.56 47.06 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.631 -1.293 . . . . 0.0 114.415 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -62.8 145.4 55.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.554 1.541 . . . . 0.0 111.979 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -117.29 154.34 31.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.926 1.29 . . . . 0.0 109.444 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.64 152.8 71.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.677 1.191 . . . . 0.0 111.332 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.78 130.9 24.32 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.783 2.322 . . . . 0.0 110.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.76 12.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.242 1.417 . . . . 0.0 110.859 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -132.71 132.18 42.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.293 1.437 . . . . 0.0 109.458 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -71.45 121.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.111 0.564 . . . . 0.0 109.623 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -95.23 -32.25 13.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 112.343 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.99 40.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.841 1.257 . . . . 0.0 112.143 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt . . . . . 0 N--CA 1.474 0.749 0 C-N-CA 125.199 1.399 . . . . 0.0 109.084 -172.436 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.4 m -131.27 134.37 46.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.883 1.273 . . . . 0.0 108.727 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 150.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.407 1.083 . . . . 0.0 111.71 -175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -118.29 134.15 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.581 1.552 . . . . 0.0 109.651 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -93.28 167.55 11.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.443 1.097 . . . . 0.0 112.156 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -53.7 -28.74 35.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.602 1.561 . . . . 0.0 114.463 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.42 -18.93 61.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.11 1.364 . . . . 0.0 113.797 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.92 -15.9 47.53 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.886 1.708 . . . . 0.0 114.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.34 146.12 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.393 1.477 . . . . 0.0 112.347 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 132.02 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.788 1.635 . . . . 0.0 109.986 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -143.71 168.73 19.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.948 1.699 . . . . 0.0 111.461 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.64 149.96 27.46 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.289 1.036 . . . . 0.0 111.712 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 mt -148.11 158.65 44.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.348 1.459 . . . . 0.0 112.458 -171.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -76.35 159.79 30.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.752 0.821 . . . . 0.0 109.534 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -56.58 -35.01 67.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.055 0.942 . . . . 0.0 112.472 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.8 mtt -64.52 -1.17 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 0.0 114.729 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -120.42 7.59 10.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.733 1.613 . . . . 0.0 113.193 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.5 mt -130.27 139.66 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.989 1.716 . . . . 0.0 108.822 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -136.72 147.09 46.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.468 1.507 . . . . 0.0 110.669 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 135.11 55.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.857 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.786 173.752 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.588 0.708 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 162.68 40.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.332 1.853 . . . . 0.0 110.491 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.22 123.83 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.992 -0.443 . . . . 0.0 111.453 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.4 -7.16 78.1 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.289 1.423 . . . . 0.0 114.877 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.92 135.52 56.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.27 1.535 . . . . 0.0 111.619 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.12 138.81 31.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.777 0.831 . . . . 0.0 112.092 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.34 167.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.071 1.748 . . . . 0.0 111.03 -171.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.08 148.45 22.34 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.3 144.16 28.6 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.439 0.696 . . . . 0.0 111.571 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -72.62 152.84 41.54 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.149 0.98 . . . . 0.0 110.015 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -131.67 -160.28 1.03 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 112.152 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 m -55.24 -36.56 66.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.155 0.982 . . . . 0.0 111.382 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -84.07 139.59 32.38 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.021 1.329 . . . . 0.0 109.747 168.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.41 -21.46 65.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 158.51 24.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.008 1.276 . . . . 0.0 112.199 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.84 149.09 23.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.688 0.795 . . . . 0.0 110.263 168.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.65 152.77 69.3 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.257 1.423 . . . . 0.0 111.29 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 136.56 29.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.999 2.466 . . . . 0.0 112.141 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.13 13.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.736 1.615 . . . . 0.0 111.221 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -128.82 141.15 51.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 110.862 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.02 124.98 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.155 0.982 . . . . 0.0 109.58 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -95.57 -30.51 13.77 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.885 0.874 . . . . 0.0 112.894 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.76 153.22 32.74 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.6 mt . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 127.645 2.378 . . . . 0.0 108.467 -171.385 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.3 m -122.06 133.33 54.79 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.204 -0.935 . . . . 0.0 109.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.94 157.07 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -128.41 128.6 44.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.154 1.382 . . . . 0.0 110.145 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -81.74 162.63 22.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 112.485 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -52.96 -31.74 42.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.339 1.456 . . . . 0.0 114.814 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.35 -17.33 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.53 -21.17 8.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.277 1.418 . . . . 0.0 115.449 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.42 146.83 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.289 1.544 . . . . 0.0 112.857 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.78 128.87 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 109.215 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -143.95 175.07 10.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.173 1.789 . . . . 0.0 110.922 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.7 m -113.68 141.73 46.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 110.523 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -144.07 146.44 32.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.404 1.882 . . . . 0.0 109.731 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.4 160.86 30.45 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.409 -0.807 . . . . 0.0 110.978 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.95 8.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.804 1.242 . . . . 0.0 113.916 168.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.67 -12.54 34.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.541 1.936 . . . . 0.0 113.892 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.41 9.51 6.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.3 1.84 . . . . 0.0 113.157 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -126.25 143.42 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.15 2.18 . . . . 0.0 108.18 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -135.31 148.69 49.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.55 1.54 . . . . 0.0 110.854 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.51 145.47 48.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.703 0.801 . . . . 0.0 111.028 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 118.814 -0.612 . . . . 0.0 110.857 -178.333 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.127 0.489 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -119.17 128.02 53.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.982 1.713 . . . . 0.0 109.911 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 133.76 52.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.146 0.578 . . . . 0.0 111.34 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.07 75.34 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.884 1.23 . . . . 0.0 115.061 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.47 154.09 20.3 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.908 1.354 . . . . 0.0 112.411 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.36 142.55 27.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.175 0.99 . . . . 0.0 112.533 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.24 174.79 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.911 2.084 . . . . 0.0 110.86 -170.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.0 124.99 52.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.724 1.21 . . . . 0.0 109.32 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.14 154.84 44.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -88.66 147.1 24.7 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.043 1.337 . . . . 0.0 111.674 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -143.73 -30.53 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -139.11 -28.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -169.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.55 -167.81 2.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.027 1.731 . . . . 0.0 110.064 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.7 m -66.73 -13.89 61.9 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.836 -1.165 . . . . 0.0 113.727 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -69.18 166.55 18.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.189 1.796 . . . . 0.0 113.378 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -129.13 152.01 49.19 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.883 1.673 . . . . 0.0 109.991 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -139.12 156.01 72.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.48 1.512 . . . . 0.0 110.738 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.41 132.08 28.25 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.428 2.085 . . . . 0.0 111.881 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.86 172.02 13.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.798 1.639 . . . . 0.0 110.59 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -128.75 129.26 45.48 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.211 1.804 . . . . 0.0 109.605 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.62 120.94 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.367 0.667 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.29 -27.37 15.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.879 0.872 . . . . 0.0 112.69 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.69 156.44 29.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.235 1.414 . . . . 0.0 111.603 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.473 0.684 0 C-N-CA 125.736 1.615 . . . . 0.0 108.936 -174.158 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -80.72 132.23 35.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.69 0.796 . . . . 0.0 110.403 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.17 146.21 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.056 1.342 . . . . 0.0 112.438 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.14 119.61 29.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.317 1.847 . . . . 0.0 109.223 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -89.67 165.58 14.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.121 0.968 . . . . 0.0 111.005 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -58.94 -18.8 36.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -69.09 -15.72 63.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.74 1.216 . . . . 0.0 113.928 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.95 -15.49 61.57 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.248 1.88 . . . . 0.0 114.321 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.26 146.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.84 1.656 . . . . 0.0 112.231 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 126.42 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 110.125 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -140.71 -162.57 1.38 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.945 2.098 . . . . 0.0 109.236 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.53 151.93 47.78 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.164 -0.96 . . . . 0.0 112.138 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -139.13 158.12 44.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.54 1.536 . . . . 0.0 111.904 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.13 158.01 36.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.65 1.18 . . . . 0.0 110.756 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.68 -17.86 57.25 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.97 -12.24 61.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.14 1.376 . . . . 0.0 113.427 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -127.03 9.88 6.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.982 1.713 . . . . 0.0 113.321 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.66 136.83 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.55 1.94 . . . . 0.0 108.243 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -134.48 148.74 50.62 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.175 1.79 . . . . 0.0 110.281 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.3 138.24 58.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.228 0.611 . . . . 0.0 110.549 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.7 ttm . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.12 175.513 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.63 160.18 39.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.58 57.78 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.728 -0.607 . . . . 0.0 112.109 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 81.58 -11.57 45.04 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.92 1.724 . . . . 0.0 114.85 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.23 131.15 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.241 1.416 . . . . 0.0 112.701 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.21 140.18 40.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.557 1.143 . . . . 0.0 112.449 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.84 171.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.685 1.994 . . . . 0.0 111.322 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.42 139.32 38.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.6 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -87.02 150.14 24.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.122 1.369 . . . . 0.0 111.312 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -143.83 -44.46 0.27 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 -5.15 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.55 177.01 11.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.29 1.436 . . . . 0.0 111.082 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 -30.09 68.4 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.076 -1.015 . . . . 0.0 112.863 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -56.71 156.78 6.01 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.843 1.657 . . . . 0.0 113.275 172.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -119.23 155.23 32.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.255 1.422 . . . . 0.0 109.596 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -136.5 155.51 76.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.693 1.197 . . . . 0.0 111.28 -170.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.03 132.33 27.79 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.778 2.319 . . . . 0.0 111.916 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.02 179.35 8.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.19 1.796 . . . . 0.0 110.349 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -141.86 151.8 43.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.105 0.962 . . . . 0.0 112.223 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 72.9 mt -75.06 122.52 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.564 1.146 . . . . 0.0 110.093 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -93.67 -31.53 14.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.404 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.69 156.28 34.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.256 1.022 . . . . 0.0 112.937 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 126.563 1.945 . . . . 0.0 108.345 -177.814 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.368 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.0 m -126.21 137.89 53.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.299 1.04 . . . . 0.0 109.123 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.65 152.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.624 1.169 . . . . 0.0 111.926 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.82 130.23 53.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.687 1.595 . . . . 0.0 109.794 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.1 169.67 9.95 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.759 1.223 . . . . 0.0 112.206 -176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -57.3 -24.22 53.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.44 -12.82 60.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.554 1.141 . . . . 0.0 113.95 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.26 -14.15 65.64 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.898 1.713 . . . . 0.0 114.493 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.42 148.28 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.503 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.97 130.63 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.914 1.686 . . . . 0.0 110.267 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -146.43 163.25 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.754 1.622 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.13 145.13 30.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.5 0.72 . . . . 0.0 110.705 168.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.14 144.8 30.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.106 1.362 . . . . 0.0 110.835 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -69.52 158.85 34.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.349 0.66 . . . . 0.0 111.337 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -57.08 -21.57 32.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.13 -12.88 58.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.608 1.563 . . . . 0.0 113.889 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -127.11 11.52 7.04 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.954 1.702 . . . . 0.0 113.354 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.58 139.54 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.593 1.957 . . . . 0.0 108.484 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.09 145.79 44.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.033 1.733 . . . . 0.0 110.883 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.44 149.26 50.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.163 0.585 . . . . 0.0 110.758 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 CA--C 1.546 0.789 0 C-N-CA 123.092 0.557 . . . . 0.0 112.332 174.117 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -138.46 157.43 46.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.738 2.015 . . . . 0.0 111.249 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.75 136.38 58.05 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.927 -0.483 . . . . 0.0 111.326 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.14 -1.34 87.22 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.645 1.117 . . . . 0.0 114.988 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.97 142.2 52.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.359 1.58 . . . . 0.0 111.877 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.17 145.32 24.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.924 0.89 . . . . 0.0 111.714 177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -148.41 162.28 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.558 1.543 . . . . 0.0 112.022 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.05 118.25 36.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.876 1.671 . . . . 0.0 107.245 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.9 48.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.219 0.608 . . . . 0.0 112.142 -172.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -74.71 150.21 39.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.992 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -134.05 -40.39 0.84 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.3 m -159.36 -51.0 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.401 1.081 . . . . 0.0 111.282 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -74.95 170.59 15.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 0.0 112.039 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.7 m -73.38 43.54 0.14 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.234 1.814 . . . . 0.0 112.56 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -140.75 162.44 35.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 110.77 -171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.428 ' CD2' ' HE2' ' A' ' 134' ' ' LYS . 53.2 m-85 -124.0 145.73 49.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.967 1.307 . . . . 0.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.85 154.31 77.75 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.117 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.68 131.27 25.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 0.0 112.016 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.69 174.6 12.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.189 1.796 . . . . 0.0 110.904 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.4 133.81 33.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.313 1.445 . . . . 0.0 110.686 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.26 120.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.166 0.986 . . . . 0.0 110.582 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.14 -30.01 14.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.416 1.486 . . . . 0.0 112.488 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.64 161.93 39.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.528 1.131 . . . . 0.0 112.803 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 109.733 -171.321 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.3 m -125.19 133.15 52.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 108.635 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.45 133.3 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.134 0.974 . . . . 0.0 111.978 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -93.12 125.19 37.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.887 1.275 . . . . 0.0 109.5 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.66 165.63 14.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.912 0.885 . . . . 0.0 111.561 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -54.5 -26.92 34.37 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.61 -20.11 62.03 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.023 1.329 . . . . 0.0 113.778 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.51 -17.14 40.2 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.169 1.842 . . . . 0.0 114.075 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.63 150.39 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.778 1.631 . . . . 0.0 112.226 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.1 mt -133.66 127.48 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 109.819 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -143.86 175.83 9.71 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.233 1.813 . . . . 0.0 110.853 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.5 m -107.4 146.03 32.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.503 1.121 . . . . 0.0 111.738 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.9 mt -147.42 152.97 39.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.093 1.757 . . . . 0.0 111.415 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.96 158.99 27.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.97 0.908 . . . . 0.0 110.872 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -57.91 -26.1 61.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.911 1.284 . . . . 0.0 113.661 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.9 ttm -54.78 -18.88 5.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.352 1.861 . . . . 0.0 114.116 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -123.75 13.17 9.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.9 1.68 . . . . 0.0 113.127 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -134.59 136.62 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.493 1.917 . . . . 0.0 109.093 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE2' ' CD2' ' A' ' 102' ' ' TYR . 55.4 mtmt -132.87 150.41 52.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.918 1.687 . . . . 0.0 110.376 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.95 152.85 35.47 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.288 0.635 . . . . 0.0 111.789 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 CA--C 1.547 0.832 0 C-N-CA 123.54 0.736 . . . . 0.0 110.461 174.628 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -140.33 160.1 40.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.884 1.674 . . . . 0.0 111.956 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.2 58.85 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.854 -0.529 . . . . 0.0 111.775 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.32 -12.81 49.15 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.786 1.66 . . . . 0.0 114.885 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.0 138.47 44.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.658 1.183 . . . . 0.0 112.277 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.52 141.79 34.81 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.461 1.104 . . . . 0.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 m -151.88 168.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.372 1.869 . . . . 0.0 111.023 -171.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.03 129.84 44.87 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.09 133.41 41.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 111.187 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -67.77 161.21 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.868 1.267 . . . . 0.0 110.994 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -135.56 -163.79 1.44 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.454 1.102 . . . . 0.0 111.238 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -29.91 70.76 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.49 -0.757 . . . . 0.0 112.602 171.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.03 154.48 28.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.558 1.143 . . . . 0.0 112.005 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.57 33.8 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.165 1.786 . . . . 0.0 115.579 -176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -137.69 157.22 46.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.472 1.909 . . . . 0.0 111.77 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.3 148.58 24.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.033 1.333 . . . . 0.0 110.215 170.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -140.04 154.32 70.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.82 1.648 . . . . 0.0 111.222 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.85 129.45 20.9 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.538 2.159 . . . . 0.0 111.358 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.86 175.29 11.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.7 1.6 . . . . 0.0 111.247 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.11 136.85 47.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.09 1.356 . . . . 0.0 110.654 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.37 140.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.692 0.797 . . . . 0.0 109.534 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -116.6 -27.99 6.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.539 1.136 . . . . 0.0 113.173 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.09 155.34 33.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.65 1.18 . . . . 0.0 111.286 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 125.661 1.584 . . . . 0.0 108.592 -170.749 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -87.74 135.42 33.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.657 0.783 . . . . 0.0 109.056 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.63 156.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.583 1.153 . . . . 0.0 112.156 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -124.5 131.01 53.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.22 1.408 . . . . 0.0 109.795 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.56 167.59 12.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 111.676 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -59.07 -23.38 62.0 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -72.33 -14.01 61.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.655 1.182 . . . . 0.0 113.87 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.62 -15.65 62.76 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.677 1.608 . . . . 0.0 114.329 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.54 146.46 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.446 1.498 . . . . 0.0 112.477 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.84 128.07 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.769 1.628 . . . . 0.0 109.387 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -144.96 178.18 8.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.635 1.974 . . . . 0.0 110.508 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 p -122.76 152.37 40.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -139.72 165.36 27.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.55 1.94 . . . . 0.0 110.937 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -79.8 159.03 26.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.572 0.749 . . . . 0.0 110.68 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -55.94 -29.33 59.97 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -70.97 -21.01 62.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.421 1.088 . . . . 0.0 113.638 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -86.08 4.63 37.32 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.72 1.208 . . . . 0.0 113.578 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.5 mt -131.93 140.34 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.372 1.069 . . . . 0.0 110.522 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -137.71 153.11 49.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.974 2.11 . . . . 0.0 110.817 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.92 165.63 22.92 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.08 0.552 . . . . 0.0 111.236 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.841 0 C-N-CA 123.185 0.594 . . . . 0.0 111.941 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 121.517 0.675 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -133.18 160.04 38.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.376 1.871 . . . . 0.0 111.488 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.05 129.0 38.82 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.773 -0.58 . . . . 0.0 110.062 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.07 83.67 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.55 -1.139 . . . . 0.0 115.365 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.04 140.13 58.84 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.041 1.921 . . . . 0.0 111.155 172.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.85 121.0 39.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.526 1.13 . . . . 0.0 109.028 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.09 174.59 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.46 . . . . 0.0 112.181 -166.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -107.09 141.48 38.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.521 1.128 . . . . 0.0 108.967 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.66 156.03 35.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -71.74 151.82 43.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.068 1.347 . . . . 0.0 111.04 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -132.99 -38.89 0.96 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 t -157.6 -32.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.71 -176.87 3.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.52 1.528 . . . . 0.0 112.612 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.3 t -73.22 39.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.103 1.761 . . . . 0.0 114.49 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.22 165.86 25.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.416 2.286 . . . . 0.0 111.021 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.48 153.57 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.417 1.087 . . . . 0.0 110.269 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -137.39 154.14 75.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 110.796 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.3 136.47 40.33 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.852 2.368 . . . . 0.0 112.523 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.09 174.69 12.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 111.467 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -134.68 135.46 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.377 1.471 . . . . 0.0 109.933 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.8 mt -74.26 120.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 0.0 109.956 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -84.38 -36.86 22.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.857 1.263 . . . . 0.0 112.314 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.78 160.32 36.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.768 1.227 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 125.674 1.589 . . . . 0.0 109.7 -175.855 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 m -74.59 134.69 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.507 -0.745 . . . . 0.0 109.425 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.44 141.14 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.69 1.196 . . . . 0.0 111.825 -170.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -115.82 125.22 52.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.403 1.481 . . . . 0.0 109.278 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.91 167.33 11.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.002 0.921 . . . . 0.0 111.875 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -52.76 -28.76 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.96 -18.71 61.98 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.833 1.253 . . . . 0.0 113.693 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.07 -16.95 38.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.3 1.905 . . . . 0.0 113.995 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.82 147.5 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.088 1.755 . . . . 0.0 112.659 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.46 130.34 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.629 1.572 . . . . 0.0 110.391 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -142.66 -163.59 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.287 2.235 . . . . 0.0 109.56 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.3 p -140.35 156.97 46.23 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.202 -0.936 . . . . 0.0 112.647 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -145.04 171.62 14.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.292 1.837 . . . . 0.0 111.776 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.09 158.3 16.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.139 1.376 . . . . 0.0 109.461 168.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -53.19 -28.88 28.85 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -65.31 -14.44 60.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.215 1.406 . . . . 0.0 114.217 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -108.9 9.14 26.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.465 1.506 . . . . 0.0 112.985 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.38 145.38 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.105 1.762 . . . . 0.0 109.694 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -139.7 151.23 45.72 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.242 2.217 . . . . 0.0 111.0 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.54 162.8 26.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.575 0.75 . . . . 0.0 111.63 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 CA--C 1.549 0.938 0 C-N-CA 123.188 0.595 . . . . 0.0 112.429 171.815 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 m 47.78 26.9 0.98 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.983 2.113 . . . . 0.0 116.358 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 p -148.58 10.37 0.84 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -171.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.58 -178.37 53.76 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.587 1.089 . . . . 0.0 114.68 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 m -155.9 30.25 0.36 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.674 1.59 . . . . 0.0 112.049 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 p -61.15 -25.06 66.75 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.38 158.38 15.25 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.612 1.101 . . . . 0.0 113.577 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.22 8.65 0.48 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.229 1.412 . . . . 0.0 113.398 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.81 117.09 10.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.88 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.86 134.23 47.39 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.857 2.063 . . . . 0.0 109.37 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -155.54 158.12 37.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.596 1.558 . . . . 0.0 111.419 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.81 127.53 32.67 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.952 -0.468 . . . . 0.0 110.887 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.66 -11.64 64.67 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.667 1.603 . . . . 0.0 114.68 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.11 134.72 51.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.3 1.55 . . . . 0.0 111.902 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.51 138.05 37.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.329 0.652 . . . . 0.0 111.003 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.1 m -146.29 176.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.193 1.797 . . . . 0.0 111.22 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.1 mt -112.87 144.94 41.57 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.05 1.34 . . . . 0.0 108.475 168.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.17 146.5 31.79 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.239 0.543 . . . . 0.0 111.673 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -74.15 140.43 45.18 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 109.438 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -121.71 -162.98 1.02 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.347 1.059 . . . . 0.0 111.472 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.9 m -55.25 -35.14 64.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.365 -0.834 . . . . 0.0 111.197 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.61 135.46 33.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.398 1.479 . . . . 0.0 109.35 167.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.2 m -65.32 -21.4 66.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -63.6 145.56 55.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.207 1.003 . . . . 0.0 111.557 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -79.46 151.78 30.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.099 0.56 . . . . 0.0 110.848 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.64 154.23 65.99 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.043 1.337 . . . . 0.0 111.648 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 130.43 23.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.04 2.493 . . . . 0.0 111.355 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.89 -179.65 6.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.983 1.713 . . . . 0.0 110.539 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -143.3 152.82 42.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.48 1.112 . . . . 0.0 111.486 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -75.54 128.96 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.409 1.083 . . . . 0.0 109.606 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -98.54 -33.59 10.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.55 1.14 . . . . 0.0 112.185 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.43 35.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.799 1.24 . . . . 0.0 112.194 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -131.98 127.74 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.615 1.566 . . . . 0.0 109.128 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.75 5.31 0.06 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.4 2.28 . . . . 0.0 116.555 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.92 -26.57 66.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.206 1.802 . . . . 0.0 113.785 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.02 43.02 1.94 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.965 1.706 . . . . 0.0 110.36 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.58 17.06 47.3 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.274 1.416 . . . . 0.0 114.812 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.2 p -149.34 171.22 16.88 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.282 2.233 . . . . 0.0 110.913 -168.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -102.64 108.03 19.16 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.906 1.682 . . . . 0.0 108.788 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -76.25 133.63 40.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.03 152.49 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.848 1.259 . . . . 0.0 111.633 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -122.99 134.34 54.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.362 1.465 . . . . 0.0 110.313 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.11 164.52 13.23 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.0 111.62 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -55.49 -27.44 48.49 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 114.371 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.29 -22.31 63.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.157 1.383 . . . . 0.0 113.712 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.5 28.36 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.987 1.756 . . . . 0.0 113.937 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.97 145.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.411 1.485 . . . . 0.0 112.585 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.5 mt -128.56 130.47 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.603 1.561 . . . . 0.0 109.481 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -142.14 173.83 11.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.216 1.807 . . . . 0.0 111.063 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -120.57 139.1 53.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.971 1.309 . . . . 0.0 110.363 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.7 mt -140.81 167.45 22.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.449 1.5 . . . . 0.0 111.659 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.61 156.55 19.44 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.173 0.989 . . . . 0.0 110.114 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -28.8 13.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 96.7 mtp -67.05 -10.43 49.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.362 1.465 . . . . 0.0 113.88 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -117.54 8.82 13.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.381 1.472 . . . . 0.0 113.572 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.7 mt -128.43 144.64 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.15 1.78 . . . . 0.0 109.215 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -138.92 150.32 45.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 0.0 111.063 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.38 132.16 45.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.3 ptp -69.53 152.98 96.13 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.784 -0.572 . . . . 0.0 111.779 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.64 164.03 36.78 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.519 2.813 . . . . 0.0 111.743 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -57.71 -33.04 68.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.34 -0.85 . . . . 0.0 112.184 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.82 -22.39 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.111 1.364 . . . . 0.0 114.112 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.77 -1.74 57.52 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.562 1.145 . . . . 0.0 113.656 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -131.24 -40.37 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.378 1.471 . . . . 0.0 112.782 -174.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.3 179.0 51.7 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.332 1.444 . . . . 0.0 114.627 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 51.39 29.64 5.38 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.15 1.78 . . . . 0.0 114.667 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.36 173.07 9.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.476 1.51 . . . . 0.0 113.621 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.95 18.24 5.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.603 1.561 . . . . 0.0 113.423 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.3 mm -59.61 125.97 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.527 1.131 . . . . 0.0 109.726 174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 54.96 31.41 15.92 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.213 1.805 . . . . 0.0 115.126 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.82 35.59 4.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.138 1.775 . . . . 0.0 111.767 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.9 m -57.87 152.8 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.201 1.4 . . . . 0.0 113.266 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.98 167.11 14.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.799 1.239 . . . . 0.0 113.464 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.409 1.884 . . . . 0.0 111.749 176.76 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.446 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.6 m -61.28 151.4 31.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.696 1.198 . . . . 0.0 113.37 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m -70.04 -15.89 63.07 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.98 13.77 72.82 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.579 1.085 . . . . 0.0 114.668 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.1 p -71.11 167.61 18.93 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.366 1.867 . . . . 0.0 113.872 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -147.56 166.61 26.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.907 1.683 . . . . 0.0 110.922 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.55 32.24 59.82 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 123.787 0.708 . . . . 0.0 113.88 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -78.14 117.33 19.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.573 1.149 . . . . 0.0 112.515 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -157.72 157.37 33.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 111.488 170.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -72.73 153.3 41.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.396 1.078 . . . . 0.0 113.117 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -138.0 148.07 44.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 113.166 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.24 132.59 54.48 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.57 -0.706 . . . . 0.0 111.723 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.77 6.15 66.32 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.73 141.47 48.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.185 1.492 . . . . 0.0 111.839 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 132.27 38.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.005 0.922 . . . . 0.0 111.669 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.16 175.62 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.506 1.522 . . . . 0.0 111.918 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.3 151.63 35.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.406 1.483 . . . . 0.0 108.971 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.67 154.82 36.06 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.207 -0.933 . . . . 0.0 112.255 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -72.01 156.85 38.78 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.022 1.329 . . . . 0.0 110.236 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -136.91 -150.09 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.53 0.732 . . . . 0.0 112.274 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.2 p -62.54 -3.0 1.23 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.792 1.637 . . . . 0.0 114.735 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -129.24 161.76 29.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.811 2.045 . . . . 0.0 110.543 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.6 -21.69 66.78 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.33 147.05 53.87 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.315 1.446 . . . . 0.0 112.259 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -86.55 152.76 22.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.111 0.564 . . . . 0.0 109.622 167.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -139.76 152.15 67.6 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.462 1.105 . . . . 0.0 111.805 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.61 137.33 38.72 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.302 2.668 . . . . 0.0 112.319 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.81 176.83 10.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.274 1.43 . . . . 0.0 111.715 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -135.25 139.94 44.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.954 1.702 . . . . 0.0 109.578 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.0 mm -61.49 134.78 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.501 0.721 . . . . 0.0 110.251 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -106.75 -29.99 9.22 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.214 1.806 . . . . 0.0 112.106 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 148.18 27.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.989 0.916 . . . . 0.0 113.154 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm -120.44 147.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 127.709 2.404 . . . . 0.0 108.246 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.0 m120 51.41 40.84 27.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.905 1.282 . . . . 0.0 113.533 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -60.41 166.27 3.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.615 1.166 . . . . 0.0 109.804 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -44.47 -31.43 1.09 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -167.92 34.59 0.2 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.977 1.275 . . . . 0.0 112.949 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.7 t -162.36 -169.19 2.06 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.746 1.218 . . . . 0.0 112.975 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -130.08 143.46 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.177 2.591 . . . . 0.0 108.15 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.4 m -111.93 140.17 46.82 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.736 -0.602 . . . . 0.0 109.561 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.67 151.77 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.763 1.225 . . . . 0.0 112.207 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -112.72 124.07 51.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.84 1.656 . . . . 0.0 108.87 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.72 163.58 27.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.561 0.745 . . . . 0.0 112.24 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -54.17 -29.75 46.84 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.652 1.181 . . . . 0.0 114.008 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.72 -21.09 62.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.478 1.511 . . . . 0.0 113.794 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -17.25 37.02 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.844 1.688 . . . . 0.0 114.419 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.28 148.96 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.982 1.313 . . . . 0.0 112.218 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -128.85 129.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.606 1.562 . . . . 0.0 109.834 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -145.63 177.37 8.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.038 2.135 . . . . 0.0 110.142 173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 28.0 p -125.52 148.16 48.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.366 1.066 . . . . 0.0 111.754 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.82 144.03 27.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 111.414 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.94 151.3 47.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.989 0.916 . . . . 0.0 111.076 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.53 12.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.9 tpp -66.59 -12.44 57.9 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.782 1.633 . . . . 0.0 113.744 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.0 15.0 15.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.713 1.605 . . . . 0.0 112.418 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.7 mt -127.64 151.36 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 127.013 2.125 . . . . 0.0 109.866 -171.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -140.18 155.23 47.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.702 2.001 . . . . 0.0 111.497 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.43 24.2 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 0.0 111.657 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.8 tpp -66.79 120.56 72.24 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.921 0.888 . . . . 0.0 110.592 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.85 162.62 40.63 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.671 2.247 . . . . 0.0 113.016 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -57.0 113.67 1.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.001 . . . . 0.0 112.137 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.37 51.45 16.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.623 1.969 . . . . 0.0 112.87 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -44.77 121.47 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.257 1.823 . . . . 0.0 114.389 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -65.03 -9.64 23.61 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.66 46.35 0.89 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.325 1.916 . . . . 0.0 114.591 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 52.85 40.31 30.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.768 2.027 . . . . 0.0 114.338 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.71 122.51 18.69 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.939 -1.101 . . . . 0.0 112.401 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -132.96 6.41 3.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.052 1.741 . . . . 0.0 111.728 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.86 -36.63 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.163 1.385 . . . . 0.0 112.037 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.71 -3.86 48.53 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.76 142.06 30.09 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.441 1.096 . . . . 0.0 112.126 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.3 159.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.715 1.606 . . . . 0.0 111.008 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -55.75 135.23 51.74 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.124 1.37 . . . . 0.0 111.759 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.694 1.598 . . . . 0.0 113.514 177.843 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.0 p -76.12 7.03 4.53 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.883 1.673 . . . . 0.0 115.511 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.6 t -60.58 -18.12 50.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.701 1.6 . . . . 0.0 114.558 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.6 178.05 28.28 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.775 1.655 . . . . 0.0 112.633 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -61.16 -28.97 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.6 t 48.26 31.96 2.9 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.696 1.998 . . . . 0.0 115.75 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.27 29.69 0.23 Allowed Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.422 -0.799 . . . . 0.0 114.992 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -68.17 141.7 55.93 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.794 0.838 . . . . 0.0 111.595 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.05 142.22 24.08 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 111.577 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.17 158.78 30.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.927 0.891 . . . . 0.0 111.698 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.99 155.81 23.77 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.196 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.74 135.81 41.77 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.84 77.6 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.653 1.12 . . . . 0.0 114.88 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -65.65 131.93 47.56 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.119 1.46 . . . . 0.0 111.782 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.22 130.06 37.63 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.285 0.564 . . . . 0.0 110.159 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.61 177.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.229 1.812 . . . . 0.0 111.31 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.5 mt -114.26 133.8 55.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.387 1.475 . . . . 0.0 109.766 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.98 155.91 42.07 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -75.76 148.35 38.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.028 1.331 . . . . 0.0 111.555 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -144.92 -36.13 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -139.22 -28.67 0.78 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -148.81 178.41 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.768 1.627 . . . . 0.0 110.787 -169.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.5 m -61.53 -17.55 55.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -73.05 114.24 10.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 110.477 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -72.33 152.27 42.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.301 0.641 . . . . 0.0 110.092 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -129.97 156.2 79.46 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.909 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 139.29 37.26 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.603 2.202 . . . . 0.0 113.029 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.47 172.58 14.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.702 1.601 . . . . 0.0 111.404 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -119.92 141.48 49.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.852 1.661 . . . . 0.0 110.088 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -80.16 110.3 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.658 0.783 . . . . 0.0 109.833 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -83.03 -31.35 27.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.447 1.099 . . . . 0.0 113.106 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.16 163.97 37.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.929 1.292 . . . . 0.0 112.14 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.09 143.84 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.781 1.632 . . . . 0.0 109.676 -171.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -135.42 134.63 39.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.472 1.509 . . . . 0.0 111.504 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -29.62 89.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 130.497 3.519 . . . . 0.0 115.211 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 38.39 40.33 0.35 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.872 2.469 . . . . 0.0 115.36 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.2 -30.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 117.094 1.597 . . . . 0.0 117.094 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.47 156.41 39.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.919 1.859 . . . . 0.0 112.753 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -143.48 127.36 17.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.455 1.502 . . . . 0.0 109.322 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.8 m -82.47 134.68 35.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.44 144.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.117 0.967 . . . . 0.0 112.257 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.36 110.19 16.66 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.598 1.559 . . . . 0.0 109.62 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 164.17 26.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.046 0.938 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -54.21 -26.34 27.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.73 -22.08 64.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.358 . . . . 0.0 113.874 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.76 -15.61 44.7 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.005 1.764 . . . . 0.0 114.083 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.43 148.23 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.655 1.582 . . . . 0.0 112.274 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.3 mt -129.92 127.59 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.147 1.379 . . . . 0.0 110.003 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -143.29 -171.05 3.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.276 2.231 . . . . 0.0 109.307 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.77 151.2 50.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.005 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.5 mt -142.15 160.22 40.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.11 1.764 . . . . 0.0 110.882 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -87.58 161.6 17.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 111.246 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.6 ptt85 -55.42 -20.9 13.62 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 169.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.87 -13.37 44.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.828 1.251 . . . . 0.0 113.97 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -128.28 10.9 6.35 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.376 1.47 . . . . 0.0 113.633 -171.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.26 140.3 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.494 1.518 . . . . 0.0 110.039 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -141.18 152.79 44.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.172 1.789 . . . . 0.0 110.927 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.05 139.98 58.23 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.706 -0.621 . . . . 0.0 109.861 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.13 153.81 93.88 Favored Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 121.716 -0.615 . . . . 0.0 111.553 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 165.08 31.89 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.204 2.602 . . . . 0.0 113.325 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.62 110.46 0.71 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.396 1.878 . . . . 0.0 111.088 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 53.1 56.11 7.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.335 1.854 . . . . 0.0 112.992 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.28 153.86 0.95 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.831 1.652 . . . . 0.0 114.401 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -61.8 -35.52 78.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.053 1.341 . . . . 0.0 113.913 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -67.91 159.57 50.94 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.049 0.833 . . . . 0.0 113.9 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.405 ' NE2' ' HE1' ' A' ' 145' ' ' TRP . 13.7 mm100 -63.4 141.02 58.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.842 0.857 . . . . 0.0 111.471 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -148.95 36.47 0.77 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 113.795 -168.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.405 ' HE1' ' NE2' ' A' ' 143' ' ' GLN . 85.0 m95 -69.23 46.67 0.06 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.279 2.232 . . . . 0.0 115.557 -175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.34 155.07 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.94 2.096 . . . . 0.0 111.018 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 50.99 23.2 1.4 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 57.1 mt -79.9 32.39 0.26 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.804 1.641 . . . . 0.0 113.534 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.0 136.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.958 1.703 . . . . 0.0 109.625 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -57.61 136.28 56.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.282 1.433 . . . . 0.0 111.993 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.28 1.832 . . . . 0.0 114.429 -176.417 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -73.6 -27.32 61.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -70.96 153.72 42.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.345 1.058 . . . . 0.0 111.905 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.21 144.59 43.1 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.636 0.636 . . . . 0.0 113.646 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.5 p -58.86 129.99 44.82 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.0 0.92 . . . . 0.0 111.568 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.9 m -132.63 -10.14 3.16 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.91 33.77 60.71 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.091 1.329 . . . . 0.0 116.353 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -56.35 145.47 27.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.445 1.123 . . . . 0.0 113.147 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.67 139.62 20.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.836 1.254 . . . . 0.0 112.146 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.7 159.41 30.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.78 0.832 . . . . 0.0 111.623 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.36 157.55 24.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.626 1.57 . . . . 0.0 111.699 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.48 133.69 46.02 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.35 0.66 . . . . 0.0 110.793 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.8 3.05 58.47 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.608 1.099 . . . . 0.0 114.849 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.7 129.41 39.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.786 1.293 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -74.95 134.58 41.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.436 0.636 . . . . 0.0 110.778 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.89 179.43 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.501 1.921 . . . . 0.0 111.023 -169.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.75 146.59 43.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.336 1.454 . . . . 0.0 108.909 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.08 149.6 26.3 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.296 -0.877 . . . . 0.0 112.979 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -80.61 110.13 15.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.252 1.421 . . . . 0.0 110.348 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -85.71 -160.06 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.111 0.965 . . . . 0.0 112.063 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -56.4 -35.14 67.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.767 1.227 . . . . 0.0 112.458 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.75 153.42 22.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.808 1.243 . . . . 0.0 111.957 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 82.7 m -77.24 50.85 0.8 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -134.41 163.22 30.17 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.526 2.331 . . . . 0.0 110.607 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -121.96 70.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.395 1.478 . . . . 0.0 110.493 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -67.54 157.39 86.08 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.429 1.092 . . . . 0.0 112.442 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.22 138.58 47.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.808 2.338 . . . . 0.0 111.965 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.17 179.57 7.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.175 1.79 . . . . 0.0 110.619 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -142.55 152.76 42.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.633 1.173 . . . . 0.0 111.987 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 91.0 mt -83.33 113.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.259 1.024 . . . . 0.0 110.108 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -80.65 -33.44 35.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.668 1.187 . . . . 0.0 112.787 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.76 38.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.461 1.104 . . . . 0.0 112.546 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.47 138.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.111 1.764 . . . . 0.0 109.118 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -128.77 126.19 39.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.456 1.102 . . . . 0.0 110.368 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.24 -17.61 58.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 0.0 113.613 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.56 -21.41 66.69 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.346 1.058 . . . . 0.0 113.628 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.54 -12.15 7.91 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.591 1.567 . . . . 0.0 114.957 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 157.71 20.32 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 111.765 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -138.51 130.21 27.84 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.515 1.526 . . . . 0.0 110.175 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.5 m -86.93 135.76 33.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.722 0.809 . . . . 0.0 108.926 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.84 148.5 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -119.7 123.82 44.72 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 109.593 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.42 164.77 16.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 111.548 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -52.7 -28.45 21.91 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.98 -21.95 65.04 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.263 1.425 . . . . 0.0 113.733 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.44 -20.15 32.9 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.206 1.86 . . . . 0.0 114.068 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.48 145.95 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.856 1.662 . . . . 0.0 112.749 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.61 125.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.241 1.416 . . . . 0.0 109.892 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -142.62 -172.68 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.153 2.181 . . . . 0.0 109.636 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 32.1 p -130.3 154.5 47.56 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.381 -0.824 . . . . 0.0 112.261 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.4 157.95 44.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.025 1.73 . . . . 0.0 111.088 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -73.05 156.64 38.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.197 0.999 . . . . 0.0 110.447 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -54.54 -25.4 25.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.61 -19.56 58.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.355 1.862 . . . . 0.0 114.139 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -120.26 12.23 11.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.137 1.375 . . . . 0.0 113.394 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.38 142.28 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.01 1.724 . . . . 0.0 108.854 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -135.69 145.76 47.06 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.053 1.741 . . . . 0.0 110.254 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.52 139.27 58.46 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.028 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.3 ttm -64.3 125.56 88.59 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.893 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.57 160.61 43.88 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.828 2.352 . . . . 0.0 113.14 -169.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.52 -10.6 36.14 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.288 1.435 . . . . 0.0 114.434 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.75 -10.2 16.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 113.593 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.3 141.17 47.15 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.013 -1.054 . . . . 0.0 111.754 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -76.95 153.56 34.49 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.138 0.975 . . . . 0.0 111.82 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.5 -24.8 1.68 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.228 1.394 . . . . 0.0 113.952 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -148.63 161.58 41.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.724 2.01 . . . . 0.0 109.915 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -132.74 168.76 17.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.368 1.467 . . . . 0.0 112.8 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -141.59 13.81 2.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.268 1.427 . . . . 0.0 114.148 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.4 pp -49.26 121.03 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.818 1.247 . . . . 0.0 113.055 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.11 43.87 11.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.274 1.83 . . . . 0.0 114.731 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 pp -47.13 143.81 2.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.701 1.6 . . . . 0.0 114.673 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.01 144.78 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.669 1.188 . . . . 0.0 112.022 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -151.45 167.93 26.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.891 1.676 . . . . 0.0 112.032 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.201 1.8 . . . . 0.0 111.882 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.396 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.1 p -154.66 172.03 18.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.299 1.44 . . . . 0.0 112.365 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.7 m -154.85 153.0 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.474 1.51 . . . . 0.0 111.214 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.92 59.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.916 0.769 . . . . 0.0 112.98 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 m -48.43 135.62 13.77 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.86 1.664 . . . . 0.0 114.22 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.1 t -63.73 146.21 54.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.245 1.018 . . . . 0.0 112.363 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.59 52.83 0.02 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.121 0.867 . . . . 0.0 113.24 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -51.46 -44.87 62.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.972 1.309 . . . . 0.0 114.209 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -153.89 148.97 26.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.047 1.739 . . . . 0.0 110.879 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -80.97 155.87 26.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.655 0.782 . . . . 0.0 110.564 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 152.12 34.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.39 1.476 . . . . 0.0 111.706 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.38 141.29 57.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.012 0.525 . . . . 0.0 111.326 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.32 -9.36 73.39 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.17 1.367 . . . . 0.0 114.626 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.38 145.06 31.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.16 1.48 . . . . 0.0 111.974 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.87 143.78 25.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.53 1.132 . . . . 0.0 112.05 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.93 170.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.438 1.895 . . . . 0.0 111.008 -170.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -109.72 133.39 53.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.6 1.16 . . . . 0.0 108.889 169.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.21 153.28 38.54 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -74.66 150.38 39.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.138 1.375 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -140.23 -44.13 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -139.63 -21.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -171.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -142.76 -178.61 5.88 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.679 1.592 . . . . 0.0 110.721 -171.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.4 m -65.47 -14.07 60.18 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.816 -1.178 . . . . 0.0 113.768 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.89 133.58 43.13 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.8 1.24 . . . . 0.0 110.571 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -89.06 152.3 21.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.577 0.751 . . . . 0.0 109.255 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.47 155.84 79.34 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.118 1.367 . . . . 0.0 110.859 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.52 137.17 38.58 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.679 2.253 . . . . 0.0 112.732 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.41 174.6 12.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.818 1.647 . . . . 0.0 111.482 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -136.39 138.3 41.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 110.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.11 130.8 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.343 0.657 . . . . 0.0 109.586 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.84 -31.51 7.99 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.764 1.226 . . . . 0.0 112.53 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.5 33.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.092 1.757 . . . . 0.0 110.749 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.21 148.12 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.849 1.26 . . . . 0.0 110.521 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -127.63 144.46 51.07 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.116 1.366 . . . . 0.0 110.719 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -68.15 -27.87 66.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -170.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.91 35.43 1.39 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.51 -43.84 0.07 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 118.458 2.143 . . . . 0.0 118.458 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 p -137.82 166.6 23.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -167.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -132.64 134.78 45.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.78 1.632 . . . . 0.0 108.895 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -81.69 130.45 35.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.954 0.902 . . . . 0.0 108.612 172.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.62 142.43 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.434 1.094 . . . . 0.0 112.027 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.78 129.51 55.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.679 1.592 . . . . 0.0 109.473 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.22 168.01 11.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.951 0.9 . . . . 0.0 111.756 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.82 -27.05 27.21 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.069 1.348 . . . . 0.0 113.841 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 -17.99 37.33 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.123 1.821 . . . . 0.0 114.193 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.11 147.0 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.789 1.636 . . . . 0.0 112.439 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 129.53 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.691 1.596 . . . . 0.0 110.136 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -143.09 -166.72 2.37 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.142 2.177 . . . . 0.0 109.351 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.13 155.45 46.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.228 -0.92 . . . . 0.0 111.564 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.42 152.79 45.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.242 1.417 . . . . 0.0 110.753 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.27 153.38 42.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.303 1.041 . . . . 0.0 110.957 171.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.33 18.56 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 169.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 tpt -65.33 -13.98 59.75 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.44 1.896 . . . . 0.0 113.804 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -120.79 13.35 11.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.492 1.517 . . . . 0.0 113.603 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.9 mt -134.3 144.41 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.035 1.734 . . . . 0.0 109.455 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -136.61 149.32 47.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.063 2.145 . . . . 0.0 110.271 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 157.24 30.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.58 0.752 . . . . 0.0 111.229 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.87 120.51 64.25 Favored Pre-proline 0 CA--C 1.55 0.962 0 O-C-N 121.964 -0.46 . . . . 0.0 110.306 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.86 164.44 34.61 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.298 2.665 . . . . 0.0 114.127 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.25 -20.81 63.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.426 1.091 . . . . 0.0 113.248 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.88 -21.66 62.38 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.361 1.464 . . . . 0.0 113.767 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.22 158.81 34.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.786 0.834 . . . . 0.0 112.522 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 157.23 15.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.281 1.032 . . . . 0.0 112.598 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.18 -148.85 48.19 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.241 0.448 . . . . 0.0 112.808 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 65.58 15.13 9.89 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.66 1.584 . . . . 0.0 113.932 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -80.41 62.94 4.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.201 1.8 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -69.95 31.77 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.505 1.522 . . . . 0.0 114.958 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.8 pt -63.44 157.58 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.35 -1.469 . . . . 0.0 111.608 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.01 34.69 4.35 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.464 1.906 . . . . 0.0 114.903 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.6 0.75 2.87 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.19 154.22 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.075 1.75 . . . . 0.0 110.688 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -54.2 125.0 17.48 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.496 1.518 . . . . 0.0 112.245 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.614 1.566 . . . . 0.0 112.99 174.806 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.9 m -63.2 157.33 22.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.693 1.197 . . . . 0.0 113.623 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -106.21 163.61 12.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 111.695 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.69 -53.84 0.13 Allowed Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.719 0.676 . . . . 0.0 112.993 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -82.71 60.9 5.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.666 1.186 . . . . 0.0 109.107 168.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -136.57 130.28 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 110.958 -167.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.03 -8.0 68.62 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.576 1.084 . . . . 0.0 114.484 -172.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -153.87 161.75 41.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.194 1.798 . . . . 0.0 111.271 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -149.45 143.84 25.95 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.613 1.565 . . . . 0.0 110.557 172.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -75.17 156.41 35.91 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.346 0.658 . . . . 0.0 111.414 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.27 164.26 30.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 111.779 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.89 132.32 53.47 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.942 0.401 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.78 -4.52 85.71 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.087 1.327 . . . . 0.0 115.054 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.88 132.68 49.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.519 1.66 . . . . 0.0 111.776 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -77.81 133.82 38.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.621 0.769 . . . . 0.0 110.792 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.34 167.05 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.715 1.606 . . . . 0.0 111.171 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.17 140.7 29.73 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.26 160.08 44.01 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.717 -0.614 . . . . 0.0 112.225 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.52 145.52 26.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.827 1.251 . . . . 0.0 111.258 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.89 -48.02 0.5 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 m -140.27 -14.55 1.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -169.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -140.25 179.14 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.209 1.404 . . . . 0.0 111.6 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.6 m -73.13 -20.49 60.91 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.762 -0.587 . . . . 0.0 111.59 167.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -71.81 131.38 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.581 1.552 . . . . 0.0 110.357 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.76 161.91 24.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.895 0.478 . . . . 0.0 110.145 168.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -136.48 154.56 76.94 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.51 1.524 . . . . 0.0 110.529 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.49 139.44 37.72 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.101 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.5 173.5 12.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.127 1.771 . . . . 0.0 110.736 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -125.06 140.42 52.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.485 1.514 . . . . 0.0 109.533 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.53 121.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.323 0.649 . . . . 0.0 109.736 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -90.36 -33.97 15.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.284 1.034 . . . . 0.0 112.379 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.58 35.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.549 1.14 . . . . 0.0 112.702 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.58 156.28 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.797 2.039 . . . . 0.0 109.187 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 57.42 43.35 23.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.502 1.521 . . . . 0.0 113.536 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -67.24 -175.86 0.5 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.617 1.167 . . . . 0.0 110.902 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -54.78 -28.59 50.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.373 1.069 . . . . 0.0 113.838 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.24 24.4 0.07 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.299 0.952 . . . . 0.0 115.14 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.4 p -148.91 179.84 7.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.615 1.566 . . . . 0.0 112.775 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.44 126.5 48.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.974 2.11 . . . . 0.0 108.006 169.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.8 m -77.37 135.9 38.39 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -143.02 151.53 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.564 1.146 . . . . 0.0 112.275 -171.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -122.31 112.86 18.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.949 1.7 . . . . 0.0 109.445 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -76.17 164.17 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 111.614 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -58.02 -21.79 46.82 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -69.96 -16.03 63.13 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.709 1.203 . . . . 0.0 114.032 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.52 -11.46 64.97 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.805 1.669 . . . . 0.0 114.542 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.51 148.19 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.095 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.6 mt -130.23 126.14 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.214 1.405 . . . . 0.0 110.099 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -144.6 -167.42 2.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.481 2.312 . . . . 0.0 109.249 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.34 153.98 49.05 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.26 -0.9 . . . . 0.0 112.067 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.1 mt -138.69 156.83 47.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 111.816 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.99 158.39 29.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.7 1.2 . . . . 0.0 110.569 169.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -57.74 -26.45 61.84 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -67.01 -11.63 57.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.146 1.378 . . . . 0.0 113.91 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -115.51 14.82 16.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.767 1.627 . . . . 0.0 112.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -134.25 145.79 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.47 1.908 . . . . 0.0 109.446 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -138.86 150.03 45.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.526 1.931 . . . . 0.0 111.36 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.42 144.52 48.12 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.006 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 48.2 tpp -62.78 125.57 86.71 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.134 0.974 . . . . 0.0 110.785 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.67 159.67 45.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.041 2.494 . . . . 0.0 112.572 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -62.56 -22.17 66.14 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.784 1.234 . . . . 0.0 113.377 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.64 -25.25 63.83 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.945 1.298 . . . . 0.0 113.704 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.79 138.44 42.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.856 . . . . 0.0 112.572 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -71.1 162.05 30.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.63 1.172 . . . . 0.0 112.66 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.05 179.69 42.37 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.224 0.916 . . . . 0.0 114.145 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.28 157.64 22.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.088 1.355 . . . . 0.0 111.86 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -131.03 146.72 52.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 111.057 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -78.13 36.06 0.23 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.466 1.907 . . . . 0.0 115.071 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.9 mt -54.87 -33.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.894 1.678 . . . . 0.0 112.151 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -12.38 61.36 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.37 91.33 4.02 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 0.0 110.888 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.51 143.82 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.765 1.626 . . . . 0.0 109.975 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -59.71 150.56 27.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 112.701 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 C-N-CA 125.061 1.344 . . . . 0.0 112.664 169.089 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.4 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 t 48.34 39.98 13.54 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.254 1.822 . . . . 0.0 114.858 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 t -153.56 153.38 32.26 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.689 1.196 . . . . 0.0 112.349 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.05 154.55 10.15 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.814 1.673 . . . . 0.0 112.619 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -149.27 149.02 30.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.185 1.394 . . . . 0.0 111.98 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 t -161.35 162.27 30.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.366 1.467 . . . . 0.0 111.414 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.36 28.16 72.67 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -64.41 156.12 30.35 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.284 1.042 . . . . 0.0 113.238 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -148.53 141.98 25.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 110.513 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -126.14 137.56 53.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.146 1.779 . . . . 0.0 109.268 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -143.46 146.14 33.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 111.571 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.49 131.44 50.95 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 122.021 -0.425 . . . . 0.0 111.154 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.78 -13.5 52.82 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.531 1.538 . . . . 0.0 115.371 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.45 149.46 45.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.356 1.578 . . . . 0.0 111.488 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -90.21 143.94 26.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 112.127 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.72 164.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.599 1.96 . . . . 0.0 111.142 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -108.71 125.25 51.71 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.091 1.756 . . . . 0.0 109.208 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.37 152.72 41.93 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -92.33 72.25 5.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.75 1.62 . . . . 0.0 112.508 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CE3' ' CE1' ' A' ' 120' ' ' PHE . 50.8 t-105 -62.33 -37.13 84.45 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -155.25 -29.17 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -136.46 163.04 31.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.103 1.361 . . . . 0.0 111.792 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.53 -20.34 54.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.892 1.277 . . . . 0.0 114.418 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.67 96.44 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.308 1.043 . . . . 0.0 108.918 168.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -55.49 143.21 30.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.386 0.675 . . . . 0.0 111.419 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.89 150.87 56.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.955 1.302 . . . . 0.0 111.522 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.68 137.77 28.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.667 2.245 . . . . 0.0 112.193 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.99 167.18 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.008 1.723 . . . . 0.0 110.954 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.01 142.29 45.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.151 1.38 . . . . 0.0 109.996 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.83 120.61 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.91 0.884 . . . . 0.0 109.383 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -92.79 -31.47 15.02 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.124 0.969 . . . . 0.0 112.561 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.03 158.68 36.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.357 1.063 . . . . 0.0 112.446 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.7 mt -134.5 143.82 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.564 1.946 . . . . 0.0 108.408 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -134.06 140.61 46.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.611 1.164 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -29.5 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.538 1.135 . . . . 0.0 113.249 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -140.63 24.33 2.24 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.636 1.574 . . . . 0.0 112.313 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.53 -111.7 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.776 1.179 . . . . 0.0 113.452 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.7 t -143.64 -177.63 5.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.027 1.331 . . . . 0.0 112.56 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -122.7 106.47 10.97 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.4 1.88 . . . . 0.0 109.896 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 m -72.4 134.8 45.6 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.52 0.728 . . . . 0.0 109.506 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.31 147.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.027 1.331 . . . . 0.0 111.751 -171.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.22 118.27 27.23 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.547 1.539 . . . . 0.0 109.954 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CE1' ' CE3' ' A' ' 97' ' ' TRP . 33.2 m-85 -85.91 172.05 11.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.709 1.203 . . . . 0.0 111.872 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -57.87 -21.75 44.55 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -70.78 -14.03 62.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.923 1.289 . . . . 0.0 114.12 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.61 -16.31 58.29 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.641 1.591 . . . . 0.0 114.883 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.47 148.56 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.689 1.596 . . . . 0.0 112.326 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.36 124.22 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.522 1.529 . . . . 0.0 110.368 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -142.57 -162.46 1.42 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.295 2.238 . . . . 0.0 108.888 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.6 p -135.52 155.29 50.74 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.134 -0.979 . . . . 0.0 112.492 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.25 149.97 40.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.314 1.446 . . . . 0.0 111.192 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -68.71 159.54 32.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.631 1.172 . . . . 0.0 111.329 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -58.27 -20.47 42.75 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 171.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.9 mmm -67.89 -12.91 61.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.915 1.286 . . . . 0.0 113.661 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.8 13.51 5.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 112.871 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.83 136.22 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.791 1.636 . . . . 0.0 109.422 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -140.53 157.61 45.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.063 1.745 . . . . 0.0 111.287 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 174.52 5.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.211 0.604 . . . . 0.0 111.0 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.59 141.96 71.51 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.201 -0.937 . . . . 0.0 111.318 169.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.25 135.18 36.12 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.836 2.357 . . . . 0.0 110.168 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 46.91 30.04 1.15 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.257 1.423 . . . . 0.0 114.123 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t0 47.49 49.53 15.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.314 1.846 . . . . 0.0 113.953 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.6 38.76 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -68.19 159.62 30.76 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.826 1.194 . . . . 0.0 112.795 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 55.79 2.19 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.355 0.502 . . . . 0.0 112.545 -175.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -59.61 1.21 0.1 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.9 -46.89 87.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.872 1.269 . . . . 0.0 112.937 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . 0.255 11.5 p-90 44.86 7.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 119.532 3.16 . . . . 0.0 119.532 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.92 -30.92 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.977 1.717 . . . . 0.0 112.992 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.73 144.05 31.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.162 . . . . 0.0 111.688 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 pp -156.99 168.49 27.32 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.509 1.924 . . . . 0.0 111.325 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.2 m -80.6 130.24 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.7 0.8 . . . . 0.0 111.406 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.9 150.97 24.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.449 1.5 . . . . 0.0 110.973 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.391 1.477 . . . . 0.0 113.272 175.409 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -160.47 158.72 29.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.613 1.565 . . . . 0.0 111.579 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 t -155.26 167.89 28.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.426 1.49 . . . . 0.0 111.233 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.14 29.86 0.12 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.184 0.897 . . . . 0.0 114.815 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.1 m -139.59 144.69 37.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.731 1.212 . . . . 0.0 112.408 -173.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 p -160.66 166.98 27.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.168 1.787 . . . . 0.0 111.336 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.54 23.7 0.43 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.093 0.797 . . . . 0.0 115.093 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.39 148.05 41.57 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 112.387 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -145.09 126.38 14.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.697 1.599 . . . . 0.0 109.366 169.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -127.8 150.68 49.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.626 1.57 . . . . 0.0 110.446 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.8 142.71 30.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.928 1.291 . . . . 0.0 112.566 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 135.96 57.78 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.831 -0.543 . . . . 0.0 110.834 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.04 -12.88 69.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.105 1.336 . . . . 0.0 114.631 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -69.26 162.17 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.4 1.6 . . . . 0.0 112.375 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.41 142.79 32.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.833 0.853 . . . . 0.0 112.175 170.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.95 162.98 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.838 2.055 . . . . 0.0 110.806 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.8 137.43 32.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.55 152.06 33.58 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.522 0.601 . . . . 0.0 112.379 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -84.95 150.01 25.23 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.846 1.258 . . . . 0.0 111.519 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 t-105 -151.42 -39.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -132.73 -32.68 1.25 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.62 178.83 7.69 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.146 1.778 . . . . 0.0 110.528 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.2 m -61.17 -22.45 64.73 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 122.78 22.22 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.647 1.179 . . . . 0.0 111.096 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -70.64 155.69 40.42 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.009 0.924 . . . . 0.0 110.745 169.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.29 157.34 76.47 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.435 1.494 . . . . 0.0 110.579 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.44 135.08 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.135 1.89 . . . . 0.0 111.564 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.16 174.14 11.14 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.722 2.009 . . . . 0.0 110.145 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -127.34 134.99 49.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.528 1.531 . . . . 0.0 110.098 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.5 mt -72.31 121.95 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.02 0.528 . . . . 0.0 110.007 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -87.47 -37.45 16.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.526 1.131 . . . . 0.0 111.858 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.1 162.11 38.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.571 1.148 . . . . 0.0 113.002 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.65 131.24 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.885 1.674 . . . . 0.0 109.242 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.35 11.32 0.25 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.233 2.213 . . . . 0.0 116.581 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -56.75 -32.08 65.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.566 1.546 . . . . 0.0 113.585 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -142.09 49.77 1.54 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 110.219 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.46 18.24 50.16 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.001 1.286 . . . . 0.0 114.859 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.1 p -149.25 170.1 19.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.458 2.303 . . . . 0.0 110.617 -169.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -98.92 112.32 24.46 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.509 1.124 . . . . 0.0 109.575 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 m -73.64 131.34 41.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.92 149.76 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.467 1.107 . . . . 0.0 112.018 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.84 127.92 52.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.034 1.733 . . . . 0.0 109.368 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.46 168.18 11.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.659 0.784 . . . . 0.0 111.488 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -59.77 -20.43 56.6 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -73.22 -14.01 61.26 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.551 1.14 . . . . 0.0 113.994 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.94 -12.08 67.36 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.935 1.731 . . . . 0.0 114.53 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.9 149.18 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.643 1.577 . . . . 0.0 112.301 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.6 130.27 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.308 1.443 . . . . 0.0 110.263 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -145.81 -169.8 3.32 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.429 2.292 . . . . 0.0 109.661 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.59 151.33 50.32 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.816 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.3 mt -139.2 159.39 42.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.231 1.412 . . . . 0.0 112.21 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.98 155.62 23.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -53.98 -25.72 22.27 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 171.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.3 ttt -61.84 -20.56 63.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.788 1.635 . . . . 0.0 113.928 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -120.89 17.63 11.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.274 1.43 . . . . 0.0 112.913 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.28 145.53 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.053 2.141 . . . . 0.0 108.929 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 110.781 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.07 152.66 42.92 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.5 mmt -61.87 148.18 88.24 Favored Pre-proline 0 CA--C 1.547 0.856 0 O-C-N 121.499 -0.751 . . . . 0.0 112.397 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.38 169.49 20.69 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.784 2.99 . . . . 0.0 112.847 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -59.34 -23.6 62.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.602 1.161 . . . . 0.0 113.929 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -80.99 -14.26 58.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.007 1.323 . . . . 0.0 114.164 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.63 152.69 41.62 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -155.67 150.58 26.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.449 1.9 . . . . 0.0 110.342 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.35 -44.99 0.07 OUTLIER Glycine 0 CA--C 1.534 1.236 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.76 171.28 14.22 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 118.056 0.928 . . . . 0.0 111.323 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -136.09 -179.78 5.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.966 1.706 . . . . 0.0 110.501 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -142.51 -12.14 0.8 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.835 1.654 . . . . 0.0 114.223 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.27 -22.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 110.708 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.45 179.67 5.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.544 2.337 . . . . 0.0 110.175 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mp 56.28 24.44 8.23 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.552 1.541 . . . . 0.0 113.43 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.29 123.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.375 1.47 . . . . 0.0 111.238 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 162.53 27.88 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.185 1.394 . . . . 0.0 113.478 178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.414 1.485 . . . . 0.0 113.194 174.428 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -142.98 165.29 27.75 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.367 1.467 . . . . 0.0 111.92 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.4 m -158.39 164.36 36.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.65 1.58 . . . . 0.0 111.686 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.12 -175.75 44.67 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.782 1.182 . . . . 0.0 113.313 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -64.12 138.39 58.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 0.0 112.195 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -149.85 170.06 19.65 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.412 1.885 . . . . 0.0 111.429 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.59 34.37 6.34 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.714 0.673 . . . . 0.0 114.573 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -143.3 161.58 37.93 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.232 1.413 . . . . 0.0 112.38 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.06 155.01 26.61 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.799 1.64 . . . . 0.0 111.695 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -76.08 149.83 37.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.237 1.015 . . . . 0.0 112.75 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.44 165.15 28.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.313 1.845 . . . . 0.0 111.477 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.61 130.06 45.02 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.859 0.464 . . . . 0.0 110.668 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.48 88.27 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.907 1.241 . . . . 0.0 115.13 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.35 146.04 53.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.758 1.779 . . . . 0.0 112.256 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -95.37 131.12 41.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.044 1.338 . . . . 0.0 110.635 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.64 177.67 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.138 1.775 . . . . 0.0 111.666 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.3 140.33 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.449 1.1 . . . . 0.0 108.434 168.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.39 34.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.555 0.742 . . . . 0.0 111.798 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -77.67 129.12 35.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.903 1.281 . . . . 0.0 109.767 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -93.36 -160.35 0.75 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.551 0.741 . . . . 0.0 111.928 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 t -61.99 -28.5 69.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.167 -0.958 . . . . 0.0 112.222 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -76.87 155.45 32.89 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.043 1.337 . . . . 0.0 112.174 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.04 34.78 0.09 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.887 1.675 . . . . 0.0 114.262 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.46 145.47 40.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.58 1.952 . . . . 0.0 111.488 -172.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.41 148.51 25.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.499 1.119 . . . . 0.0 111.432 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.38 155.45 64.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.995 1.718 . . . . 0.0 111.185 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.62 134.44 32.84 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.023 2.482 . . . . 0.0 111.739 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.88 172.51 15.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.227 1.411 . . . . 0.0 111.933 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -134.1 130.86 38.02 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.537 1.535 . . . . 0.0 110.054 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.14 118.39 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.044 0.938 . . . . 0.0 110.536 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.5 -31.84 15.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.14 1.376 . . . . 0.0 112.474 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.65 160.67 38.27 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.716 1.206 . . . . 0.0 112.523 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 26.5 mt -133.49 133.64 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 126.017 1.727 . . . . 0.0 108.905 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -140.05 99.36 3.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.727 1.211 . . . . 0.0 110.753 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -51.72 148.18 5.84 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.945 1.298 . . . . 0.0 113.469 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 50.96 34.94 11.46 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.507 1.523 . . . . 0.0 113.798 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.0 -93.49 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.09 -1.006 . . . . 0.0 114.636 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.2 p -148.38 175.36 11.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.003 1.321 . . . . 0.0 113.327 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -131.94 139.84 48.82 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.877 1.671 . . . . 0.0 108.475 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -98.88 134.7 41.38 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 108.982 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.91 140.73 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.34 1.056 . . . . 0.0 111.953 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -99.65 128.46 45.75 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.857 1.263 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.73 165.16 18.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.305 1.042 . . . . 0.0 112.444 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.31 -29.7 34.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.302 1.441 . . . . 0.0 114.266 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.94 -20.03 61.13 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 113.797 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.49 -20.88 31.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.104 1.811 . . . . 0.0 114.278 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 150.14 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.56 1.544 . . . . 0.0 112.457 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.61 126.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.283 1.433 . . . . 0.0 109.896 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -142.83 177.93 8.0 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.168 2.187 . . . . 0.0 110.036 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 29.1 p -121.95 154.05 37.68 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.134 0.974 . . . . 0.0 112.522 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.41 157.22 44.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.621 1.569 . . . . 0.0 112.059 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -72.2 158.59 35.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.087 1.355 . . . . 0.0 111.497 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -52.34 -39.14 60.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.293 1.437 . . . . 0.0 113.657 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.16 2.61 2.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.69 1.996 . . . . 0.0 114.238 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -122.91 13.33 9.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.888 1.675 . . . . 0.0 112.654 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -135.7 141.63 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.873 1.269 . . . . 0.0 110.025 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -138.12 152.28 48.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.509 1.924 . . . . 0.0 110.662 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.27 135.95 55.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.812 0.445 . . . . 0.0 110.416 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.7 ttm -67.87 129.83 93.08 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.864 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.21 163.51 38.46 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.645 2.23 . . . . 0.0 113.351 -171.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.8 6.06 1.67 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.379 1.872 . . . . 0.0 114.094 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -133.82 27.85 3.92 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.52 1.928 . . . . 0.0 112.374 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.78 157.78 45.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.621 1.569 . . . . 0.0 112.105 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -66.57 104.97 1.38 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.073 1.349 . . . . 0.0 111.164 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.3 -149.83 14.99 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.95 1.262 . . . . 0.0 112.528 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -126.42 158.26 36.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 113.028 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -151.73 160.98 43.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.074 1.75 . . . . 0.0 110.533 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.26 23.92 2.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.463 1.105 . . . . 0.0 112.497 -171.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.7 140.43 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.899 1.679 . . . . 0.0 110.582 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 51.69 40.38 27.3 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.449 1.9 . . . . 0.0 114.709 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.53 2.84 0.82 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.8 159.95 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.064 1.746 . . . . 0.0 111.145 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -137.31 142.36 41.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.796 1.639 . . . . 0.0 113.59 178.41 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.467 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 t -152.09 148.55 27.8 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.816 1.247 . . . . 0.0 111.607 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.6 m -80.61 42.6 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.268 1.827 . . . . 0.0 113.614 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.64 138.78 40.57 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.702 1.144 . . . . 0.0 113.798 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.9 p -74.71 154.4 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.585 1.154 . . . . 0.0 113.71 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 t -75.09 148.45 39.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.115 0.966 . . . . 0.0 111.742 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.76 -26.08 3.04 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.322 1.439 . . . . 0.0 114.006 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -84.46 143.93 29.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.842 1.257 . . . . 0.0 111.88 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -150.17 147.62 27.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.687 1.595 . . . . 0.0 110.866 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -72.42 156.29 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.39 0.676 . . . . 0.0 111.053 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -144.46 151.61 39.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.648 1.579 . . . . 0.0 111.458 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.69 58.29 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.042 0.449 . . . . 0.0 110.927 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.13 -18.34 54.24 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 125.287 1.423 . . . . 0.0 114.384 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -72.02 147.28 47.0 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.591 1.196 . . . . 0.0 111.755 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 141.34 28.57 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 122.024 0.916 . . . . 0.0 112.148 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 166.87 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.826 2.05 . . . . 0.0 110.46 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.55 137.75 32.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.869 0.868 . . . . 0.0 109.037 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.31 153.37 38.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.527 -0.733 . . . . 0.0 112.488 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -82.77 148.03 28.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.795 1.238 . . . . 0.0 110.994 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -142.74 -42.51 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -134.55 -29.11 1.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -149.85 -161.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.348 1.459 . . . . 0.0 110.955 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.1 t -67.2 -32.24 73.18 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -63.78 153.27 37.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 0.0 112.582 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -101.27 157.43 16.79 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.263 1.025 . . . . 0.0 110.387 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -138.26 153.0 72.65 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.644 1.577 . . . . 0.0 110.092 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 137.79 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.518 2.145 . . . . 0.0 112.499 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.81 160.25 42.51 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.36 1.464 . . . . 0.0 111.842 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.14 127.79 54.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.553 1.941 . . . . 0.0 109.555 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.74 135.68 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.031 0.532 . . . . 0.0 109.686 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -115.78 -26.33 7.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.656 1.182 . . . . 0.0 113.008 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.0 153.41 30.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 111.377 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -132.09 119.46 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.591 1.556 . . . . 0.0 109.064 -174.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.8 t30 51.51 18.51 0.69 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.731 2.012 . . . . 0.0 115.507 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.59 -35.58 72.64 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.731 1.612 . . . . 0.0 113.539 -172.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.76 21.87 4.62 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.296 1.838 . . . . 0.0 111.37 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.11 12.3 61.98 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.841 1.21 . . . . 0.0 114.221 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -147.85 159.62 43.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.106 1.763 . . . . 0.0 110.501 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.65 138.86 33.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.961 1.305 . . . . 0.0 109.327 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.6 m -110.29 135.76 50.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.872 0.869 . . . . 0.0 109.354 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.82 151.26 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.19 0.996 . . . . 0.0 112.669 -169.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -121.11 111.36 17.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 109.114 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.16 161.33 30.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.25 0.62 . . . . 0.0 111.806 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -55.15 -26.1 36.38 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.7 -21.88 64.39 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.135 1.374 . . . . 0.0 113.762 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.51 -12.95 36.08 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 126.183 1.849 . . . . 0.0 114.232 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.63 149.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.453 1.501 . . . . 0.0 112.407 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.6 mt -131.83 124.55 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.466 1.506 . . . . 0.0 109.952 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -144.17 -174.93 4.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.171 2.188 . . . . 0.0 109.883 170.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.1 p -125.17 151.35 45.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.723 1.209 . . . . 0.0 111.732 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.6 mt -143.18 152.54 41.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.815 1.646 . . . . 0.0 111.704 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -70.09 151.49 45.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.53 0.732 . . . . 0.0 109.338 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -57.88 -29.59 65.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.881 0.873 . . . . 0.0 113.121 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -59.31 -7.33 1.24 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.504 1.922 . . . . 0.0 114.488 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -115.97 10.72 15.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.079 1.752 . . . . 0.0 112.626 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.4 mt -131.53 143.73 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 109.625 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.16 152.6 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.155 2.182 . . . . 0.0 111.05 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.85 159.19 25.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.294 0.638 . . . . 0.0 111.712 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.9 mmt -62.11 157.68 50.84 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.706 0.802 . . . . 0.0 112.32 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.11 9.21 1.8 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.35 3.367 . . . . 0.0 116.302 -170.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 64.34 28.2 13.74 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.665 1.986 . . . . 0.0 112.577 -172.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.02 -28.61 1.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.081 1.753 . . . . 0.0 112.857 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.43 122.67 18.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.229 1.012 . . . . 0.0 111.208 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -153.62 153.45 32.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.596 1.558 . . . . 0.0 110.981 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -167.93 -151.06 6.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.306 0.955 . . . . 0.0 112.988 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.18 105.84 3.56 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.075 -0.662 . . . . 0.0 109.246 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -148.62 -177.5 5.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.035 1.334 . . . . 0.0 113.029 -171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -130.96 38.08 3.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.544 1.538 . . . . 0.0 112.282 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.2 pt -58.53 -20.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.96 137.1 23.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.028 1.731 . . . . 0.0 110.072 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.24 23.24 0.64 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.293 1.437 . . . . 0.0 113.235 -173.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.97 155.23 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.58 1.552 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -55.52 141.3 37.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.855 1.662 . . . . 0.0 112.566 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.394 1.877 . . . . 0.0 111.782 178.752 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.334 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -143.94 163.48 33.34 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.802 1.641 . . . . 0.0 111.619 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 m -59.44 148.7 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.56 1.144 . . . . 0.0 112.987 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.04 -12.64 84.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.197 0.904 . . . . 0.0 114.947 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -151.97 165.83 33.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.996 1.718 . . . . 0.0 112.032 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.4 p -70.59 167.22 18.98 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.905 1.282 . . . . 0.0 113.433 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -178.11 -138.93 3.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.098 1.332 . . . . 0.0 112.001 -175.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.24 159.68 5.79 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.827 0.851 . . . . 0.0 112.799 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -141.56 144.44 34.27 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.49 1.516 . . . . 0.0 110.932 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.83 160.58 31.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.85 0.86 . . . . 0.0 112.206 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.01 159.81 43.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.86 1.664 . . . . 0.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.55 37.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.692 0.397 . . . . 0.0 110.989 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.36 -10.72 72.82 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.474 1.511 . . . . 0.0 114.559 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.11 132.04 47.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.133 1.466 . . . . 0.0 111.61 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.65 143.4 33.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.34 169.5 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.855 1.662 . . . . 0.0 111.645 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.3 141.72 45.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.396 1.478 . . . . 0.0 108.325 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.99 151.32 30.16 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.51 -0.744 . . . . 0.0 112.886 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -81.4 113.22 19.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.938 1.295 . . . . 0.0 110.247 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -93.75 -159.7 0.71 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.347 1.059 . . . . 0.0 112.044 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 t -61.14 -12.17 11.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.538 1.135 . . . . 0.0 113.712 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.16 149.7 43.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.423 2.289 . . . . 0.0 110.055 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.34 -17.24 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -169.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.71 155.98 39.1 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.254 0.934 . . . . 0.0 111.682 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -101.52 80.92 2.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.195 1.398 . . . . 0.0 110.25 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -71.62 153.66 93.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.476 1.11 . . . . 0.0 112.085 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.75 137.78 33.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.132 2.555 . . . . 0.0 112.447 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.03 -178.32 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.568 1.547 . . . . 0.0 111.606 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -143.32 154.41 43.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.354 1.462 . . . . 0.0 111.255 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -82.6 133.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.157 0.983 . . . . 0.0 109.743 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -104.38 -30.16 10.27 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.446 1.499 . . . . 0.0 112.794 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.32 154.44 32.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.609 1.164 . . . . 0.0 112.301 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt -141.97 141.73 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.044 1.738 . . . . 0.0 110.085 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -152.71 157.71 41.28 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.959 0.904 . . . . 0.0 111.459 168.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -67.1 -26.14 66.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.522 1.129 . . . . 0.0 112.95 171.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.31 63.53 1.58 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.663 1.985 . . . . 0.0 109.968 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.98 120.64 0.56 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.241 1.4 . . . . 0.0 110.266 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 p -44.07 146.99 0.55 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.129 1.772 . . . . 0.0 113.883 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -73.36 111.09 8.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.582 1.153 . . . . 0.0 109.929 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.7 m -68.4 135.84 52.38 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.62 150.1 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.694 1.197 . . . . 0.0 111.5 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -126.86 125.58 41.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.129 1.371 . . . . 0.0 110.233 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -87.95 162.29 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.013 0.925 . . . . 0.0 111.672 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -52.39 -29.44 24.18 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.0 -20.15 58.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.41 -22.91 8.2 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.694 1.616 . . . . 0.0 115.472 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.31 148.0 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.109 1.454 . . . . 0.0 113.176 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.5 mt -130.2 127.84 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.214 1.405 . . . . 0.0 110.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -143.7 -169.03 2.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.413 2.285 . . . . 0.0 109.436 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.5 p -127.77 150.81 49.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.413 1.085 . . . . 0.0 112.133 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -141.21 163.09 33.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 111.557 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -89.0 155.89 19.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.138 1.375 . . . . 0.0 110.715 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.99 -28.7 10.5 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.3 ttt -63.94 -12.83 40.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.942 1.697 . . . . 0.0 113.811 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -128.18 13.36 6.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.049 1.74 . . . . 0.0 113.354 -172.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.6 mt -131.56 143.58 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.458 1.903 . . . . 0.0 109.148 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -137.21 149.89 47.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.637 1.975 . . . . 0.0 110.521 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 150.14 48.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.304 0.642 . . . . 0.0 111.094 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -63.43 119.32 52.37 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.464 0.706 . . . . 0.0 110.821 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.22 168.83 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.807 2.338 . . . . 0.0 113.57 -172.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.58 118.49 4.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.141 1.776 . . . . 0.0 111.291 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 t70 57.76 36.54 26.6 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.529 1.932 . . . . 0.0 113.605 176.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -46.84 89.79 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.886 2.474 . . . . 0.0 115.212 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? 45.81 27.24 0.44 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.497 2.319 . . . . 0.0 114.65 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.82 179.4 36.46 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.429 1.49 . . . . 0.0 113.178 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -129.98 133.57 46.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.826 1.25 . . . . 0.0 111.468 -173.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -146.4 156.91 43.66 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.947 1.699 . . . . 0.0 110.796 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -81.78 38.92 0.53 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.721 1.609 . . . . 0.0 114.251 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.453 HG21 ' H ' ' A' ' 147' ' ' ALA . 2.8 mm -85.93 -149.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.883 1.673 . . . . 0.0 109.936 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.453 ' H ' HG21 ' A' ' 146' ' ' ILE . . . -72.02 48.32 0.16 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 114.37 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.29 -6.43 9.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.877 2.071 . . . . 0.0 115.307 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.43 162.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.914 2.086 . . . . 0.0 110.475 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.33 144.84 51.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.081 1.752 . . . . 0.0 111.103 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.623 1.569 . . . . 0.0 113.361 176.042 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.388 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 t -152.12 168.44 25.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.459 1.504 . . . . 0.0 111.452 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.2 p -149.73 80.6 1.39 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.379 1.472 . . . . 0.0 112.54 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.76 169.55 42.68 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.571 1.081 . . . . 0.0 113.586 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.5 m -163.17 160.05 23.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.181 1.793 . . . . 0.0 111.212 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 m -66.65 136.57 55.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.424 0.689 . . . . 0.0 111.587 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.65 -33.84 1.07 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.968 1.27 . . . . 0.0 113.283 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -81.19 144.07 31.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.501 1.12 . . . . 0.0 111.301 171.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -148.21 137.67 22.18 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.214 1.406 . . . . 0.0 110.927 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -77.91 166.72 22.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.807 0.843 . . . . 0.0 112.036 169.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -126.35 152.67 45.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.006 1.722 . . . . 0.0 111.795 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.9 137.85 54.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.173 0.589 . . . . 0.0 111.051 173.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.18 72.33 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.77 1.176 . . . . 0.0 114.886 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.51 142.45 28.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.738 1.269 . . . . 0.0 112.199 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.38 141.13 30.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.175 0.99 . . . . 0.0 111.849 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -146.39 170.16 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.185 1.794 . . . . 0.0 111.061 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.73 133.54 52.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.533 1.133 . . . . 0.0 107.998 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.42 159.04 44.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.4 -0.813 . . . . 0.0 112.526 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 139.61 35.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.211 1.004 . . . . 0.0 111.549 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -135.72 -29.24 1.05 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.2 m -142.41 -56.5 0.44 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.063 0.847 . . . . 0.0 112.19 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -119.28 176.97 5.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.015 1.326 . . . . 0.0 111.814 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.8 m -60.74 -20.74 61.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.44 128.02 33.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.655 1.182 . . . . 0.0 110.508 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -68.37 161.02 28.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.759 168.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.4 156.42 80.15 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.751 1.621 . . . . 0.0 110.37 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.57 135.52 36.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.407 2.071 . . . . 0.0 111.64 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.24 173.87 12.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.846 1.658 . . . . 0.0 111.093 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -144.15 133.12 22.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.6 117.86 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.991 0.917 . . . . 0.0 110.15 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -84.03 -37.28 22.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.087 1.355 . . . . 0.0 112.167 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.45 160.82 38.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.788 1.235 . . . . 0.0 112.347 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.64 143.21 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.799 1.64 . . . . 0.0 109.246 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -132.47 -50.93 0.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.857 0.863 . . . . 0.0 112.57 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -159.47 163.39 35.36 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.532 1.533 . . . . 0.0 110.283 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.67 -13.73 1.82 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.95 -11.59 39.5 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.296 1.427 . . . . 0.0 115.396 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.6 p -149.61 127.81 12.07 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 120.124 1.962 . . . . 0.0 113.535 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.25 144.34 46.8 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.861 1.664 . . . . 0.0 110.109 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -97.89 126.1 43.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.843 0.857 . . . . 0.0 109.121 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.28 130.81 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.052 0.941 . . . . 0.0 112.449 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.77 140.87 29.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.08 1.352 . . . . 0.0 109.529 169.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.58 168.25 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 111.43 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -58.17 -22.88 53.28 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.53 -13.54 61.05 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.24 -14.12 63.92 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.0 1.762 . . . . 0.0 114.258 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.65 151.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.735 1.614 . . . . 0.0 112.182 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.32 129.93 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.504 1.521 . . . . 0.0 109.993 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -146.45 167.7 23.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.015 1.726 . . . . 0.0 111.515 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 79.0 m -82.65 145.43 29.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.935 0.494 . . . . 0.0 110.346 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 37.3 mt -139.25 157.15 46.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.541 1.536 . . . . 0.0 111.252 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -81.49 155.65 25.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.906 1.282 . . . . 0.0 111.268 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -56.37 -29.3 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.859 1.264 . . . . 0.0 113.365 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 21.9 ttt -59.0 -14.85 10.56 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.707 1.603 . . . . 0.0 114.157 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -130.35 16.19 5.51 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.306 1.842 . . . . 0.0 112.805 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.4 mt -132.43 143.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.676 1.99 . . . . 0.0 108.825 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -136.87 149.2 47.52 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.227 2.211 . . . . 0.0 110.07 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.12 155.83 38.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.172 0.589 . . . . 0.0 111.114 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.1 mmt -64.47 145.67 98.37 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 121.949 -0.469 . . . . 0.0 111.824 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 169.03 20.35 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.649 2.899 . . . . 0.0 113.281 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.44 -17.81 46.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.964 1.706 . . . . 0.0 114.337 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.84 13.35 17.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.01 1.724 . . . . 0.0 113.886 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.68 37.52 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.504 1.922 . . . . 0.0 115.051 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.9 139.67 26.64 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.707 1.603 . . . . 0.0 114.149 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.66 143.48 3.71 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.633 1.587 . . . . 0.0 111.997 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 38.13 42.52 0.49 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.964 2.106 . . . . 0.0 115.194 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -82.18 77.19 9.01 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.54 1.536 . . . . 0.0 112.569 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -122.59 15.03 10.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.635 1.574 . . . . 0.0 113.958 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.2 pt -110.06 168.47 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.591 1.956 . . . . 0.0 111.366 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 51.44 26.11 3.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.567 1.947 . . . . 0.0 115.267 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.403 ' CD2' ' H ' ' A' ' 148' ' ' LEU . 2.2 pt? -74.85 29.98 0.09 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.899 2.48 . . . . 0.0 114.913 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.4 m -63.29 155.59 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 113.445 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.58 14.71 1.41 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.508 1.523 . . . . 0.0 114.062 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.471 1.908 . . . . 0.0 111.863 -178.379 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.363 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.7 p -152.88 163.49 39.67 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.909 1.284 . . . . 0.0 112.241 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 t 52.48 29.69 7.38 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.744 1.618 . . . . 0.0 114.593 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.64 160.24 48.8 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 121.085 -1.01 . . . . 0.0 114.571 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -81.61 160.12 23.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.986 1.314 . . . . 0.0 112.483 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.0 -9.94 59.14 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.321 1.048 . . . . 0.0 113.568 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.02 169.37 41.99 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.006 1.765 . . . . 0.0 112.424 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -59.96 -38.31 82.11 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -174.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.89 165.34 25.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.006 1.722 . . . . 0.0 110.908 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.12 176.61 3.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 0.0 111.768 168.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -122.89 128.08 49.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.624 1.57 . . . . 0.0 110.475 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.96 134.54 54.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.148 0.579 . . . . 0.0 111.528 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.23 -7.74 35.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.784 1.659 . . . . 0.0 115.178 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -79.12 146.82 32.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.776 1.288 . . . . 0.0 112.599 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.43 138.92 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.811 1.245 . . . . 0.0 111.807 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.6 174.23 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 127.174 2.19 . . . . 0.0 110.896 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.26 136.45 47.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.182 . . . . 0.0 107.98 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.41 31.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.597 -0.689 . . . . 0.0 112.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -72.97 142.68 47.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -146.72 -44.23 0.18 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 m -136.51 -16.7 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -147.97 -176.24 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.428 1.491 . . . . 0.0 111.228 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 77.3 m -67.89 -24.16 65.19 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.142 -0.974 . . . . 0.0 111.439 166.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -68.31 141.7 55.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.229 1.812 . . . . 0.0 111.953 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.47 163.87 22.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.563 0.745 . . . . 0.0 110.593 168.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -134.79 153.26 78.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.191 1.796 . . . . 0.0 110.669 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.57 135.1 25.56 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.683 2.256 . . . . 0.0 111.825 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.52 177.69 9.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.559 1.543 . . . . 0.0 110.581 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.92 151.71 51.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.133 0.973 . . . . 0.0 110.819 168.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.6 mt -81.14 113.68 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.675 0.79 . . . . 0.0 109.922 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -80.4 -32.83 37.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 112.747 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.77 36.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.064 0.946 . . . . 0.0 113.177 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.5 mt -130.79 133.31 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.424 1.89 . . . . 0.0 108.609 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.64 16.1 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.96 2.504 . . . . 0.0 117.288 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.97 -40.53 93.78 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.581 1.552 . . . . 0.0 113.26 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -137.45 17.57 2.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.739 1.616 . . . . 0.0 112.428 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.59 -1.87 64.32 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.249 1.404 . . . . 0.0 114.5 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.5 p -144.72 160.95 40.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.759 2.024 . . . . 0.0 110.973 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -70.41 148.2 48.63 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.285 0.634 . . . . 0.0 110.468 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.5 m -115.48 136.61 52.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.646 1.178 . . . . 0.0 108.392 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.5 m -135.95 156.15 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.899 . . . . 0.0 112.15 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -125.0 117.29 23.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.274 1.43 . . . . 0.0 109.473 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.71 165.39 22.88 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.119 0.968 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -54.0 -27.03 29.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.872 1.269 . . . . 0.0 114.367 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.94 -21.88 64.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.475 . . . . 0.0 113.863 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.14 56.78 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.668 1.604 . . . . 0.0 114.766 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.51 144.65 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.239 1.416 . . . . 0.0 112.179 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.78 109.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.038 1.335 . . . . 0.0 109.515 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -138.51 175.58 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.978 1.711 . . . . 0.0 111.644 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.56 155.6 18.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.326 1.05 . . . . 0.0 112.199 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.2 mt -144.77 156.91 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.11 156.32 38.8 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.417 1.087 . . . . 0.0 110.732 169.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -57.12 -24.83 56.87 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.05 -12.16 53.42 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.001 1.72 . . . . 0.0 114.126 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -120.86 12.04 11.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.727 1.611 . . . . 0.0 113.109 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -132.67 143.2 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.667 1.587 . . . . 0.0 109.565 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -134.72 147.29 50.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.765 2.026 . . . . 0.0 110.697 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.45 141.63 48.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.929 0.892 . . . . 0.0 110.959 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.2 tpp -64.98 122.32 78.86 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.663 0.785 . . . . 0.0 110.437 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 168.13 24.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.584 2.19 . . . . 0.0 113.092 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -51.57 106.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.852 2.461 . . . . 0.0 112.54 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.3 t70 51.71 44.44 29.23 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.684 1.994 . . . . 0.0 113.573 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.87 37.65 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.652 1.581 . . . . 0.0 115.038 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -153.71 151.87 30.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.629 1.972 . . . . 0.0 110.209 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.82 -156.26 4.15 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.866 1.222 . . . . 0.0 113.539 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 62.36 16.41 8.52 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.712 1.605 . . . . 0.0 114.375 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.7 153.44 34.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.078 1.751 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -140.98 -21.16 0.79 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.82 -13.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -171.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.56 -19.76 65.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.597 1.159 . . . . 0.0 113.593 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.76 61.96 4.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 111.398 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.26 142.21 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 111.926 -173.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.21 151.24 45.59 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.422 1.489 . . . . 0.0 112.239 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.257 1.823 . . . . 0.0 111.614 176.645 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -151.27 141.69 22.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.841 1.256 . . . . 0.0 111.113 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.4 m -148.24 162.67 39.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.994 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.27 169.99 42.71 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.698 1.142 . . . . 0.0 113.18 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -156.16 148.56 23.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 111.534 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -147.22 154.68 41.32 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.894 1.678 . . . . 0.0 111.143 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.08 172.63 45.85 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.819 0.723 . . . . 0.0 113.273 171.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.11 147.37 43.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.391 1.477 . . . . 0.0 110.521 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -141.33 54.66 1.54 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.065 1.346 . . . . 0.0 111.279 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -49.01 144.2 4.96 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.074 1.349 . . . . 0.0 112.575 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 154.81 43.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.864 1.266 . . . . 0.0 112.428 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.52 130.23 43.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.367 0.667 . . . . 0.0 111.547 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.61 -8.71 68.81 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.463 1.506 . . . . 0.0 114.371 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.24 132.52 41.13 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.018 1.409 . . . . 0.0 112.5 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.45 135.65 37.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.425 1.09 . . . . 0.0 111.64 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.35 -176.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.418 2.287 . . . . 0.0 111.009 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -111.39 145.09 39.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.132 0.973 . . . . 0.0 109.247 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 150.43 35.41 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.443 0.64 . . . . 0.0 112.46 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -80.72 154.29 27.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.543 1.537 . . . . 0.0 110.638 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.39 -47.51 0.52 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -142.95 -29.36 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -138.58 -169.51 2.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.095 1.758 . . . . 0.0 110.301 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.0 p -62.17 -15.56 47.06 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.631 -1.293 . . . . 0.0 114.415 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -62.8 145.4 55.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.554 1.541 . . . . 0.0 111.979 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -117.29 154.34 31.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.926 1.29 . . . . 0.0 109.444 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.64 152.8 71.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.677 1.191 . . . . 0.0 111.332 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.78 130.9 24.32 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.783 2.322 . . . . 0.0 110.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.76 12.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.242 1.417 . . . . 0.0 110.859 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -132.71 132.18 42.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.293 1.437 . . . . 0.0 109.458 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -71.45 121.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.111 0.564 . . . . 0.0 109.623 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -95.23 -32.25 13.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 112.343 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.99 40.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.841 1.257 . . . . 0.0 112.143 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -135.2 117.02 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.199 1.399 . . . . 0.0 109.084 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.71 14.52 0.29 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.078 2.151 . . . . 0.0 116.156 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.61 -34.12 66.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.025 1.73 . . . . 0.0 113.809 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -129.61 29.92 4.98 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.064 1.745 . . . . 0.0 111.012 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.95 2.67 88.33 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.969 1.271 . . . . 0.0 114.571 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.5 p -144.43 162.82 35.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.886 2.074 . . . . 0.0 111.066 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -75.96 160.39 29.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.443 0.697 . . . . 0.0 110.056 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.4 m -131.27 134.37 46.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.883 1.273 . . . . 0.0 108.727 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 150.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.407 1.083 . . . . 0.0 111.71 -175.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -118.29 134.15 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.581 1.552 . . . . 0.0 109.651 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -93.28 167.55 11.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.443 1.097 . . . . 0.0 112.156 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -53.7 -28.74 35.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.602 1.561 . . . . 0.0 114.463 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.42 -18.93 61.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.11 1.364 . . . . 0.0 113.797 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.92 -15.9 47.53 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.886 1.708 . . . . 0.0 114.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.34 146.12 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.393 1.477 . . . . 0.0 112.347 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 132.02 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.788 1.635 . . . . 0.0 109.986 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -143.71 168.73 19.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.948 1.699 . . . . 0.0 111.461 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.64 149.96 27.46 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.289 1.036 . . . . 0.0 111.712 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 mt -148.11 158.65 44.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.348 1.459 . . . . 0.0 112.458 -171.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -76.35 159.79 30.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.752 0.821 . . . . 0.0 109.534 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -56.58 -35.01 67.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.055 0.942 . . . . 0.0 112.472 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.8 mtt -64.52 -1.17 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 0.0 114.729 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -120.42 7.59 10.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.733 1.613 . . . . 0.0 113.193 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.5 mt -130.27 139.66 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.989 1.716 . . . . 0.0 108.822 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -136.72 147.09 46.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.468 1.507 . . . . 0.0 110.669 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 135.11 55.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.857 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 55.7 ttm -66.01 128.81 94.07 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.786 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.28 159.04 53.02 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.776 2.317 . . . . 0.0 112.06 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -60.93 -19.15 60.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.134 0.974 . . . . 0.0 113.492 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -72.72 -9.74 58.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.471 1.508 . . . . 0.0 114.156 172.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -135.31 -34.46 0.86 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.078 1.351 . . . . 0.0 114.001 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -62.73 127.5 31.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.436 1.494 . . . . 0.0 109.621 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.5 141.13 27.73 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.539 1.066 . . . . 0.0 114.566 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -61.33 129.92 43.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.228 . . . . 0.0 111.764 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . 0.321 2.3 p30 53.65 12.65 0.41 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 118.194 2.665 . . . . 0.0 118.194 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -60.87 -11.24 7.21 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.681 -1.262 . . . . 0.0 114.083 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.7 mm -56.76 -23.64 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.292 1.837 . . . . 0.0 112.736 170.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.24 138.19 47.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.136 1.374 . . . . 0.0 111.656 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.43 173.27 17.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.71 1.604 . . . . 0.0 112.133 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.1 p -146.45 160.63 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.711 1.604 . . . . 0.0 110.999 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 165.06 29.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.829 1.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.729 1.611 . . . . 0.0 113.488 178.319 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.405 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -142.43 164.13 30.96 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.7 1.6 . . . . 0.0 111.654 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -151.61 163.64 38.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.53 1.132 . . . . 0.0 112.878 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.85 162.72 25.88 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.207 1.384 . . . . 0.0 113.984 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.7 m -72.74 155.6 39.79 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.943 -0.739 . . . . 0.0 111.45 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.5 m -149.98 158.3 44.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.931 1.292 . . . . 0.0 112.094 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.97 70.84 1.47 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.881 1.705 . . . . 0.0 113.738 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -57.63 -20.95 36.6 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.461 1.505 . . . . 0.0 114.212 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -128.57 145.75 51.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.206 1.802 . . . . 0.0 111.48 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -119.55 151.08 39.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.809 1.644 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 162.68 40.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.332 1.853 . . . . 0.0 110.491 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.22 123.83 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.992 -0.443 . . . . 0.0 111.453 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.4 -7.16 78.1 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.289 1.423 . . . . 0.0 114.877 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.92 135.52 56.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.27 1.535 . . . . 0.0 111.619 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.12 138.81 31.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.777 0.831 . . . . 0.0 112.092 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.34 167.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.071 1.748 . . . . 0.0 111.03 -171.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.08 148.45 22.34 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.3 144.16 28.6 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.439 0.696 . . . . 0.0 111.571 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -72.62 152.84 41.54 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.149 0.98 . . . . 0.0 110.015 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -131.67 -160.28 1.03 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 112.152 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 m -55.24 -36.56 66.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.155 0.982 . . . . 0.0 111.382 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -84.07 139.59 32.38 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.021 1.329 . . . . 0.0 109.747 168.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.41 -21.46 65.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 158.51 24.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.008 1.276 . . . . 0.0 112.199 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.84 149.09 23.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.688 0.795 . . . . 0.0 110.263 168.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.65 152.77 69.3 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.257 1.423 . . . . 0.0 111.29 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 136.56 29.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.999 2.466 . . . . 0.0 112.141 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.13 13.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.736 1.615 . . . . 0.0 111.221 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -128.82 141.15 51.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 110.862 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.02 124.98 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.155 0.982 . . . . 0.0 109.58 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -95.57 -30.51 13.77 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.885 0.874 . . . . 0.0 112.894 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.76 153.22 32.74 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.6 mt -137.64 149.89 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.645 2.378 . . . . 0.0 108.467 -171.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.38 44.99 29.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.168 1.387 . . . . 0.0 113.571 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -70.34 -154.5 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.099 1.76 . . . . 0.0 110.012 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.91 -16.35 11.79 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.46 -1.4 . . . . 0.0 114.569 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 161.81 -30.93 0.31 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.528 2.013 . . . . 0.0 112.51 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 171.8 13.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.784 2.434 . . . . 0.0 112.057 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -113.4 162.98 15.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.891 1.676 . . . . 0.0 108.714 168.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.3 m -122.06 133.33 54.79 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.204 -0.935 . . . . 0.0 109.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.94 157.07 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -128.41 128.6 44.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.154 1.382 . . . . 0.0 110.145 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -81.74 162.63 22.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 112.485 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -52.96 -31.74 42.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.339 1.456 . . . . 0.0 114.814 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.35 -17.33 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.53 -21.17 8.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.277 1.418 . . . . 0.0 115.449 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.42 146.83 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.289 1.544 . . . . 0.0 112.857 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.78 128.87 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 109.215 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -143.95 175.07 10.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.173 1.789 . . . . 0.0 110.922 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.7 m -113.68 141.73 46.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 110.523 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -144.07 146.44 32.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.404 1.882 . . . . 0.0 109.731 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.4 160.86 30.45 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.409 -0.807 . . . . 0.0 110.978 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.95 8.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.804 1.242 . . . . 0.0 113.916 168.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.67 -12.54 34.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.541 1.936 . . . . 0.0 113.892 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.41 9.51 6.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.3 1.84 . . . . 0.0 113.157 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -126.25 143.42 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.15 2.18 . . . . 0.0 108.18 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -135.31 148.69 49.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.55 1.54 . . . . 0.0 110.854 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.51 145.47 48.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.703 0.801 . . . . 0.0 111.028 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -62.54 131.12 93.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 118.814 -0.612 . . . . 0.0 110.857 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 172.09 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.581 2.854 . . . . 0.0 113.941 -171.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -60.81 -18.61 56.53 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -148.27 133.36 18.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.299 1.44 . . . . 0.0 111.292 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -159.61 -38.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.798 1.639 . . . . 0.0 112.362 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -147.21 141.54 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.029 2.132 . . . . 0.0 109.196 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.39 113.38 5.63 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.669 1.128 . . . . 0.0 113.766 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -156.02 170.55 21.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.973 1.309 . . . . 0.0 112.605 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.06 31.62 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.511 1.924 . . . . 0.0 115.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.32 26.67 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.893 1.677 . . . . 0.0 114.007 172.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.04 131.8 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.631 1.972 . . . . 0.0 109.123 -170.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.48 33.13 3.75 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.56 1.544 . . . . 0.0 114.218 -173.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.46 165.85 5.76 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.674 1.59 . . . . 0.0 114.218 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.72 129.81 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.744 1.218 . . . . 0.0 111.272 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -60.31 156.66 15.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.172 1.389 . . . . 0.0 114.026 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.452 1.501 . . . . 0.0 113.128 174.669 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -64.41 -25.63 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.7 m -136.7 -7.39 1.91 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -171.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.09 172.66 10.75 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.778 1.18 . . . . 0.0 114.658 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -158.55 38.88 0.24 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.109 1.364 . . . . 0.0 111.762 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 m -57.21 -31.8 65.85 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.24 165.57 17.37 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.664 1.126 . . . . 0.0 113.987 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -86.37 88.03 7.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.99 158.53 43.92 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.516 1.527 . . . . 0.0 111.474 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -138.45 -178.46 5.3 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.511 1.924 . . . . 0.0 111.479 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -119.17 128.02 53.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.982 1.713 . . . . 0.0 109.911 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 133.76 52.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.146 0.578 . . . . 0.0 111.34 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.07 75.34 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.884 1.23 . . . . 0.0 115.061 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.47 154.09 20.3 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.908 1.354 . . . . 0.0 112.411 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.36 142.55 27.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.175 0.99 . . . . 0.0 112.533 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.24 174.79 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.911 2.084 . . . . 0.0 110.86 -170.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.0 124.99 52.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.724 1.21 . . . . 0.0 109.32 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.14 154.84 44.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -88.66 147.1 24.7 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.043 1.337 . . . . 0.0 111.674 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -143.73 -30.53 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -139.11 -28.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -169.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.55 -167.81 2.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.027 1.731 . . . . 0.0 110.064 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.7 m -66.73 -13.89 61.9 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.836 -1.165 . . . . 0.0 113.727 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -69.18 166.55 18.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.189 1.796 . . . . 0.0 113.378 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -129.13 152.01 49.19 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.883 1.673 . . . . 0.0 109.991 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -139.12 156.01 72.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.48 1.512 . . . . 0.0 110.738 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.41 132.08 28.25 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.428 2.085 . . . . 0.0 111.881 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.86 172.02 13.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.798 1.639 . . . . 0.0 110.59 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -128.75 129.26 45.48 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.211 1.804 . . . . 0.0 109.605 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.62 120.94 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.367 0.667 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.29 -27.37 15.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.879 0.872 . . . . 0.0 112.69 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.69 156.44 29.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.235 1.414 . . . . 0.0 111.603 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.48 127.75 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.736 1.615 . . . . 0.0 108.936 -174.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -153.0 114.67 4.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.783 0.833 . . . . 0.0 111.697 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -63.12 -7.63 6.09 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.89 -28.88 39.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.399 1.48 . . . . 0.0 113.509 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.28 -22.45 0.08 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 117.991 1.957 . . . . 0.0 117.991 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.93 153.04 37.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.03 1.915 . . . . 0.0 113.111 -169.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.44 124.92 52.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.786 1.634 . . . . 0.0 109.839 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -80.72 132.23 35.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.69 0.796 . . . . 0.0 110.403 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.17 146.21 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.056 1.342 . . . . 0.0 112.438 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.14 119.61 29.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.317 1.847 . . . . 0.0 109.223 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -89.67 165.58 14.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.121 0.968 . . . . 0.0 111.005 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -58.94 -18.8 36.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -69.09 -15.72 63.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.74 1.216 . . . . 0.0 113.928 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.95 -15.49 61.57 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.248 1.88 . . . . 0.0 114.321 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.26 146.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.84 1.656 . . . . 0.0 112.231 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 126.42 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 110.125 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -140.71 -162.57 1.38 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.945 2.098 . . . . 0.0 109.236 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.53 151.93 47.78 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.164 -0.96 . . . . 0.0 112.138 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -139.13 158.12 44.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.54 1.536 . . . . 0.0 111.904 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.13 158.01 36.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.65 1.18 . . . . 0.0 110.756 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.68 -17.86 57.25 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.97 -12.24 61.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.14 1.376 . . . . 0.0 113.427 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -127.03 9.88 6.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.982 1.713 . . . . 0.0 113.321 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.66 136.83 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.55 1.94 . . . . 0.0 108.243 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -134.48 148.74 50.62 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.175 1.79 . . . . 0.0 110.281 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.3 138.24 58.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.228 0.611 . . . . 0.0 110.549 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.7 ttm -64.92 127.04 92.32 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.12 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 162.11 40.85 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.063 2.509 . . . . 0.0 113.704 -169.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.87 -19.79 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.32 -23.05 60.2 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.773 1.229 . . . . 0.0 113.361 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.19 173.59 12.38 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.653 1.181 . . . . 0.0 112.933 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -72.37 30.77 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.144 2.177 . . . . 0.0 114.092 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.12 51.22 0.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.627 1.108 . . . . 0.0 114.361 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -56.13 155.21 6.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -93.78 162.29 13.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.631 1.172 . . . . 0.0 113.188 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -73.23 54.34 0.41 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.993 2.517 . . . . 0.0 113.248 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pp -59.81 -5.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.68 18.93 6.21 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.381 1.872 . . . . 0.0 113.406 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.73 159.68 5.08 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.83 146.12 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.143 1.377 . . . . 0.0 112.753 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -139.74 137.87 35.46 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 110.948 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.203 1.801 . . . . 0.0 111.829 -179.302 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.39 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.1 m 57.68 20.89 6.74 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.083 1.753 . . . . 0.0 115.718 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.6 t -73.58 175.06 7.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.706 1.202 . . . . 0.0 112.598 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.93 -35.2 0.03 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.612 1.101 . . . . 0.0 114.092 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 p -157.36 141.64 16.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.818 1.247 . . . . 0.0 111.799 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -142.11 1.02 1.41 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.79 35.27 0.02 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.037 0.827 . . . . 0.0 114.609 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -138.77 131.32 28.9 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.451 1.1 . . . . 0.0 112.059 -170.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.64 159.51 33.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.405 1.882 . . . . 0.0 110.254 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -60.11 150.23 30.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.777 0.831 . . . . 0.0 112.26 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.63 160.18 39.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.58 57.78 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.728 -0.607 . . . . 0.0 112.109 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 81.58 -11.57 45.04 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.92 1.724 . . . . 0.0 114.85 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.23 131.15 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.241 1.416 . . . . 0.0 112.701 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.21 140.18 40.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.557 1.143 . . . . 0.0 112.449 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.84 171.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.685 1.994 . . . . 0.0 111.322 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.42 139.32 38.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.6 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -87.02 150.14 24.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.122 1.369 . . . . 0.0 111.312 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -143.83 -44.46 0.27 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 -5.15 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.55 177.01 11.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.29 1.436 . . . . 0.0 111.082 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 -30.09 68.4 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.076 -1.015 . . . . 0.0 112.863 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -56.71 156.78 6.01 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.843 1.657 . . . . 0.0 113.275 172.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -119.23 155.23 32.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.255 1.422 . . . . 0.0 109.596 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -136.5 155.51 76.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.693 1.197 . . . . 0.0 111.28 -170.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.03 132.33 27.79 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.778 2.319 . . . . 0.0 111.916 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.02 179.35 8.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.19 1.796 . . . . 0.0 110.349 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -141.86 151.8 43.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.105 0.962 . . . . 0.0 112.223 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 72.9 mt -75.06 122.52 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.564 1.146 . . . . 0.0 110.093 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -93.67 -31.53 14.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.404 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.69 156.28 34.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.256 1.022 . . . . 0.0 112.937 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -133.13 131.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.563 1.945 . . . . 0.0 108.345 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 p30 50.33 -5.44 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.4 3.111 . . . . 0.0 119.4 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.46 -18.67 41.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.76 1.618 . . . . 0.0 114.903 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.61 19.92 4.7 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.019 1.727 . . . . 0.0 111.015 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.07 -50.81 2.35 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.733 2.111 . . . . 0.0 112.311 -169.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -71.19 158.78 35.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.652 1.981 . . . . 0.0 111.343 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -81.0 160.31 24.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.888 0.875 . . . . 0.0 110.407 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.0 m -126.21 137.89 53.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.299 1.04 . . . . 0.0 109.123 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.65 152.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.624 1.169 . . . . 0.0 111.926 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.82 130.23 53.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.687 1.595 . . . . 0.0 109.794 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.1 169.67 9.95 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.759 1.223 . . . . 0.0 112.206 -176.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -57.3 -24.22 53.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.44 -12.82 60.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.554 1.141 . . . . 0.0 113.95 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.26 -14.15 65.64 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.898 1.713 . . . . 0.0 114.493 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.42 148.28 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.503 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.97 130.63 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.914 1.686 . . . . 0.0 110.267 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -146.43 163.25 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.754 1.622 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.13 145.13 30.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.5 0.72 . . . . 0.0 110.705 168.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.14 144.8 30.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.106 1.362 . . . . 0.0 110.835 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -69.52 158.85 34.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.349 0.66 . . . . 0.0 111.337 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -57.08 -21.57 32.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.13 -12.88 58.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.608 1.563 . . . . 0.0 113.889 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -127.11 11.52 7.04 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.954 1.702 . . . . 0.0 113.354 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.58 139.54 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.593 1.957 . . . . 0.0 108.484 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.09 145.79 44.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.033 1.733 . . . . 0.0 110.883 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.44 149.26 50.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.163 0.585 . . . . 0.0 110.758 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.5 mtt -65.1 145.53 99.08 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.092 0.557 . . . . 0.0 112.332 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.82 166.75 28.57 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.332 2.688 . . . . 0.0 112.425 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.25 -31.91 67.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.606 1.162 . . . . 0.0 113.923 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.48 -15.76 54.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 45.82 1.03 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.236 1.414 . . . . 0.0 112.749 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -61.07 160.19 10.46 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.939 1.696 . . . . 0.0 112.863 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -177.45 -35.12 0.05 OUTLIER Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.137 0.875 . . . . 0.0 114.375 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -143.39 168.32 20.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.031 1.732 . . . . 0.0 111.042 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -142.74 132.04 23.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.081 1.352 . . . . 0.0 110.781 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -151.75 107.04 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.736 1.615 . . . . 0.0 109.872 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 57.6 mt -136.16 141.67 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.757 1.623 . . . . 0.0 109.343 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 52.75 22.48 2.31 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.668 1.987 . . . . 0.0 115.982 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -74.07 -1.4 19.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.937 1.695 . . . . 0.0 115.106 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.84 151.07 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.769 1.228 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.2 22.33 3.55 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.492 1.917 . . . . 0.0 115.374 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.367 1.467 . . . . 0.0 113.18 173.153 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.398 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.3 t -59.87 152.21 23.89 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.03 0.932 . . . . 0.0 112.39 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.1 p -68.71 -17.99 64.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.43 -162.2 36.0 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.655 1.121 . . . . 0.0 113.813 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t 53.98 36.77 25.25 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.154 1.782 . . . . 0.0 114.556 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -56.11 124.77 18.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.15 1.38 . . . . 0.0 112.347 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.05 -15.94 1.14 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.531 1.063 . . . . 0.0 115.262 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 47.61 14.73 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.47 143.12 25.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.227 1.411 . . . . 0.0 111.331 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -83.2 170.3 14.85 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.02 1.328 . . . . 0.0 113.636 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -138.46 157.43 46.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.738 2.015 . . . . 0.0 111.249 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.75 136.38 58.05 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.927 -0.483 . . . . 0.0 111.326 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.14 -1.34 87.22 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.645 1.117 . . . . 0.0 114.988 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.97 142.2 52.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.359 1.58 . . . . 0.0 111.877 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.17 145.32 24.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.924 0.89 . . . . 0.0 111.714 177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -148.41 162.28 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.558 1.543 . . . . 0.0 112.022 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.05 118.25 36.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.876 1.671 . . . . 0.0 107.245 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.9 48.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.219 0.608 . . . . 0.0 112.142 -172.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -74.71 150.21 39.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.992 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -134.05 -40.39 0.84 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.3 m -159.36 -51.0 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.401 1.081 . . . . 0.0 111.282 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -74.95 170.59 15.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 0.0 112.039 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.7 m -73.38 43.54 0.14 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.234 1.814 . . . . 0.0 112.56 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -140.75 162.44 35.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 110.77 -171.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.428 ' CD2' ' HE2' ' A' ' 134' ' ' LYS . 53.2 m-85 -124.0 145.73 49.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.967 1.307 . . . . 0.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.85 154.31 77.75 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.117 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.68 131.27 25.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 0.0 112.016 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.69 174.6 12.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.189 1.796 . . . . 0.0 110.904 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.4 133.81 33.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.313 1.445 . . . . 0.0 110.686 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.26 120.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.166 0.986 . . . . 0.0 110.582 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.14 -30.01 14.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.416 1.486 . . . . 0.0 112.488 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.64 161.93 39.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.528 1.131 . . . . 0.0 112.803 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.37 148.62 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 109.733 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.82 6.4 2.13 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.501 2.32 . . . . 0.0 116.462 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.85 110.54 1.19 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.721 -1.237 . . . . 0.0 110.373 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.254 4.3 pm0 39.28 43.6 0.94 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.897 1.679 . . . . 0.0 114.785 -169.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.71 68.54 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.181 -0.949 . . . . 0.0 114.238 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 m -138.98 162.74 34.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -111.6 159.63 17.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.482 1.513 . . . . 0.0 109.856 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.3 m -125.19 133.15 52.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 108.635 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.45 133.3 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.134 0.974 . . . . 0.0 111.978 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -93.12 125.19 37.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.887 1.275 . . . . 0.0 109.5 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.66 165.63 14.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.912 0.885 . . . . 0.0 111.561 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -54.5 -26.92 34.37 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.61 -20.11 62.03 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.023 1.329 . . . . 0.0 113.778 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.51 -17.14 40.2 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.169 1.842 . . . . 0.0 114.075 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.63 150.39 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.778 1.631 . . . . 0.0 112.226 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.1 mt -133.66 127.48 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 109.819 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -143.86 175.83 9.71 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.233 1.813 . . . . 0.0 110.853 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.5 m -107.4 146.03 32.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.503 1.121 . . . . 0.0 111.738 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.9 mt -147.42 152.97 39.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.093 1.757 . . . . 0.0 111.415 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.96 158.99 27.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.97 0.908 . . . . 0.0 110.872 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -57.91 -26.1 61.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.911 1.284 . . . . 0.0 113.661 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.9 ttm -54.78 -18.88 5.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.352 1.861 . . . . 0.0 114.116 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -123.75 13.17 9.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.9 1.68 . . . . 0.0 113.127 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -134.59 136.62 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.493 1.917 . . . . 0.0 109.093 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.428 ' HE2' ' CD2' ' A' ' 102' ' ' TYR . 55.4 mtmt -132.87 150.41 52.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.918 1.687 . . . . 0.0 110.376 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.95 152.85 35.47 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.288 0.635 . . . . 0.0 111.789 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.4 tpt -59.21 125.93 80.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.54 0.736 . . . . 0.0 110.461 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.65 153.05 65.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.431 2.088 . . . . 0.0 112.117 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.5 -27.24 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.74 0.816 . . . . 0.0 112.78 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -84.47 1.58 44.9 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.669 1.588 . . . . 0.0 114.194 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.58 137.45 53.64 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.074 -1.016 . . . . 0.0 112.861 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -69.69 140.33 53.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 111.766 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.0 164.19 31.62 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.308 1.432 . . . . 0.0 114.535 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -159.59 176.94 11.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.886 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -130.94 86.55 2.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.792 1.637 . . . . 0.0 109.569 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -54.01 -23.59 13.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 114.894 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.45 HD12 ' H ' ' A' ' 146' ' ' ILE . 5.0 mp -59.26 -27.68 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.912 1.685 . . . . 0.0 111.923 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.17 21.02 2.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.778 1.631 . . . . 0.0 114.095 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.13 151.38 40.3 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.846 -1.159 . . . . 0.0 113.682 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -143.96 147.58 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.338 1.855 . . . . 0.0 109.154 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -137.0 45.49 2.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.547 1.539 . . . . 0.0 111.968 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.555 1.942 . . . . 0.0 111.772 -176.751 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.441 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.4 t -154.06 153.98 32.86 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -66.91 -24.29 66.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.356 1.062 . . . . 0.0 113.436 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -53.61 1.64 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.329 1.919 . . . . 0.0 114.388 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -75.96 174.35 10.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.509 1.524 . . . . 0.0 112.179 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -59.04 150.32 25.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.57 1.148 . . . . 0.0 112.134 172.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.56 158.76 19.27 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.422 1.01 . . . . 0.0 113.871 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.627 1.571 . . . . 0.0 111.144 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -144.47 137.56 27.02 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.299 1.44 . . . . 0.0 110.64 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.0 168.09 20.19 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.59 0.756 . . . . 0.0 112.447 171.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -140.33 160.1 40.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.884 1.674 . . . . 0.0 111.956 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.2 58.85 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.854 -0.529 . . . . 0.0 111.775 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.32 -12.81 49.15 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.786 1.66 . . . . 0.0 114.885 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.0 138.47 44.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.658 1.183 . . . . 0.0 112.277 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.52 141.79 34.81 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.461 1.104 . . . . 0.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 m -151.88 168.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.372 1.869 . . . . 0.0 111.023 -171.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.03 129.84 44.87 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.09 133.41 41.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 111.187 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -67.77 161.21 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.868 1.267 . . . . 0.0 110.994 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -135.56 -163.79 1.44 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.454 1.102 . . . . 0.0 111.238 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -29.91 70.76 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.49 -0.757 . . . . 0.0 112.602 171.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.03 154.48 28.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.558 1.143 . . . . 0.0 112.005 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.57 33.8 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.165 1.786 . . . . 0.0 115.579 -176.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -137.69 157.22 46.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.472 1.909 . . . . 0.0 111.77 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.3 148.58 24.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.033 1.333 . . . . 0.0 110.215 170.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -140.04 154.32 70.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.82 1.648 . . . . 0.0 111.222 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.85 129.45 20.9 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.538 2.159 . . . . 0.0 111.358 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.86 175.29 11.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.7 1.6 . . . . 0.0 111.247 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.11 136.85 47.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.09 1.356 . . . . 0.0 110.654 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.37 140.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.692 0.797 . . . . 0.0 109.534 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -116.6 -27.99 6.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.539 1.136 . . . . 0.0 113.173 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.09 155.34 33.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.65 1.18 . . . . 0.0 111.286 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.02 138.87 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.661 1.584 . . . . 0.0 108.592 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.87 130.29 35.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.7 1.2 . . . . 0.0 111.57 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -42.31 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.251 2.621 . . . . 0.0 114.409 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 54.31 17.26 1.47 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.011 2.124 . . . . 0.0 115.293 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.16 -61.14 0.21 Allowed Glycine 0 N--CA 1.469 0.874 0 O-C-N 120.991 -1.068 . . . . 0.0 114.729 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 17.7 p -146.8 162.68 38.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -137.86 124.62 21.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.921 2.089 . . . . 0.0 108.711 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -87.74 135.42 33.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.657 0.783 . . . . 0.0 109.056 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.63 156.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.583 1.153 . . . . 0.0 112.156 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -124.5 131.01 53.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.22 1.408 . . . . 0.0 109.795 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.56 167.59 12.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 111.676 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -59.07 -23.38 62.0 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -72.33 -14.01 61.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.655 1.182 . . . . 0.0 113.87 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.62 -15.65 62.76 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.677 1.608 . . . . 0.0 114.329 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.54 146.46 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.446 1.498 . . . . 0.0 112.477 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.84 128.07 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.769 1.628 . . . . 0.0 109.387 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -144.96 178.18 8.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.635 1.974 . . . . 0.0 110.508 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 p -122.76 152.37 40.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -139.72 165.36 27.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.55 1.94 . . . . 0.0 110.937 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -79.8 159.03 26.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.572 0.749 . . . . 0.0 110.68 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -55.94 -29.33 59.97 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -70.97 -21.01 62.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.421 1.088 . . . . 0.0 113.638 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -86.08 4.63 37.32 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.72 1.208 . . . . 0.0 113.578 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.5 mt -131.93 140.34 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.372 1.069 . . . . 0.0 110.522 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -137.71 153.11 49.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.974 2.11 . . . . 0.0 110.817 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.92 165.63 22.92 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.08 0.552 . . . . 0.0 111.236 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 146.91 72.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.185 0.594 . . . . 0.0 111.941 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.43 163.62 35.86 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.164 2.576 . . . . 0.0 113.402 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.25 -9.34 23.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.485 1.514 . . . . 0.0 114.745 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.38 26.31 4.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.651 1.981 . . . . 0.0 112.978 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.82 72.88 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.373 2.269 . . . . 0.0 114.542 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.0 tttt 51.59 28.42 4.66 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 127.11 2.164 . . . . 0.0 113.472 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.28 -167.65 33.97 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 126.125 1.821 . . . . 0.0 112.062 -171.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -144.41 171.01 14.94 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.521 1.528 . . . . 0.0 111.363 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -145.6 128.88 16.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 112.116 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -144.39 16.59 1.68 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.651 1.58 . . . . 0.0 113.365 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.7 pt -56.14 131.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 40.58 48.8 2.6 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.686 1.994 . . . . 0.0 114.433 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.94 162.73 2.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.062 1.345 . . . . 0.0 114.07 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.45 175.65 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.759 1.624 . . . . 0.0 112.681 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 56.39 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.797 2.039 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.534 1.934 . . . . 0.0 113.306 176.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 m -70.02 98.36 1.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.985 1.314 . . . . 0.0 112.512 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 m -73.42 46.62 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.689 1.996 . . . . 0.0 113.853 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.79 29.25 1.28 Allowed Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.131 1.824 . . . . 0.0 113.313 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -74.93 4.88 5.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.693 1.997 . . . . 0.0 115.488 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -141.86 166.84 23.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.229 1.412 . . . . 0.0 113.034 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.91 -133.76 1.93 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.208 1.385 . . . . 0.0 111.948 -172.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -130.99 139.38 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.98 1.312 . . . . 0.0 111.347 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -157.15 157.76 35.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.287 1.435 . . . . 0.0 111.101 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -81.25 179.15 7.98 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.105 1.362 . . . . 0.0 112.37 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -133.18 160.04 38.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.376 1.871 . . . . 0.0 111.488 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.05 129.0 38.82 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.773 -0.58 . . . . 0.0 110.062 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.07 83.67 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.55 -1.139 . . . . 0.0 115.365 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.04 140.13 58.84 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.041 1.921 . . . . 0.0 111.155 172.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.85 121.0 39.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.526 1.13 . . . . 0.0 109.028 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.09 174.59 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.46 . . . . 0.0 112.181 -166.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -107.09 141.48 38.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.521 1.128 . . . . 0.0 108.967 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.66 156.03 35.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -71.74 151.82 43.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.068 1.347 . . . . 0.0 111.04 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -132.99 -38.89 0.96 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 t -157.6 -32.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.71 -176.87 3.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.52 1.528 . . . . 0.0 112.612 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.3 t -73.22 39.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.103 1.761 . . . . 0.0 114.49 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.22 165.86 25.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.416 2.286 . . . . 0.0 111.021 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.48 153.57 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.417 1.087 . . . . 0.0 110.269 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -137.39 154.14 75.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 110.796 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.3 136.47 40.33 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.852 2.368 . . . . 0.0 112.523 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.09 174.69 12.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 111.467 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -134.68 135.46 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.377 1.471 . . . . 0.0 109.933 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.8 mt -74.26 120.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 0.0 109.956 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -84.38 -36.86 22.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.857 1.263 . . . . 0.0 112.314 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.78 160.32 36.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.768 1.227 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt -134.55 130.88 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.674 1.589 . . . . 0.0 109.7 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -163.65 110.86 1.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.55 -24.08 59.88 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.749 1.22 . . . . 0.0 113.078 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.81 -8.94 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.744 1.618 . . . . 0.0 114.368 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.24 -84.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.318 -0.864 . . . . 0.0 113.532 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.7 p -154.41 158.83 40.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.948 1.299 . . . . 0.0 112.917 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -84.26 112.48 20.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.053 1.741 . . . . 0.0 109.296 169.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 m -74.59 134.69 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.507 -0.745 . . . . 0.0 109.425 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.44 141.14 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.69 1.196 . . . . 0.0 111.825 -170.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -115.82 125.22 52.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.403 1.481 . . . . 0.0 109.278 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.91 167.33 11.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.002 0.921 . . . . 0.0 111.875 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -52.76 -28.76 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.96 -18.71 61.98 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.833 1.253 . . . . 0.0 113.693 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.07 -16.95 38.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.3 1.905 . . . . 0.0 113.995 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.82 147.5 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.088 1.755 . . . . 0.0 112.659 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.46 130.34 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.629 1.572 . . . . 0.0 110.391 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -142.66 -163.59 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.287 2.235 . . . . 0.0 109.56 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.3 p -140.35 156.97 46.23 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.202 -0.936 . . . . 0.0 112.647 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -145.04 171.62 14.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.292 1.837 . . . . 0.0 111.776 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.09 158.3 16.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.139 1.376 . . . . 0.0 109.461 168.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -53.19 -28.88 28.85 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -65.31 -14.44 60.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.215 1.406 . . . . 0.0 114.217 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -108.9 9.14 26.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.465 1.506 . . . . 0.0 112.985 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.38 145.38 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.105 1.762 . . . . 0.0 109.694 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -139.7 151.23 45.72 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.242 2.217 . . . . 0.0 111.0 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.54 162.8 26.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.575 0.75 . . . . 0.0 111.63 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.9 mmt -64.34 149.27 94.99 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.188 0.595 . . . . 0.0 112.429 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.12 175.64 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.192 3.262 . . . . 0.0 113.239 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.8 -13.31 31.81 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.968 1.307 . . . . 0.0 114.07 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.25 -7.53 59.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.187 1.395 . . . . 0.0 113.532 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.05 47.49 2.02 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.76 2.024 . . . . 0.0 111.174 -170.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -57.46 -23.35 49.25 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.802 2.041 . . . . 0.0 115.87 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.44 -162.59 49.5 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.962 0.792 . . . . 0.0 113.715 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -132.79 29.49 4.14 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.807 1.643 . . . . 0.0 111.896 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.0 -31.16 69.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 84.9 m95 40.5 44.89 1.82 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.822 2.049 . . . . 0.0 114.762 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . 0.423 HG21 ' H ' ' A' ' 147' ' ' ALA . 0.5 OUTLIER -68.04 -177.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.69 1.596 . . . . 0.0 110.009 170.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.423 ' H ' HG21 ' A' ' 146' ' ' ILE . . . -50.87 119.24 3.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.564 1.145 . . . . 0.0 111.408 173.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.8 -0.79 4.26 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.801 1.24 . . . . 0.0 114.291 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 56.7 t -77.85 145.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.294 1.438 . . . . 0.0 110.435 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -146.76 168.07 22.27 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.594 1.558 . . . . 0.0 112.459 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.324 1.849 . . . . 0.0 111.742 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -155.54 158.12 37.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.596 1.558 . . . . 0.0 111.419 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.81 127.53 32.67 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.952 -0.468 . . . . 0.0 110.887 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.66 -11.64 64.67 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.667 1.603 . . . . 0.0 114.68 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.11 134.72 51.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.3 1.55 . . . . 0.0 111.902 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.51 138.05 37.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.329 0.652 . . . . 0.0 111.003 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.1 m -146.29 176.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.193 1.797 . . . . 0.0 111.22 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.1 mt -112.87 144.94 41.57 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.05 1.34 . . . . 0.0 108.475 168.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.17 146.5 31.79 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.239 0.543 . . . . 0.0 111.673 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -74.15 140.43 45.18 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 109.438 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -121.71 -162.98 1.02 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.347 1.059 . . . . 0.0 111.472 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.9 m -55.25 -35.14 64.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.365 -0.834 . . . . 0.0 111.197 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.61 135.46 33.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.398 1.479 . . . . 0.0 109.35 167.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.2 m -65.32 -21.4 66.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -63.6 145.56 55.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.207 1.003 . . . . 0.0 111.557 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -79.46 151.78 30.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.099 0.56 . . . . 0.0 110.848 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.64 154.23 65.99 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.043 1.337 . . . . 0.0 111.648 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 130.43 23.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.04 2.493 . . . . 0.0 111.355 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.89 -179.65 6.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.983 1.713 . . . . 0.0 110.539 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -143.3 152.82 42.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.48 1.112 . . . . 0.0 111.486 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -75.54 128.96 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.409 1.083 . . . . 0.0 109.606 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -98.54 -33.59 10.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.55 1.14 . . . . 0.0 112.185 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.43 35.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.799 1.24 . . . . 0.0 112.194 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 125.615 1.566 . . . . 0.0 109.128 -176.397 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 C--O 1.236 0.364 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -76.25 133.63 40.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.03 152.49 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.848 1.259 . . . . 0.0 111.633 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -122.99 134.34 54.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.362 1.465 . . . . 0.0 110.313 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.11 164.52 13.23 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.0 111.62 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -55.49 -27.44 48.49 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 114.371 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.29 -22.31 63.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.157 1.383 . . . . 0.0 113.712 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.5 28.36 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.987 1.756 . . . . 0.0 113.937 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.97 145.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.411 1.485 . . . . 0.0 112.585 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.5 mt -128.56 130.47 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.603 1.561 . . . . 0.0 109.481 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -142.14 173.83 11.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.216 1.807 . . . . 0.0 111.063 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -120.57 139.1 53.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.971 1.309 . . . . 0.0 110.363 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.7 mt -140.81 167.45 22.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.449 1.5 . . . . 0.0 111.659 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.61 156.55 19.44 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.173 0.989 . . . . 0.0 110.114 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -28.8 13.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 96.7 mtp -67.05 -10.43 49.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.362 1.465 . . . . 0.0 113.88 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -117.54 8.82 13.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.381 1.472 . . . . 0.0 113.572 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.7 mt -128.43 144.64 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.15 1.78 . . . . 0.0 109.215 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -138.92 150.32 45.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 0.0 111.063 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.38 132.16 45.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 CA--C 1.55 0.947 0 O-C-N 121.784 -0.572 . . . . 0.0 111.779 176.053 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -138.0 148.07 44.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 113.166 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.24 132.59 54.48 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.57 -0.706 . . . . 0.0 111.723 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.77 6.15 66.32 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.73 141.47 48.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.185 1.492 . . . . 0.0 111.839 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 132.27 38.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.005 0.922 . . . . 0.0 111.669 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.16 175.62 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.506 1.522 . . . . 0.0 111.918 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.3 151.63 35.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.406 1.483 . . . . 0.0 108.971 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.67 154.82 36.06 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.207 -0.933 . . . . 0.0 112.255 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -72.01 156.85 38.78 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.022 1.329 . . . . 0.0 110.236 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -136.91 -150.09 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.53 0.732 . . . . 0.0 112.274 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.2 p -62.54 -3.0 1.23 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.792 1.637 . . . . 0.0 114.735 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -129.24 161.76 29.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.811 2.045 . . . . 0.0 110.543 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.6 -21.69 66.78 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.33 147.05 53.87 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.315 1.446 . . . . 0.0 112.259 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -86.55 152.76 22.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.111 0.564 . . . . 0.0 109.622 167.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -139.76 152.15 67.6 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.462 1.105 . . . . 0.0 111.805 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.61 137.33 38.72 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.302 2.668 . . . . 0.0 112.319 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.81 176.83 10.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.274 1.43 . . . . 0.0 111.715 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -135.25 139.94 44.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.954 1.702 . . . . 0.0 109.578 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.0 mm -61.49 134.78 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.501 0.721 . . . . 0.0 110.251 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -106.75 -29.99 9.22 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.214 1.806 . . . . 0.0 112.106 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 148.18 27.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.989 0.916 . . . . 0.0 113.154 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 127.709 2.404 . . . . 0.0 108.246 176.938 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.4 m -111.93 140.17 46.82 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.736 -0.602 . . . . 0.0 109.561 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.67 151.77 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.763 1.225 . . . . 0.0 112.207 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -112.72 124.07 51.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.84 1.656 . . . . 0.0 108.87 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.72 163.58 27.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.561 0.745 . . . . 0.0 112.24 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -54.17 -29.75 46.84 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.652 1.181 . . . . 0.0 114.008 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.72 -21.09 62.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.478 1.511 . . . . 0.0 113.794 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -17.25 37.02 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.844 1.688 . . . . 0.0 114.419 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.28 148.96 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.982 1.313 . . . . 0.0 112.218 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -128.85 129.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.606 1.562 . . . . 0.0 109.834 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -145.63 177.37 8.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.038 2.135 . . . . 0.0 110.142 173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 28.0 p -125.52 148.16 48.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.366 1.066 . . . . 0.0 111.754 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.82 144.03 27.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 111.414 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.94 151.3 47.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.989 0.916 . . . . 0.0 111.076 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.53 12.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.9 tpp -66.59 -12.44 57.9 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.782 1.633 . . . . 0.0 113.744 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.0 15.0 15.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.713 1.605 . . . . 0.0 112.418 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.7 mt -127.64 151.36 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 127.013 2.125 . . . . 0.0 109.866 -171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -140.18 155.23 47.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.702 2.001 . . . . 0.0 111.497 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.43 24.2 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 0.0 111.657 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 123.921 0.888 . . . . 0.0 110.592 172.074 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.266 0.555 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.99 155.81 23.77 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.196 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.74 135.81 41.77 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.84 77.6 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.653 1.12 . . . . 0.0 114.88 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -65.65 131.93 47.56 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.119 1.46 . . . . 0.0 111.782 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.22 130.06 37.63 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.285 0.564 . . . . 0.0 110.159 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.61 177.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.229 1.812 . . . . 0.0 111.31 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.5 mt -114.26 133.8 55.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.387 1.475 . . . . 0.0 109.766 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.98 155.91 42.07 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -75.76 148.35 38.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.028 1.331 . . . . 0.0 111.555 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -144.92 -36.13 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -139.22 -28.67 0.78 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -148.81 178.41 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.768 1.627 . . . . 0.0 110.787 -169.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.5 m -61.53 -17.55 55.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -73.05 114.24 10.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 110.477 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -72.33 152.27 42.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.301 0.641 . . . . 0.0 110.092 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -129.97 156.2 79.46 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.909 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 139.29 37.26 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.603 2.202 . . . . 0.0 113.029 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.47 172.58 14.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.702 1.601 . . . . 0.0 111.404 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -119.92 141.48 49.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.852 1.661 . . . . 0.0 110.088 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -80.16 110.3 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.658 0.783 . . . . 0.0 109.833 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -83.03 -31.35 27.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.447 1.099 . . . . 0.0 113.106 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.16 163.97 37.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.929 1.292 . . . . 0.0 112.14 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 125.781 1.632 . . . . 0.0 109.676 -171.49 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.8 m -82.47 134.68 35.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.44 144.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.117 0.967 . . . . 0.0 112.257 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.36 110.19 16.66 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.598 1.559 . . . . 0.0 109.62 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 164.17 26.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.046 0.938 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -54.21 -26.34 27.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.73 -22.08 64.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.358 . . . . 0.0 113.874 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.76 -15.61 44.7 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.005 1.764 . . . . 0.0 114.083 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.43 148.23 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.655 1.582 . . . . 0.0 112.274 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.3 mt -129.92 127.59 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.147 1.379 . . . . 0.0 110.003 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -143.29 -171.05 3.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.276 2.231 . . . . 0.0 109.307 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.77 151.2 50.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.005 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.5 mt -142.15 160.22 40.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.11 1.764 . . . . 0.0 110.882 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -87.58 161.6 17.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 111.246 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.6 ptt85 -55.42 -20.9 13.62 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 169.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.87 -13.37 44.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.828 1.251 . . . . 0.0 113.97 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -128.28 10.9 6.35 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.376 1.47 . . . . 0.0 113.633 -171.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.26 140.3 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.494 1.518 . . . . 0.0 110.039 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -141.18 152.79 44.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.172 1.789 . . . . 0.0 110.927 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.05 139.98 58.23 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.706 -0.621 . . . . 0.0 109.861 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 CA--C 1.55 0.968 0 O-C-N 121.716 -0.615 . . . . 0.0 111.553 175.303 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.36 157.55 24.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.626 1.57 . . . . 0.0 111.699 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.48 133.69 46.02 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.35 0.66 . . . . 0.0 110.793 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.8 3.05 58.47 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.608 1.099 . . . . 0.0 114.849 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.7 129.41 39.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.786 1.293 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -74.95 134.58 41.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.436 0.636 . . . . 0.0 110.778 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.89 179.43 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.501 1.921 . . . . 0.0 111.023 -169.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.75 146.59 43.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.336 1.454 . . . . 0.0 108.909 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.08 149.6 26.3 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.296 -0.877 . . . . 0.0 112.979 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -80.61 110.13 15.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.252 1.421 . . . . 0.0 110.348 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -85.71 -160.06 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.111 0.965 . . . . 0.0 112.063 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -56.4 -35.14 67.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.767 1.227 . . . . 0.0 112.458 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.75 153.42 22.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.808 1.243 . . . . 0.0 111.957 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 82.7 m -77.24 50.85 0.8 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -134.41 163.22 30.17 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.526 2.331 . . . . 0.0 110.607 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -121.96 70.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.395 1.478 . . . . 0.0 110.493 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -67.54 157.39 86.08 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.429 1.092 . . . . 0.0 112.442 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.22 138.58 47.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.808 2.338 . . . . 0.0 111.965 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.17 179.57 7.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.175 1.79 . . . . 0.0 110.619 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -142.55 152.76 42.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.633 1.173 . . . . 0.0 111.987 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 91.0 mt -83.33 113.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.259 1.024 . . . . 0.0 110.108 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -80.65 -33.44 35.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.668 1.187 . . . . 0.0 112.787 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.76 38.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.461 1.104 . . . . 0.0 112.546 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 126.111 1.764 . . . . 0.0 109.118 -174.924 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.5 m -86.93 135.76 33.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.722 0.809 . . . . 0.0 108.926 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.84 148.5 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -119.7 123.82 44.72 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 109.593 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.42 164.77 16.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 111.548 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -52.7 -28.45 21.91 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.98 -21.95 65.04 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.263 1.425 . . . . 0.0 113.733 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.44 -20.15 32.9 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.206 1.86 . . . . 0.0 114.068 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.48 145.95 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.856 1.662 . . . . 0.0 112.749 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.61 125.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.241 1.416 . . . . 0.0 109.892 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -142.62 -172.68 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.153 2.181 . . . . 0.0 109.636 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 32.1 p -130.3 154.5 47.56 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.381 -0.824 . . . . 0.0 112.261 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.4 157.95 44.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.025 1.73 . . . . 0.0 111.088 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -73.05 156.64 38.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.197 0.999 . . . . 0.0 110.447 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -54.54 -25.4 25.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.61 -19.56 58.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.355 1.862 . . . . 0.0 114.139 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -120.26 12.23 11.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.137 1.375 . . . . 0.0 113.394 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.38 142.28 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.01 1.724 . . . . 0.0 108.854 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -135.69 145.76 47.06 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.053 1.741 . . . . 0.0 110.254 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.52 139.27 58.46 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.028 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 CA--C 1.549 0.907 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.893 174.369 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 121.048 0.451 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 152.12 34.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.39 1.476 . . . . 0.0 111.706 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.38 141.29 57.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.012 0.525 . . . . 0.0 111.326 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.32 -9.36 73.39 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.17 1.367 . . . . 0.0 114.626 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.38 145.06 31.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.16 1.48 . . . . 0.0 111.974 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.87 143.78 25.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.53 1.132 . . . . 0.0 112.05 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.93 170.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.438 1.895 . . . . 0.0 111.008 -170.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -109.72 133.39 53.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.6 1.16 . . . . 0.0 108.889 169.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.21 153.28 38.54 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -74.66 150.38 39.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.138 1.375 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -140.23 -44.13 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -139.63 -21.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -171.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -142.76 -178.61 5.88 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.679 1.592 . . . . 0.0 110.721 -171.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.4 m -65.47 -14.07 60.18 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.816 -1.178 . . . . 0.0 113.768 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.89 133.58 43.13 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.8 1.24 . . . . 0.0 110.571 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -89.06 152.3 21.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.577 0.751 . . . . 0.0 109.255 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.47 155.84 79.34 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.118 1.367 . . . . 0.0 110.859 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.52 137.17 38.58 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.679 2.253 . . . . 0.0 112.732 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.41 174.6 12.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.818 1.647 . . . . 0.0 111.482 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -136.39 138.3 41.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 110.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.11 130.8 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.343 0.657 . . . . 0.0 109.586 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.84 -31.51 7.99 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.764 1.226 . . . . 0.0 112.53 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.5 33.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.092 1.757 . . . . 0.0 110.749 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 124.849 1.26 . . . . 0.0 110.521 -169.666 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -81.69 130.45 35.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.954 0.902 . . . . 0.0 108.612 172.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.62 142.43 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.434 1.094 . . . . 0.0 112.027 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.78 129.51 55.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.679 1.592 . . . . 0.0 109.473 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.22 168.01 11.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.951 0.9 . . . . 0.0 111.756 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.82 -27.05 27.21 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.069 1.348 . . . . 0.0 113.841 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 -17.99 37.33 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.123 1.821 . . . . 0.0 114.193 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.11 147.0 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.789 1.636 . . . . 0.0 112.439 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 129.53 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.691 1.596 . . . . 0.0 110.136 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -143.09 -166.72 2.37 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.142 2.177 . . . . 0.0 109.351 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.13 155.45 46.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.228 -0.92 . . . . 0.0 111.564 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.42 152.79 45.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.242 1.417 . . . . 0.0 110.753 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.27 153.38 42.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.303 1.041 . . . . 0.0 110.957 171.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.33 18.56 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 169.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 tpt -65.33 -13.98 59.75 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.44 1.896 . . . . 0.0 113.804 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -120.79 13.35 11.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.492 1.517 . . . . 0.0 113.603 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.9 mt -134.3 144.41 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.035 1.734 . . . . 0.0 109.455 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -136.61 149.32 47.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.063 2.145 . . . . 0.0 110.271 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 157.24 30.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.58 0.752 . . . . 0.0 111.229 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 CA--C 1.55 0.962 0 O-C-N 121.964 -0.46 . . . . 0.0 110.306 177.612 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.221 0.534 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.27 164.26 30.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 111.779 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.89 132.32 53.47 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.942 0.401 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.78 -4.52 85.71 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.087 1.327 . . . . 0.0 115.054 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.88 132.68 49.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.519 1.66 . . . . 0.0 111.776 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -77.81 133.82 38.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.621 0.769 . . . . 0.0 110.792 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.34 167.05 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.715 1.606 . . . . 0.0 111.171 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.17 140.7 29.73 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.26 160.08 44.01 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.717 -0.614 . . . . 0.0 112.225 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.52 145.52 26.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.827 1.251 . . . . 0.0 111.258 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.89 -48.02 0.5 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 m -140.27 -14.55 1.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -169.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -140.25 179.14 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.209 1.404 . . . . 0.0 111.6 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.6 m -73.13 -20.49 60.91 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.762 -0.587 . . . . 0.0 111.59 167.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -71.81 131.38 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.581 1.552 . . . . 0.0 110.357 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.76 161.91 24.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.895 0.478 . . . . 0.0 110.145 168.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -136.48 154.56 76.94 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.51 1.524 . . . . 0.0 110.529 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.49 139.44 37.72 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.101 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.5 173.5 12.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.127 1.771 . . . . 0.0 110.736 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -125.06 140.42 52.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.485 1.514 . . . . 0.0 109.533 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.53 121.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.323 0.649 . . . . 0.0 109.736 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -90.36 -33.97 15.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.284 1.034 . . . . 0.0 112.379 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.58 35.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.549 1.14 . . . . 0.0 112.702 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 126.797 2.039 . . . . 0.0 109.187 -172.194 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.8 m -77.37 135.9 38.39 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -143.02 151.53 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.564 1.146 . . . . 0.0 112.275 -171.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -122.31 112.86 18.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.949 1.7 . . . . 0.0 109.445 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -76.17 164.17 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 111.614 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -58.02 -21.79 46.82 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -69.96 -16.03 63.13 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.709 1.203 . . . . 0.0 114.032 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.52 -11.46 64.97 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.805 1.669 . . . . 0.0 114.542 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.51 148.19 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.095 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.6 mt -130.23 126.14 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.214 1.405 . . . . 0.0 110.099 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -144.6 -167.42 2.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.481 2.312 . . . . 0.0 109.249 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.34 153.98 49.05 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.26 -0.9 . . . . 0.0 112.067 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.1 mt -138.69 156.83 47.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 111.816 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.99 158.39 29.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.7 1.2 . . . . 0.0 110.569 169.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -57.74 -26.45 61.84 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -67.01 -11.63 57.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.146 1.378 . . . . 0.0 113.91 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -115.51 14.82 16.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.767 1.627 . . . . 0.0 112.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -134.25 145.79 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.47 1.908 . . . . 0.0 109.446 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -138.86 150.03 45.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.526 1.931 . . . . 0.0 111.36 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.42 144.52 48.12 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.006 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 CA--C 1.548 0.896 0 C-N-CA 124.134 0.974 . . . . 0.0 110.785 176.296 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -143.46 146.14 33.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 111.571 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.49 131.44 50.95 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 122.021 -0.425 . . . . 0.0 111.154 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.78 -13.5 52.82 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.531 1.538 . . . . 0.0 115.371 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.45 149.46 45.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.356 1.578 . . . . 0.0 111.488 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -90.21 143.94 26.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 112.127 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.72 164.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.599 1.96 . . . . 0.0 111.142 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -108.71 125.25 51.71 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.091 1.756 . . . . 0.0 109.208 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.37 152.72 41.93 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -92.33 72.25 5.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.75 1.62 . . . . 0.0 112.508 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CE3' ' CE1' ' A' ' 120' ' ' PHE . 50.8 t-105 -62.33 -37.13 84.45 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -155.25 -29.17 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -136.46 163.04 31.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.103 1.361 . . . . 0.0 111.792 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.53 -20.34 54.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.892 1.277 . . . . 0.0 114.418 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.67 96.44 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.308 1.043 . . . . 0.0 108.918 168.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -55.49 143.21 30.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.386 0.675 . . . . 0.0 111.419 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.89 150.87 56.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.955 1.302 . . . . 0.0 111.522 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.68 137.77 28.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.667 2.245 . . . . 0.0 112.193 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.99 167.18 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.008 1.723 . . . . 0.0 110.954 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.01 142.29 45.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.151 1.38 . . . . 0.0 109.996 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.83 120.61 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.91 0.884 . . . . 0.0 109.383 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -92.79 -31.47 15.02 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.124 0.969 . . . . 0.0 112.561 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.03 158.68 36.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.357 1.063 . . . . 0.0 112.446 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 126.564 1.946 . . . . 0.0 108.408 -177.555 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.1 0.476 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 m -72.4 134.8 45.6 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.52 0.728 . . . . 0.0 109.506 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.31 147.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.027 1.331 . . . . 0.0 111.751 -171.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.22 118.27 27.23 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.547 1.539 . . . . 0.0 109.954 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CE1' ' CE3' ' A' ' 97' ' ' TRP . 33.2 m-85 -85.91 172.05 11.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.709 1.203 . . . . 0.0 111.872 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -57.87 -21.75 44.55 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -70.78 -14.03 62.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.923 1.289 . . . . 0.0 114.12 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.61 -16.31 58.29 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.641 1.591 . . . . 0.0 114.883 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.47 148.56 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.689 1.596 . . . . 0.0 112.326 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.36 124.22 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.522 1.529 . . . . 0.0 110.368 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -142.57 -162.46 1.42 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.295 2.238 . . . . 0.0 108.888 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.6 p -135.52 155.29 50.74 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.134 -0.979 . . . . 0.0 112.492 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.25 149.97 40.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.314 1.446 . . . . 0.0 111.192 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -68.71 159.54 32.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.631 1.172 . . . . 0.0 111.329 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -58.27 -20.47 42.75 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 171.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.9 mmm -67.89 -12.91 61.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.915 1.286 . . . . 0.0 113.661 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.8 13.51 5.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 112.871 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.83 136.22 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.791 1.636 . . . . 0.0 109.422 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -140.53 157.61 45.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.063 1.745 . . . . 0.0 111.287 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 174.52 5.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.211 0.604 . . . . 0.0 111.0 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.866 0 O-C-N 121.201 -0.937 . . . . 0.0 111.318 169.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.8 142.71 30.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.928 1.291 . . . . 0.0 112.566 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 135.96 57.78 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.831 -0.543 . . . . 0.0 110.834 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.04 -12.88 69.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.105 1.336 . . . . 0.0 114.631 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -69.26 162.17 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.4 1.6 . . . . 0.0 112.375 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.41 142.79 32.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.833 0.853 . . . . 0.0 112.175 170.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.95 162.98 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.838 2.055 . . . . 0.0 110.806 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.8 137.43 32.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.55 152.06 33.58 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.522 0.601 . . . . 0.0 112.379 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -84.95 150.01 25.23 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.846 1.258 . . . . 0.0 111.519 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 t-105 -151.42 -39.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -132.73 -32.68 1.25 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.62 178.83 7.69 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.146 1.778 . . . . 0.0 110.528 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.2 m -61.17 -22.45 64.73 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 122.78 22.22 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.647 1.179 . . . . 0.0 111.096 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -70.64 155.69 40.42 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.009 0.924 . . . . 0.0 110.745 169.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.29 157.34 76.47 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.435 1.494 . . . . 0.0 110.579 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.44 135.08 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.135 1.89 . . . . 0.0 111.564 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.16 174.14 11.14 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.722 2.009 . . . . 0.0 110.145 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -127.34 134.99 49.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.528 1.531 . . . . 0.0 110.098 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.5 mt -72.31 121.95 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.02 0.528 . . . . 0.0 110.007 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -87.47 -37.45 16.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.526 1.131 . . . . 0.0 111.858 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.1 162.11 38.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.571 1.148 . . . . 0.0 113.002 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.885 1.674 . . . . 0.0 109.242 -175.979 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 m -73.64 131.34 41.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.92 149.76 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.467 1.107 . . . . 0.0 112.018 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.84 127.92 52.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.034 1.733 . . . . 0.0 109.368 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.46 168.18 11.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.659 0.784 . . . . 0.0 111.488 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -59.77 -20.43 56.6 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -73.22 -14.01 61.26 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.551 1.14 . . . . 0.0 113.994 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.94 -12.08 67.36 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.935 1.731 . . . . 0.0 114.53 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.9 149.18 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.643 1.577 . . . . 0.0 112.301 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.6 130.27 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.308 1.443 . . . . 0.0 110.263 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -145.81 -169.8 3.32 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.429 2.292 . . . . 0.0 109.661 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.59 151.33 50.32 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.816 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.3 mt -139.2 159.39 42.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.231 1.412 . . . . 0.0 112.21 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.98 155.62 23.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -53.98 -25.72 22.27 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.3 ttt -61.84 -20.56 63.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.788 1.635 . . . . 0.0 113.928 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -120.89 17.63 11.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.274 1.43 . . . . 0.0 112.913 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.28 145.53 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.053 2.141 . . . . 0.0 108.929 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 110.781 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.07 152.66 42.92 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 CA--C 1.547 0.856 0 O-C-N 121.499 -0.751 . . . . 0.0 112.397 176.062 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.44 165.15 28.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.313 1.845 . . . . 0.0 111.477 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.61 130.06 45.02 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.859 0.464 . . . . 0.0 110.668 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.48 88.27 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.907 1.241 . . . . 0.0 115.13 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.35 146.04 53.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.758 1.779 . . . . 0.0 112.256 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -95.37 131.12 41.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.044 1.338 . . . . 0.0 110.635 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.64 177.67 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.138 1.775 . . . . 0.0 111.666 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.3 140.33 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.449 1.1 . . . . 0.0 108.434 168.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.39 34.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.555 0.742 . . . . 0.0 111.798 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -77.67 129.12 35.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.903 1.281 . . . . 0.0 109.767 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -93.36 -160.35 0.75 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.551 0.741 . . . . 0.0 111.928 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 t -61.99 -28.5 69.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.167 -0.958 . . . . 0.0 112.222 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -76.87 155.45 32.89 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.043 1.337 . . . . 0.0 112.174 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.04 34.78 0.09 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.887 1.675 . . . . 0.0 114.262 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.46 145.47 40.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.58 1.952 . . . . 0.0 111.488 -172.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.41 148.51 25.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.499 1.119 . . . . 0.0 111.432 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.38 155.45 64.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.995 1.718 . . . . 0.0 111.185 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.62 134.44 32.84 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.023 2.482 . . . . 0.0 111.739 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.88 172.51 15.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.227 1.411 . . . . 0.0 111.933 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -134.1 130.86 38.02 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.537 1.535 . . . . 0.0 110.054 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.14 118.39 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.044 0.938 . . . . 0.0 110.536 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.5 -31.84 15.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.14 1.376 . . . . 0.0 112.474 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.65 160.67 38.27 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.716 1.206 . . . . 0.0 112.523 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.473 0.681 0 C-N-CA 126.017 1.727 . . . . 0.0 108.905 -177.373 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -98.88 134.7 41.38 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 108.982 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.91 140.73 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.34 1.056 . . . . 0.0 111.953 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -99.65 128.46 45.75 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.857 1.263 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.73 165.16 18.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.305 1.042 . . . . 0.0 112.444 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.31 -29.7 34.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.302 1.441 . . . . 0.0 114.266 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.94 -20.03 61.13 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 113.797 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.49 -20.88 31.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.104 1.811 . . . . 0.0 114.278 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 150.14 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.56 1.544 . . . . 0.0 112.457 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.61 126.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.283 1.433 . . . . 0.0 109.896 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -142.83 177.93 8.0 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.168 2.187 . . . . 0.0 110.036 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 29.1 p -121.95 154.05 37.68 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.134 0.974 . . . . 0.0 112.522 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.41 157.22 44.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.621 1.569 . . . . 0.0 112.059 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -72.2 158.59 35.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.087 1.355 . . . . 0.0 111.497 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -52.34 -39.14 60.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.293 1.437 . . . . 0.0 113.657 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.16 2.61 2.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.69 1.996 . . . . 0.0 114.238 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -122.91 13.33 9.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.888 1.675 . . . . 0.0 112.654 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -135.7 141.63 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.873 1.269 . . . . 0.0 110.025 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -138.12 152.28 48.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.509 1.924 . . . . 0.0 110.662 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.27 135.95 55.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.812 0.445 . . . . 0.0 110.416 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.864 172.052 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 121.162 0.506 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -144.46 151.61 39.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.648 1.579 . . . . 0.0 111.458 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.69 58.29 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.042 0.449 . . . . 0.0 110.927 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.13 -18.34 54.24 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 125.287 1.423 . . . . 0.0 114.384 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -72.02 147.28 47.0 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.591 1.196 . . . . 0.0 111.755 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 141.34 28.57 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 122.024 0.916 . . . . 0.0 112.148 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 166.87 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.826 2.05 . . . . 0.0 110.46 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.55 137.75 32.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.869 0.868 . . . . 0.0 109.037 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.31 153.37 38.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.527 -0.733 . . . . 0.0 112.488 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -82.77 148.03 28.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.795 1.238 . . . . 0.0 110.994 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -142.74 -42.51 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -134.55 -29.11 1.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -149.85 -161.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.348 1.459 . . . . 0.0 110.955 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.1 t -67.2 -32.24 73.18 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -63.78 153.27 37.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 0.0 112.582 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -101.27 157.43 16.79 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.263 1.025 . . . . 0.0 110.387 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -138.26 153.0 72.65 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.644 1.577 . . . . 0.0 110.092 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 137.79 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.518 2.145 . . . . 0.0 112.499 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.81 160.25 42.51 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.36 1.464 . . . . 0.0 111.842 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.14 127.79 54.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.553 1.941 . . . . 0.0 109.555 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.74 135.68 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.031 0.532 . . . . 0.0 109.686 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -115.78 -26.33 7.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.656 1.182 . . . . 0.0 113.008 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.0 153.41 30.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 111.377 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.591 1.556 . . . . 0.0 109.064 -174.008 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.6 m -110.29 135.76 50.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.872 0.869 . . . . 0.0 109.354 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.82 151.26 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.19 0.996 . . . . 0.0 112.669 -169.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -121.11 111.36 17.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 109.114 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.16 161.33 30.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.25 0.62 . . . . 0.0 111.806 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -55.15 -26.1 36.38 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.7 -21.88 64.39 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.135 1.374 . . . . 0.0 113.762 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.51 -12.95 36.08 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 126.183 1.849 . . . . 0.0 114.232 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.63 149.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.453 1.501 . . . . 0.0 112.407 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.6 mt -131.83 124.55 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.466 1.506 . . . . 0.0 109.952 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -144.17 -174.93 4.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.171 2.188 . . . . 0.0 109.883 170.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.1 p -125.17 151.35 45.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.723 1.209 . . . . 0.0 111.732 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.6 mt -143.18 152.54 41.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.815 1.646 . . . . 0.0 111.704 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -70.09 151.49 45.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.53 0.732 . . . . 0.0 109.338 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -57.88 -29.59 65.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.881 0.873 . . . . 0.0 113.121 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -59.31 -7.33 1.24 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.504 1.922 . . . . 0.0 114.488 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -115.97 10.72 15.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.079 1.752 . . . . 0.0 112.626 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.4 mt -131.53 143.73 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 109.625 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.16 152.6 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.155 2.182 . . . . 0.0 111.05 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.85 159.19 25.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.294 0.638 . . . . 0.0 111.712 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 CA--C 1.55 0.968 0 C-N-CA 123.706 0.802 . . . . 0.0 112.32 170.437 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.399 0.618 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.01 159.81 43.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.86 1.664 . . . . 0.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.55 37.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.692 0.397 . . . . 0.0 110.989 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.36 -10.72 72.82 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.474 1.511 . . . . 0.0 114.559 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.11 132.04 47.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.133 1.466 . . . . 0.0 111.61 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.65 143.4 33.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.34 169.5 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.855 1.662 . . . . 0.0 111.645 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.3 141.72 45.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.396 1.478 . . . . 0.0 108.325 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.99 151.32 30.16 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.51 -0.744 . . . . 0.0 112.886 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -81.4 113.22 19.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.938 1.295 . . . . 0.0 110.247 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -93.75 -159.7 0.71 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.347 1.059 . . . . 0.0 112.044 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 t -61.14 -12.17 11.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.538 1.135 . . . . 0.0 113.712 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.16 149.7 43.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.423 2.289 . . . . 0.0 110.055 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.34 -17.24 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -169.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.71 155.98 39.1 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.254 0.934 . . . . 0.0 111.682 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -101.52 80.92 2.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.195 1.398 . . . . 0.0 110.25 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -71.62 153.66 93.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.476 1.11 . . . . 0.0 112.085 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.75 137.78 33.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.132 2.555 . . . . 0.0 112.447 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.03 -178.32 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.568 1.547 . . . . 0.0 111.606 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -143.32 154.41 43.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.354 1.462 . . . . 0.0 111.255 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -82.6 133.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.157 0.983 . . . . 0.0 109.743 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -104.38 -30.16 10.27 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.446 1.499 . . . . 0.0 112.794 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.32 154.44 32.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.609 1.164 . . . . 0.0 112.301 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.044 1.738 . . . . 0.0 110.085 -172.47 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.7 m -68.4 135.84 52.38 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.62 150.1 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.694 1.197 . . . . 0.0 111.5 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -126.86 125.58 41.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.129 1.371 . . . . 0.0 110.233 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -87.95 162.29 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.013 0.925 . . . . 0.0 111.672 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -52.39 -29.44 24.18 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.0 -20.15 58.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.41 -22.91 8.2 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.694 1.616 . . . . 0.0 115.472 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.31 148.0 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.109 1.454 . . . . 0.0 113.176 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.5 mt -130.2 127.84 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.214 1.405 . . . . 0.0 110.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -143.7 -169.03 2.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.413 2.285 . . . . 0.0 109.436 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.5 p -127.77 150.81 49.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.413 1.085 . . . . 0.0 112.133 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -141.21 163.09 33.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 111.557 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -89.0 155.89 19.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.138 1.375 . . . . 0.0 110.715 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.99 -28.7 10.5 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.3 ttt -63.94 -12.83 40.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.942 1.697 . . . . 0.0 113.811 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -128.18 13.36 6.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.049 1.74 . . . . 0.0 113.354 -172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.6 mt -131.56 143.58 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.458 1.903 . . . . 0.0 109.148 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -137.21 149.89 47.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.637 1.975 . . . . 0.0 110.521 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 150.14 48.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.304 0.642 . . . . 0.0 111.094 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 123.464 0.706 . . . . 0.0 110.821 179.307 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.344 0.592 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -126.35 152.67 45.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.006 1.722 . . . . 0.0 111.795 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.9 137.85 54.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.173 0.589 . . . . 0.0 111.051 173.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.18 72.33 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.77 1.176 . . . . 0.0 114.886 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.51 142.45 28.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.738 1.269 . . . . 0.0 112.199 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.38 141.13 30.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.175 0.99 . . . . 0.0 111.849 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -146.39 170.16 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.185 1.794 . . . . 0.0 111.061 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.73 133.54 52.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.533 1.133 . . . . 0.0 107.998 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.42 159.04 44.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.4 -0.813 . . . . 0.0 112.526 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 139.61 35.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.211 1.004 . . . . 0.0 111.549 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -135.72 -29.24 1.05 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.2 m -142.41 -56.5 0.44 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.063 0.847 . . . . 0.0 112.19 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -119.28 176.97 5.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.015 1.326 . . . . 0.0 111.814 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.8 m -60.74 -20.74 61.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.44 128.02 33.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.655 1.182 . . . . 0.0 110.508 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -68.37 161.02 28.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.759 168.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.4 156.42 80.15 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.751 1.621 . . . . 0.0 110.37 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.57 135.52 36.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.407 2.071 . . . . 0.0 111.64 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.24 173.87 12.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.846 1.658 . . . . 0.0 111.093 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -144.15 133.12 22.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.6 117.86 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.991 0.917 . . . . 0.0 110.15 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -84.03 -37.28 22.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.087 1.355 . . . . 0.0 112.167 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.45 160.82 38.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.788 1.235 . . . . 0.0 112.347 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 125.799 1.64 . . . . 0.0 109.246 -174.912 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -97.89 126.1 43.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.843 0.857 . . . . 0.0 109.121 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.28 130.81 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.052 0.941 . . . . 0.0 112.449 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.77 140.87 29.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.08 1.352 . . . . 0.0 109.529 169.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.58 168.25 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 111.43 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -58.17 -22.88 53.28 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.53 -13.54 61.05 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.24 -14.12 63.92 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.0 1.762 . . . . 0.0 114.258 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.65 151.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.735 1.614 . . . . 0.0 112.182 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.32 129.93 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.504 1.521 . . . . 0.0 109.993 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -146.45 167.7 23.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.015 1.726 . . . . 0.0 111.515 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 79.0 m -82.65 145.43 29.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.935 0.494 . . . . 0.0 110.346 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 37.3 mt -139.25 157.15 46.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.541 1.536 . . . . 0.0 111.252 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -81.49 155.65 25.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.906 1.282 . . . . 0.0 111.268 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -56.37 -29.3 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.859 1.264 . . . . 0.0 113.365 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 21.9 ttt -59.0 -14.85 10.56 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.707 1.603 . . . . 0.0 114.157 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -130.35 16.19 5.51 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.306 1.842 . . . . 0.0 112.805 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.4 mt -132.43 143.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.676 1.99 . . . . 0.0 108.825 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -136.87 149.2 47.52 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.227 2.211 . . . . 0.0 110.07 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.12 155.83 38.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.172 0.589 . . . . 0.0 111.114 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 CA--C 1.547 0.85 0 O-C-N 121.949 -0.469 . . . . 0.0 111.824 171.251 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 121.498 0.666 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -122.89 128.08 49.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.624 1.57 . . . . 0.0 110.475 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.96 134.54 54.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.148 0.579 . . . . 0.0 111.528 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.23 -7.74 35.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.784 1.659 . . . . 0.0 115.178 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -79.12 146.82 32.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.776 1.288 . . . . 0.0 112.599 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.43 138.92 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.811 1.245 . . . . 0.0 111.807 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.6 174.23 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 127.174 2.19 . . . . 0.0 110.896 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.26 136.45 47.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.182 . . . . 0.0 107.98 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.41 31.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.597 -0.689 . . . . 0.0 112.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -72.97 142.68 47.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -146.72 -44.23 0.18 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 m -136.51 -16.7 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -147.97 -176.24 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.428 1.491 . . . . 0.0 111.228 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 77.3 m -67.89 -24.16 65.19 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.142 -0.974 . . . . 0.0 111.439 166.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -68.31 141.7 55.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.229 1.812 . . . . 0.0 111.953 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.47 163.87 22.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.563 0.745 . . . . 0.0 110.593 168.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -134.79 153.26 78.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.191 1.796 . . . . 0.0 110.669 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.57 135.1 25.56 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.683 2.256 . . . . 0.0 111.825 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.52 177.69 9.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.559 1.543 . . . . 0.0 110.581 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.92 151.71 51.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.133 0.973 . . . . 0.0 110.819 168.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.6 mt -81.14 113.68 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.675 0.79 . . . . 0.0 109.922 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -80.4 -32.83 37.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 112.747 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.77 36.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.064 0.946 . . . . 0.0 113.177 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 126.424 1.89 . . . . 0.0 108.609 -177.06 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.5 m -115.48 136.61 52.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.646 1.178 . . . . 0.0 108.392 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.5 m -135.95 156.15 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.899 . . . . 0.0 112.15 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -125.0 117.29 23.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.274 1.43 . . . . 0.0 109.473 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.71 165.39 22.88 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.119 0.968 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -54.0 -27.03 29.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.872 1.269 . . . . 0.0 114.367 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.94 -21.88 64.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.475 . . . . 0.0 113.863 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.14 56.78 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.668 1.604 . . . . 0.0 114.766 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.51 144.65 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.239 1.416 . . . . 0.0 112.179 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.78 109.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.038 1.335 . . . . 0.0 109.515 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -138.51 175.58 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.978 1.711 . . . . 0.0 111.644 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.56 155.6 18.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.326 1.05 . . . . 0.0 112.199 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.2 mt -144.77 156.91 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.11 156.32 38.8 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.417 1.087 . . . . 0.0 110.732 169.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -57.12 -24.83 56.87 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.05 -12.16 53.42 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.001 1.72 . . . . 0.0 114.126 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -120.86 12.04 11.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.727 1.611 . . . . 0.0 113.109 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -132.67 143.2 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.667 1.587 . . . . 0.0 109.565 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -134.72 147.29 50.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.765 2.026 . . . . 0.0 110.697 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.45 141.63 48.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.929 0.892 . . . . 0.0 110.959 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.663 0.785 . . . . 0.0 110.437 175.056 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 154.81 43.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.864 1.266 . . . . 0.0 112.428 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.52 130.23 43.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.367 0.667 . . . . 0.0 111.547 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.61 -8.71 68.81 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.463 1.506 . . . . 0.0 114.371 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.24 132.52 41.13 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.018 1.409 . . . . 0.0 112.5 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.45 135.65 37.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.425 1.09 . . . . 0.0 111.64 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.35 -176.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.418 2.287 . . . . 0.0 111.009 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -111.39 145.09 39.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.132 0.973 . . . . 0.0 109.247 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 150.43 35.41 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.443 0.64 . . . . 0.0 112.46 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -80.72 154.29 27.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.543 1.537 . . . . 0.0 110.638 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.39 -47.51 0.52 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -142.95 -29.36 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -138.58 -169.51 2.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.095 1.758 . . . . 0.0 110.301 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.0 p -62.17 -15.56 47.06 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.631 -1.293 . . . . 0.0 114.415 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -62.8 145.4 55.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.554 1.541 . . . . 0.0 111.979 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -117.29 154.34 31.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.926 1.29 . . . . 0.0 109.444 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.64 152.8 71.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.677 1.191 . . . . 0.0 111.332 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.78 130.9 24.32 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.783 2.322 . . . . 0.0 110.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.76 12.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.242 1.417 . . . . 0.0 110.859 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -132.71 132.18 42.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.293 1.437 . . . . 0.0 109.458 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -71.45 121.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.111 0.564 . . . . 0.0 109.623 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -95.23 -32.25 13.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 112.343 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.99 40.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.841 1.257 . . . . 0.0 112.143 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt . . . . . 0 N--CA 1.474 0.749 0 C-N-CA 125.199 1.399 . . . . 0.0 109.084 -172.436 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.4 m -131.27 134.37 46.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.883 1.273 . . . . 0.0 108.727 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 150.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.407 1.083 . . . . 0.0 111.71 -175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -118.29 134.15 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.581 1.552 . . . . 0.0 109.651 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -93.28 167.55 11.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.443 1.097 . . . . 0.0 112.156 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -53.7 -28.74 35.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.602 1.561 . . . . 0.0 114.463 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.42 -18.93 61.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.11 1.364 . . . . 0.0 113.797 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.92 -15.9 47.53 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.886 1.708 . . . . 0.0 114.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.34 146.12 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.393 1.477 . . . . 0.0 112.347 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 132.02 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.788 1.635 . . . . 0.0 109.986 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -143.71 168.73 19.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.948 1.699 . . . . 0.0 111.461 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.64 149.96 27.46 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.289 1.036 . . . . 0.0 111.712 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 mt -148.11 158.65 44.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.348 1.459 . . . . 0.0 112.458 -171.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -76.35 159.79 30.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.752 0.821 . . . . 0.0 109.534 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -56.58 -35.01 67.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.055 0.942 . . . . 0.0 112.472 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.8 mtt -64.52 -1.17 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 0.0 114.729 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -120.42 7.59 10.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.733 1.613 . . . . 0.0 113.193 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.5 mt -130.27 139.66 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.989 1.716 . . . . 0.0 108.822 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -136.72 147.09 46.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.468 1.507 . . . . 0.0 110.669 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 135.11 55.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.857 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.786 173.752 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.588 0.708 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 162.68 40.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.332 1.853 . . . . 0.0 110.491 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.22 123.83 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.992 -0.443 . . . . 0.0 111.453 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.4 -7.16 78.1 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.289 1.423 . . . . 0.0 114.877 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.92 135.52 56.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.27 1.535 . . . . 0.0 111.619 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.12 138.81 31.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.777 0.831 . . . . 0.0 112.092 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.34 167.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.071 1.748 . . . . 0.0 111.03 -171.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.08 148.45 22.34 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.3 144.16 28.6 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.439 0.696 . . . . 0.0 111.571 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -72.62 152.84 41.54 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.149 0.98 . . . . 0.0 110.015 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -131.67 -160.28 1.03 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 112.152 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 m -55.24 -36.56 66.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.155 0.982 . . . . 0.0 111.382 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -84.07 139.59 32.38 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.021 1.329 . . . . 0.0 109.747 168.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.41 -21.46 65.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 158.51 24.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.008 1.276 . . . . 0.0 112.199 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.84 149.09 23.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.688 0.795 . . . . 0.0 110.263 168.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.65 152.77 69.3 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.257 1.423 . . . . 0.0 111.29 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 136.56 29.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.999 2.466 . . . . 0.0 112.141 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.13 13.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.736 1.615 . . . . 0.0 111.221 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -128.82 141.15 51.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 110.862 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.02 124.98 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.155 0.982 . . . . 0.0 109.58 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -95.57 -30.51 13.77 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.885 0.874 . . . . 0.0 112.894 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.76 153.22 32.74 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.6 mt . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 127.645 2.378 . . . . 0.0 108.467 -171.385 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.3 m -122.06 133.33 54.79 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.204 -0.935 . . . . 0.0 109.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.94 157.07 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -128.41 128.6 44.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.154 1.382 . . . . 0.0 110.145 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -81.74 162.63 22.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 112.485 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -52.96 -31.74 42.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.339 1.456 . . . . 0.0 114.814 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.35 -17.33 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.53 -21.17 8.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.277 1.418 . . . . 0.0 115.449 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.42 146.83 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.289 1.544 . . . . 0.0 112.857 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.78 128.87 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 109.215 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -143.95 175.07 10.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.173 1.789 . . . . 0.0 110.922 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.7 m -113.68 141.73 46.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 110.523 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -144.07 146.44 32.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.404 1.882 . . . . 0.0 109.731 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.4 160.86 30.45 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.409 -0.807 . . . . 0.0 110.978 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.95 8.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.804 1.242 . . . . 0.0 113.916 168.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.67 -12.54 34.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.541 1.936 . . . . 0.0 113.892 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.41 9.51 6.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.3 1.84 . . . . 0.0 113.157 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -126.25 143.42 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.15 2.18 . . . . 0.0 108.18 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -135.31 148.69 49.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.55 1.54 . . . . 0.0 110.854 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.51 145.47 48.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.703 0.801 . . . . 0.0 111.028 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 118.814 -0.612 . . . . 0.0 110.857 -178.333 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.127 0.489 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -119.17 128.02 53.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.982 1.713 . . . . 0.0 109.911 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 133.76 52.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.146 0.578 . . . . 0.0 111.34 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.07 75.34 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.884 1.23 . . . . 0.0 115.061 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.47 154.09 20.3 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.908 1.354 . . . . 0.0 112.411 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.36 142.55 27.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.175 0.99 . . . . 0.0 112.533 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.24 174.79 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.911 2.084 . . . . 0.0 110.86 -170.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.0 124.99 52.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.724 1.21 . . . . 0.0 109.32 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.14 154.84 44.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -88.66 147.1 24.7 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.043 1.337 . . . . 0.0 111.674 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -143.73 -30.53 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -139.11 -28.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -169.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.55 -167.81 2.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.027 1.731 . . . . 0.0 110.064 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.7 m -66.73 -13.89 61.9 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.836 -1.165 . . . . 0.0 113.727 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -69.18 166.55 18.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.189 1.796 . . . . 0.0 113.378 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -129.13 152.01 49.19 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.883 1.673 . . . . 0.0 109.991 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -139.12 156.01 72.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.48 1.512 . . . . 0.0 110.738 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.41 132.08 28.25 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.428 2.085 . . . . 0.0 111.881 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.86 172.02 13.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.798 1.639 . . . . 0.0 110.59 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -128.75 129.26 45.48 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.211 1.804 . . . . 0.0 109.605 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.62 120.94 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.367 0.667 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.29 -27.37 15.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.879 0.872 . . . . 0.0 112.69 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.69 156.44 29.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.235 1.414 . . . . 0.0 111.603 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.473 0.684 0 C-N-CA 125.736 1.615 . . . . 0.0 108.936 -174.158 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -80.72 132.23 35.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.69 0.796 . . . . 0.0 110.403 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.17 146.21 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.056 1.342 . . . . 0.0 112.438 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.14 119.61 29.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.317 1.847 . . . . 0.0 109.223 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -89.67 165.58 14.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.121 0.968 . . . . 0.0 111.005 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -58.94 -18.8 36.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -69.09 -15.72 63.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.74 1.216 . . . . 0.0 113.928 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.95 -15.49 61.57 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.248 1.88 . . . . 0.0 114.321 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.26 146.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.84 1.656 . . . . 0.0 112.231 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 126.42 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 110.125 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -140.71 -162.57 1.38 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.945 2.098 . . . . 0.0 109.236 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.53 151.93 47.78 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.164 -0.96 . . . . 0.0 112.138 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -139.13 158.12 44.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.54 1.536 . . . . 0.0 111.904 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.13 158.01 36.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.65 1.18 . . . . 0.0 110.756 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.68 -17.86 57.25 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.97 -12.24 61.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.14 1.376 . . . . 0.0 113.427 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -127.03 9.88 6.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.982 1.713 . . . . 0.0 113.321 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.66 136.83 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.55 1.94 . . . . 0.0 108.243 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -134.48 148.74 50.62 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.175 1.79 . . . . 0.0 110.281 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.3 138.24 58.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.228 0.611 . . . . 0.0 110.549 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.7 ttm . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.12 175.513 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.63 160.18 39.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.58 57.78 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.728 -0.607 . . . . 0.0 112.109 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 81.58 -11.57 45.04 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.92 1.724 . . . . 0.0 114.85 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.23 131.15 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.241 1.416 . . . . 0.0 112.701 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.21 140.18 40.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.557 1.143 . . . . 0.0 112.449 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.84 171.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.685 1.994 . . . . 0.0 111.322 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.42 139.32 38.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.6 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -87.02 150.14 24.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.122 1.369 . . . . 0.0 111.312 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -143.83 -44.46 0.27 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 -5.15 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.55 177.01 11.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.29 1.436 . . . . 0.0 111.082 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 -30.09 68.4 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.076 -1.015 . . . . 0.0 112.863 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -56.71 156.78 6.01 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.843 1.657 . . . . 0.0 113.275 172.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -119.23 155.23 32.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.255 1.422 . . . . 0.0 109.596 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -136.5 155.51 76.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.693 1.197 . . . . 0.0 111.28 -170.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.03 132.33 27.79 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.778 2.319 . . . . 0.0 111.916 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.02 179.35 8.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.19 1.796 . . . . 0.0 110.349 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -141.86 151.8 43.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.105 0.962 . . . . 0.0 112.223 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 72.9 mt -75.06 122.52 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.564 1.146 . . . . 0.0 110.093 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -93.67 -31.53 14.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.404 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.69 156.28 34.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.256 1.022 . . . . 0.0 112.937 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 126.563 1.945 . . . . 0.0 108.345 -177.814 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.368 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.0 m -126.21 137.89 53.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.299 1.04 . . . . 0.0 109.123 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.65 152.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.624 1.169 . . . . 0.0 111.926 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.82 130.23 53.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.687 1.595 . . . . 0.0 109.794 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.1 169.67 9.95 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.759 1.223 . . . . 0.0 112.206 -176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -57.3 -24.22 53.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.44 -12.82 60.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.554 1.141 . . . . 0.0 113.95 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.26 -14.15 65.64 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.898 1.713 . . . . 0.0 114.493 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.42 148.28 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.503 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.97 130.63 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.914 1.686 . . . . 0.0 110.267 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -146.43 163.25 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.754 1.622 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.13 145.13 30.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.5 0.72 . . . . 0.0 110.705 168.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.14 144.8 30.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.106 1.362 . . . . 0.0 110.835 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -69.52 158.85 34.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.349 0.66 . . . . 0.0 111.337 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -57.08 -21.57 32.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.13 -12.88 58.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.608 1.563 . . . . 0.0 113.889 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -127.11 11.52 7.04 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.954 1.702 . . . . 0.0 113.354 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.58 139.54 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.593 1.957 . . . . 0.0 108.484 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.09 145.79 44.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.033 1.733 . . . . 0.0 110.883 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.44 149.26 50.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.163 0.585 . . . . 0.0 110.758 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 CA--C 1.546 0.789 0 C-N-CA 123.092 0.557 . . . . 0.0 112.332 174.117 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -138.46 157.43 46.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.738 2.015 . . . . 0.0 111.249 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.75 136.38 58.05 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.927 -0.483 . . . . 0.0 111.326 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.14 -1.34 87.22 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.645 1.117 . . . . 0.0 114.988 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.97 142.2 52.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.359 1.58 . . . . 0.0 111.877 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.17 145.32 24.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.924 0.89 . . . . 0.0 111.714 177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -148.41 162.28 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.558 1.543 . . . . 0.0 112.022 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.05 118.25 36.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.876 1.671 . . . . 0.0 107.245 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.9 48.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.219 0.608 . . . . 0.0 112.142 -172.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -74.71 150.21 39.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.992 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -134.05 -40.39 0.84 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.3 m -159.36 -51.0 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.401 1.081 . . . . 0.0 111.282 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -74.95 170.59 15.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 0.0 112.039 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.7 m -73.38 43.54 0.14 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.234 1.814 . . . . 0.0 112.56 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -140.75 162.44 35.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 110.77 -171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 134' ' ' LYS . 53.2 m-85 -124.0 145.73 49.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.967 1.307 . . . . 0.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.85 154.31 77.75 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.117 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.68 131.27 25.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 0.0 112.016 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.69 174.6 12.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.189 1.796 . . . . 0.0 110.904 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.4 133.81 33.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.313 1.445 . . . . 0.0 110.686 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.26 120.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.166 0.986 . . . . 0.0 110.582 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.14 -30.01 14.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.416 1.486 . . . . 0.0 112.488 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.64 161.93 39.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.528 1.131 . . . . 0.0 112.803 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 109.733 -171.321 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.3 m -125.19 133.15 52.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 108.635 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.45 133.3 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.134 0.974 . . . . 0.0 111.978 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -93.12 125.19 37.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.887 1.275 . . . . 0.0 109.5 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.66 165.63 14.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.912 0.885 . . . . 0.0 111.561 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -54.5 -26.92 34.37 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.61 -20.11 62.03 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.023 1.329 . . . . 0.0 113.778 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.51 -17.14 40.2 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.169 1.842 . . . . 0.0 114.075 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.63 150.39 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.778 1.631 . . . . 0.0 112.226 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.1 mt -133.66 127.48 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 109.819 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -143.86 175.83 9.71 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.233 1.813 . . . . 0.0 110.853 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.5 m -107.4 146.03 32.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.503 1.121 . . . . 0.0 111.738 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.9 mt -147.42 152.97 39.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.093 1.757 . . . . 0.0 111.415 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.96 158.99 27.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.97 0.908 . . . . 0.0 110.872 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -57.91 -26.1 61.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.911 1.284 . . . . 0.0 113.661 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.9 ttm -54.78 -18.88 5.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.352 1.861 . . . . 0.0 114.116 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -123.75 13.17 9.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.9 1.68 . . . . 0.0 113.127 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -134.59 136.62 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.493 1.917 . . . . 0.0 109.093 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 102' ' ' TYR . 55.4 mtmt -132.87 150.41 52.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.918 1.687 . . . . 0.0 110.376 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.95 152.85 35.47 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.288 0.635 . . . . 0.0 111.789 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 CA--C 1.547 0.832 0 C-N-CA 123.54 0.736 . . . . 0.0 110.461 174.628 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -140.33 160.1 40.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.884 1.674 . . . . 0.0 111.956 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.2 58.85 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.854 -0.529 . . . . 0.0 111.775 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.32 -12.81 49.15 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.786 1.66 . . . . 0.0 114.885 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.0 138.47 44.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.658 1.183 . . . . 0.0 112.277 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.52 141.79 34.81 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.461 1.104 . . . . 0.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 m -151.88 168.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.372 1.869 . . . . 0.0 111.023 -171.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.03 129.84 44.87 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.09 133.41 41.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 111.187 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -67.77 161.21 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.868 1.267 . . . . 0.0 110.994 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -135.56 -163.79 1.44 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.454 1.102 . . . . 0.0 111.238 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -29.91 70.76 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.49 -0.757 . . . . 0.0 112.602 171.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.03 154.48 28.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.558 1.143 . . . . 0.0 112.005 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.57 33.8 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.165 1.786 . . . . 0.0 115.579 -176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -137.69 157.22 46.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.472 1.909 . . . . 0.0 111.77 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.3 148.58 24.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.033 1.333 . . . . 0.0 110.215 170.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -140.04 154.32 70.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.82 1.648 . . . . 0.0 111.222 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.85 129.45 20.9 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.538 2.159 . . . . 0.0 111.358 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.86 175.29 11.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.7 1.6 . . . . 0.0 111.247 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.11 136.85 47.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.09 1.356 . . . . 0.0 110.654 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.37 140.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.692 0.797 . . . . 0.0 109.534 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -116.6 -27.99 6.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.539 1.136 . . . . 0.0 113.173 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.09 155.34 33.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.65 1.18 . . . . 0.0 111.286 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 125.661 1.584 . . . . 0.0 108.592 -170.749 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -87.74 135.42 33.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.657 0.783 . . . . 0.0 109.056 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.63 156.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.583 1.153 . . . . 0.0 112.156 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -124.5 131.01 53.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.22 1.408 . . . . 0.0 109.795 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.56 167.59 12.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 111.676 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -59.07 -23.38 62.0 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -72.33 -14.01 61.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.655 1.182 . . . . 0.0 113.87 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.62 -15.65 62.76 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.677 1.608 . . . . 0.0 114.329 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.54 146.46 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.446 1.498 . . . . 0.0 112.477 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.84 128.07 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.769 1.628 . . . . 0.0 109.387 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -144.96 178.18 8.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.635 1.974 . . . . 0.0 110.508 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 p -122.76 152.37 40.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -139.72 165.36 27.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.55 1.94 . . . . 0.0 110.937 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -79.8 159.03 26.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.572 0.749 . . . . 0.0 110.68 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -55.94 -29.33 59.97 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -70.97 -21.01 62.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.421 1.088 . . . . 0.0 113.638 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -86.08 4.63 37.32 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.72 1.208 . . . . 0.0 113.578 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.5 mt -131.93 140.34 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.372 1.069 . . . . 0.0 110.522 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -137.71 153.11 49.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.974 2.11 . . . . 0.0 110.817 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.92 165.63 22.92 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.08 0.552 . . . . 0.0 111.236 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.841 0 C-N-CA 123.185 0.594 . . . . 0.0 111.941 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 121.517 0.675 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -133.18 160.04 38.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.376 1.871 . . . . 0.0 111.488 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.05 129.0 38.82 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.773 -0.58 . . . . 0.0 110.062 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.07 83.67 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.55 -1.139 . . . . 0.0 115.365 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.04 140.13 58.84 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.041 1.921 . . . . 0.0 111.155 172.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.85 121.0 39.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.526 1.13 . . . . 0.0 109.028 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.09 174.59 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.46 . . . . 0.0 112.181 -166.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -107.09 141.48 38.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.521 1.128 . . . . 0.0 108.967 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.66 156.03 35.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -71.74 151.82 43.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.068 1.347 . . . . 0.0 111.04 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -132.99 -38.89 0.96 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 t -157.6 -32.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.71 -176.87 3.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.52 1.528 . . . . 0.0 112.612 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.3 t -73.22 39.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.103 1.761 . . . . 0.0 114.49 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.22 165.86 25.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.416 2.286 . . . . 0.0 111.021 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.48 153.57 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.417 1.087 . . . . 0.0 110.269 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -137.39 154.14 75.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 110.796 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.3 136.47 40.33 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.852 2.368 . . . . 0.0 112.523 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.09 174.69 12.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 111.467 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -134.68 135.46 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.377 1.471 . . . . 0.0 109.933 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.8 mt -74.26 120.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 0.0 109.956 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -84.38 -36.86 22.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.857 1.263 . . . . 0.0 112.314 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.78 160.32 36.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.768 1.227 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 125.674 1.589 . . . . 0.0 109.7 -175.855 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 m -74.59 134.69 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.507 -0.745 . . . . 0.0 109.425 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.44 141.14 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.69 1.196 . . . . 0.0 111.825 -170.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -115.82 125.22 52.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.403 1.481 . . . . 0.0 109.278 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.91 167.33 11.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.002 0.921 . . . . 0.0 111.875 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -52.76 -28.76 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.96 -18.71 61.98 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.833 1.253 . . . . 0.0 113.693 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.07 -16.95 38.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.3 1.905 . . . . 0.0 113.995 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.82 147.5 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.088 1.755 . . . . 0.0 112.659 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.46 130.34 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.629 1.572 . . . . 0.0 110.391 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -142.66 -163.59 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.287 2.235 . . . . 0.0 109.56 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.3 p -140.35 156.97 46.23 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.202 -0.936 . . . . 0.0 112.647 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -145.04 171.62 14.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.292 1.837 . . . . 0.0 111.776 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.09 158.3 16.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.139 1.376 . . . . 0.0 109.461 168.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -53.19 -28.88 28.85 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -65.31 -14.44 60.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.215 1.406 . . . . 0.0 114.217 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -108.9 9.14 26.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.465 1.506 . . . . 0.0 112.985 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.38 145.38 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.105 1.762 . . . . 0.0 109.694 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -139.7 151.23 45.72 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.242 2.217 . . . . 0.0 111.0 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.54 162.8 26.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.575 0.75 . . . . 0.0 111.63 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 CA--C 1.549 0.938 0 C-N-CA 123.188 0.595 . . . . 0.0 112.429 171.815 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 m 47.78 26.9 0.98 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.983 2.113 . . . . 0.0 116.358 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 p -148.58 10.37 0.84 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -171.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.58 -178.37 53.76 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.587 1.089 . . . . 0.0 114.68 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 m -155.9 30.25 0.36 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.674 1.59 . . . . 0.0 112.049 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 p -61.15 -25.06 66.75 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.38 158.38 15.25 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.612 1.101 . . . . 0.0 113.577 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.22 8.65 0.48 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.229 1.412 . . . . 0.0 113.398 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.81 117.09 10.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.88 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.86 134.23 47.39 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.857 2.063 . . . . 0.0 109.37 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -155.54 158.12 37.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.596 1.558 . . . . 0.0 111.419 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.81 127.53 32.67 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.952 -0.468 . . . . 0.0 110.887 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.66 -11.64 64.67 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.667 1.603 . . . . 0.0 114.68 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.11 134.72 51.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.3 1.55 . . . . 0.0 111.902 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.51 138.05 37.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.329 0.652 . . . . 0.0 111.003 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.1 m -146.29 176.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.193 1.797 . . . . 0.0 111.22 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.1 mt -112.87 144.94 41.57 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.05 1.34 . . . . 0.0 108.475 168.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.17 146.5 31.79 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.239 0.543 . . . . 0.0 111.673 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -74.15 140.43 45.18 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 109.438 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -121.71 -162.98 1.02 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.347 1.059 . . . . 0.0 111.472 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.9 m -55.25 -35.14 64.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.365 -0.834 . . . . 0.0 111.197 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.61 135.46 33.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.398 1.479 . . . . 0.0 109.35 167.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.2 m -65.32 -21.4 66.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -63.6 145.56 55.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.207 1.003 . . . . 0.0 111.557 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -79.46 151.78 30.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.099 0.56 . . . . 0.0 110.848 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.64 154.23 65.99 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.043 1.337 . . . . 0.0 111.648 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 130.43 23.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.04 2.493 . . . . 0.0 111.355 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.89 -179.65 6.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.983 1.713 . . . . 0.0 110.539 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -143.3 152.82 42.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.48 1.112 . . . . 0.0 111.486 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -75.54 128.96 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.409 1.083 . . . . 0.0 109.606 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -98.54 -33.59 10.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.55 1.14 . . . . 0.0 112.185 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.43 35.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.799 1.24 . . . . 0.0 112.194 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -131.98 127.74 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.615 1.566 . . . . 0.0 109.128 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.75 5.31 0.06 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.4 2.28 . . . . 0.0 116.555 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.92 -26.57 66.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.206 1.802 . . . . 0.0 113.785 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.02 43.02 1.94 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.965 1.706 . . . . 0.0 110.36 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.58 17.06 47.3 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.274 1.416 . . . . 0.0 114.812 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.2 p -149.34 171.22 16.88 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.282 2.233 . . . . 0.0 110.913 -168.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -102.64 108.03 19.16 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.906 1.682 . . . . 0.0 108.788 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -76.25 133.63 40.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.03 152.49 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.848 1.259 . . . . 0.0 111.633 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -122.99 134.34 54.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.362 1.465 . . . . 0.0 110.313 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.11 164.52 13.23 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.0 111.62 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -55.49 -27.44 48.49 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 114.371 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.29 -22.31 63.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.157 1.383 . . . . 0.0 113.712 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.5 28.36 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.987 1.756 . . . . 0.0 113.937 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.97 145.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.411 1.485 . . . . 0.0 112.585 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.5 mt -128.56 130.47 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.603 1.561 . . . . 0.0 109.481 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -142.14 173.83 11.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.216 1.807 . . . . 0.0 111.063 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -120.57 139.1 53.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.971 1.309 . . . . 0.0 110.363 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.7 mt -140.81 167.45 22.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.449 1.5 . . . . 0.0 111.659 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.61 156.55 19.44 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.173 0.989 . . . . 0.0 110.114 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -28.8 13.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 96.7 mtp -67.05 -10.43 49.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.362 1.465 . . . . 0.0 113.88 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -117.54 8.82 13.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.381 1.472 . . . . 0.0 113.572 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.7 mt -128.43 144.64 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.15 1.78 . . . . 0.0 109.215 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -138.92 150.32 45.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 0.0 111.063 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.38 132.16 45.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.3 ptp -69.53 152.98 96.13 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.784 -0.572 . . . . 0.0 111.779 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.64 164.03 36.78 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.519 2.813 . . . . 0.0 111.743 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -57.71 -33.04 68.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.34 -0.85 . . . . 0.0 112.184 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.82 -22.39 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.111 1.364 . . . . 0.0 114.112 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.77 -1.74 57.52 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.562 1.145 . . . . 0.0 113.656 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -131.24 -40.37 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.378 1.471 . . . . 0.0 112.782 -174.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.3 179.0 51.7 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.332 1.444 . . . . 0.0 114.627 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 51.39 29.64 5.38 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.15 1.78 . . . . 0.0 114.667 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.36 173.07 9.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.476 1.51 . . . . 0.0 113.621 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.95 18.24 5.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.603 1.561 . . . . 0.0 113.423 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.3 mm -59.61 125.97 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.527 1.131 . . . . 0.0 109.726 174.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 54.96 31.41 15.92 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.213 1.805 . . . . 0.0 115.126 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.82 35.59 4.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.138 1.775 . . . . 0.0 111.767 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.9 m -57.87 152.8 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.201 1.4 . . . . 0.0 113.266 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.98 167.11 14.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.799 1.239 . . . . 0.0 113.464 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.409 1.884 . . . . 0.0 111.749 176.76 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.446 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.6 m -61.28 151.4 31.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.696 1.198 . . . . 0.0 113.37 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m -70.04 -15.89 63.07 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.98 13.77 72.82 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.579 1.085 . . . . 0.0 114.668 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.1 p -71.11 167.61 18.93 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.366 1.867 . . . . 0.0 113.872 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -147.56 166.61 26.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.907 1.683 . . . . 0.0 110.922 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.55 32.24 59.82 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 123.787 0.708 . . . . 0.0 113.88 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -78.14 117.33 19.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.573 1.149 . . . . 0.0 112.515 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -157.72 157.37 33.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 111.488 170.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -72.73 153.3 41.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.396 1.078 . . . . 0.0 113.117 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -138.0 148.07 44.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 113.166 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.24 132.59 54.48 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.57 -0.706 . . . . 0.0 111.723 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.77 6.15 66.32 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.73 141.47 48.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.185 1.492 . . . . 0.0 111.839 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 132.27 38.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.005 0.922 . . . . 0.0 111.669 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.16 175.62 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.506 1.522 . . . . 0.0 111.918 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.3 151.63 35.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.406 1.483 . . . . 0.0 108.971 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.67 154.82 36.06 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.207 -0.933 . . . . 0.0 112.255 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -72.01 156.85 38.78 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.022 1.329 . . . . 0.0 110.236 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -136.91 -150.09 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.53 0.732 . . . . 0.0 112.274 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.2 p -62.54 -3.0 1.23 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.792 1.637 . . . . 0.0 114.735 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -129.24 161.76 29.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.811 2.045 . . . . 0.0 110.543 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.6 -21.69 66.78 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.33 147.05 53.87 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.315 1.446 . . . . 0.0 112.259 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -86.55 152.76 22.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.111 0.564 . . . . 0.0 109.622 167.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -139.76 152.15 67.6 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.462 1.105 . . . . 0.0 111.805 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.61 137.33 38.72 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.302 2.668 . . . . 0.0 112.319 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.81 176.83 10.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.274 1.43 . . . . 0.0 111.715 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -135.25 139.94 44.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.954 1.702 . . . . 0.0 109.578 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.0 mm -61.49 134.78 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.501 0.721 . . . . 0.0 110.251 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -106.75 -29.99 9.22 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.214 1.806 . . . . 0.0 112.106 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 148.18 27.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.989 0.916 . . . . 0.0 113.154 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm -120.44 147.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 127.709 2.404 . . . . 0.0 108.246 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.0 m120 51.41 40.84 27.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.905 1.282 . . . . 0.0 113.533 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -60.41 166.27 3.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.615 1.166 . . . . 0.0 109.804 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -44.47 -31.43 1.09 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -167.92 34.59 0.2 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.977 1.275 . . . . 0.0 112.949 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.7 t -162.36 -169.19 2.06 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.746 1.218 . . . . 0.0 112.975 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -130.08 143.46 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.177 2.591 . . . . 0.0 108.15 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.4 m -111.93 140.17 46.82 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.736 -0.602 . . . . 0.0 109.561 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.67 151.77 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.763 1.225 . . . . 0.0 112.207 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -112.72 124.07 51.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.84 1.656 . . . . 0.0 108.87 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.72 163.58 27.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.561 0.745 . . . . 0.0 112.24 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -54.17 -29.75 46.84 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.652 1.181 . . . . 0.0 114.008 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.72 -21.09 62.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.478 1.511 . . . . 0.0 113.794 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -17.25 37.02 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.844 1.688 . . . . 0.0 114.419 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.28 148.96 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.982 1.313 . . . . 0.0 112.218 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -128.85 129.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.606 1.562 . . . . 0.0 109.834 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -145.63 177.37 8.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.038 2.135 . . . . 0.0 110.142 173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 28.0 p -125.52 148.16 48.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.366 1.066 . . . . 0.0 111.754 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.82 144.03 27.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 111.414 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.94 151.3 47.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.989 0.916 . . . . 0.0 111.076 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.53 12.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.9 tpp -66.59 -12.44 57.9 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.782 1.633 . . . . 0.0 113.744 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.0 15.0 15.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.713 1.605 . . . . 0.0 112.418 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.7 mt -127.64 151.36 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 127.013 2.125 . . . . 0.0 109.866 -171.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -140.18 155.23 47.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.702 2.001 . . . . 0.0 111.497 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.43 24.2 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 0.0 111.657 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.8 tpp -66.79 120.56 72.24 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.921 0.888 . . . . 0.0 110.592 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.85 162.62 40.63 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.671 2.247 . . . . 0.0 113.016 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -57.0 113.67 1.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.001 . . . . 0.0 112.137 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.37 51.45 16.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.623 1.969 . . . . 0.0 112.87 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -44.77 121.47 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.257 1.823 . . . . 0.0 114.389 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -65.03 -9.64 23.61 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.66 46.35 0.89 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.325 1.916 . . . . 0.0 114.591 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 52.85 40.31 30.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.768 2.027 . . . . 0.0 114.338 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.71 122.51 18.69 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.939 -1.101 . . . . 0.0 112.401 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -132.96 6.41 3.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.052 1.741 . . . . 0.0 111.728 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.86 -36.63 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.163 1.385 . . . . 0.0 112.037 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.71 -3.86 48.53 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.76 142.06 30.09 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.441 1.096 . . . . 0.0 112.126 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.3 159.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.715 1.606 . . . . 0.0 111.008 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -55.75 135.23 51.74 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.124 1.37 . . . . 0.0 111.759 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.694 1.598 . . . . 0.0 113.514 177.843 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.0 p -76.12 7.03 4.53 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.883 1.673 . . . . 0.0 115.511 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.6 t -60.58 -18.12 50.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.701 1.6 . . . . 0.0 114.558 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.6 178.05 28.28 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.775 1.655 . . . . 0.0 112.633 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -61.16 -28.97 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.6 t 48.26 31.96 2.9 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.696 1.998 . . . . 0.0 115.75 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.27 29.69 0.23 Allowed Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.422 -0.799 . . . . 0.0 114.992 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -68.17 141.7 55.93 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.794 0.838 . . . . 0.0 111.595 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.05 142.22 24.08 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 111.577 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.17 158.78 30.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.927 0.891 . . . . 0.0 111.698 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.99 155.81 23.77 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.196 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.74 135.81 41.77 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.84 77.6 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.653 1.12 . . . . 0.0 114.88 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -65.65 131.93 47.56 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.119 1.46 . . . . 0.0 111.782 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.22 130.06 37.63 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.285 0.564 . . . . 0.0 110.159 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.61 177.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.229 1.812 . . . . 0.0 111.31 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.5 mt -114.26 133.8 55.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.387 1.475 . . . . 0.0 109.766 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.98 155.91 42.07 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -75.76 148.35 38.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.028 1.331 . . . . 0.0 111.555 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -144.92 -36.13 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -139.22 -28.67 0.78 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -148.81 178.41 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.768 1.627 . . . . 0.0 110.787 -169.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.5 m -61.53 -17.55 55.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -73.05 114.24 10.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 110.477 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -72.33 152.27 42.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.301 0.641 . . . . 0.0 110.092 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -129.97 156.2 79.46 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.909 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 139.29 37.26 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.603 2.202 . . . . 0.0 113.029 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.47 172.58 14.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.702 1.601 . . . . 0.0 111.404 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -119.92 141.48 49.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.852 1.661 . . . . 0.0 110.088 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -80.16 110.3 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.658 0.783 . . . . 0.0 109.833 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -83.03 -31.35 27.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.447 1.099 . . . . 0.0 113.106 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.16 163.97 37.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.929 1.292 . . . . 0.0 112.14 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.09 143.84 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.781 1.632 . . . . 0.0 109.676 -171.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -135.42 134.63 39.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.472 1.509 . . . . 0.0 111.504 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -29.62 89.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 130.497 3.519 . . . . 0.0 115.211 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 38.39 40.33 0.35 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.872 2.469 . . . . 0.0 115.36 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.2 -30.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 117.094 1.597 . . . . 0.0 117.094 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.47 156.41 39.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.919 1.859 . . . . 0.0 112.753 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -143.48 127.36 17.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.455 1.502 . . . . 0.0 109.322 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.8 m -82.47 134.68 35.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.44 144.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.117 0.967 . . . . 0.0 112.257 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.36 110.19 16.66 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.598 1.559 . . . . 0.0 109.62 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 164.17 26.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.046 0.938 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -54.21 -26.34 27.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.73 -22.08 64.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.358 . . . . 0.0 113.874 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.76 -15.61 44.7 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.005 1.764 . . . . 0.0 114.083 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.43 148.23 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.655 1.582 . . . . 0.0 112.274 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.3 mt -129.92 127.59 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.147 1.379 . . . . 0.0 110.003 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -143.29 -171.05 3.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.276 2.231 . . . . 0.0 109.307 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.77 151.2 50.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.005 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.5 mt -142.15 160.22 40.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.11 1.764 . . . . 0.0 110.882 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -87.58 161.6 17.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 111.246 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.6 ptt85 -55.42 -20.9 13.62 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 169.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.87 -13.37 44.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.828 1.251 . . . . 0.0 113.97 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -128.28 10.9 6.35 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.376 1.47 . . . . 0.0 113.633 -171.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.26 140.3 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.494 1.518 . . . . 0.0 110.039 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -141.18 152.79 44.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.172 1.789 . . . . 0.0 110.927 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.05 139.98 58.23 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.706 -0.621 . . . . 0.0 109.861 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.13 153.81 93.88 Favored Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 121.716 -0.615 . . . . 0.0 111.553 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 165.08 31.89 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.204 2.602 . . . . 0.0 113.325 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.62 110.46 0.71 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.396 1.878 . . . . 0.0 111.088 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 53.1 56.11 7.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.335 1.854 . . . . 0.0 112.992 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.28 153.86 0.95 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.831 1.652 . . . . 0.0 114.401 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -61.8 -35.52 78.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.053 1.341 . . . . 0.0 113.913 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -67.91 159.57 50.94 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.049 0.833 . . . . 0.0 113.9 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -63.4 141.02 58.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.842 0.857 . . . . 0.0 111.471 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -148.95 36.47 0.77 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 113.795 -168.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 85.0 m95 -69.23 46.67 0.06 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.279 2.232 . . . . 0.0 115.557 -175.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.34 155.07 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.94 2.096 . . . . 0.0 111.018 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 50.99 23.2 1.4 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 57.1 mt -79.9 32.39 0.26 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.804 1.641 . . . . 0.0 113.534 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.0 136.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.958 1.703 . . . . 0.0 109.625 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -57.61 136.28 56.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.282 1.433 . . . . 0.0 111.993 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.28 1.832 . . . . 0.0 114.429 -176.417 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -73.6 -27.32 61.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -70.96 153.72 42.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.345 1.058 . . . . 0.0 111.905 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.21 144.59 43.1 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.636 0.636 . . . . 0.0 113.646 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.5 p -58.86 129.99 44.82 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.0 0.92 . . . . 0.0 111.568 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.9 m -132.63 -10.14 3.16 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.91 33.77 60.71 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.091 1.329 . . . . 0.0 116.353 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -56.35 145.47 27.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.445 1.123 . . . . 0.0 113.147 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.67 139.62 20.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.836 1.254 . . . . 0.0 112.146 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.7 159.41 30.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.78 0.832 . . . . 0.0 111.623 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.36 157.55 24.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.626 1.57 . . . . 0.0 111.699 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.48 133.69 46.02 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.35 0.66 . . . . 0.0 110.793 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.8 3.05 58.47 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.608 1.099 . . . . 0.0 114.849 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.7 129.41 39.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.786 1.293 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -74.95 134.58 41.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.436 0.636 . . . . 0.0 110.778 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.89 179.43 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.501 1.921 . . . . 0.0 111.023 -169.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.75 146.59 43.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.336 1.454 . . . . 0.0 108.909 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.08 149.6 26.3 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.296 -0.877 . . . . 0.0 112.979 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -80.61 110.13 15.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.252 1.421 . . . . 0.0 110.348 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -85.71 -160.06 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.111 0.965 . . . . 0.0 112.063 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -56.4 -35.14 67.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.767 1.227 . . . . 0.0 112.458 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.75 153.42 22.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.808 1.243 . . . . 0.0 111.957 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 82.7 m -77.24 50.85 0.8 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -134.41 163.22 30.17 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.526 2.331 . . . . 0.0 110.607 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -121.96 70.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.395 1.478 . . . . 0.0 110.493 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -67.54 157.39 86.08 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.429 1.092 . . . . 0.0 112.442 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.22 138.58 47.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.808 2.338 . . . . 0.0 111.965 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.17 179.57 7.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.175 1.79 . . . . 0.0 110.619 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -142.55 152.76 42.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.633 1.173 . . . . 0.0 111.987 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 91.0 mt -83.33 113.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.259 1.024 . . . . 0.0 110.108 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -80.65 -33.44 35.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.668 1.187 . . . . 0.0 112.787 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.76 38.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.461 1.104 . . . . 0.0 112.546 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.47 138.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.111 1.764 . . . . 0.0 109.118 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -128.77 126.19 39.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.456 1.102 . . . . 0.0 110.368 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.24 -17.61 58.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 0.0 113.613 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.56 -21.41 66.69 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.346 1.058 . . . . 0.0 113.628 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.54 -12.15 7.91 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.591 1.567 . . . . 0.0 114.957 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 157.71 20.32 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 111.765 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -138.51 130.21 27.84 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.515 1.526 . . . . 0.0 110.175 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.5 m -86.93 135.76 33.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.722 0.809 . . . . 0.0 108.926 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.84 148.5 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -119.7 123.82 44.72 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 109.593 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.42 164.77 16.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 111.548 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -52.7 -28.45 21.91 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.98 -21.95 65.04 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.263 1.425 . . . . 0.0 113.733 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.44 -20.15 32.9 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.206 1.86 . . . . 0.0 114.068 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.48 145.95 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.856 1.662 . . . . 0.0 112.749 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.61 125.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.241 1.416 . . . . 0.0 109.892 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -142.62 -172.68 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.153 2.181 . . . . 0.0 109.636 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 32.1 p -130.3 154.5 47.56 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.381 -0.824 . . . . 0.0 112.261 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.4 157.95 44.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.025 1.73 . . . . 0.0 111.088 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -73.05 156.64 38.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.197 0.999 . . . . 0.0 110.447 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -54.54 -25.4 25.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.61 -19.56 58.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.355 1.862 . . . . 0.0 114.139 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -120.26 12.23 11.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.137 1.375 . . . . 0.0 113.394 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.38 142.28 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.01 1.724 . . . . 0.0 108.854 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -135.69 145.76 47.06 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.053 1.741 . . . . 0.0 110.254 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.52 139.27 58.46 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.028 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.3 ttm -64.3 125.56 88.59 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.893 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.57 160.61 43.88 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.828 2.352 . . . . 0.0 113.14 -169.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.52 -10.6 36.14 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.288 1.435 . . . . 0.0 114.434 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.75 -10.2 16.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 113.593 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.3 141.17 47.15 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.013 -1.054 . . . . 0.0 111.754 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -76.95 153.56 34.49 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.138 0.975 . . . . 0.0 111.82 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.5 -24.8 1.68 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.228 1.394 . . . . 0.0 113.952 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -148.63 161.58 41.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.724 2.01 . . . . 0.0 109.915 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -132.74 168.76 17.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.368 1.467 . . . . 0.0 112.8 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -141.59 13.81 2.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.268 1.427 . . . . 0.0 114.148 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.4 pp -49.26 121.03 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.818 1.247 . . . . 0.0 113.055 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.11 43.87 11.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.274 1.83 . . . . 0.0 114.731 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 pp -47.13 143.81 2.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.701 1.6 . . . . 0.0 114.673 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.01 144.78 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.669 1.188 . . . . 0.0 112.022 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -151.45 167.93 26.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.891 1.676 . . . . 0.0 112.032 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.201 1.8 . . . . 0.0 111.882 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.396 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.1 p -154.66 172.03 18.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.299 1.44 . . . . 0.0 112.365 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.7 m -154.85 153.0 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.474 1.51 . . . . 0.0 111.214 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.92 59.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.916 0.769 . . . . 0.0 112.98 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 m -48.43 135.62 13.77 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.86 1.664 . . . . 0.0 114.22 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.1 t -63.73 146.21 54.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.245 1.018 . . . . 0.0 112.363 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.59 52.83 0.02 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.121 0.867 . . . . 0.0 113.24 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -51.46 -44.87 62.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.972 1.309 . . . . 0.0 114.209 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -153.89 148.97 26.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.047 1.739 . . . . 0.0 110.879 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -80.97 155.87 26.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.655 0.782 . . . . 0.0 110.564 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 152.12 34.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.39 1.476 . . . . 0.0 111.706 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.38 141.29 57.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.012 0.525 . . . . 0.0 111.326 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.32 -9.36 73.39 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.17 1.367 . . . . 0.0 114.626 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.38 145.06 31.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.16 1.48 . . . . 0.0 111.974 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.87 143.78 25.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.53 1.132 . . . . 0.0 112.05 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.93 170.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.438 1.895 . . . . 0.0 111.008 -170.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -109.72 133.39 53.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.6 1.16 . . . . 0.0 108.889 169.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.21 153.28 38.54 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -74.66 150.38 39.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.138 1.375 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -140.23 -44.13 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -139.63 -21.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -171.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -142.76 -178.61 5.88 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.679 1.592 . . . . 0.0 110.721 -171.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.4 m -65.47 -14.07 60.18 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.816 -1.178 . . . . 0.0 113.768 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.89 133.58 43.13 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.8 1.24 . . . . 0.0 110.571 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -89.06 152.3 21.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.577 0.751 . . . . 0.0 109.255 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.47 155.84 79.34 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.118 1.367 . . . . 0.0 110.859 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.52 137.17 38.58 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.679 2.253 . . . . 0.0 112.732 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.41 174.6 12.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.818 1.647 . . . . 0.0 111.482 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -136.39 138.3 41.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 110.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.11 130.8 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.343 0.657 . . . . 0.0 109.586 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.84 -31.51 7.99 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.764 1.226 . . . . 0.0 112.53 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.5 33.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.092 1.757 . . . . 0.0 110.749 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.21 148.12 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.849 1.26 . . . . 0.0 110.521 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -127.63 144.46 51.07 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.116 1.366 . . . . 0.0 110.719 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -68.15 -27.87 66.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -170.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.91 35.43 1.39 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.51 -43.84 0.07 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 118.458 2.143 . . . . 0.0 118.458 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 p -137.82 166.6 23.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -167.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -132.64 134.78 45.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.78 1.632 . . . . 0.0 108.895 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -81.69 130.45 35.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.954 0.902 . . . . 0.0 108.612 172.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.62 142.43 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.434 1.094 . . . . 0.0 112.027 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.78 129.51 55.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.679 1.592 . . . . 0.0 109.473 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.22 168.01 11.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.951 0.9 . . . . 0.0 111.756 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.82 -27.05 27.21 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.069 1.348 . . . . 0.0 113.841 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 -17.99 37.33 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.123 1.821 . . . . 0.0 114.193 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.11 147.0 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.789 1.636 . . . . 0.0 112.439 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 129.53 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.691 1.596 . . . . 0.0 110.136 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -143.09 -166.72 2.37 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.142 2.177 . . . . 0.0 109.351 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.13 155.45 46.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.228 -0.92 . . . . 0.0 111.564 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.42 152.79 45.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.242 1.417 . . . . 0.0 110.753 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.27 153.38 42.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.303 1.041 . . . . 0.0 110.957 171.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.33 18.56 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 169.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 tpt -65.33 -13.98 59.75 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.44 1.896 . . . . 0.0 113.804 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -120.79 13.35 11.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.492 1.517 . . . . 0.0 113.603 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.9 mt -134.3 144.41 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.035 1.734 . . . . 0.0 109.455 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -136.61 149.32 47.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.063 2.145 . . . . 0.0 110.271 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 157.24 30.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.58 0.752 . . . . 0.0 111.229 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.87 120.51 64.25 Favored Pre-proline 0 CA--C 1.55 0.962 0 O-C-N 121.964 -0.46 . . . . 0.0 110.306 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.86 164.44 34.61 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.298 2.665 . . . . 0.0 114.127 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.25 -20.81 63.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.426 1.091 . . . . 0.0 113.248 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.88 -21.66 62.38 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.361 1.464 . . . . 0.0 113.767 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.22 158.81 34.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.786 0.834 . . . . 0.0 112.522 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 157.23 15.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.281 1.032 . . . . 0.0 112.598 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.18 -148.85 48.19 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.241 0.448 . . . . 0.0 112.808 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 65.58 15.13 9.89 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.66 1.584 . . . . 0.0 113.932 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -80.41 62.94 4.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.201 1.8 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -69.95 31.77 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.505 1.522 . . . . 0.0 114.958 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.8 pt -63.44 157.58 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.35 -1.469 . . . . 0.0 111.608 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.01 34.69 4.35 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.464 1.906 . . . . 0.0 114.903 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.6 0.75 2.87 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.19 154.22 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.075 1.75 . . . . 0.0 110.688 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -54.2 125.0 17.48 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.496 1.518 . . . . 0.0 112.245 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.614 1.566 . . . . 0.0 112.99 174.806 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.9 m -63.2 157.33 22.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.693 1.197 . . . . 0.0 113.623 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -106.21 163.61 12.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 111.695 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.69 -53.84 0.13 Allowed Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.719 0.676 . . . . 0.0 112.993 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -82.71 60.9 5.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.666 1.186 . . . . 0.0 109.107 168.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -136.57 130.28 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 110.958 -167.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.03 -8.0 68.62 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.576 1.084 . . . . 0.0 114.484 -172.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -153.87 161.75 41.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.194 1.798 . . . . 0.0 111.271 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -149.45 143.84 25.95 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.613 1.565 . . . . 0.0 110.557 172.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -75.17 156.41 35.91 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.346 0.658 . . . . 0.0 111.414 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.27 164.26 30.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 111.779 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.89 132.32 53.47 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.942 0.401 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.78 -4.52 85.71 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.087 1.327 . . . . 0.0 115.054 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.88 132.68 49.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.519 1.66 . . . . 0.0 111.776 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -77.81 133.82 38.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.621 0.769 . . . . 0.0 110.792 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.34 167.05 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.715 1.606 . . . . 0.0 111.171 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.17 140.7 29.73 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.26 160.08 44.01 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.717 -0.614 . . . . 0.0 112.225 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.52 145.52 26.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.827 1.251 . . . . 0.0 111.258 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.89 -48.02 0.5 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 m -140.27 -14.55 1.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -169.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -140.25 179.14 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.209 1.404 . . . . 0.0 111.6 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.6 m -73.13 -20.49 60.91 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.762 -0.587 . . . . 0.0 111.59 167.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -71.81 131.38 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.581 1.552 . . . . 0.0 110.357 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.76 161.91 24.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.895 0.478 . . . . 0.0 110.145 168.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -136.48 154.56 76.94 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.51 1.524 . . . . 0.0 110.529 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.49 139.44 37.72 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.101 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.5 173.5 12.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.127 1.771 . . . . 0.0 110.736 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -125.06 140.42 52.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.485 1.514 . . . . 0.0 109.533 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.53 121.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.323 0.649 . . . . 0.0 109.736 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -90.36 -33.97 15.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.284 1.034 . . . . 0.0 112.379 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.58 35.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.549 1.14 . . . . 0.0 112.702 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.58 156.28 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.797 2.039 . . . . 0.0 109.187 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 57.42 43.35 23.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.502 1.521 . . . . 0.0 113.536 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -67.24 -175.86 0.5 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.617 1.167 . . . . 0.0 110.902 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -54.78 -28.59 50.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.373 1.069 . . . . 0.0 113.838 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.24 24.4 0.07 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.299 0.952 . . . . 0.0 115.14 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.4 p -148.91 179.84 7.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.615 1.566 . . . . 0.0 112.775 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.44 126.5 48.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.974 2.11 . . . . 0.0 108.006 169.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.8 m -77.37 135.9 38.39 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -143.02 151.53 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.564 1.146 . . . . 0.0 112.275 -171.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -122.31 112.86 18.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.949 1.7 . . . . 0.0 109.445 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -76.17 164.17 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 111.614 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -58.02 -21.79 46.82 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -69.96 -16.03 63.13 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.709 1.203 . . . . 0.0 114.032 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.52 -11.46 64.97 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.805 1.669 . . . . 0.0 114.542 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.51 148.19 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.095 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.6 mt -130.23 126.14 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.214 1.405 . . . . 0.0 110.099 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -144.6 -167.42 2.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.481 2.312 . . . . 0.0 109.249 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.34 153.98 49.05 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.26 -0.9 . . . . 0.0 112.067 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.1 mt -138.69 156.83 47.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 111.816 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.99 158.39 29.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.7 1.2 . . . . 0.0 110.569 169.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -57.74 -26.45 61.84 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -67.01 -11.63 57.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.146 1.378 . . . . 0.0 113.91 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -115.51 14.82 16.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.767 1.627 . . . . 0.0 112.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -134.25 145.79 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.47 1.908 . . . . 0.0 109.446 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -138.86 150.03 45.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.526 1.931 . . . . 0.0 111.36 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.42 144.52 48.12 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.006 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 48.2 tpp -62.78 125.57 86.71 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.134 0.974 . . . . 0.0 110.785 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.67 159.67 45.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.041 2.494 . . . . 0.0 112.572 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -62.56 -22.17 66.14 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.784 1.234 . . . . 0.0 113.377 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.64 -25.25 63.83 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.945 1.298 . . . . 0.0 113.704 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.79 138.44 42.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.856 . . . . 0.0 112.572 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -71.1 162.05 30.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.63 1.172 . . . . 0.0 112.66 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.05 179.69 42.37 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.224 0.916 . . . . 0.0 114.145 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.28 157.64 22.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.088 1.355 . . . . 0.0 111.86 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -131.03 146.72 52.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 111.057 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -78.13 36.06 0.23 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.466 1.907 . . . . 0.0 115.071 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.9 mt -54.87 -33.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.894 1.678 . . . . 0.0 112.151 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -12.38 61.36 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.37 91.33 4.02 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 0.0 110.888 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.51 143.82 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.765 1.626 . . . . 0.0 109.975 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -59.71 150.56 27.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 112.701 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 C-N-CA 125.061 1.344 . . . . 0.0 112.664 169.089 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.4 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 t 48.34 39.98 13.54 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.254 1.822 . . . . 0.0 114.858 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 t -153.56 153.38 32.26 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.689 1.196 . . . . 0.0 112.349 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.05 154.55 10.15 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.814 1.673 . . . . 0.0 112.619 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -149.27 149.02 30.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.185 1.394 . . . . 0.0 111.98 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 t -161.35 162.27 30.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.366 1.467 . . . . 0.0 111.414 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.36 28.16 72.67 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -64.41 156.12 30.35 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.284 1.042 . . . . 0.0 113.238 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -148.53 141.98 25.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 110.513 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -126.14 137.56 53.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.146 1.779 . . . . 0.0 109.268 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -143.46 146.14 33.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 111.571 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.49 131.44 50.95 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 122.021 -0.425 . . . . 0.0 111.154 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.78 -13.5 52.82 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.531 1.538 . . . . 0.0 115.371 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.45 149.46 45.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.356 1.578 . . . . 0.0 111.488 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -90.21 143.94 26.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 112.127 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.72 164.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.599 1.96 . . . . 0.0 111.142 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -108.71 125.25 51.71 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.091 1.756 . . . . 0.0 109.208 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.37 152.72 41.93 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -92.33 72.25 5.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.75 1.62 . . . . 0.0 112.508 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CE3' ' CE1' ' A' ' 120' ' ' PHE . 50.8 t-105 -62.33 -37.13 84.45 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -155.25 -29.17 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -136.46 163.04 31.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.103 1.361 . . . . 0.0 111.792 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.53 -20.34 54.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.892 1.277 . . . . 0.0 114.418 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.67 96.44 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.308 1.043 . . . . 0.0 108.918 168.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -55.49 143.21 30.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.386 0.675 . . . . 0.0 111.419 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.89 150.87 56.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.955 1.302 . . . . 0.0 111.522 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.68 137.77 28.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.667 2.245 . . . . 0.0 112.193 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.99 167.18 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.008 1.723 . . . . 0.0 110.954 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.01 142.29 45.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.151 1.38 . . . . 0.0 109.996 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.83 120.61 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.91 0.884 . . . . 0.0 109.383 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -92.79 -31.47 15.02 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.124 0.969 . . . . 0.0 112.561 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.03 158.68 36.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.357 1.063 . . . . 0.0 112.446 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.7 mt -134.5 143.82 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.564 1.946 . . . . 0.0 108.408 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -134.06 140.61 46.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.611 1.164 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -29.5 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.538 1.135 . . . . 0.0 113.249 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -140.63 24.33 2.24 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.636 1.574 . . . . 0.0 112.313 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.53 -111.7 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.776 1.179 . . . . 0.0 113.452 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.7 t -143.64 -177.63 5.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.027 1.331 . . . . 0.0 112.56 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -122.7 106.47 10.97 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.4 1.88 . . . . 0.0 109.896 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 m -72.4 134.8 45.6 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.52 0.728 . . . . 0.0 109.506 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.31 147.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.027 1.331 . . . . 0.0 111.751 -171.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.22 118.27 27.23 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.547 1.539 . . . . 0.0 109.954 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CE1' ' CE3' ' A' ' 97' ' ' TRP . 33.2 m-85 -85.91 172.05 11.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.709 1.203 . . . . 0.0 111.872 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -57.87 -21.75 44.55 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -70.78 -14.03 62.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.923 1.289 . . . . 0.0 114.12 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.61 -16.31 58.29 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.641 1.591 . . . . 0.0 114.883 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.47 148.56 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.689 1.596 . . . . 0.0 112.326 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.36 124.22 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.522 1.529 . . . . 0.0 110.368 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -142.57 -162.46 1.42 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.295 2.238 . . . . 0.0 108.888 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.6 p -135.52 155.29 50.74 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.134 -0.979 . . . . 0.0 112.492 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.25 149.97 40.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.314 1.446 . . . . 0.0 111.192 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -68.71 159.54 32.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.631 1.172 . . . . 0.0 111.329 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -58.27 -20.47 42.75 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 171.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.9 mmm -67.89 -12.91 61.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.915 1.286 . . . . 0.0 113.661 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.8 13.51 5.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 112.871 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.83 136.22 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.791 1.636 . . . . 0.0 109.422 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -140.53 157.61 45.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.063 1.745 . . . . 0.0 111.287 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 174.52 5.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.211 0.604 . . . . 0.0 111.0 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.59 141.96 71.51 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.201 -0.937 . . . . 0.0 111.318 169.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.25 135.18 36.12 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.836 2.357 . . . . 0.0 110.168 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 46.91 30.04 1.15 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.257 1.423 . . . . 0.0 114.123 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t0 47.49 49.53 15.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.314 1.846 . . . . 0.0 113.953 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.6 38.76 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -68.19 159.62 30.76 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.826 1.194 . . . . 0.0 112.795 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 55.79 2.19 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.355 0.502 . . . . 0.0 112.545 -175.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -59.61 1.21 0.1 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.9 -46.89 87.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.872 1.269 . . . . 0.0 112.937 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . 0.255 11.5 p-90 44.86 7.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 119.532 3.16 . . . . 0.0 119.532 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.92 -30.92 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.977 1.717 . . . . 0.0 112.992 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.73 144.05 31.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.162 . . . . 0.0 111.688 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 pp -156.99 168.49 27.32 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.509 1.924 . . . . 0.0 111.325 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.2 m -80.6 130.24 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.7 0.8 . . . . 0.0 111.406 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.9 150.97 24.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.449 1.5 . . . . 0.0 110.973 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.391 1.477 . . . . 0.0 113.272 175.409 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -160.47 158.72 29.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.613 1.565 . . . . 0.0 111.579 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 t -155.26 167.89 28.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.426 1.49 . . . . 0.0 111.233 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.14 29.86 0.12 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.184 0.897 . . . . 0.0 114.815 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.1 m -139.59 144.69 37.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.731 1.212 . . . . 0.0 112.408 -173.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 p -160.66 166.98 27.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.168 1.787 . . . . 0.0 111.336 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.54 23.7 0.43 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.093 0.797 . . . . 0.0 115.093 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.39 148.05 41.57 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 112.387 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -145.09 126.38 14.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.697 1.599 . . . . 0.0 109.366 169.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -127.8 150.68 49.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.626 1.57 . . . . 0.0 110.446 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.8 142.71 30.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.928 1.291 . . . . 0.0 112.566 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 135.96 57.78 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.831 -0.543 . . . . 0.0 110.834 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.04 -12.88 69.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.105 1.336 . . . . 0.0 114.631 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -69.26 162.17 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.4 1.6 . . . . 0.0 112.375 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.41 142.79 32.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.833 0.853 . . . . 0.0 112.175 170.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.95 162.98 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.838 2.055 . . . . 0.0 110.806 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.8 137.43 32.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.55 152.06 33.58 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.522 0.601 . . . . 0.0 112.379 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -84.95 150.01 25.23 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.846 1.258 . . . . 0.0 111.519 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 t-105 -151.42 -39.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -132.73 -32.68 1.25 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.62 178.83 7.69 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.146 1.778 . . . . 0.0 110.528 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.2 m -61.17 -22.45 64.73 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 122.78 22.22 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.647 1.179 . . . . 0.0 111.096 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -70.64 155.69 40.42 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.009 0.924 . . . . 0.0 110.745 169.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.29 157.34 76.47 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.435 1.494 . . . . 0.0 110.579 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.44 135.08 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.135 1.89 . . . . 0.0 111.564 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.16 174.14 11.14 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.722 2.009 . . . . 0.0 110.145 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -127.34 134.99 49.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.528 1.531 . . . . 0.0 110.098 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.5 mt -72.31 121.95 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.02 0.528 . . . . 0.0 110.007 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -87.47 -37.45 16.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.526 1.131 . . . . 0.0 111.858 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.1 162.11 38.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.571 1.148 . . . . 0.0 113.002 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.65 131.24 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.885 1.674 . . . . 0.0 109.242 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.35 11.32 0.25 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.233 2.213 . . . . 0.0 116.581 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -56.75 -32.08 65.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.566 1.546 . . . . 0.0 113.585 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -142.09 49.77 1.54 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 110.219 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.46 18.24 50.16 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.001 1.286 . . . . 0.0 114.859 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.1 p -149.25 170.1 19.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.458 2.303 . . . . 0.0 110.617 -169.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -98.92 112.32 24.46 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.509 1.124 . . . . 0.0 109.575 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 m -73.64 131.34 41.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.92 149.76 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.467 1.107 . . . . 0.0 112.018 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.84 127.92 52.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.034 1.733 . . . . 0.0 109.368 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.46 168.18 11.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.659 0.784 . . . . 0.0 111.488 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -59.77 -20.43 56.6 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -73.22 -14.01 61.26 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.551 1.14 . . . . 0.0 113.994 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.94 -12.08 67.36 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.935 1.731 . . . . 0.0 114.53 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.9 149.18 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.643 1.577 . . . . 0.0 112.301 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.6 130.27 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.308 1.443 . . . . 0.0 110.263 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -145.81 -169.8 3.32 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.429 2.292 . . . . 0.0 109.661 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.59 151.33 50.32 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.816 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.3 mt -139.2 159.39 42.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.231 1.412 . . . . 0.0 112.21 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.98 155.62 23.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -53.98 -25.72 22.27 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 171.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.3 ttt -61.84 -20.56 63.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.788 1.635 . . . . 0.0 113.928 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -120.89 17.63 11.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.274 1.43 . . . . 0.0 112.913 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.28 145.53 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.053 2.141 . . . . 0.0 108.929 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 110.781 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.07 152.66 42.92 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.5 mmt -61.87 148.18 88.24 Favored Pre-proline 0 CA--C 1.547 0.856 0 O-C-N 121.499 -0.751 . . . . 0.0 112.397 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.38 169.49 20.69 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.784 2.99 . . . . 0.0 112.847 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -59.34 -23.6 62.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.602 1.161 . . . . 0.0 113.929 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -80.99 -14.26 58.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.007 1.323 . . . . 0.0 114.164 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.63 152.69 41.62 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -155.67 150.58 26.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.449 1.9 . . . . 0.0 110.342 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.35 -44.99 0.07 OUTLIER Glycine 0 CA--C 1.534 1.236 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.76 171.28 14.22 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 118.056 0.928 . . . . 0.0 111.323 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -136.09 -179.78 5.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.966 1.706 . . . . 0.0 110.501 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -142.51 -12.14 0.8 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.835 1.654 . . . . 0.0 114.223 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.27 -22.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 110.708 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.45 179.67 5.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.544 2.337 . . . . 0.0 110.175 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mp 56.28 24.44 8.23 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.552 1.541 . . . . 0.0 113.43 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.29 123.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.375 1.47 . . . . 0.0 111.238 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' H ' ' HD2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.94 162.53 27.88 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.185 1.394 . . . . 0.0 113.478 178.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.414 1.485 . . . . 0.0 113.194 174.428 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -142.98 165.29 27.75 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.367 1.467 . . . . 0.0 111.92 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.4 m -158.39 164.36 36.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.65 1.58 . . . . 0.0 111.686 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.12 -175.75 44.67 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.782 1.182 . . . . 0.0 113.313 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -64.12 138.39 58.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 0.0 112.195 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -149.85 170.06 19.65 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.412 1.885 . . . . 0.0 111.429 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.59 34.37 6.34 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.714 0.673 . . . . 0.0 114.573 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -143.3 161.58 37.93 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.232 1.413 . . . . 0.0 112.38 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.06 155.01 26.61 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.799 1.64 . . . . 0.0 111.695 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -76.08 149.83 37.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.237 1.015 . . . . 0.0 112.75 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.44 165.15 28.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.313 1.845 . . . . 0.0 111.477 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.61 130.06 45.02 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.859 0.464 . . . . 0.0 110.668 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.48 88.27 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.907 1.241 . . . . 0.0 115.13 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.35 146.04 53.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.758 1.779 . . . . 0.0 112.256 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -95.37 131.12 41.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.044 1.338 . . . . 0.0 110.635 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.64 177.67 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.138 1.775 . . . . 0.0 111.666 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.3 140.33 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.449 1.1 . . . . 0.0 108.434 168.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.39 34.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.555 0.742 . . . . 0.0 111.798 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -77.67 129.12 35.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.903 1.281 . . . . 0.0 109.767 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -93.36 -160.35 0.75 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.551 0.741 . . . . 0.0 111.928 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 t -61.99 -28.5 69.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.167 -0.958 . . . . 0.0 112.222 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -76.87 155.45 32.89 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.043 1.337 . . . . 0.0 112.174 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.04 34.78 0.09 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.887 1.675 . . . . 0.0 114.262 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.46 145.47 40.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.58 1.952 . . . . 0.0 111.488 -172.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.41 148.51 25.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.499 1.119 . . . . 0.0 111.432 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.38 155.45 64.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.995 1.718 . . . . 0.0 111.185 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.62 134.44 32.84 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.023 2.482 . . . . 0.0 111.739 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.88 172.51 15.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.227 1.411 . . . . 0.0 111.933 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -134.1 130.86 38.02 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.537 1.535 . . . . 0.0 110.054 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.14 118.39 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.044 0.938 . . . . 0.0 110.536 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.5 -31.84 15.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.14 1.376 . . . . 0.0 112.474 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.65 160.67 38.27 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.716 1.206 . . . . 0.0 112.523 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 26.5 mt -133.49 133.64 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 126.017 1.727 . . . . 0.0 108.905 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -140.05 99.36 3.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.727 1.211 . . . . 0.0 110.753 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -51.72 148.18 5.84 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.945 1.298 . . . . 0.0 113.469 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 50.96 34.94 11.46 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.507 1.523 . . . . 0.0 113.798 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.0 -93.49 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.09 -1.006 . . . . 0.0 114.636 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.2 p -148.38 175.36 11.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.003 1.321 . . . . 0.0 113.327 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -131.94 139.84 48.82 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.877 1.671 . . . . 0.0 108.475 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -98.88 134.7 41.38 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 108.982 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.91 140.73 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.34 1.056 . . . . 0.0 111.953 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -99.65 128.46 45.75 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.857 1.263 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.73 165.16 18.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.305 1.042 . . . . 0.0 112.444 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.31 -29.7 34.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.302 1.441 . . . . 0.0 114.266 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.94 -20.03 61.13 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 113.797 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.49 -20.88 31.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.104 1.811 . . . . 0.0 114.278 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 150.14 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.56 1.544 . . . . 0.0 112.457 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.61 126.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.283 1.433 . . . . 0.0 109.896 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -142.83 177.93 8.0 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.168 2.187 . . . . 0.0 110.036 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 29.1 p -121.95 154.05 37.68 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.134 0.974 . . . . 0.0 112.522 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.41 157.22 44.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.621 1.569 . . . . 0.0 112.059 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -72.2 158.59 35.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.087 1.355 . . . . 0.0 111.497 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -52.34 -39.14 60.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.293 1.437 . . . . 0.0 113.657 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.16 2.61 2.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.69 1.996 . . . . 0.0 114.238 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -122.91 13.33 9.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.888 1.675 . . . . 0.0 112.654 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -135.7 141.63 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.873 1.269 . . . . 0.0 110.025 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -138.12 152.28 48.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.509 1.924 . . . . 0.0 110.662 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.27 135.95 55.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.812 0.445 . . . . 0.0 110.416 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.7 ttm -67.87 129.83 93.08 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.864 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.21 163.51 38.46 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.645 2.23 . . . . 0.0 113.351 -171.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.8 6.06 1.67 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.379 1.872 . . . . 0.0 114.094 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -133.82 27.85 3.92 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.52 1.928 . . . . 0.0 112.374 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.78 157.78 45.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.621 1.569 . . . . 0.0 112.105 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -66.57 104.97 1.38 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.073 1.349 . . . . 0.0 111.164 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.3 -149.83 14.99 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.95 1.262 . . . . 0.0 112.528 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -126.42 158.26 36.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 113.028 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -151.73 160.98 43.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.074 1.75 . . . . 0.0 110.533 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.26 23.92 2.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.463 1.105 . . . . 0.0 112.497 -171.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.7 140.43 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.899 1.679 . . . . 0.0 110.582 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 51.69 40.38 27.3 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.449 1.9 . . . . 0.0 114.709 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.53 2.84 0.82 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.8 159.95 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.064 1.746 . . . . 0.0 111.145 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -137.31 142.36 41.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.796 1.639 . . . . 0.0 113.59 178.41 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.467 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 t -152.09 148.55 27.8 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.816 1.247 . . . . 0.0 111.607 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.6 m -80.61 42.6 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.268 1.827 . . . . 0.0 113.614 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.64 138.78 40.57 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.702 1.144 . . . . 0.0 113.798 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.9 p -74.71 154.4 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.585 1.154 . . . . 0.0 113.71 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 t -75.09 148.45 39.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.115 0.966 . . . . 0.0 111.742 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.76 -26.08 3.04 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.322 1.439 . . . . 0.0 114.006 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -84.46 143.93 29.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.842 1.257 . . . . 0.0 111.88 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -150.17 147.62 27.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.687 1.595 . . . . 0.0 110.866 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -72.42 156.29 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.39 0.676 . . . . 0.0 111.053 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -144.46 151.61 39.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.648 1.579 . . . . 0.0 111.458 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.69 58.29 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.042 0.449 . . . . 0.0 110.927 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.13 -18.34 54.24 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 125.287 1.423 . . . . 0.0 114.384 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -72.02 147.28 47.0 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.591 1.196 . . . . 0.0 111.755 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 141.34 28.57 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 122.024 0.916 . . . . 0.0 112.148 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 166.87 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.826 2.05 . . . . 0.0 110.46 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.55 137.75 32.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.869 0.868 . . . . 0.0 109.037 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.31 153.37 38.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.527 -0.733 . . . . 0.0 112.488 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -82.77 148.03 28.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.795 1.238 . . . . 0.0 110.994 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -142.74 -42.51 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -134.55 -29.11 1.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -149.85 -161.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.348 1.459 . . . . 0.0 110.955 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.1 t -67.2 -32.24 73.18 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -63.78 153.27 37.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 0.0 112.582 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -101.27 157.43 16.79 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.263 1.025 . . . . 0.0 110.387 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -138.26 153.0 72.65 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.644 1.577 . . . . 0.0 110.092 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 137.79 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.518 2.145 . . . . 0.0 112.499 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.81 160.25 42.51 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.36 1.464 . . . . 0.0 111.842 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.14 127.79 54.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.553 1.941 . . . . 0.0 109.555 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.74 135.68 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.031 0.532 . . . . 0.0 109.686 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -115.78 -26.33 7.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.656 1.182 . . . . 0.0 113.008 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.0 153.41 30.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 111.377 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -132.09 119.46 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.591 1.556 . . . . 0.0 109.064 -174.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.8 t30 51.51 18.51 0.69 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.731 2.012 . . . . 0.0 115.507 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.59 -35.58 72.64 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.731 1.612 . . . . 0.0 113.539 -172.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.76 21.87 4.62 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.296 1.838 . . . . 0.0 111.37 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.11 12.3 61.98 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.841 1.21 . . . . 0.0 114.221 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -147.85 159.62 43.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.106 1.763 . . . . 0.0 110.501 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.65 138.86 33.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.961 1.305 . . . . 0.0 109.327 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.6 m -110.29 135.76 50.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.872 0.869 . . . . 0.0 109.354 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.82 151.26 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.19 0.996 . . . . 0.0 112.669 -169.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -121.11 111.36 17.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 109.114 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.16 161.33 30.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.25 0.62 . . . . 0.0 111.806 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -55.15 -26.1 36.38 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.7 -21.88 64.39 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.135 1.374 . . . . 0.0 113.762 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.51 -12.95 36.08 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 126.183 1.849 . . . . 0.0 114.232 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.63 149.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.453 1.501 . . . . 0.0 112.407 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.6 mt -131.83 124.55 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.466 1.506 . . . . 0.0 109.952 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -144.17 -174.93 4.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.171 2.188 . . . . 0.0 109.883 170.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.1 p -125.17 151.35 45.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.723 1.209 . . . . 0.0 111.732 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.6 mt -143.18 152.54 41.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.815 1.646 . . . . 0.0 111.704 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -70.09 151.49 45.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.53 0.732 . . . . 0.0 109.338 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -57.88 -29.59 65.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.881 0.873 . . . . 0.0 113.121 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -59.31 -7.33 1.24 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.504 1.922 . . . . 0.0 114.488 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -115.97 10.72 15.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.079 1.752 . . . . 0.0 112.626 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.4 mt -131.53 143.73 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 109.625 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.16 152.6 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.155 2.182 . . . . 0.0 111.05 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.85 159.19 25.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.294 0.638 . . . . 0.0 111.712 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.9 mmt -62.11 157.68 50.84 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.706 0.802 . . . . 0.0 112.32 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.11 9.21 1.8 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.35 3.367 . . . . 0.0 116.302 -170.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 64.34 28.2 13.74 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.665 1.986 . . . . 0.0 112.577 -172.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.02 -28.61 1.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.081 1.753 . . . . 0.0 112.857 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.43 122.67 18.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.229 1.012 . . . . 0.0 111.208 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -153.62 153.45 32.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.596 1.558 . . . . 0.0 110.981 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -167.93 -151.06 6.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.306 0.955 . . . . 0.0 112.988 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.18 105.84 3.56 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.075 -0.662 . . . . 0.0 109.246 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -148.62 -177.5 5.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.035 1.334 . . . . 0.0 113.029 -171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -130.96 38.08 3.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.544 1.538 . . . . 0.0 112.282 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.2 pt -58.53 -20.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.96 137.1 23.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.028 1.731 . . . . 0.0 110.072 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.24 23.24 0.64 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.293 1.437 . . . . 0.0 113.235 -173.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.97 155.23 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.58 1.552 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -55.52 141.3 37.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.855 1.662 . . . . 0.0 112.566 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.394 1.877 . . . . 0.0 111.782 178.752 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.334 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -143.94 163.48 33.34 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.802 1.641 . . . . 0.0 111.619 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 m -59.44 148.7 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.56 1.144 . . . . 0.0 112.987 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.04 -12.64 84.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.197 0.904 . . . . 0.0 114.947 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -151.97 165.83 33.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.996 1.718 . . . . 0.0 112.032 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.4 p -70.59 167.22 18.98 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.905 1.282 . . . . 0.0 113.433 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -178.11 -138.93 3.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.098 1.332 . . . . 0.0 112.001 -175.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.24 159.68 5.79 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.827 0.851 . . . . 0.0 112.799 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -141.56 144.44 34.27 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.49 1.516 . . . . 0.0 110.932 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.83 160.58 31.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.85 0.86 . . . . 0.0 112.206 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.01 159.81 43.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.86 1.664 . . . . 0.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.55 37.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.692 0.397 . . . . 0.0 110.989 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.36 -10.72 72.82 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.474 1.511 . . . . 0.0 114.559 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.11 132.04 47.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.133 1.466 . . . . 0.0 111.61 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.65 143.4 33.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.34 169.5 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.855 1.662 . . . . 0.0 111.645 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.3 141.72 45.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.396 1.478 . . . . 0.0 108.325 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.99 151.32 30.16 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.51 -0.744 . . . . 0.0 112.886 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -81.4 113.22 19.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.938 1.295 . . . . 0.0 110.247 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -93.75 -159.7 0.71 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.347 1.059 . . . . 0.0 112.044 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 t -61.14 -12.17 11.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.538 1.135 . . . . 0.0 113.712 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.16 149.7 43.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.423 2.289 . . . . 0.0 110.055 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.34 -17.24 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -169.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.71 155.98 39.1 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.254 0.934 . . . . 0.0 111.682 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -101.52 80.92 2.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.195 1.398 . . . . 0.0 110.25 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -71.62 153.66 93.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.476 1.11 . . . . 0.0 112.085 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.75 137.78 33.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.132 2.555 . . . . 0.0 112.447 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.03 -178.32 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.568 1.547 . . . . 0.0 111.606 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -143.32 154.41 43.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.354 1.462 . . . . 0.0 111.255 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -82.6 133.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.157 0.983 . . . . 0.0 109.743 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -104.38 -30.16 10.27 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.446 1.499 . . . . 0.0 112.794 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.32 154.44 32.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.609 1.164 . . . . 0.0 112.301 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt -141.97 141.73 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.044 1.738 . . . . 0.0 110.085 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -152.71 157.71 41.28 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.959 0.904 . . . . 0.0 111.459 168.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -67.1 -26.14 66.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.522 1.129 . . . . 0.0 112.95 171.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.31 63.53 1.58 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.663 1.985 . . . . 0.0 109.968 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.98 120.64 0.56 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.241 1.4 . . . . 0.0 110.266 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 p -44.07 146.99 0.55 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.129 1.772 . . . . 0.0 113.883 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -73.36 111.09 8.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.582 1.153 . . . . 0.0 109.929 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.7 m -68.4 135.84 52.38 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.62 150.1 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.694 1.197 . . . . 0.0 111.5 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -126.86 125.58 41.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.129 1.371 . . . . 0.0 110.233 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -87.95 162.29 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.013 0.925 . . . . 0.0 111.672 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -52.39 -29.44 24.18 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.0 -20.15 58.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.41 -22.91 8.2 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.694 1.616 . . . . 0.0 115.472 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.31 148.0 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.109 1.454 . . . . 0.0 113.176 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.5 mt -130.2 127.84 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.214 1.405 . . . . 0.0 110.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -143.7 -169.03 2.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.413 2.285 . . . . 0.0 109.436 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.5 p -127.77 150.81 49.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.413 1.085 . . . . 0.0 112.133 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -141.21 163.09 33.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 111.557 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -89.0 155.89 19.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.138 1.375 . . . . 0.0 110.715 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.99 -28.7 10.5 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.3 ttt -63.94 -12.83 40.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.942 1.697 . . . . 0.0 113.811 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -128.18 13.36 6.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.049 1.74 . . . . 0.0 113.354 -172.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.6 mt -131.56 143.58 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.458 1.903 . . . . 0.0 109.148 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -137.21 149.89 47.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.637 1.975 . . . . 0.0 110.521 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 150.14 48.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.304 0.642 . . . . 0.0 111.094 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -63.43 119.32 52.37 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.464 0.706 . . . . 0.0 110.821 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.22 168.83 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.807 2.338 . . . . 0.0 113.57 -172.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.58 118.49 4.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.141 1.776 . . . . 0.0 111.291 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 t70 57.76 36.54 26.6 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.529 1.932 . . . . 0.0 113.605 176.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -46.84 89.79 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.886 2.474 . . . . 0.0 115.212 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? 45.81 27.24 0.44 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.497 2.319 . . . . 0.0 114.65 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.82 179.4 36.46 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.429 1.49 . . . . 0.0 113.178 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -129.98 133.57 46.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.826 1.25 . . . . 0.0 111.468 -173.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -146.4 156.91 43.66 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.947 1.699 . . . . 0.0 110.796 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -81.78 38.92 0.53 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.721 1.609 . . . . 0.0 114.251 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 147' ' ' ALA . 2.8 mm -85.93 -149.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.883 1.673 . . . . 0.0 109.936 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 146' ' ' ILE . . . -72.02 48.32 0.16 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 114.37 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.29 -6.43 9.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.877 2.071 . . . . 0.0 115.307 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.43 162.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.914 2.086 . . . . 0.0 110.475 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.33 144.84 51.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.081 1.752 . . . . 0.0 111.103 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.623 1.569 . . . . 0.0 113.361 176.042 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.388 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 t -152.12 168.44 25.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.459 1.504 . . . . 0.0 111.452 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.2 p -149.73 80.6 1.39 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.379 1.472 . . . . 0.0 112.54 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.76 169.55 42.68 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.571 1.081 . . . . 0.0 113.586 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.5 m -163.17 160.05 23.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.181 1.793 . . . . 0.0 111.212 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 m -66.65 136.57 55.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.424 0.689 . . . . 0.0 111.587 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.65 -33.84 1.07 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.968 1.27 . . . . 0.0 113.283 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -81.19 144.07 31.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.501 1.12 . . . . 0.0 111.301 171.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -148.21 137.67 22.18 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.214 1.406 . . . . 0.0 110.927 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -77.91 166.72 22.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.807 0.843 . . . . 0.0 112.036 169.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -126.35 152.67 45.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.006 1.722 . . . . 0.0 111.795 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.9 137.85 54.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.173 0.589 . . . . 0.0 111.051 173.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.18 72.33 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.77 1.176 . . . . 0.0 114.886 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.51 142.45 28.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.738 1.269 . . . . 0.0 112.199 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.38 141.13 30.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.175 0.99 . . . . 0.0 111.849 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -146.39 170.16 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.185 1.794 . . . . 0.0 111.061 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.73 133.54 52.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.533 1.133 . . . . 0.0 107.998 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.42 159.04 44.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.4 -0.813 . . . . 0.0 112.526 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 139.61 35.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.211 1.004 . . . . 0.0 111.549 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -135.72 -29.24 1.05 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.2 m -142.41 -56.5 0.44 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.063 0.847 . . . . 0.0 112.19 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -119.28 176.97 5.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.015 1.326 . . . . 0.0 111.814 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.8 m -60.74 -20.74 61.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.44 128.02 33.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.655 1.182 . . . . 0.0 110.508 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -68.37 161.02 28.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.759 168.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.4 156.42 80.15 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.751 1.621 . . . . 0.0 110.37 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.57 135.52 36.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.407 2.071 . . . . 0.0 111.64 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.24 173.87 12.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.846 1.658 . . . . 0.0 111.093 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -144.15 133.12 22.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.6 117.86 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.991 0.917 . . . . 0.0 110.15 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -84.03 -37.28 22.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.087 1.355 . . . . 0.0 112.167 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.45 160.82 38.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.788 1.235 . . . . 0.0 112.347 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.64 143.21 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.799 1.64 . . . . 0.0 109.246 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -132.47 -50.93 0.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.857 0.863 . . . . 0.0 112.57 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -159.47 163.39 35.36 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.532 1.533 . . . . 0.0 110.283 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.67 -13.73 1.82 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.95 -11.59 39.5 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.296 1.427 . . . . 0.0 115.396 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.6 p -149.61 127.81 12.07 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 120.124 1.962 . . . . 0.0 113.535 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.25 144.34 46.8 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.861 1.664 . . . . 0.0 110.109 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -97.89 126.1 43.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.843 0.857 . . . . 0.0 109.121 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.28 130.81 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.052 0.941 . . . . 0.0 112.449 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.77 140.87 29.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.08 1.352 . . . . 0.0 109.529 169.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.58 168.25 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 111.43 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -58.17 -22.88 53.28 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.53 -13.54 61.05 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.24 -14.12 63.92 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.0 1.762 . . . . 0.0 114.258 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.65 151.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.735 1.614 . . . . 0.0 112.182 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.32 129.93 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.504 1.521 . . . . 0.0 109.993 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -146.45 167.7 23.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.015 1.726 . . . . 0.0 111.515 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 79.0 m -82.65 145.43 29.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.935 0.494 . . . . 0.0 110.346 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 37.3 mt -139.25 157.15 46.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.541 1.536 . . . . 0.0 111.252 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -81.49 155.65 25.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.906 1.282 . . . . 0.0 111.268 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -56.37 -29.3 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.859 1.264 . . . . 0.0 113.365 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 21.9 ttt -59.0 -14.85 10.56 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.707 1.603 . . . . 0.0 114.157 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -130.35 16.19 5.51 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.306 1.842 . . . . 0.0 112.805 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.4 mt -132.43 143.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.676 1.99 . . . . 0.0 108.825 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -136.87 149.2 47.52 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.227 2.211 . . . . 0.0 110.07 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.12 155.83 38.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.172 0.589 . . . . 0.0 111.114 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.1 mmt -64.47 145.67 98.37 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 121.949 -0.469 . . . . 0.0 111.824 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 169.03 20.35 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.649 2.899 . . . . 0.0 113.281 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.44 -17.81 46.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.964 1.706 . . . . 0.0 114.337 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.84 13.35 17.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.01 1.724 . . . . 0.0 113.886 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.68 37.52 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.504 1.922 . . . . 0.0 115.051 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.9 139.67 26.64 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.707 1.603 . . . . 0.0 114.149 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.66 143.48 3.71 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.633 1.587 . . . . 0.0 111.997 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 38.13 42.52 0.49 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.964 2.106 . . . . 0.0 115.194 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -82.18 77.19 9.01 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.54 1.536 . . . . 0.0 112.569 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -122.59 15.03 10.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.635 1.574 . . . . 0.0 113.958 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.2 pt -110.06 168.47 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.591 1.956 . . . . 0.0 111.366 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 51.44 26.11 3.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.567 1.947 . . . . 0.0 115.267 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 148' ' ' LEU . 2.2 pt? -74.85 29.98 0.09 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.899 2.48 . . . . 0.0 114.913 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.4 m -63.29 155.59 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 113.445 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.58 14.71 1.41 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.508 1.523 . . . . 0.0 114.062 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.471 1.908 . . . . 0.0 111.863 -178.379 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.363 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.7 p -152.88 163.49 39.67 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.909 1.284 . . . . 0.0 112.241 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 t 52.48 29.69 7.38 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.744 1.618 . . . . 0.0 114.593 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.64 160.24 48.8 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 121.085 -1.01 . . . . 0.0 114.571 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -81.61 160.12 23.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.986 1.314 . . . . 0.0 112.483 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.0 -9.94 59.14 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.321 1.048 . . . . 0.0 113.568 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.02 169.37 41.99 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.006 1.765 . . . . 0.0 112.424 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -59.96 -38.31 82.11 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -174.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.89 165.34 25.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.006 1.722 . . . . 0.0 110.908 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.12 176.61 3.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 0.0 111.768 168.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -122.89 128.08 49.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.624 1.57 . . . . 0.0 110.475 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.96 134.54 54.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.148 0.579 . . . . 0.0 111.528 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.23 -7.74 35.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.784 1.659 . . . . 0.0 115.178 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -79.12 146.82 32.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.776 1.288 . . . . 0.0 112.599 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.43 138.92 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.811 1.245 . . . . 0.0 111.807 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.6 174.23 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 127.174 2.19 . . . . 0.0 110.896 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.26 136.45 47.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.182 . . . . 0.0 107.98 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.41 31.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.597 -0.689 . . . . 0.0 112.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -72.97 142.68 47.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -146.72 -44.23 0.18 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 m -136.51 -16.7 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -147.97 -176.24 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.428 1.491 . . . . 0.0 111.228 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 77.3 m -67.89 -24.16 65.19 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.142 -0.974 . . . . 0.0 111.439 166.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -68.31 141.7 55.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.229 1.812 . . . . 0.0 111.953 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.47 163.87 22.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.563 0.745 . . . . 0.0 110.593 168.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -134.79 153.26 78.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.191 1.796 . . . . 0.0 110.669 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.57 135.1 25.56 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.683 2.256 . . . . 0.0 111.825 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.52 177.69 9.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.559 1.543 . . . . 0.0 110.581 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.92 151.71 51.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.133 0.973 . . . . 0.0 110.819 168.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.6 mt -81.14 113.68 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.675 0.79 . . . . 0.0 109.922 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -80.4 -32.83 37.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 112.747 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.77 36.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.064 0.946 . . . . 0.0 113.177 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.5 mt -130.79 133.31 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.424 1.89 . . . . 0.0 108.609 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.64 16.1 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.96 2.504 . . . . 0.0 117.288 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.97 -40.53 93.78 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.581 1.552 . . . . 0.0 113.26 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -137.45 17.57 2.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.739 1.616 . . . . 0.0 112.428 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.59 -1.87 64.32 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.249 1.404 . . . . 0.0 114.5 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.5 p -144.72 160.95 40.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.759 2.024 . . . . 0.0 110.973 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -70.41 148.2 48.63 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.285 0.634 . . . . 0.0 110.468 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.5 m -115.48 136.61 52.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.646 1.178 . . . . 0.0 108.392 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.5 m -135.95 156.15 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.899 . . . . 0.0 112.15 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -125.0 117.29 23.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.274 1.43 . . . . 0.0 109.473 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.71 165.39 22.88 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.119 0.968 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -54.0 -27.03 29.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.872 1.269 . . . . 0.0 114.367 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.94 -21.88 64.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.475 . . . . 0.0 113.863 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.14 56.78 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.668 1.604 . . . . 0.0 114.766 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.51 144.65 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.239 1.416 . . . . 0.0 112.179 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.78 109.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.038 1.335 . . . . 0.0 109.515 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -138.51 175.58 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.978 1.711 . . . . 0.0 111.644 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.56 155.6 18.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.326 1.05 . . . . 0.0 112.199 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.2 mt -144.77 156.91 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.11 156.32 38.8 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.417 1.087 . . . . 0.0 110.732 169.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -57.12 -24.83 56.87 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.05 -12.16 53.42 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.001 1.72 . . . . 0.0 114.126 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -120.86 12.04 11.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.727 1.611 . . . . 0.0 113.109 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -132.67 143.2 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.667 1.587 . . . . 0.0 109.565 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -134.72 147.29 50.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.765 2.026 . . . . 0.0 110.697 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.45 141.63 48.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.929 0.892 . . . . 0.0 110.959 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.2 tpp -64.98 122.32 78.86 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.663 0.785 . . . . 0.0 110.437 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 168.13 24.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.584 2.19 . . . . 0.0 113.092 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -51.57 106.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.852 2.461 . . . . 0.0 112.54 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.3 t70 51.71 44.44 29.23 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.684 1.994 . . . . 0.0 113.573 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.87 37.65 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.652 1.581 . . . . 0.0 115.038 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -153.71 151.87 30.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.629 1.972 . . . . 0.0 110.209 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.82 -156.26 4.15 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.866 1.222 . . . . 0.0 113.539 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 62.36 16.41 8.52 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.712 1.605 . . . . 0.0 114.375 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.7 153.44 34.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.078 1.751 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -140.98 -21.16 0.79 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.82 -13.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -171.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.56 -19.76 65.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.597 1.159 . . . . 0.0 113.593 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.76 61.96 4.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 111.398 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.26 142.21 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 111.926 -173.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.21 151.24 45.59 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.422 1.489 . . . . 0.0 112.239 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.257 1.823 . . . . 0.0 111.614 176.645 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -151.27 141.69 22.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.841 1.256 . . . . 0.0 111.113 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.4 m -148.24 162.67 39.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.994 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.27 169.99 42.71 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.698 1.142 . . . . 0.0 113.18 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -156.16 148.56 23.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 111.534 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -147.22 154.68 41.32 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.894 1.678 . . . . 0.0 111.143 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.08 172.63 45.85 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.819 0.723 . . . . 0.0 113.273 171.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.11 147.37 43.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.391 1.477 . . . . 0.0 110.521 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -141.33 54.66 1.54 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.065 1.346 . . . . 0.0 111.279 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -49.01 144.2 4.96 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.074 1.349 . . . . 0.0 112.575 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 154.81 43.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.864 1.266 . . . . 0.0 112.428 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.52 130.23 43.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.367 0.667 . . . . 0.0 111.547 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.61 -8.71 68.81 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.463 1.506 . . . . 0.0 114.371 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.24 132.52 41.13 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.018 1.409 . . . . 0.0 112.5 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.45 135.65 37.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.425 1.09 . . . . 0.0 111.64 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.35 -176.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.418 2.287 . . . . 0.0 111.009 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -111.39 145.09 39.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.132 0.973 . . . . 0.0 109.247 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 150.43 35.41 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.443 0.64 . . . . 0.0 112.46 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -80.72 154.29 27.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.543 1.537 . . . . 0.0 110.638 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.39 -47.51 0.52 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -142.95 -29.36 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -138.58 -169.51 2.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.095 1.758 . . . . 0.0 110.301 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.0 p -62.17 -15.56 47.06 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.631 -1.293 . . . . 0.0 114.415 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -62.8 145.4 55.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.554 1.541 . . . . 0.0 111.979 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -117.29 154.34 31.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.926 1.29 . . . . 0.0 109.444 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.64 152.8 71.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.677 1.191 . . . . 0.0 111.332 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.78 130.9 24.32 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.783 2.322 . . . . 0.0 110.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.76 12.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.242 1.417 . . . . 0.0 110.859 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -132.71 132.18 42.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.293 1.437 . . . . 0.0 109.458 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -71.45 121.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.111 0.564 . . . . 0.0 109.623 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -95.23 -32.25 13.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 112.343 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.99 40.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.841 1.257 . . . . 0.0 112.143 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -135.2 117.02 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.199 1.399 . . . . 0.0 109.084 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.71 14.52 0.29 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.078 2.151 . . . . 0.0 116.156 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.61 -34.12 66.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.025 1.73 . . . . 0.0 113.809 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -129.61 29.92 4.98 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.064 1.745 . . . . 0.0 111.012 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.95 2.67 88.33 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.969 1.271 . . . . 0.0 114.571 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.5 p -144.43 162.82 35.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.886 2.074 . . . . 0.0 111.066 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -75.96 160.39 29.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.443 0.697 . . . . 0.0 110.056 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.4 m -131.27 134.37 46.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.883 1.273 . . . . 0.0 108.727 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 150.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.407 1.083 . . . . 0.0 111.71 -175.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -118.29 134.15 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.581 1.552 . . . . 0.0 109.651 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -93.28 167.55 11.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.443 1.097 . . . . 0.0 112.156 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -53.7 -28.74 35.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.602 1.561 . . . . 0.0 114.463 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.42 -18.93 61.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.11 1.364 . . . . 0.0 113.797 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.92 -15.9 47.53 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.886 1.708 . . . . 0.0 114.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.34 146.12 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.393 1.477 . . . . 0.0 112.347 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 132.02 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.788 1.635 . . . . 0.0 109.986 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -143.71 168.73 19.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.948 1.699 . . . . 0.0 111.461 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.64 149.96 27.46 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.289 1.036 . . . . 0.0 111.712 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 mt -148.11 158.65 44.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.348 1.459 . . . . 0.0 112.458 -171.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -76.35 159.79 30.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.752 0.821 . . . . 0.0 109.534 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -56.58 -35.01 67.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.055 0.942 . . . . 0.0 112.472 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.8 mtt -64.52 -1.17 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 0.0 114.729 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -120.42 7.59 10.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.733 1.613 . . . . 0.0 113.193 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.5 mt -130.27 139.66 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.989 1.716 . . . . 0.0 108.822 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -136.72 147.09 46.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.468 1.507 . . . . 0.0 110.669 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 135.11 55.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.857 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 55.7 ttm -66.01 128.81 94.07 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.786 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.28 159.04 53.02 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.776 2.317 . . . . 0.0 112.06 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -60.93 -19.15 60.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.134 0.974 . . . . 0.0 113.492 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -72.72 -9.74 58.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.471 1.508 . . . . 0.0 114.156 172.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -135.31 -34.46 0.86 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.078 1.351 . . . . 0.0 114.001 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -62.73 127.5 31.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.436 1.494 . . . . 0.0 109.621 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.5 141.13 27.73 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.539 1.066 . . . . 0.0 114.566 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -61.33 129.92 43.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.228 . . . . 0.0 111.764 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . 0.321 2.3 p30 53.65 12.65 0.41 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 118.194 2.665 . . . . 0.0 118.194 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -60.87 -11.24 7.21 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.681 -1.262 . . . . 0.0 114.083 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.7 mm -56.76 -23.64 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.292 1.837 . . . . 0.0 112.736 170.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.24 138.19 47.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.136 1.374 . . . . 0.0 111.656 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.43 173.27 17.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.71 1.604 . . . . 0.0 112.133 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.1 p -146.45 160.63 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.711 1.604 . . . . 0.0 110.999 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 165.06 29.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.829 1.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.729 1.611 . . . . 0.0 113.488 178.319 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.405 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -142.43 164.13 30.96 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.7 1.6 . . . . 0.0 111.654 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -151.61 163.64 38.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.53 1.132 . . . . 0.0 112.878 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.85 162.72 25.88 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.207 1.384 . . . . 0.0 113.984 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.7 m -72.74 155.6 39.79 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.943 -0.739 . . . . 0.0 111.45 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.5 m -149.98 158.3 44.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.931 1.292 . . . . 0.0 112.094 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.97 70.84 1.47 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.881 1.705 . . . . 0.0 113.738 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -57.63 -20.95 36.6 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.461 1.505 . . . . 0.0 114.212 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -128.57 145.75 51.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.206 1.802 . . . . 0.0 111.48 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -119.55 151.08 39.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.809 1.644 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 162.68 40.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.332 1.853 . . . . 0.0 110.491 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.22 123.83 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.992 -0.443 . . . . 0.0 111.453 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.4 -7.16 78.1 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.289 1.423 . . . . 0.0 114.877 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.92 135.52 56.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.27 1.535 . . . . 0.0 111.619 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.12 138.81 31.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.777 0.831 . . . . 0.0 112.092 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.34 167.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.071 1.748 . . . . 0.0 111.03 -171.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.08 148.45 22.34 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.3 144.16 28.6 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.439 0.696 . . . . 0.0 111.571 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -72.62 152.84 41.54 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.149 0.98 . . . . 0.0 110.015 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -131.67 -160.28 1.03 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 112.152 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 m -55.24 -36.56 66.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.155 0.982 . . . . 0.0 111.382 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -84.07 139.59 32.38 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.021 1.329 . . . . 0.0 109.747 168.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.41 -21.46 65.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 158.51 24.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.008 1.276 . . . . 0.0 112.199 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.84 149.09 23.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.688 0.795 . . . . 0.0 110.263 168.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.65 152.77 69.3 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.257 1.423 . . . . 0.0 111.29 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 136.56 29.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.999 2.466 . . . . 0.0 112.141 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.13 13.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.736 1.615 . . . . 0.0 111.221 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -128.82 141.15 51.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 110.862 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.02 124.98 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.155 0.982 . . . . 0.0 109.58 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -95.57 -30.51 13.77 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.885 0.874 . . . . 0.0 112.894 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.76 153.22 32.74 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.6 mt -137.64 149.89 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.645 2.378 . . . . 0.0 108.467 -171.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.38 44.99 29.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.168 1.387 . . . . 0.0 113.571 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -70.34 -154.5 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.099 1.76 . . . . 0.0 110.012 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.91 -16.35 11.79 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.46 -1.4 . . . . 0.0 114.569 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 161.81 -30.93 0.31 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.528 2.013 . . . . 0.0 112.51 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 171.8 13.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.784 2.434 . . . . 0.0 112.057 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -113.4 162.98 15.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.891 1.676 . . . . 0.0 108.714 168.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.3 m -122.06 133.33 54.79 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.204 -0.935 . . . . 0.0 109.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.94 157.07 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -128.41 128.6 44.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.154 1.382 . . . . 0.0 110.145 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -81.74 162.63 22.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 112.485 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -52.96 -31.74 42.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.339 1.456 . . . . 0.0 114.814 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.35 -17.33 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.53 -21.17 8.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.277 1.418 . . . . 0.0 115.449 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.42 146.83 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.289 1.544 . . . . 0.0 112.857 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.78 128.87 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 109.215 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -143.95 175.07 10.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.173 1.789 . . . . 0.0 110.922 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.7 m -113.68 141.73 46.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 110.523 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -144.07 146.44 32.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.404 1.882 . . . . 0.0 109.731 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.4 160.86 30.45 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.409 -0.807 . . . . 0.0 110.978 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.95 8.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.804 1.242 . . . . 0.0 113.916 168.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.67 -12.54 34.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.541 1.936 . . . . 0.0 113.892 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.41 9.51 6.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.3 1.84 . . . . 0.0 113.157 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -126.25 143.42 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.15 2.18 . . . . 0.0 108.18 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -135.31 148.69 49.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.55 1.54 . . . . 0.0 110.854 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.51 145.47 48.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.703 0.801 . . . . 0.0 111.028 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -62.54 131.12 93.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 118.814 -0.612 . . . . 0.0 110.857 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 172.09 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.581 2.854 . . . . 0.0 113.941 -171.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -60.81 -18.61 56.53 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -148.27 133.36 18.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.299 1.44 . . . . 0.0 111.292 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -159.61 -38.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.798 1.639 . . . . 0.0 112.362 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -147.21 141.54 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.029 2.132 . . . . 0.0 109.196 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.39 113.38 5.63 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.669 1.128 . . . . 0.0 113.766 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -156.02 170.55 21.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.973 1.309 . . . . 0.0 112.605 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.06 31.62 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.511 1.924 . . . . 0.0 115.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.32 26.67 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.893 1.677 . . . . 0.0 114.007 172.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.04 131.8 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.631 1.972 . . . . 0.0 109.123 -170.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.48 33.13 3.75 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.56 1.544 . . . . 0.0 114.218 -173.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.46 165.85 5.76 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.674 1.59 . . . . 0.0 114.218 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.72 129.81 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.744 1.218 . . . . 0.0 111.272 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -60.31 156.66 15.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.172 1.389 . . . . 0.0 114.026 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.452 1.501 . . . . 0.0 113.128 174.669 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -64.41 -25.63 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.7 m -136.7 -7.39 1.91 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -171.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.09 172.66 10.75 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.778 1.18 . . . . 0.0 114.658 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -158.55 38.88 0.24 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.109 1.364 . . . . 0.0 111.762 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 m -57.21 -31.8 65.85 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.24 165.57 17.37 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.664 1.126 . . . . 0.0 113.987 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -86.37 88.03 7.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.99 158.53 43.92 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.516 1.527 . . . . 0.0 111.474 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -138.45 -178.46 5.3 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.511 1.924 . . . . 0.0 111.479 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -119.17 128.02 53.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.982 1.713 . . . . 0.0 109.911 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 133.76 52.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.146 0.578 . . . . 0.0 111.34 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.07 75.34 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.884 1.23 . . . . 0.0 115.061 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.47 154.09 20.3 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.908 1.354 . . . . 0.0 112.411 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.36 142.55 27.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.175 0.99 . . . . 0.0 112.533 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.24 174.79 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.911 2.084 . . . . 0.0 110.86 -170.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.0 124.99 52.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.724 1.21 . . . . 0.0 109.32 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.14 154.84 44.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -88.66 147.1 24.7 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.043 1.337 . . . . 0.0 111.674 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -143.73 -30.53 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -139.11 -28.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -169.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.55 -167.81 2.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.027 1.731 . . . . 0.0 110.064 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.7 m -66.73 -13.89 61.9 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.836 -1.165 . . . . 0.0 113.727 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -69.18 166.55 18.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.189 1.796 . . . . 0.0 113.378 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -129.13 152.01 49.19 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.883 1.673 . . . . 0.0 109.991 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -139.12 156.01 72.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.48 1.512 . . . . 0.0 110.738 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.41 132.08 28.25 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.428 2.085 . . . . 0.0 111.881 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.86 172.02 13.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.798 1.639 . . . . 0.0 110.59 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -128.75 129.26 45.48 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.211 1.804 . . . . 0.0 109.605 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.62 120.94 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.367 0.667 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.29 -27.37 15.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.879 0.872 . . . . 0.0 112.69 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.69 156.44 29.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.235 1.414 . . . . 0.0 111.603 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.48 127.75 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.736 1.615 . . . . 0.0 108.936 -174.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -153.0 114.67 4.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.783 0.833 . . . . 0.0 111.697 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -63.12 -7.63 6.09 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.89 -28.88 39.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.399 1.48 . . . . 0.0 113.509 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.28 -22.45 0.08 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 117.991 1.957 . . . . 0.0 117.991 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.93 153.04 37.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.03 1.915 . . . . 0.0 113.111 -169.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.44 124.92 52.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.786 1.634 . . . . 0.0 109.839 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -80.72 132.23 35.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.69 0.796 . . . . 0.0 110.403 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.17 146.21 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.056 1.342 . . . . 0.0 112.438 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.14 119.61 29.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.317 1.847 . . . . 0.0 109.223 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -89.67 165.58 14.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.121 0.968 . . . . 0.0 111.005 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -58.94 -18.8 36.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -69.09 -15.72 63.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.74 1.216 . . . . 0.0 113.928 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.95 -15.49 61.57 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.248 1.88 . . . . 0.0 114.321 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.26 146.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.84 1.656 . . . . 0.0 112.231 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 126.42 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 110.125 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -140.71 -162.57 1.38 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.945 2.098 . . . . 0.0 109.236 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.53 151.93 47.78 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.164 -0.96 . . . . 0.0 112.138 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -139.13 158.12 44.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.54 1.536 . . . . 0.0 111.904 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.13 158.01 36.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.65 1.18 . . . . 0.0 110.756 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.68 -17.86 57.25 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.97 -12.24 61.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.14 1.376 . . . . 0.0 113.427 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -127.03 9.88 6.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.982 1.713 . . . . 0.0 113.321 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.66 136.83 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.55 1.94 . . . . 0.0 108.243 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -134.48 148.74 50.62 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.175 1.79 . . . . 0.0 110.281 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.3 138.24 58.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.228 0.611 . . . . 0.0 110.549 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.7 ttm -64.92 127.04 92.32 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.12 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 162.11 40.85 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.063 2.509 . . . . 0.0 113.704 -169.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.87 -19.79 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.32 -23.05 60.2 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.773 1.229 . . . . 0.0 113.361 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.19 173.59 12.38 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.653 1.181 . . . . 0.0 112.933 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -72.37 30.77 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.144 2.177 . . . . 0.0 114.092 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.12 51.22 0.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.627 1.108 . . . . 0.0 114.361 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -56.13 155.21 6.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -93.78 162.29 13.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.631 1.172 . . . . 0.0 113.188 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -73.23 54.34 0.41 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.993 2.517 . . . . 0.0 113.248 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pp -59.81 -5.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.68 18.93 6.21 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.381 1.872 . . . . 0.0 113.406 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.73 159.68 5.08 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.83 146.12 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.143 1.377 . . . . 0.0 112.753 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -139.74 137.87 35.46 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 110.948 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.203 1.801 . . . . 0.0 111.829 -179.302 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.39 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.1 m 57.68 20.89 6.74 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.083 1.753 . . . . 0.0 115.718 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.6 t -73.58 175.06 7.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.706 1.202 . . . . 0.0 112.598 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.93 -35.2 0.03 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.612 1.101 . . . . 0.0 114.092 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 p -157.36 141.64 16.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.818 1.247 . . . . 0.0 111.799 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -142.11 1.02 1.41 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.79 35.27 0.02 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.037 0.827 . . . . 0.0 114.609 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -138.77 131.32 28.9 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.451 1.1 . . . . 0.0 112.059 -170.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.64 159.51 33.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.405 1.882 . . . . 0.0 110.254 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -60.11 150.23 30.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.777 0.831 . . . . 0.0 112.26 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.63 160.18 39.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.58 57.78 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.728 -0.607 . . . . 0.0 112.109 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 81.58 -11.57 45.04 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.92 1.724 . . . . 0.0 114.85 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.23 131.15 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.241 1.416 . . . . 0.0 112.701 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.21 140.18 40.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.557 1.143 . . . . 0.0 112.449 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.84 171.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.685 1.994 . . . . 0.0 111.322 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.42 139.32 38.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.6 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -87.02 150.14 24.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.122 1.369 . . . . 0.0 111.312 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -143.83 -44.46 0.27 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 -5.15 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.55 177.01 11.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.29 1.436 . . . . 0.0 111.082 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 -30.09 68.4 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.076 -1.015 . . . . 0.0 112.863 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -56.71 156.78 6.01 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.843 1.657 . . . . 0.0 113.275 172.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -119.23 155.23 32.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.255 1.422 . . . . 0.0 109.596 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -136.5 155.51 76.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.693 1.197 . . . . 0.0 111.28 -170.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.03 132.33 27.79 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.778 2.319 . . . . 0.0 111.916 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.02 179.35 8.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.19 1.796 . . . . 0.0 110.349 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -141.86 151.8 43.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.105 0.962 . . . . 0.0 112.223 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 72.9 mt -75.06 122.52 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.564 1.146 . . . . 0.0 110.093 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -93.67 -31.53 14.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.404 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.69 156.28 34.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.256 1.022 . . . . 0.0 112.937 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -133.13 131.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.563 1.945 . . . . 0.0 108.345 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 p30 50.33 -5.44 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.4 3.111 . . . . 0.0 119.4 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.46 -18.67 41.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.76 1.618 . . . . 0.0 114.903 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.61 19.92 4.7 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.019 1.727 . . . . 0.0 111.015 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.07 -50.81 2.35 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.733 2.111 . . . . 0.0 112.311 -169.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -71.19 158.78 35.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.652 1.981 . . . . 0.0 111.343 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -81.0 160.31 24.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.888 0.875 . . . . 0.0 110.407 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.0 m -126.21 137.89 53.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.299 1.04 . . . . 0.0 109.123 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.65 152.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.624 1.169 . . . . 0.0 111.926 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.82 130.23 53.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.687 1.595 . . . . 0.0 109.794 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.1 169.67 9.95 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.759 1.223 . . . . 0.0 112.206 -176.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -57.3 -24.22 53.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.44 -12.82 60.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.554 1.141 . . . . 0.0 113.95 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.26 -14.15 65.64 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.898 1.713 . . . . 0.0 114.493 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.42 148.28 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.503 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.97 130.63 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.914 1.686 . . . . 0.0 110.267 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -146.43 163.25 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.754 1.622 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.13 145.13 30.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.5 0.72 . . . . 0.0 110.705 168.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.14 144.8 30.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.106 1.362 . . . . 0.0 110.835 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -69.52 158.85 34.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.349 0.66 . . . . 0.0 111.337 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -57.08 -21.57 32.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.13 -12.88 58.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.608 1.563 . . . . 0.0 113.889 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -127.11 11.52 7.04 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.954 1.702 . . . . 0.0 113.354 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.58 139.54 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.593 1.957 . . . . 0.0 108.484 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.09 145.79 44.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.033 1.733 . . . . 0.0 110.883 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.44 149.26 50.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.163 0.585 . . . . 0.0 110.758 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.5 mtt -65.1 145.53 99.08 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.092 0.557 . . . . 0.0 112.332 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.82 166.75 28.57 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.332 2.688 . . . . 0.0 112.425 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.25 -31.91 67.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.606 1.162 . . . . 0.0 113.923 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.48 -15.76 54.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 45.82 1.03 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.236 1.414 . . . . 0.0 112.749 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -61.07 160.19 10.46 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.939 1.696 . . . . 0.0 112.863 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -177.45 -35.12 0.05 OUTLIER Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.137 0.875 . . . . 0.0 114.375 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -143.39 168.32 20.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.031 1.732 . . . . 0.0 111.042 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -142.74 132.04 23.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.081 1.352 . . . . 0.0 110.781 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -151.75 107.04 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.736 1.615 . . . . 0.0 109.872 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 57.6 mt -136.16 141.67 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.757 1.623 . . . . 0.0 109.343 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 52.75 22.48 2.31 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.668 1.987 . . . . 0.0 115.982 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 148' ' ' LEU . 2.7 pt? -74.07 -1.4 19.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.937 1.695 . . . . 0.0 115.106 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.84 151.07 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.769 1.228 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.2 22.33 3.55 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.492 1.917 . . . . 0.0 115.374 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.367 1.467 . . . . 0.0 113.18 173.153 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.398 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.3 t -59.87 152.21 23.89 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.03 0.932 . . . . 0.0 112.39 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.1 p -68.71 -17.99 64.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.43 -162.2 36.0 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.655 1.121 . . . . 0.0 113.813 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t 53.98 36.77 25.25 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.154 1.782 . . . . 0.0 114.556 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -56.11 124.77 18.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.15 1.38 . . . . 0.0 112.347 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.05 -15.94 1.14 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.531 1.063 . . . . 0.0 115.262 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 47.61 14.73 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.47 143.12 25.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.227 1.411 . . . . 0.0 111.331 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -83.2 170.3 14.85 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.02 1.328 . . . . 0.0 113.636 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -138.46 157.43 46.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.738 2.015 . . . . 0.0 111.249 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.75 136.38 58.05 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.927 -0.483 . . . . 0.0 111.326 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.14 -1.34 87.22 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.645 1.117 . . . . 0.0 114.988 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.97 142.2 52.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.359 1.58 . . . . 0.0 111.877 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.17 145.32 24.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.924 0.89 . . . . 0.0 111.714 177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -148.41 162.28 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.558 1.543 . . . . 0.0 112.022 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.05 118.25 36.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.876 1.671 . . . . 0.0 107.245 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.9 48.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.219 0.608 . . . . 0.0 112.142 -172.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -74.71 150.21 39.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.992 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -134.05 -40.39 0.84 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.3 m -159.36 -51.0 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.401 1.081 . . . . 0.0 111.282 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -74.95 170.59 15.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 0.0 112.039 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.7 m -73.38 43.54 0.14 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.234 1.814 . . . . 0.0 112.56 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -140.75 162.44 35.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 110.77 -171.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 134' ' ' LYS . 53.2 m-85 -124.0 145.73 49.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.967 1.307 . . . . 0.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.85 154.31 77.75 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.117 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.68 131.27 25.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 0.0 112.016 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.69 174.6 12.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.189 1.796 . . . . 0.0 110.904 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.4 133.81 33.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.313 1.445 . . . . 0.0 110.686 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.26 120.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.166 0.986 . . . . 0.0 110.582 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.14 -30.01 14.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.416 1.486 . . . . 0.0 112.488 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.64 161.93 39.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.528 1.131 . . . . 0.0 112.803 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.37 148.62 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 109.733 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.82 6.4 2.13 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.501 2.32 . . . . 0.0 116.462 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.85 110.54 1.19 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.721 -1.237 . . . . 0.0 110.373 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.254 4.3 pm0 39.28 43.6 0.94 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.897 1.679 . . . . 0.0 114.785 -169.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.71 68.54 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.181 -0.949 . . . . 0.0 114.238 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 m -138.98 162.74 34.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -111.6 159.63 17.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.482 1.513 . . . . 0.0 109.856 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.3 m -125.19 133.15 52.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 108.635 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.45 133.3 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.134 0.974 . . . . 0.0 111.978 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -93.12 125.19 37.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.887 1.275 . . . . 0.0 109.5 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.66 165.63 14.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.912 0.885 . . . . 0.0 111.561 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -54.5 -26.92 34.37 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.61 -20.11 62.03 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.023 1.329 . . . . 0.0 113.778 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.51 -17.14 40.2 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.169 1.842 . . . . 0.0 114.075 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.63 150.39 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.778 1.631 . . . . 0.0 112.226 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.1 mt -133.66 127.48 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 109.819 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -143.86 175.83 9.71 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.233 1.813 . . . . 0.0 110.853 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.5 m -107.4 146.03 32.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.503 1.121 . . . . 0.0 111.738 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.9 mt -147.42 152.97 39.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.093 1.757 . . . . 0.0 111.415 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.96 158.99 27.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.97 0.908 . . . . 0.0 110.872 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -57.91 -26.1 61.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.911 1.284 . . . . 0.0 113.661 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.9 ttm -54.78 -18.88 5.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.352 1.861 . . . . 0.0 114.116 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -123.75 13.17 9.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.9 1.68 . . . . 0.0 113.127 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -134.59 136.62 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.493 1.917 . . . . 0.0 109.093 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 102' ' ' TYR . 55.4 mtmt -132.87 150.41 52.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.918 1.687 . . . . 0.0 110.376 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.95 152.85 35.47 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.288 0.635 . . . . 0.0 111.789 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.4 tpt -59.21 125.93 80.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.54 0.736 . . . . 0.0 110.461 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.65 153.05 65.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.431 2.088 . . . . 0.0 112.117 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.5 -27.24 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.74 0.816 . . . . 0.0 112.78 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -84.47 1.58 44.9 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.669 1.588 . . . . 0.0 114.194 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.58 137.45 53.64 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.074 -1.016 . . . . 0.0 112.861 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -69.69 140.33 53.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 111.766 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.0 164.19 31.62 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.308 1.432 . . . . 0.0 114.535 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -159.59 176.94 11.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.886 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -130.94 86.55 2.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.792 1.637 . . . . 0.0 109.569 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -54.01 -23.59 13.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 114.894 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 146' ' ' ILE . 5.0 mp -59.26 -27.68 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.912 1.685 . . . . 0.0 111.923 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.17 21.02 2.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.778 1.631 . . . . 0.0 114.095 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.13 151.38 40.3 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.846 -1.159 . . . . 0.0 113.682 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -143.96 147.58 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.338 1.855 . . . . 0.0 109.154 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -137.0 45.49 2.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.547 1.539 . . . . 0.0 111.968 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.555 1.942 . . . . 0.0 111.772 -176.751 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.441 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.4 t -154.06 153.98 32.86 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -66.91 -24.29 66.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.356 1.062 . . . . 0.0 113.436 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -53.61 1.64 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.329 1.919 . . . . 0.0 114.388 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -75.96 174.35 10.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.509 1.524 . . . . 0.0 112.179 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -59.04 150.32 25.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.57 1.148 . . . . 0.0 112.134 172.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.56 158.76 19.27 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.422 1.01 . . . . 0.0 113.871 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.627 1.571 . . . . 0.0 111.144 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -144.47 137.56 27.02 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.299 1.44 . . . . 0.0 110.64 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.0 168.09 20.19 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.59 0.756 . . . . 0.0 112.447 171.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -140.33 160.1 40.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.884 1.674 . . . . 0.0 111.956 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.2 58.85 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.854 -0.529 . . . . 0.0 111.775 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.32 -12.81 49.15 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.786 1.66 . . . . 0.0 114.885 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.0 138.47 44.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.658 1.183 . . . . 0.0 112.277 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.52 141.79 34.81 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.461 1.104 . . . . 0.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 m -151.88 168.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.372 1.869 . . . . 0.0 111.023 -171.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.03 129.84 44.87 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.09 133.41 41.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 111.187 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -67.77 161.21 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.868 1.267 . . . . 0.0 110.994 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -135.56 -163.79 1.44 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.454 1.102 . . . . 0.0 111.238 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -29.91 70.76 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.49 -0.757 . . . . 0.0 112.602 171.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.03 154.48 28.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.558 1.143 . . . . 0.0 112.005 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.57 33.8 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.165 1.786 . . . . 0.0 115.579 -176.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -137.69 157.22 46.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.472 1.909 . . . . 0.0 111.77 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.3 148.58 24.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.033 1.333 . . . . 0.0 110.215 170.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -140.04 154.32 70.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.82 1.648 . . . . 0.0 111.222 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.85 129.45 20.9 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.538 2.159 . . . . 0.0 111.358 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.86 175.29 11.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.7 1.6 . . . . 0.0 111.247 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.11 136.85 47.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.09 1.356 . . . . 0.0 110.654 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.37 140.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.692 0.797 . . . . 0.0 109.534 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -116.6 -27.99 6.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.539 1.136 . . . . 0.0 113.173 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.09 155.34 33.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.65 1.18 . . . . 0.0 111.286 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.02 138.87 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.661 1.584 . . . . 0.0 108.592 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.87 130.29 35.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.7 1.2 . . . . 0.0 111.57 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -42.31 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.251 2.621 . . . . 0.0 114.409 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 54.31 17.26 1.47 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.011 2.124 . . . . 0.0 115.293 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.16 -61.14 0.21 Allowed Glycine 0 N--CA 1.469 0.874 0 O-C-N 120.991 -1.068 . . . . 0.0 114.729 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 17.7 p -146.8 162.68 38.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -137.86 124.62 21.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.921 2.089 . . . . 0.0 108.711 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -87.74 135.42 33.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.657 0.783 . . . . 0.0 109.056 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.63 156.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.583 1.153 . . . . 0.0 112.156 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -124.5 131.01 53.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.22 1.408 . . . . 0.0 109.795 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.56 167.59 12.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 111.676 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -59.07 -23.38 62.0 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -72.33 -14.01 61.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.655 1.182 . . . . 0.0 113.87 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.62 -15.65 62.76 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.677 1.608 . . . . 0.0 114.329 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.54 146.46 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.446 1.498 . . . . 0.0 112.477 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.84 128.07 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.769 1.628 . . . . 0.0 109.387 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -144.96 178.18 8.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.635 1.974 . . . . 0.0 110.508 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 p -122.76 152.37 40.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -139.72 165.36 27.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.55 1.94 . . . . 0.0 110.937 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -79.8 159.03 26.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.572 0.749 . . . . 0.0 110.68 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -55.94 -29.33 59.97 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -70.97 -21.01 62.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.421 1.088 . . . . 0.0 113.638 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -86.08 4.63 37.32 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.72 1.208 . . . . 0.0 113.578 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.5 mt -131.93 140.34 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.372 1.069 . . . . 0.0 110.522 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -137.71 153.11 49.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.974 2.11 . . . . 0.0 110.817 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.92 165.63 22.92 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.08 0.552 . . . . 0.0 111.236 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 146.91 72.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.185 0.594 . . . . 0.0 111.941 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.43 163.62 35.86 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.164 2.576 . . . . 0.0 113.402 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.25 -9.34 23.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.485 1.514 . . . . 0.0 114.745 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.38 26.31 4.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.651 1.981 . . . . 0.0 112.978 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.82 72.88 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.373 2.269 . . . . 0.0 114.542 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.0 tttt 51.59 28.42 4.66 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 127.11 2.164 . . . . 0.0 113.472 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.28 -167.65 33.97 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 126.125 1.821 . . . . 0.0 112.062 -171.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -144.41 171.01 14.94 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.521 1.528 . . . . 0.0 111.363 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -145.6 128.88 16.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 112.116 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -144.39 16.59 1.68 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.651 1.58 . . . . 0.0 113.365 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.7 pt -56.14 131.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 40.58 48.8 2.6 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.686 1.994 . . . . 0.0 114.433 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.94 162.73 2.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.062 1.345 . . . . 0.0 114.07 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.45 175.65 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.759 1.624 . . . . 0.0 112.681 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 56.39 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.797 2.039 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.534 1.934 . . . . 0.0 113.306 176.655 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 m -70.02 98.36 1.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.985 1.314 . . . . 0.0 112.512 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 m -73.42 46.62 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.689 1.996 . . . . 0.0 113.853 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.79 29.25 1.28 Allowed Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.131 1.824 . . . . 0.0 113.313 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -74.93 4.88 5.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.693 1.997 . . . . 0.0 115.488 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -141.86 166.84 23.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.229 1.412 . . . . 0.0 113.034 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.91 -133.76 1.93 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.208 1.385 . . . . 0.0 111.948 -172.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -130.99 139.38 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.98 1.312 . . . . 0.0 111.347 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -157.15 157.76 35.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.287 1.435 . . . . 0.0 111.101 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -81.25 179.15 7.98 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.105 1.362 . . . . 0.0 112.37 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -133.18 160.04 38.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.376 1.871 . . . . 0.0 111.488 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.05 129.0 38.82 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.773 -0.58 . . . . 0.0 110.062 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.07 83.67 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.55 -1.139 . . . . 0.0 115.365 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.04 140.13 58.84 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.041 1.921 . . . . 0.0 111.155 172.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.85 121.0 39.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.526 1.13 . . . . 0.0 109.028 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.09 174.59 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.46 . . . . 0.0 112.181 -166.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -107.09 141.48 38.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.521 1.128 . . . . 0.0 108.967 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.66 156.03 35.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -71.74 151.82 43.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.068 1.347 . . . . 0.0 111.04 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -132.99 -38.89 0.96 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 t -157.6 -32.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.71 -176.87 3.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.52 1.528 . . . . 0.0 112.612 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.3 t -73.22 39.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.103 1.761 . . . . 0.0 114.49 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.22 165.86 25.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.416 2.286 . . . . 0.0 111.021 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.48 153.57 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.417 1.087 . . . . 0.0 110.269 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -137.39 154.14 75.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 110.796 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.3 136.47 40.33 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.852 2.368 . . . . 0.0 112.523 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.09 174.69 12.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 111.467 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -134.68 135.46 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.377 1.471 . . . . 0.0 109.933 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.8 mt -74.26 120.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 0.0 109.956 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -84.38 -36.86 22.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.857 1.263 . . . . 0.0 112.314 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.78 160.32 36.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.768 1.227 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt -134.55 130.88 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.674 1.589 . . . . 0.0 109.7 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -163.65 110.86 1.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.55 -24.08 59.88 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.749 1.22 . . . . 0.0 113.078 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.81 -8.94 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.744 1.618 . . . . 0.0 114.368 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.24 -84.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.318 -0.864 . . . . 0.0 113.532 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.7 p -154.41 158.83 40.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.948 1.299 . . . . 0.0 112.917 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -84.26 112.48 20.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.053 1.741 . . . . 0.0 109.296 169.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 m -74.59 134.69 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.507 -0.745 . . . . 0.0 109.425 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.44 141.14 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.69 1.196 . . . . 0.0 111.825 -170.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -115.82 125.22 52.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.403 1.481 . . . . 0.0 109.278 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.91 167.33 11.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.002 0.921 . . . . 0.0 111.875 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -52.76 -28.76 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.96 -18.71 61.98 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.833 1.253 . . . . 0.0 113.693 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.07 -16.95 38.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.3 1.905 . . . . 0.0 113.995 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.82 147.5 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.088 1.755 . . . . 0.0 112.659 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.46 130.34 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.629 1.572 . . . . 0.0 110.391 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -142.66 -163.59 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.287 2.235 . . . . 0.0 109.56 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.3 p -140.35 156.97 46.23 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.202 -0.936 . . . . 0.0 112.647 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -145.04 171.62 14.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.292 1.837 . . . . 0.0 111.776 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.09 158.3 16.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.139 1.376 . . . . 0.0 109.461 168.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -53.19 -28.88 28.85 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -65.31 -14.44 60.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.215 1.406 . . . . 0.0 114.217 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -108.9 9.14 26.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.465 1.506 . . . . 0.0 112.985 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.38 145.38 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.105 1.762 . . . . 0.0 109.694 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -139.7 151.23 45.72 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.242 2.217 . . . . 0.0 111.0 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.54 162.8 26.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.575 0.75 . . . . 0.0 111.63 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.9 mmt -64.34 149.27 94.99 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.188 0.595 . . . . 0.0 112.429 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.12 175.64 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.192 3.262 . . . . 0.0 113.239 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.8 -13.31 31.81 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.968 1.307 . . . . 0.0 114.07 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.25 -7.53 59.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.187 1.395 . . . . 0.0 113.532 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.05 47.49 2.02 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.76 2.024 . . . . 0.0 111.174 -170.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -57.46 -23.35 49.25 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.802 2.041 . . . . 0.0 115.87 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.44 -162.59 49.5 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.962 0.792 . . . . 0.0 113.715 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -132.79 29.49 4.14 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.807 1.643 . . . . 0.0 111.896 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.0 -31.16 69.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 84.9 m95 40.5 44.89 1.82 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.822 2.049 . . . . 0.0 114.762 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -177.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.69 1.596 . . . . 0.0 110.009 170.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.87 119.24 3.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.564 1.145 . . . . 0.0 111.408 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.8 -0.79 4.26 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.801 1.24 . . . . 0.0 114.291 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 56.7 t -77.85 145.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.294 1.438 . . . . 0.0 110.435 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -146.76 168.07 22.27 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.594 1.558 . . . . 0.0 112.459 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.324 1.849 . . . . 0.0 111.742 179.833 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -155.54 158.12 37.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.596 1.558 . . . . 0.0 111.419 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.81 127.53 32.67 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.952 -0.468 . . . . 0.0 110.887 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.66 -11.64 64.67 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.667 1.603 . . . . 0.0 114.68 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.11 134.72 51.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.3 1.55 . . . . 0.0 111.902 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.51 138.05 37.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.329 0.652 . . . . 0.0 111.003 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.1 m -146.29 176.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.193 1.797 . . . . 0.0 111.22 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.1 mt -112.87 144.94 41.57 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.05 1.34 . . . . 0.0 108.475 168.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.17 146.5 31.79 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.239 0.543 . . . . 0.0 111.673 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -74.15 140.43 45.18 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 109.438 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -121.71 -162.98 1.02 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.347 1.059 . . . . 0.0 111.472 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.9 m -55.25 -35.14 64.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.365 -0.834 . . . . 0.0 111.197 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.61 135.46 33.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.398 1.479 . . . . 0.0 109.35 167.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.2 m -65.32 -21.4 66.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -63.6 145.56 55.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.207 1.003 . . . . 0.0 111.557 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -79.46 151.78 30.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.099 0.56 . . . . 0.0 110.848 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.64 154.23 65.99 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.043 1.337 . . . . 0.0 111.648 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 130.43 23.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.04 2.493 . . . . 0.0 111.355 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.89 -179.65 6.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.983 1.713 . . . . 0.0 110.539 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -143.3 152.82 42.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.48 1.112 . . . . 0.0 111.486 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -75.54 128.96 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.409 1.083 . . . . 0.0 109.606 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -98.54 -33.59 10.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.55 1.14 . . . . 0.0 112.185 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.43 35.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.799 1.24 . . . . 0.0 112.194 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt . . . . . 0 N--CA 1.475 0.823 0 C-N-CA 125.615 1.566 . . . . 0.0 109.128 -176.397 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 . . . . . 0 C--O 1.236 0.364 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -76.25 133.63 40.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.03 152.49 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.848 1.259 . . . . 0.0 111.633 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -122.99 134.34 54.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.362 1.465 . . . . 0.0 110.313 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.11 164.52 13.23 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.0 111.62 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -55.49 -27.44 48.49 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 114.371 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.29 -22.31 63.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.157 1.383 . . . . 0.0 113.712 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.5 28.36 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.987 1.756 . . . . 0.0 113.937 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.97 145.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.411 1.485 . . . . 0.0 112.585 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.5 mt -128.56 130.47 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.603 1.561 . . . . 0.0 109.481 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -142.14 173.83 11.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.216 1.807 . . . . 0.0 111.063 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -120.57 139.1 53.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.971 1.309 . . . . 0.0 110.363 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.7 mt -140.81 167.45 22.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.449 1.5 . . . . 0.0 111.659 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.61 156.55 19.44 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.173 0.989 . . . . 0.0 110.114 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -28.8 13.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 96.7 mtp -67.05 -10.43 49.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.362 1.465 . . . . 0.0 113.88 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -117.54 8.82 13.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.381 1.472 . . . . 0.0 113.572 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.7 mt -128.43 144.64 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.15 1.78 . . . . 0.0 109.215 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -138.92 150.32 45.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 0.0 111.063 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.38 132.16 45.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.3 ptp . . . . . 0 CA--C 1.55 0.947 0 O-C-N 121.784 -0.572 . . . . 0.0 111.779 176.053 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -138.0 148.07 44.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 113.166 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.24 132.59 54.48 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.57 -0.706 . . . . 0.0 111.723 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.77 6.15 66.32 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.73 141.47 48.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.185 1.492 . . . . 0.0 111.839 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 132.27 38.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.005 0.922 . . . . 0.0 111.669 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.16 175.62 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.506 1.522 . . . . 0.0 111.918 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.3 151.63 35.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.406 1.483 . . . . 0.0 108.971 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.67 154.82 36.06 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.207 -0.933 . . . . 0.0 112.255 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -72.01 156.85 38.78 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.022 1.329 . . . . 0.0 110.236 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -136.91 -150.09 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.53 0.732 . . . . 0.0 112.274 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.2 p -62.54 -3.0 1.23 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.792 1.637 . . . . 0.0 114.735 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -129.24 161.76 29.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.811 2.045 . . . . 0.0 110.543 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.6 -21.69 66.78 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.33 147.05 53.87 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.315 1.446 . . . . 0.0 112.259 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -86.55 152.76 22.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.111 0.564 . . . . 0.0 109.622 167.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -139.76 152.15 67.6 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.462 1.105 . . . . 0.0 111.805 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.61 137.33 38.72 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.302 2.668 . . . . 0.0 112.319 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.81 176.83 10.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.274 1.43 . . . . 0.0 111.715 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -135.25 139.94 44.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.954 1.702 . . . . 0.0 109.578 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.0 mm -61.49 134.78 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.501 0.721 . . . . 0.0 110.251 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -106.75 -29.99 9.22 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.214 1.806 . . . . 0.0 112.106 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 148.18 27.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.989 0.916 . . . . 0.0 113.154 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 127.709 2.404 . . . . 0.0 108.246 176.938 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 . . . . . 0 N--CA 1.471 0.606 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.4 m -111.93 140.17 46.82 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.736 -0.602 . . . . 0.0 109.561 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.67 151.77 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.763 1.225 . . . . 0.0 112.207 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -112.72 124.07 51.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.84 1.656 . . . . 0.0 108.87 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.72 163.58 27.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.561 0.745 . . . . 0.0 112.24 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -54.17 -29.75 46.84 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.652 1.181 . . . . 0.0 114.008 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.72 -21.09 62.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.478 1.511 . . . . 0.0 113.794 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -17.25 37.02 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.844 1.688 . . . . 0.0 114.419 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.28 148.96 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.982 1.313 . . . . 0.0 112.218 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -128.85 129.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.606 1.562 . . . . 0.0 109.834 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -145.63 177.37 8.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.038 2.135 . . . . 0.0 110.142 173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 28.0 p -125.52 148.16 48.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.366 1.066 . . . . 0.0 111.754 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.82 144.03 27.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 111.414 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.94 151.3 47.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.989 0.916 . . . . 0.0 111.076 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.53 12.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.9 tpp -66.59 -12.44 57.9 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.782 1.633 . . . . 0.0 113.744 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.0 15.0 15.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.713 1.605 . . . . 0.0 112.418 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.7 mt -127.64 151.36 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 127.013 2.125 . . . . 0.0 109.866 -171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -140.18 155.23 47.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.702 2.001 . . . . 0.0 111.497 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.43 24.2 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 0.0 111.657 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.8 tpp . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 123.921 0.888 . . . . 0.0 110.592 172.074 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 . . . . . 0 CA--C 1.542 0.635 0 CA-C-O 121.266 0.555 . . . . 0.0 111.698 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.99 155.81 23.77 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.196 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.74 135.81 41.77 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.84 77.6 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.653 1.12 . . . . 0.0 114.88 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -65.65 131.93 47.56 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.119 1.46 . . . . 0.0 111.782 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.22 130.06 37.63 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.285 0.564 . . . . 0.0 110.159 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.61 177.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.229 1.812 . . . . 0.0 111.31 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.5 mt -114.26 133.8 55.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.387 1.475 . . . . 0.0 109.766 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.98 155.91 42.07 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -75.76 148.35 38.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.028 1.331 . . . . 0.0 111.555 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -144.92 -36.13 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -139.22 -28.67 0.78 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -148.81 178.41 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.768 1.627 . . . . 0.0 110.787 -169.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.5 m -61.53 -17.55 55.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -73.05 114.24 10.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 110.477 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -72.33 152.27 42.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.301 0.641 . . . . 0.0 110.092 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -129.97 156.2 79.46 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.909 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 139.29 37.26 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.603 2.202 . . . . 0.0 113.029 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.47 172.58 14.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.702 1.601 . . . . 0.0 111.404 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -119.92 141.48 49.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.852 1.661 . . . . 0.0 110.088 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -80.16 110.3 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.658 0.783 . . . . 0.0 109.833 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -83.03 -31.35 27.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.447 1.099 . . . . 0.0 113.106 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.16 163.97 37.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.929 1.292 . . . . 0.0 112.14 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt . . . . . 0 N--CA 1.475 0.791 0 C-N-CA 125.781 1.632 . . . . 0.0 109.676 -171.49 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 . . . . . 0 CA--C 1.532 0.265 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.8 m -82.47 134.68 35.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.44 144.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.117 0.967 . . . . 0.0 112.257 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.36 110.19 16.66 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.598 1.559 . . . . 0.0 109.62 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 164.17 26.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.046 0.938 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -54.21 -26.34 27.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.73 -22.08 64.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.358 . . . . 0.0 113.874 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.76 -15.61 44.7 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.005 1.764 . . . . 0.0 114.083 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.43 148.23 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.655 1.582 . . . . 0.0 112.274 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.3 mt -129.92 127.59 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.147 1.379 . . . . 0.0 110.003 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -143.29 -171.05 3.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.276 2.231 . . . . 0.0 109.307 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.77 151.2 50.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.005 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.5 mt -142.15 160.22 40.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.11 1.764 . . . . 0.0 110.882 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -87.58 161.6 17.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 111.246 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.6 ptt85 -55.42 -20.9 13.62 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 169.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.87 -13.37 44.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.828 1.251 . . . . 0.0 113.97 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -128.28 10.9 6.35 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.376 1.47 . . . . 0.0 113.633 -171.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.26 140.3 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.494 1.518 . . . . 0.0 110.039 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -141.18 152.79 44.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.172 1.789 . . . . 0.0 110.927 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.05 139.98 58.23 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.706 -0.621 . . . . 0.0 109.861 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.9 ptp . . . . . 0 CA--C 1.55 0.968 0 O-C-N 121.716 -0.615 . . . . 0.0 111.553 175.303 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 . . . . . 0 CA--C 1.543 0.706 0 CA-C-O 120.79 0.329 . . . . 0.0 111.623 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.36 157.55 24.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.626 1.57 . . . . 0.0 111.699 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.48 133.69 46.02 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.35 0.66 . . . . 0.0 110.793 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.8 3.05 58.47 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.608 1.099 . . . . 0.0 114.849 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.7 129.41 39.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.786 1.293 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -74.95 134.58 41.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.436 0.636 . . . . 0.0 110.778 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.89 179.43 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.501 1.921 . . . . 0.0 111.023 -169.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.75 146.59 43.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.336 1.454 . . . . 0.0 108.909 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.08 149.6 26.3 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.296 -0.877 . . . . 0.0 112.979 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -80.61 110.13 15.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.252 1.421 . . . . 0.0 110.348 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -85.71 -160.06 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.111 0.965 . . . . 0.0 112.063 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -56.4 -35.14 67.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.767 1.227 . . . . 0.0 112.458 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.75 153.42 22.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.808 1.243 . . . . 0.0 111.957 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 82.7 m -77.24 50.85 0.8 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -134.41 163.22 30.17 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.526 2.331 . . . . 0.0 110.607 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -121.96 70.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.395 1.478 . . . . 0.0 110.493 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -67.54 157.39 86.08 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.429 1.092 . . . . 0.0 112.442 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.22 138.58 47.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.808 2.338 . . . . 0.0 111.965 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.17 179.57 7.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.175 1.79 . . . . 0.0 110.619 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -142.55 152.76 42.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.633 1.173 . . . . 0.0 111.987 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 91.0 mt -83.33 113.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.259 1.024 . . . . 0.0 110.108 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -80.65 -33.44 35.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.668 1.187 . . . . 0.0 112.787 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.76 38.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.461 1.104 . . . . 0.0 112.546 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 N--CA 1.471 0.601 0 C-N-CA 126.111 1.764 . . . . 0.0 109.118 -174.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.5 m -86.93 135.76 33.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.722 0.809 . . . . 0.0 108.926 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.84 148.5 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -119.7 123.82 44.72 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 109.593 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.42 164.77 16.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 111.548 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -52.7 -28.45 21.91 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.98 -21.95 65.04 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.263 1.425 . . . . 0.0 113.733 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.44 -20.15 32.9 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.206 1.86 . . . . 0.0 114.068 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.48 145.95 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.856 1.662 . . . . 0.0 112.749 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.61 125.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.241 1.416 . . . . 0.0 109.892 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -142.62 -172.68 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.153 2.181 . . . . 0.0 109.636 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 32.1 p -130.3 154.5 47.56 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.381 -0.824 . . . . 0.0 112.261 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.4 157.95 44.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.025 1.73 . . . . 0.0 111.088 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -73.05 156.64 38.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.197 0.999 . . . . 0.0 110.447 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -54.54 -25.4 25.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.61 -19.56 58.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.355 1.862 . . . . 0.0 114.139 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -120.26 12.23 11.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.137 1.375 . . . . 0.0 113.394 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.38 142.28 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.01 1.724 . . . . 0.0 108.854 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -135.69 145.76 47.06 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.053 1.741 . . . . 0.0 110.254 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.52 139.27 58.46 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.028 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.3 ttm . . . . . 0 CA--C 1.549 0.907 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.893 174.369 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 . . . . . 0 CA--C 1.544 0.726 0 CA-C-O 121.048 0.451 . . . . 0.0 110.564 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 152.12 34.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.39 1.476 . . . . 0.0 111.706 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.38 141.29 57.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.012 0.525 . . . . 0.0 111.326 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.32 -9.36 73.39 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.17 1.367 . . . . 0.0 114.626 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.38 145.06 31.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.16 1.48 . . . . 0.0 111.974 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.87 143.78 25.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.53 1.132 . . . . 0.0 112.05 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.93 170.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.438 1.895 . . . . 0.0 111.008 -170.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -109.72 133.39 53.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.6 1.16 . . . . 0.0 108.889 169.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.21 153.28 38.54 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -74.66 150.38 39.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.138 1.375 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -140.23 -44.13 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -139.63 -21.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -171.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -142.76 -178.61 5.88 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.679 1.592 . . . . 0.0 110.721 -171.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.4 m -65.47 -14.07 60.18 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.816 -1.178 . . . . 0.0 113.768 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.89 133.58 43.13 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.8 1.24 . . . . 0.0 110.571 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -89.06 152.3 21.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.577 0.751 . . . . 0.0 109.255 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.47 155.84 79.34 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.118 1.367 . . . . 0.0 110.859 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.52 137.17 38.58 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.679 2.253 . . . . 0.0 112.732 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.41 174.6 12.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.818 1.647 . . . . 0.0 111.482 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -136.39 138.3 41.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 110.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.11 130.8 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.343 0.657 . . . . 0.0 109.586 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.84 -31.51 7.99 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.764 1.226 . . . . 0.0 112.53 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.5 33.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.092 1.757 . . . . 0.0 110.749 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.8 mt . . . . . 0 N--CA 1.473 0.714 0 C-N-CA 124.849 1.26 . . . . 0.0 110.521 -169.666 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -81.69 130.45 35.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.954 0.902 . . . . 0.0 108.612 172.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.62 142.43 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.434 1.094 . . . . 0.0 112.027 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.78 129.51 55.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.679 1.592 . . . . 0.0 109.473 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.22 168.01 11.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.951 0.9 . . . . 0.0 111.756 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.82 -27.05 27.21 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.069 1.348 . . . . 0.0 113.841 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 -17.99 37.33 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.123 1.821 . . . . 0.0 114.193 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.11 147.0 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.789 1.636 . . . . 0.0 112.439 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 129.53 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.691 1.596 . . . . 0.0 110.136 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -143.09 -166.72 2.37 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.142 2.177 . . . . 0.0 109.351 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.13 155.45 46.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.228 -0.92 . . . . 0.0 111.564 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.42 152.79 45.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.242 1.417 . . . . 0.0 110.753 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.27 153.38 42.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.303 1.041 . . . . 0.0 110.957 171.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.33 18.56 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 169.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 tpt -65.33 -13.98 59.75 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.44 1.896 . . . . 0.0 113.804 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -120.79 13.35 11.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.492 1.517 . . . . 0.0 113.603 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.9 mt -134.3 144.41 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.035 1.734 . . . . 0.0 109.455 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -136.61 149.32 47.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.063 2.145 . . . . 0.0 110.271 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 157.24 30.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.58 0.752 . . . . 0.0 111.229 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 CA--C 1.55 0.962 0 O-C-N 121.964 -0.46 . . . . 0.0 110.306 177.612 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 . . . . . 0 CA--C 1.543 0.698 0 CA-C-O 121.221 0.534 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.27 164.26 30.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 111.779 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.89 132.32 53.47 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.942 0.401 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.78 -4.52 85.71 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.087 1.327 . . . . 0.0 115.054 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.88 132.68 49.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.519 1.66 . . . . 0.0 111.776 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -77.81 133.82 38.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.621 0.769 . . . . 0.0 110.792 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.34 167.05 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.715 1.606 . . . . 0.0 111.171 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.17 140.7 29.73 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.26 160.08 44.01 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.717 -0.614 . . . . 0.0 112.225 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.52 145.52 26.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.827 1.251 . . . . 0.0 111.258 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.89 -48.02 0.5 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 m -140.27 -14.55 1.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -169.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -140.25 179.14 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.209 1.404 . . . . 0.0 111.6 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.6 m -73.13 -20.49 60.91 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.762 -0.587 . . . . 0.0 111.59 167.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -71.81 131.38 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.581 1.552 . . . . 0.0 110.357 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.76 161.91 24.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.895 0.478 . . . . 0.0 110.145 168.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -136.48 154.56 76.94 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.51 1.524 . . . . 0.0 110.529 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.49 139.44 37.72 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.101 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.5 173.5 12.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.127 1.771 . . . . 0.0 110.736 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -125.06 140.42 52.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.485 1.514 . . . . 0.0 109.533 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.53 121.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.323 0.649 . . . . 0.0 109.736 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -90.36 -33.97 15.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.284 1.034 . . . . 0.0 112.379 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.58 35.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.549 1.14 . . . . 0.0 112.702 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.6 mt . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 126.797 2.039 . . . . 0.0 109.187 -172.194 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 . . . . . 0 CA--C 1.534 0.353 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.8 m -77.37 135.9 38.39 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -143.02 151.53 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.564 1.146 . . . . 0.0 112.275 -171.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -122.31 112.86 18.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.949 1.7 . . . . 0.0 109.445 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -76.17 164.17 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 111.614 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -58.02 -21.79 46.82 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -69.96 -16.03 63.13 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.709 1.203 . . . . 0.0 114.032 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.52 -11.46 64.97 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.805 1.669 . . . . 0.0 114.542 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.51 148.19 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.095 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.6 mt -130.23 126.14 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.214 1.405 . . . . 0.0 110.099 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -144.6 -167.42 2.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.481 2.312 . . . . 0.0 109.249 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.34 153.98 49.05 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.26 -0.9 . . . . 0.0 112.067 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.1 mt -138.69 156.83 47.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 111.816 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.99 158.39 29.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.7 1.2 . . . . 0.0 110.569 169.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -57.74 -26.45 61.84 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -67.01 -11.63 57.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.146 1.378 . . . . 0.0 113.91 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -115.51 14.82 16.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.767 1.627 . . . . 0.0 112.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -134.25 145.79 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.47 1.908 . . . . 0.0 109.446 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -138.86 150.03 45.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.526 1.931 . . . . 0.0 111.36 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.42 144.52 48.12 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.006 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 48.2 tpp . . . . . 0 CA--C 1.548 0.896 0 C-N-CA 124.134 0.974 . . . . 0.0 110.785 176.296 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -143.46 146.14 33.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 111.571 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.49 131.44 50.95 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 122.021 -0.425 . . . . 0.0 111.154 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.78 -13.5 52.82 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.531 1.538 . . . . 0.0 115.371 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.45 149.46 45.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.356 1.578 . . . . 0.0 111.488 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -90.21 143.94 26.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 112.127 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.72 164.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.599 1.96 . . . . 0.0 111.142 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -108.71 125.25 51.71 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.091 1.756 . . . . 0.0 109.208 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.37 152.72 41.93 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -92.33 72.25 5.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.75 1.62 . . . . 0.0 112.508 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CE3' ' CE1' ' A' ' 120' ' ' PHE . 50.8 t-105 -62.33 -37.13 84.45 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -155.25 -29.17 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -136.46 163.04 31.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.103 1.361 . . . . 0.0 111.792 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.53 -20.34 54.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.892 1.277 . . . . 0.0 114.418 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.67 96.44 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.308 1.043 . . . . 0.0 108.918 168.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -55.49 143.21 30.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.386 0.675 . . . . 0.0 111.419 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.89 150.87 56.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.955 1.302 . . . . 0.0 111.522 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.68 137.77 28.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.667 2.245 . . . . 0.0 112.193 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.99 167.18 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.008 1.723 . . . . 0.0 110.954 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.01 142.29 45.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.151 1.38 . . . . 0.0 109.996 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.83 120.61 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.91 0.884 . . . . 0.0 109.383 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -92.79 -31.47 15.02 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.124 0.969 . . . . 0.0 112.561 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.03 158.68 36.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.357 1.063 . . . . 0.0 112.446 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 126.564 1.946 . . . . 0.0 108.408 -177.555 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 . . . . . 0 C--O 1.235 0.317 0 CA-C-O 121.1 0.476 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 m -72.4 134.8 45.6 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.52 0.728 . . . . 0.0 109.506 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.31 147.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.027 1.331 . . . . 0.0 111.751 -171.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.22 118.27 27.23 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.547 1.539 . . . . 0.0 109.954 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CE1' ' CE3' ' A' ' 97' ' ' TRP . 33.2 m-85 -85.91 172.05 11.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.709 1.203 . . . . 0.0 111.872 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -57.87 -21.75 44.55 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -70.78 -14.03 62.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.923 1.289 . . . . 0.0 114.12 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.61 -16.31 58.29 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.641 1.591 . . . . 0.0 114.883 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.47 148.56 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.689 1.596 . . . . 0.0 112.326 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.36 124.22 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.522 1.529 . . . . 0.0 110.368 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -142.57 -162.46 1.42 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.295 2.238 . . . . 0.0 108.888 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.6 p -135.52 155.29 50.74 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.134 -0.979 . . . . 0.0 112.492 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.25 149.97 40.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.314 1.446 . . . . 0.0 111.192 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -68.71 159.54 32.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.631 1.172 . . . . 0.0 111.329 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -58.27 -20.47 42.75 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 171.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.9 mmm -67.89 -12.91 61.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.915 1.286 . . . . 0.0 113.661 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.8 13.51 5.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 112.871 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.83 136.22 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.791 1.636 . . . . 0.0 109.422 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -140.53 157.61 45.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.063 1.745 . . . . 0.0 111.287 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 174.52 5.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.211 0.604 . . . . 0.0 111.0 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.548 0.866 0 O-C-N 121.201 -0.937 . . . . 0.0 111.318 169.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 . . . . . 0 CA--C 1.545 0.751 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.8 142.71 30.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.928 1.291 . . . . 0.0 112.566 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 135.96 57.78 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.831 -0.543 . . . . 0.0 110.834 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.04 -12.88 69.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.105 1.336 . . . . 0.0 114.631 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -69.26 162.17 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.4 1.6 . . . . 0.0 112.375 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.41 142.79 32.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.833 0.853 . . . . 0.0 112.175 170.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.95 162.98 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.838 2.055 . . . . 0.0 110.806 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.8 137.43 32.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.55 152.06 33.58 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.522 0.601 . . . . 0.0 112.379 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -84.95 150.01 25.23 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.846 1.258 . . . . 0.0 111.519 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 t-105 -151.42 -39.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -132.73 -32.68 1.25 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.62 178.83 7.69 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.146 1.778 . . . . 0.0 110.528 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.2 m -61.17 -22.45 64.73 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 122.78 22.22 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.647 1.179 . . . . 0.0 111.096 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -70.64 155.69 40.42 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.009 0.924 . . . . 0.0 110.745 169.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.29 157.34 76.47 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.435 1.494 . . . . 0.0 110.579 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.44 135.08 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.135 1.89 . . . . 0.0 111.564 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.16 174.14 11.14 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.722 2.009 . . . . 0.0 110.145 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -127.34 134.99 49.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.528 1.531 . . . . 0.0 110.098 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.5 mt -72.31 121.95 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.02 0.528 . . . . 0.0 110.007 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -87.47 -37.45 16.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.526 1.131 . . . . 0.0 111.858 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.1 162.11 38.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.571 1.148 . . . . 0.0 113.002 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.8 mt . . . . . 0 N--CA 1.473 0.68 0 C-N-CA 125.885 1.674 . . . . 0.0 109.242 -175.979 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 m -73.64 131.34 41.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.92 149.76 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.467 1.107 . . . . 0.0 112.018 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.84 127.92 52.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.034 1.733 . . . . 0.0 109.368 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.46 168.18 11.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.659 0.784 . . . . 0.0 111.488 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -59.77 -20.43 56.6 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -73.22 -14.01 61.26 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.551 1.14 . . . . 0.0 113.994 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.94 -12.08 67.36 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.935 1.731 . . . . 0.0 114.53 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.9 149.18 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.643 1.577 . . . . 0.0 112.301 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.6 130.27 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.308 1.443 . . . . 0.0 110.263 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -145.81 -169.8 3.32 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.429 2.292 . . . . 0.0 109.661 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.59 151.33 50.32 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.816 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.3 mt -139.2 159.39 42.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.231 1.412 . . . . 0.0 112.21 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.98 155.62 23.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -53.98 -25.72 22.27 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.3 ttt -61.84 -20.56 63.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.788 1.635 . . . . 0.0 113.928 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -120.89 17.63 11.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.274 1.43 . . . . 0.0 112.913 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.28 145.53 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.053 2.141 . . . . 0.0 108.929 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 110.781 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.07 152.66 42.92 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.5 mmt . . . . . 0 CA--C 1.547 0.856 0 O-C-N 121.499 -0.751 . . . . 0.0 112.397 176.062 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.44 165.15 28.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.313 1.845 . . . . 0.0 111.477 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.61 130.06 45.02 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.859 0.464 . . . . 0.0 110.668 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.48 88.27 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.907 1.241 . . . . 0.0 115.13 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.35 146.04 53.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.758 1.779 . . . . 0.0 112.256 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -95.37 131.12 41.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.044 1.338 . . . . 0.0 110.635 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.64 177.67 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.138 1.775 . . . . 0.0 111.666 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.3 140.33 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.449 1.1 . . . . 0.0 108.434 168.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.39 34.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.555 0.742 . . . . 0.0 111.798 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -77.67 129.12 35.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.903 1.281 . . . . 0.0 109.767 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -93.36 -160.35 0.75 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.551 0.741 . . . . 0.0 111.928 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 t -61.99 -28.5 69.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.167 -0.958 . . . . 0.0 112.222 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -76.87 155.45 32.89 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.043 1.337 . . . . 0.0 112.174 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.04 34.78 0.09 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.887 1.675 . . . . 0.0 114.262 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.46 145.47 40.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.58 1.952 . . . . 0.0 111.488 -172.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.41 148.51 25.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.499 1.119 . . . . 0.0 111.432 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.38 155.45 64.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.995 1.718 . . . . 0.0 111.185 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.62 134.44 32.84 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.023 2.482 . . . . 0.0 111.739 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.88 172.51 15.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.227 1.411 . . . . 0.0 111.933 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -134.1 130.86 38.02 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.537 1.535 . . . . 0.0 110.054 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.14 118.39 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.044 0.938 . . . . 0.0 110.536 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.5 -31.84 15.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.14 1.376 . . . . 0.0 112.474 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.65 160.67 38.27 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.716 1.206 . . . . 0.0 112.523 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 26.5 mt . . . . . 0 N--CA 1.473 0.681 0 C-N-CA 126.017 1.727 . . . . 0.0 108.905 -177.373 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 . . . . . 0 CA--C 1.533 0.319 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -98.88 134.7 41.38 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 108.982 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.91 140.73 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.34 1.056 . . . . 0.0 111.953 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -99.65 128.46 45.75 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.857 1.263 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.73 165.16 18.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.305 1.042 . . . . 0.0 112.444 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.31 -29.7 34.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.302 1.441 . . . . 0.0 114.266 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.94 -20.03 61.13 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 113.797 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.49 -20.88 31.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.104 1.811 . . . . 0.0 114.278 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 150.14 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.56 1.544 . . . . 0.0 112.457 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.61 126.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.283 1.433 . . . . 0.0 109.896 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -142.83 177.93 8.0 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.168 2.187 . . . . 0.0 110.036 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 29.1 p -121.95 154.05 37.68 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.134 0.974 . . . . 0.0 112.522 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.41 157.22 44.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.621 1.569 . . . . 0.0 112.059 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -72.2 158.59 35.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.087 1.355 . . . . 0.0 111.497 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -52.34 -39.14 60.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.293 1.437 . . . . 0.0 113.657 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.16 2.61 2.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.69 1.996 . . . . 0.0 114.238 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -122.91 13.33 9.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.888 1.675 . . . . 0.0 112.654 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -135.7 141.63 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.873 1.269 . . . . 0.0 110.025 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -138.12 152.28 48.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.509 1.924 . . . . 0.0 110.662 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.27 135.95 55.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.812 0.445 . . . . 0.0 110.416 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.7 ttm . . . . . 0 CA--C 1.548 0.882 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.864 172.052 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 . . . . . 0 CA--C 1.543 0.707 0 CA-C-O 121.162 0.506 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -144.46 151.61 39.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.648 1.579 . . . . 0.0 111.458 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.69 58.29 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.042 0.449 . . . . 0.0 110.927 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.13 -18.34 54.24 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 125.287 1.423 . . . . 0.0 114.384 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -72.02 147.28 47.0 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.591 1.196 . . . . 0.0 111.755 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 141.34 28.57 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 122.024 0.916 . . . . 0.0 112.148 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 166.87 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.826 2.05 . . . . 0.0 110.46 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.55 137.75 32.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.869 0.868 . . . . 0.0 109.037 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.31 153.37 38.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.527 -0.733 . . . . 0.0 112.488 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -82.77 148.03 28.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.795 1.238 . . . . 0.0 110.994 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -142.74 -42.51 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -134.55 -29.11 1.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -149.85 -161.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.348 1.459 . . . . 0.0 110.955 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.1 t -67.2 -32.24 73.18 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -63.78 153.27 37.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 0.0 112.582 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -101.27 157.43 16.79 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.263 1.025 . . . . 0.0 110.387 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -138.26 153.0 72.65 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.644 1.577 . . . . 0.0 110.092 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 137.79 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.518 2.145 . . . . 0.0 112.499 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.81 160.25 42.51 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.36 1.464 . . . . 0.0 111.842 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.14 127.79 54.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.553 1.941 . . . . 0.0 109.555 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.74 135.68 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.031 0.532 . . . . 0.0 109.686 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -115.78 -26.33 7.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.656 1.182 . . . . 0.0 113.008 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.0 153.41 30.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 111.377 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt . . . . . 0 N--CA 1.473 0.709 0 C-N-CA 125.591 1.556 . . . . 0.0 109.064 -174.008 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.6 m -110.29 135.76 50.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.872 0.869 . . . . 0.0 109.354 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.82 151.26 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.19 0.996 . . . . 0.0 112.669 -169.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -121.11 111.36 17.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 109.114 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.16 161.33 30.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.25 0.62 . . . . 0.0 111.806 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -55.15 -26.1 36.38 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.7 -21.88 64.39 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.135 1.374 . . . . 0.0 113.762 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.51 -12.95 36.08 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 126.183 1.849 . . . . 0.0 114.232 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.63 149.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.453 1.501 . . . . 0.0 112.407 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.6 mt -131.83 124.55 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.466 1.506 . . . . 0.0 109.952 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -144.17 -174.93 4.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.171 2.188 . . . . 0.0 109.883 170.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.1 p -125.17 151.35 45.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.723 1.209 . . . . 0.0 111.732 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.6 mt -143.18 152.54 41.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.815 1.646 . . . . 0.0 111.704 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -70.09 151.49 45.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.53 0.732 . . . . 0.0 109.338 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -57.88 -29.59 65.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.881 0.873 . . . . 0.0 113.121 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -59.31 -7.33 1.24 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.504 1.922 . . . . 0.0 114.488 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -115.97 10.72 15.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.079 1.752 . . . . 0.0 112.626 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.4 mt -131.53 143.73 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 109.625 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.16 152.6 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.155 2.182 . . . . 0.0 111.05 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.85 159.19 25.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.294 0.638 . . . . 0.0 111.712 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 CA--C 1.55 0.968 0 C-N-CA 123.706 0.802 . . . . 0.0 112.32 170.437 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 CA--C 1.542 0.671 0 CA-C-O 121.399 0.618 . . . . 0.0 112.206 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.01 159.81 43.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.86 1.664 . . . . 0.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.55 37.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.692 0.397 . . . . 0.0 110.989 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.36 -10.72 72.82 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.474 1.511 . . . . 0.0 114.559 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.11 132.04 47.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.133 1.466 . . . . 0.0 111.61 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.65 143.4 33.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.34 169.5 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.855 1.662 . . . . 0.0 111.645 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.3 141.72 45.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.396 1.478 . . . . 0.0 108.325 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.99 151.32 30.16 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.51 -0.744 . . . . 0.0 112.886 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -81.4 113.22 19.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.938 1.295 . . . . 0.0 110.247 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -93.75 -159.7 0.71 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.347 1.059 . . . . 0.0 112.044 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 t -61.14 -12.17 11.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.538 1.135 . . . . 0.0 113.712 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.16 149.7 43.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.423 2.289 . . . . 0.0 110.055 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.34 -17.24 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -169.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.71 155.98 39.1 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.254 0.934 . . . . 0.0 111.682 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -101.52 80.92 2.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.195 1.398 . . . . 0.0 110.25 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -71.62 153.66 93.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.476 1.11 . . . . 0.0 112.085 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.75 137.78 33.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.132 2.555 . . . . 0.0 112.447 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.03 -178.32 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.568 1.547 . . . . 0.0 111.606 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -143.32 154.41 43.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.354 1.462 . . . . 0.0 111.255 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -82.6 133.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.157 0.983 . . . . 0.0 109.743 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -104.38 -30.16 10.27 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.446 1.499 . . . . 0.0 112.794 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.32 154.44 32.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.609 1.164 . . . . 0.0 112.301 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt . . . . . 0 N--CA 1.475 0.8 0 C-N-CA 126.044 1.738 . . . . 0.0 110.085 -172.47 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.235 0.318 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.7 m -68.4 135.84 52.38 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.62 150.1 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.694 1.197 . . . . 0.0 111.5 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -126.86 125.58 41.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.129 1.371 . . . . 0.0 110.233 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -87.95 162.29 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.013 0.925 . . . . 0.0 111.672 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -52.39 -29.44 24.18 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.0 -20.15 58.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.41 -22.91 8.2 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.694 1.616 . . . . 0.0 115.472 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.31 148.0 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.109 1.454 . . . . 0.0 113.176 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.5 mt -130.2 127.84 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.214 1.405 . . . . 0.0 110.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -143.7 -169.03 2.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.413 2.285 . . . . 0.0 109.436 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.5 p -127.77 150.81 49.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.413 1.085 . . . . 0.0 112.133 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -141.21 163.09 33.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 111.557 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -89.0 155.89 19.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.138 1.375 . . . . 0.0 110.715 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.99 -28.7 10.5 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.3 ttt -63.94 -12.83 40.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.942 1.697 . . . . 0.0 113.811 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -128.18 13.36 6.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.049 1.74 . . . . 0.0 113.354 -172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.6 mt -131.56 143.58 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.458 1.903 . . . . 0.0 109.148 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -137.21 149.89 47.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.637 1.975 . . . . 0.0 110.521 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 150.14 48.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.304 0.642 . . . . 0.0 111.094 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt . . . . . 0 CA--C 1.55 0.962 0 C-N-CA 123.464 0.706 . . . . 0.0 110.821 179.307 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 . . . . . 0 CA--C 1.544 0.716 0 CA-C-O 121.344 0.592 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -126.35 152.67 45.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.006 1.722 . . . . 0.0 111.795 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.9 137.85 54.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.173 0.589 . . . . 0.0 111.051 173.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.18 72.33 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.77 1.176 . . . . 0.0 114.886 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.51 142.45 28.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.738 1.269 . . . . 0.0 112.199 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.38 141.13 30.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.175 0.99 . . . . 0.0 111.849 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -146.39 170.16 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.185 1.794 . . . . 0.0 111.061 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.73 133.54 52.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.533 1.133 . . . . 0.0 107.998 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.42 159.04 44.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.4 -0.813 . . . . 0.0 112.526 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 139.61 35.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.211 1.004 . . . . 0.0 111.549 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -135.72 -29.24 1.05 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.2 m -142.41 -56.5 0.44 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.063 0.847 . . . . 0.0 112.19 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -119.28 176.97 5.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.015 1.326 . . . . 0.0 111.814 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.8 m -60.74 -20.74 61.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.44 128.02 33.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.655 1.182 . . . . 0.0 110.508 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -68.37 161.02 28.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.759 168.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.4 156.42 80.15 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.751 1.621 . . . . 0.0 110.37 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.57 135.52 36.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.407 2.071 . . . . 0.0 111.64 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.24 173.87 12.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.846 1.658 . . . . 0.0 111.093 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -144.15 133.12 22.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.6 117.86 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.991 0.917 . . . . 0.0 110.15 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -84.03 -37.28 22.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.087 1.355 . . . . 0.0 112.167 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.45 160.82 38.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.788 1.235 . . . . 0.0 112.347 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.3 mt . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 125.799 1.64 . . . . 0.0 109.246 -174.912 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -97.89 126.1 43.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.843 0.857 . . . . 0.0 109.121 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.28 130.81 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.052 0.941 . . . . 0.0 112.449 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.77 140.87 29.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.08 1.352 . . . . 0.0 109.529 169.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.58 168.25 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 111.43 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -58.17 -22.88 53.28 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.53 -13.54 61.05 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.24 -14.12 63.92 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.0 1.762 . . . . 0.0 114.258 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.65 151.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.735 1.614 . . . . 0.0 112.182 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.32 129.93 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.504 1.521 . . . . 0.0 109.993 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -146.45 167.7 23.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.015 1.726 . . . . 0.0 111.515 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 79.0 m -82.65 145.43 29.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.935 0.494 . . . . 0.0 110.346 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 37.3 mt -139.25 157.15 46.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.541 1.536 . . . . 0.0 111.252 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -81.49 155.65 25.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.906 1.282 . . . . 0.0 111.268 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -56.37 -29.3 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.859 1.264 . . . . 0.0 113.365 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 21.9 ttt -59.0 -14.85 10.56 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.707 1.603 . . . . 0.0 114.157 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -130.35 16.19 5.51 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.306 1.842 . . . . 0.0 112.805 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.4 mt -132.43 143.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.676 1.99 . . . . 0.0 108.825 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -136.87 149.2 47.52 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.227 2.211 . . . . 0.0 110.07 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.12 155.83 38.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.172 0.589 . . . . 0.0 111.114 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.1 mmt . . . . . 0 CA--C 1.547 0.85 0 O-C-N 121.949 -0.469 . . . . 0.0 111.824 171.251 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 CA--C 1.548 0.892 0 CA-C-O 121.498 0.666 . . . . 0.0 111.768 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -122.89 128.08 49.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.624 1.57 . . . . 0.0 110.475 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.96 134.54 54.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.148 0.579 . . . . 0.0 111.528 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.23 -7.74 35.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.784 1.659 . . . . 0.0 115.178 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -79.12 146.82 32.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.776 1.288 . . . . 0.0 112.599 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.43 138.92 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.811 1.245 . . . . 0.0 111.807 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.6 174.23 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 127.174 2.19 . . . . 0.0 110.896 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.26 136.45 47.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.182 . . . . 0.0 107.98 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.41 31.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.597 -0.689 . . . . 0.0 112.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -72.97 142.68 47.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -146.72 -44.23 0.18 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 m -136.51 -16.7 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -147.97 -176.24 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.428 1.491 . . . . 0.0 111.228 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 77.3 m -67.89 -24.16 65.19 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.142 -0.974 . . . . 0.0 111.439 166.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -68.31 141.7 55.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.229 1.812 . . . . 0.0 111.953 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.47 163.87 22.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.563 0.745 . . . . 0.0 110.593 168.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -134.79 153.26 78.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.191 1.796 . . . . 0.0 110.669 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.57 135.1 25.56 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.683 2.256 . . . . 0.0 111.825 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.52 177.69 9.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.559 1.543 . . . . 0.0 110.581 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.92 151.71 51.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.133 0.973 . . . . 0.0 110.819 168.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.6 mt -81.14 113.68 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.675 0.79 . . . . 0.0 109.922 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -80.4 -32.83 37.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 112.747 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.77 36.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.064 0.946 . . . . 0.0 113.177 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 126.424 1.89 . . . . 0.0 108.609 -177.06 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 . . . . . 0 CA--C 1.534 0.346 0 N-CA-C 110.468 -0.197 . . . . 0.0 110.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.5 m -115.48 136.61 52.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.646 1.178 . . . . 0.0 108.392 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.5 m -135.95 156.15 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.899 . . . . 0.0 112.15 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -125.0 117.29 23.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.274 1.43 . . . . 0.0 109.473 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.71 165.39 22.88 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.119 0.968 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -54.0 -27.03 29.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.872 1.269 . . . . 0.0 114.367 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.94 -21.88 64.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.475 . . . . 0.0 113.863 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.14 56.78 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.668 1.604 . . . . 0.0 114.766 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.51 144.65 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.239 1.416 . . . . 0.0 112.179 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.78 109.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.038 1.335 . . . . 0.0 109.515 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -138.51 175.58 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.978 1.711 . . . . 0.0 111.644 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.56 155.6 18.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.326 1.05 . . . . 0.0 112.199 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.2 mt -144.77 156.91 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.11 156.32 38.8 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.417 1.087 . . . . 0.0 110.732 169.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -57.12 -24.83 56.87 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.05 -12.16 53.42 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.001 1.72 . . . . 0.0 114.126 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -120.86 12.04 11.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.727 1.611 . . . . 0.0 113.109 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -132.67 143.2 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.667 1.587 . . . . 0.0 109.565 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -134.72 147.29 50.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.765 2.026 . . . . 0.0 110.697 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.45 141.63 48.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.929 0.892 . . . . 0.0 110.959 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.2 tpp . . . . . 0 CA--C 1.548 0.888 0 C-N-CA 123.663 0.785 . . . . 0.0 110.437 175.056 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 154.81 43.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.864 1.266 . . . . 0.0 112.428 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.52 130.23 43.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.367 0.667 . . . . 0.0 111.547 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.61 -8.71 68.81 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.463 1.506 . . . . 0.0 114.371 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.24 132.52 41.13 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.018 1.409 . . . . 0.0 112.5 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.45 135.65 37.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.425 1.09 . . . . 0.0 111.64 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.35 -176.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.418 2.287 . . . . 0.0 111.009 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -111.39 145.09 39.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.132 0.973 . . . . 0.0 109.247 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 150.43 35.41 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.443 0.64 . . . . 0.0 112.46 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -80.72 154.29 27.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.543 1.537 . . . . 0.0 110.638 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.39 -47.51 0.52 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -142.95 -29.36 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -138.58 -169.51 2.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.095 1.758 . . . . 0.0 110.301 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.0 p -62.17 -15.56 47.06 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.631 -1.293 . . . . 0.0 114.415 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -62.8 145.4 55.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.554 1.541 . . . . 0.0 111.979 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -117.29 154.34 31.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.926 1.29 . . . . 0.0 109.444 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.64 152.8 71.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.677 1.191 . . . . 0.0 111.332 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.78 130.9 24.32 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.783 2.322 . . . . 0.0 110.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.76 12.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.242 1.417 . . . . 0.0 110.859 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -132.71 132.18 42.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.293 1.437 . . . . 0.0 109.458 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -71.45 121.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.111 0.564 . . . . 0.0 109.623 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -95.23 -32.25 13.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 112.343 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.99 40.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.841 1.257 . . . . 0.0 112.143 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt . . . . . 0 N--CA 1.474 0.749 0 C-N-CA 125.199 1.399 . . . . 0.0 109.084 -172.436 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 . . . . . 0 CA--C 1.539 0.539 0 CA-C-O 120.908 0.385 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.4 m -131.27 134.37 46.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.883 1.273 . . . . 0.0 108.727 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 150.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.407 1.083 . . . . 0.0 111.71 -175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -118.29 134.15 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.581 1.552 . . . . 0.0 109.651 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -93.28 167.55 11.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.443 1.097 . . . . 0.0 112.156 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -53.7 -28.74 35.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.602 1.561 . . . . 0.0 114.463 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.42 -18.93 61.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.11 1.364 . . . . 0.0 113.797 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.92 -15.9 47.53 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.886 1.708 . . . . 0.0 114.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.34 146.12 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.393 1.477 . . . . 0.0 112.347 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 132.02 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.788 1.635 . . . . 0.0 109.986 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -143.71 168.73 19.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.948 1.699 . . . . 0.0 111.461 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.64 149.96 27.46 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.289 1.036 . . . . 0.0 111.712 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 mt -148.11 158.65 44.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.348 1.459 . . . . 0.0 112.458 -171.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -76.35 159.79 30.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.752 0.821 . . . . 0.0 109.534 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -56.58 -35.01 67.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.055 0.942 . . . . 0.0 112.472 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.8 mtt -64.52 -1.17 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 0.0 114.729 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -120.42 7.59 10.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.733 1.613 . . . . 0.0 113.193 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.5 mt -130.27 139.66 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.989 1.716 . . . . 0.0 108.822 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -136.72 147.09 46.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.468 1.507 . . . . 0.0 110.669 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 135.11 55.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.857 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 55.7 ttm . . . . . 0 CA--C 1.547 0.836 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.786 173.752 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 121.588 0.708 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 162.68 40.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.332 1.853 . . . . 0.0 110.491 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.22 123.83 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.992 -0.443 . . . . 0.0 111.453 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.4 -7.16 78.1 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.289 1.423 . . . . 0.0 114.877 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.92 135.52 56.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.27 1.535 . . . . 0.0 111.619 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.12 138.81 31.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.777 0.831 . . . . 0.0 112.092 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.34 167.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.071 1.748 . . . . 0.0 111.03 -171.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.08 148.45 22.34 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.3 144.16 28.6 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.439 0.696 . . . . 0.0 111.571 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -72.62 152.84 41.54 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.149 0.98 . . . . 0.0 110.015 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -131.67 -160.28 1.03 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 112.152 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 m -55.24 -36.56 66.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.155 0.982 . . . . 0.0 111.382 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -84.07 139.59 32.38 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.021 1.329 . . . . 0.0 109.747 168.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.41 -21.46 65.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 158.51 24.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.008 1.276 . . . . 0.0 112.199 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.84 149.09 23.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.688 0.795 . . . . 0.0 110.263 168.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.65 152.77 69.3 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.257 1.423 . . . . 0.0 111.29 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 136.56 29.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.999 2.466 . . . . 0.0 112.141 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.13 13.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.736 1.615 . . . . 0.0 111.221 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -128.82 141.15 51.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 110.862 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.02 124.98 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.155 0.982 . . . . 0.0 109.58 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -95.57 -30.51 13.77 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.885 0.874 . . . . 0.0 112.894 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.76 153.22 32.74 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.6 mt . . . . . 0 N--CA 1.473 0.707 0 C-N-CA 127.645 2.378 . . . . 0.0 108.467 -171.385 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 . . . . . 0 N--CA 1.474 0.736 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.3 m -122.06 133.33 54.79 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.204 -0.935 . . . . 0.0 109.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.94 157.07 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -128.41 128.6 44.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.154 1.382 . . . . 0.0 110.145 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -81.74 162.63 22.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 112.485 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -52.96 -31.74 42.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.339 1.456 . . . . 0.0 114.814 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.35 -17.33 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.53 -21.17 8.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.277 1.418 . . . . 0.0 115.449 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.42 146.83 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.289 1.544 . . . . 0.0 112.857 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.78 128.87 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 109.215 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -143.95 175.07 10.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.173 1.789 . . . . 0.0 110.922 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.7 m -113.68 141.73 46.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 110.523 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -144.07 146.44 32.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.404 1.882 . . . . 0.0 109.731 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.4 160.86 30.45 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.409 -0.807 . . . . 0.0 110.978 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.95 8.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.804 1.242 . . . . 0.0 113.916 168.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.67 -12.54 34.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.541 1.936 . . . . 0.0 113.892 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.41 9.51 6.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.3 1.84 . . . . 0.0 113.157 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -126.25 143.42 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.15 2.18 . . . . 0.0 108.18 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -135.31 148.69 49.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.55 1.54 . . . . 0.0 110.854 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.51 145.47 48.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.703 0.801 . . . . 0.0 111.028 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt . . . . . 0 CA--C 1.55 0.971 0 CA-C-O 118.814 -0.612 . . . . 0.0 110.857 -178.333 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 . . . . . 0 CA--C 1.543 0.7 0 CA-C-O 121.127 0.489 . . . . 0.0 111.479 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -119.17 128.02 53.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.982 1.713 . . . . 0.0 109.911 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 133.76 52.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.146 0.578 . . . . 0.0 111.34 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.07 75.34 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.884 1.23 . . . . 0.0 115.061 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.47 154.09 20.3 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.908 1.354 . . . . 0.0 112.411 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.36 142.55 27.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.175 0.99 . . . . 0.0 112.533 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.24 174.79 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.911 2.084 . . . . 0.0 110.86 -170.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.0 124.99 52.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.724 1.21 . . . . 0.0 109.32 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.14 154.84 44.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -88.66 147.1 24.7 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.043 1.337 . . . . 0.0 111.674 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -143.73 -30.53 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -139.11 -28.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -169.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.55 -167.81 2.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.027 1.731 . . . . 0.0 110.064 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.7 m -66.73 -13.89 61.9 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.836 -1.165 . . . . 0.0 113.727 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -69.18 166.55 18.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.189 1.796 . . . . 0.0 113.378 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -129.13 152.01 49.19 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.883 1.673 . . . . 0.0 109.991 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -139.12 156.01 72.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.48 1.512 . . . . 0.0 110.738 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.41 132.08 28.25 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.428 2.085 . . . . 0.0 111.881 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.86 172.02 13.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.798 1.639 . . . . 0.0 110.59 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -128.75 129.26 45.48 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.211 1.804 . . . . 0.0 109.605 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.62 120.94 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.367 0.667 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.29 -27.37 15.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.879 0.872 . . . . 0.0 112.69 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.69 156.44 29.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.235 1.414 . . . . 0.0 111.603 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.2 mt . . . . . 0 N--CA 1.473 0.684 0 C-N-CA 125.736 1.615 . . . . 0.0 108.936 -174.158 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 . . . . . 0 N--CA 1.469 0.515 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -80.72 132.23 35.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.69 0.796 . . . . 0.0 110.403 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.17 146.21 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.056 1.342 . . . . 0.0 112.438 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.14 119.61 29.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.317 1.847 . . . . 0.0 109.223 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -89.67 165.58 14.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.121 0.968 . . . . 0.0 111.005 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -58.94 -18.8 36.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -69.09 -15.72 63.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.74 1.216 . . . . 0.0 113.928 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.95 -15.49 61.57 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.248 1.88 . . . . 0.0 114.321 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.26 146.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.84 1.656 . . . . 0.0 112.231 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 126.42 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 110.125 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -140.71 -162.57 1.38 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.945 2.098 . . . . 0.0 109.236 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.53 151.93 47.78 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.164 -0.96 . . . . 0.0 112.138 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -139.13 158.12 44.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.54 1.536 . . . . 0.0 111.904 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.13 158.01 36.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.65 1.18 . . . . 0.0 110.756 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.68 -17.86 57.25 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.97 -12.24 61.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.14 1.376 . . . . 0.0 113.427 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -127.03 9.88 6.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.982 1.713 . . . . 0.0 113.321 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.66 136.83 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.55 1.94 . . . . 0.0 108.243 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -134.48 148.74 50.62 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.175 1.79 . . . . 0.0 110.281 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.3 138.24 58.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.228 0.611 . . . . 0.0 110.549 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.7 ttm . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.12 175.513 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 CA--C 1.541 0.634 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.63 160.18 39.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.58 57.78 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.728 -0.607 . . . . 0.0 112.109 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 81.58 -11.57 45.04 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.92 1.724 . . . . 0.0 114.85 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.23 131.15 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.241 1.416 . . . . 0.0 112.701 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.21 140.18 40.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.557 1.143 . . . . 0.0 112.449 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.84 171.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.685 1.994 . . . . 0.0 111.322 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.42 139.32 38.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.6 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -87.02 150.14 24.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.122 1.369 . . . . 0.0 111.312 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -143.83 -44.46 0.27 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 -5.15 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.55 177.01 11.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.29 1.436 . . . . 0.0 111.082 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 -30.09 68.4 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.076 -1.015 . . . . 0.0 112.863 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -56.71 156.78 6.01 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.843 1.657 . . . . 0.0 113.275 172.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -119.23 155.23 32.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.255 1.422 . . . . 0.0 109.596 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -136.5 155.51 76.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.693 1.197 . . . . 0.0 111.28 -170.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.03 132.33 27.79 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.778 2.319 . . . . 0.0 111.916 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.02 179.35 8.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.19 1.796 . . . . 0.0 110.349 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -141.86 151.8 43.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.105 0.962 . . . . 0.0 112.223 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 72.9 mt -75.06 122.52 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.564 1.146 . . . . 0.0 110.093 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -93.67 -31.53 14.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.404 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.69 156.28 34.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.256 1.022 . . . . 0.0 112.937 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 126.563 1.945 . . . . 0.0 108.345 -177.814 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 . . . . . 0 N--CA 1.471 0.618 0 CA-C-O 120.872 0.368 . . . . 0.0 110.407 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.0 m -126.21 137.89 53.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.299 1.04 . . . . 0.0 109.123 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.65 152.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.624 1.169 . . . . 0.0 111.926 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.82 130.23 53.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.687 1.595 . . . . 0.0 109.794 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.1 169.67 9.95 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.759 1.223 . . . . 0.0 112.206 -176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -57.3 -24.22 53.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.44 -12.82 60.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.554 1.141 . . . . 0.0 113.95 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.26 -14.15 65.64 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.898 1.713 . . . . 0.0 114.493 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.42 148.28 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.503 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.97 130.63 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.914 1.686 . . . . 0.0 110.267 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -146.43 163.25 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.754 1.622 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.13 145.13 30.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.5 0.72 . . . . 0.0 110.705 168.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.14 144.8 30.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.106 1.362 . . . . 0.0 110.835 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -69.52 158.85 34.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.349 0.66 . . . . 0.0 111.337 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -57.08 -21.57 32.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.13 -12.88 58.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.608 1.563 . . . . 0.0 113.889 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -127.11 11.52 7.04 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.954 1.702 . . . . 0.0 113.354 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.58 139.54 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.593 1.957 . . . . 0.0 108.484 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.09 145.79 44.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.033 1.733 . . . . 0.0 110.883 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.44 149.26 50.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.163 0.585 . . . . 0.0 110.758 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.5 mtt . . . . . 0 CA--C 1.546 0.789 0 C-N-CA 123.092 0.557 . . . . 0.0 112.332 174.117 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -138.46 157.43 46.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.738 2.015 . . . . 0.0 111.249 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.75 136.38 58.05 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.927 -0.483 . . . . 0.0 111.326 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.14 -1.34 87.22 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.645 1.117 . . . . 0.0 114.988 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.97 142.2 52.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.359 1.58 . . . . 0.0 111.877 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.17 145.32 24.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.924 0.89 . . . . 0.0 111.714 177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -148.41 162.28 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.558 1.543 . . . . 0.0 112.022 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.05 118.25 36.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.876 1.671 . . . . 0.0 107.245 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.9 48.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.219 0.608 . . . . 0.0 112.142 -172.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -74.71 150.21 39.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.992 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -134.05 -40.39 0.84 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.3 m -159.36 -51.0 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.401 1.081 . . . . 0.0 111.282 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -74.95 170.59 15.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 0.0 112.039 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.7 m -73.38 43.54 0.14 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.234 1.814 . . . . 0.0 112.56 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -140.75 162.44 35.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 110.77 -171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 134' ' ' LYS . 53.2 m-85 -124.0 145.73 49.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.967 1.307 . . . . 0.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.85 154.31 77.75 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.117 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.68 131.27 25.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 0.0 112.016 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.69 174.6 12.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.189 1.796 . . . . 0.0 110.904 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.4 133.81 33.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.313 1.445 . . . . 0.0 110.686 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.26 120.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.166 0.986 . . . . 0.0 110.582 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.14 -30.01 14.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.416 1.486 . . . . 0.0 112.488 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.64 161.93 39.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.528 1.131 . . . . 0.0 112.803 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.8 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 109.733 -171.321 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 N--CA 1.467 0.42 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.3 m -125.19 133.15 52.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 108.635 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.45 133.3 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.134 0.974 . . . . 0.0 111.978 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -93.12 125.19 37.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.887 1.275 . . . . 0.0 109.5 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.66 165.63 14.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.912 0.885 . . . . 0.0 111.561 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -54.5 -26.92 34.37 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.61 -20.11 62.03 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.023 1.329 . . . . 0.0 113.778 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.51 -17.14 40.2 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.169 1.842 . . . . 0.0 114.075 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.63 150.39 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.778 1.631 . . . . 0.0 112.226 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.1 mt -133.66 127.48 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 109.819 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -143.86 175.83 9.71 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.233 1.813 . . . . 0.0 110.853 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.5 m -107.4 146.03 32.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.503 1.121 . . . . 0.0 111.738 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.9 mt -147.42 152.97 39.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.093 1.757 . . . . 0.0 111.415 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.96 158.99 27.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.97 0.908 . . . . 0.0 110.872 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -57.91 -26.1 61.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.911 1.284 . . . . 0.0 113.661 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.9 ttm -54.78 -18.88 5.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.352 1.861 . . . . 0.0 114.116 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -123.75 13.17 9.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.9 1.68 . . . . 0.0 113.127 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -134.59 136.62 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.493 1.917 . . . . 0.0 109.093 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 102' ' ' TYR . 55.4 mtmt -132.87 150.41 52.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.918 1.687 . . . . 0.0 110.376 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.95 152.85 35.47 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.288 0.635 . . . . 0.0 111.789 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.4 tpt . . . . . 0 CA--C 1.547 0.832 0 C-N-CA 123.54 0.736 . . . . 0.0 110.461 174.628 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -140.33 160.1 40.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.884 1.674 . . . . 0.0 111.956 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.2 58.85 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.854 -0.529 . . . . 0.0 111.775 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.32 -12.81 49.15 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.786 1.66 . . . . 0.0 114.885 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.0 138.47 44.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.658 1.183 . . . . 0.0 112.277 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.52 141.79 34.81 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.461 1.104 . . . . 0.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 m -151.88 168.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.372 1.869 . . . . 0.0 111.023 -171.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.03 129.84 44.87 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.09 133.41 41.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 111.187 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -67.77 161.21 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.868 1.267 . . . . 0.0 110.994 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -135.56 -163.79 1.44 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.454 1.102 . . . . 0.0 111.238 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -29.91 70.76 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.49 -0.757 . . . . 0.0 112.602 171.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.03 154.48 28.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.558 1.143 . . . . 0.0 112.005 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.57 33.8 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.165 1.786 . . . . 0.0 115.579 -176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -137.69 157.22 46.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.472 1.909 . . . . 0.0 111.77 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.3 148.58 24.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.033 1.333 . . . . 0.0 110.215 170.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -140.04 154.32 70.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.82 1.648 . . . . 0.0 111.222 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.85 129.45 20.9 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.538 2.159 . . . . 0.0 111.358 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.86 175.29 11.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.7 1.6 . . . . 0.0 111.247 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.11 136.85 47.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.09 1.356 . . . . 0.0 110.654 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.37 140.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.692 0.797 . . . . 0.0 109.534 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -116.6 -27.99 6.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.539 1.136 . . . . 0.0 113.173 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.09 155.34 33.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.65 1.18 . . . . 0.0 111.286 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.1 mt . . . . . 0 N--CA 1.472 0.671 0 C-N-CA 125.661 1.584 . . . . 0.0 108.592 -170.749 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 . . . . . 0 CA--C 1.535 0.368 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -87.74 135.42 33.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.657 0.783 . . . . 0.0 109.056 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.63 156.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.583 1.153 . . . . 0.0 112.156 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -124.5 131.01 53.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.22 1.408 . . . . 0.0 109.795 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.56 167.59 12.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 111.676 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -59.07 -23.38 62.0 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -72.33 -14.01 61.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.655 1.182 . . . . 0.0 113.87 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.62 -15.65 62.76 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.677 1.608 . . . . 0.0 114.329 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.54 146.46 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.446 1.498 . . . . 0.0 112.477 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.84 128.07 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.769 1.628 . . . . 0.0 109.387 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -144.96 178.18 8.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.635 1.974 . . . . 0.0 110.508 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 p -122.76 152.37 40.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -139.72 165.36 27.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.55 1.94 . . . . 0.0 110.937 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -79.8 159.03 26.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.572 0.749 . . . . 0.0 110.68 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -55.94 -29.33 59.97 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -70.97 -21.01 62.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.421 1.088 . . . . 0.0 113.638 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -86.08 4.63 37.32 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.72 1.208 . . . . 0.0 113.578 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.5 mt -131.93 140.34 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.372 1.069 . . . . 0.0 110.522 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -137.71 153.11 49.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.974 2.11 . . . . 0.0 110.817 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.92 165.63 22.92 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.08 0.552 . . . . 0.0 111.236 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.841 0 C-N-CA 123.185 0.594 . . . . 0.0 111.941 170.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 . . . . . 0 CA--C 1.548 0.889 0 CA-C-O 121.517 0.675 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -133.18 160.04 38.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.376 1.871 . . . . 0.0 111.488 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.05 129.0 38.82 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.773 -0.58 . . . . 0.0 110.062 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.07 83.67 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.55 -1.139 . . . . 0.0 115.365 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.04 140.13 58.84 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.041 1.921 . . . . 0.0 111.155 172.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.85 121.0 39.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.526 1.13 . . . . 0.0 109.028 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.09 174.59 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.46 . . . . 0.0 112.181 -166.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -107.09 141.48 38.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.521 1.128 . . . . 0.0 108.967 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.66 156.03 35.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -71.74 151.82 43.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.068 1.347 . . . . 0.0 111.04 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -132.99 -38.89 0.96 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 t -157.6 -32.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.71 -176.87 3.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.52 1.528 . . . . 0.0 112.612 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.3 t -73.22 39.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.103 1.761 . . . . 0.0 114.49 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.22 165.86 25.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.416 2.286 . . . . 0.0 111.021 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.48 153.57 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.417 1.087 . . . . 0.0 110.269 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -137.39 154.14 75.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 110.796 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.3 136.47 40.33 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.852 2.368 . . . . 0.0 112.523 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.09 174.69 12.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 111.467 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -134.68 135.46 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.377 1.471 . . . . 0.0 109.933 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.8 mt -74.26 120.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 0.0 109.956 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -84.38 -36.86 22.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.857 1.263 . . . . 0.0 112.314 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.78 160.32 36.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.768 1.227 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt . . . . . 0 N--CA 1.473 0.686 0 C-N-CA 125.674 1.589 . . . . 0.0 109.7 -175.855 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 . . . . . 0 CA--C 1.535 0.399 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 m -74.59 134.69 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.507 -0.745 . . . . 0.0 109.425 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.44 141.14 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.69 1.196 . . . . 0.0 111.825 -170.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -115.82 125.22 52.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.403 1.481 . . . . 0.0 109.278 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.91 167.33 11.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.002 0.921 . . . . 0.0 111.875 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -52.76 -28.76 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.96 -18.71 61.98 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.833 1.253 . . . . 0.0 113.693 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.07 -16.95 38.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.3 1.905 . . . . 0.0 113.995 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.82 147.5 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.088 1.755 . . . . 0.0 112.659 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.46 130.34 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.629 1.572 . . . . 0.0 110.391 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -142.66 -163.59 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.287 2.235 . . . . 0.0 109.56 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.3 p -140.35 156.97 46.23 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.202 -0.936 . . . . 0.0 112.647 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -145.04 171.62 14.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.292 1.837 . . . . 0.0 111.776 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.09 158.3 16.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.139 1.376 . . . . 0.0 109.461 168.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -53.19 -28.88 28.85 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -65.31 -14.44 60.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.215 1.406 . . . . 0.0 114.217 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -108.9 9.14 26.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.465 1.506 . . . . 0.0 112.985 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.38 145.38 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.105 1.762 . . . . 0.0 109.694 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -139.7 151.23 45.72 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.242 2.217 . . . . 0.0 111.0 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.54 162.8 26.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.575 0.75 . . . . 0.0 111.63 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.9 mmt . . . . . 0 CA--C 1.549 0.938 0 C-N-CA 123.188 0.595 . . . . 0.0 112.429 171.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.52 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 m 47.78 26.9 0.98 Allowed 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 126.983 2.113 . . . . 0.0 116.358 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 29.9 p -148.58 10.37 0.84 Allowed 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -171.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.58 -178.37 53.76 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 124.587 1.089 . . . . 0.0 114.68 177.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 m -155.9 30.25 0.36 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.674 1.59 . . . . 0.0 112.049 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.7 p -61.15 -25.06 66.75 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.38 158.38 15.25 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.612 1.101 . . . . 0.0 113.577 172.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.22 8.65 0.48 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.229 1.412 . . . . 0.0 113.398 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.81 117.09 10.06 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.232 1.413 . . . . 0.0 111.88 -177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -129.86 134.23 47.39 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.857 2.063 . . . . 0.0 109.37 178.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -155.54 158.12 37.94 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.596 1.558 . . . . 0.0 111.419 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.81 127.53 32.67 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 121.952 -0.468 . . . . 0.0 110.887 173.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 97.66 -11.64 64.67 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 125.667 1.603 . . . . 0.0 114.68 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -68.11 134.72 51.04 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.3 1.55 . . . . 0.0 111.902 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -79.51 138.05 37.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.329 0.652 . . . . 0.0 111.003 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.1 m -146.29 176.98 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 126.193 1.797 . . . . 0.0 111.22 -171.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.1 mt -112.87 144.94 41.57 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 125.05 1.34 . . . . 0.0 108.475 168.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.17 146.5 31.79 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.239 0.543 . . . . 0.0 111.673 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.5 ttt180 -74.15 140.43 45.18 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.433 1.093 . . . . 0.0 109.438 170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -121.71 -162.98 1.02 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.347 1.059 . . . . 0.0 111.472 -176.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 14.9 m -55.25 -35.14 64.67 Favored 'General case' 0 N--CA 1.48 1.057 0 O-C-N 121.365 -0.834 . . . . 0.0 111.197 169.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -86.61 135.46 33.41 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.398 1.479 . . . . 0.0 109.35 167.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.2 m -65.32 -21.4 66.7 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -174.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 78.8 mtm180 -63.6 145.56 55.45 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.207 1.003 . . . . 0.0 111.557 173.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -79.46 151.78 30.64 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.099 0.56 . . . . 0.0 110.848 169.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -141.64 154.23 65.99 Favored Pre-proline 0 N--CA 1.472 0.641 0 C-N-CA 125.043 1.337 . . . . 0.0 111.648 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -66.62 130.43 23.49 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.04 2.493 . . . . 0.0 111.355 176.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.89 -179.65 6.95 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.983 1.713 . . . . 0.0 110.539 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -143.3 152.82 42.11 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.48 1.112 . . . . 0.0 111.486 170.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -75.54 128.96 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 124.409 1.083 . . . . 0.0 109.606 176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -98.54 -33.59 10.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.55 1.14 . . . . 0.0 112.185 173.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.38 159.43 35.79 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.799 1.24 . . . . 0.0 112.194 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 59.3 mt -131.98 127.74 58.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 125.615 1.566 . . . . 0.0 109.128 -176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.75 5.31 0.06 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 127.4 2.28 . . . . 0.0 116.555 -175.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -59.92 -26.57 66.05 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.206 1.802 . . . . 0.0 113.785 -176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -140.02 43.02 1.94 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.965 1.706 . . . . 0.0 110.36 175.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.58 17.06 47.3 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 125.274 1.416 . . . . 0.0 114.812 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 19.2 p -149.34 171.22 16.88 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.282 2.233 . . . . 0.0 110.913 -168.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -102.64 108.03 19.16 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.906 1.682 . . . . 0.0 108.788 175.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -76.25 133.63 40.04 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 21.8 m -137.03 152.49 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 124.848 1.259 . . . . 0.0 111.633 -177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -122.99 134.34 54.33 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.362 1.465 . . . . 0.0 110.313 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -93.11 164.52 13.23 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.0 111.62 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -55.49 -27.44 48.49 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 124.952 1.301 . . . . 0.0 114.371 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.29 -22.31 63.81 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.157 1.383 . . . . 0.0 113.712 174.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 109.15 -20.5 28.36 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.987 1.756 . . . . 0.0 113.937 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -57.97 145.71 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 C-N-CA 125.411 1.485 . . . . 0.0 112.585 177.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 27.5 mt -128.56 130.47 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 125.603 1.561 . . . . 0.0 109.481 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -142.14 173.83 11.16 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.216 1.807 . . . . 0.0 111.063 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -120.57 139.1 53.43 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.971 1.309 . . . . 0.0 110.363 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 84.7 mt -140.81 167.45 22.15 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.449 1.5 . . . . 0.0 111.659 -174.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -87.61 156.55 19.44 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.173 0.989 . . . . 0.0 110.114 168.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.32 -28.8 13.15 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 171.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 96.7 mtp -67.05 -10.43 49.74 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.362 1.465 . . . . 0.0 113.88 177.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 -117.54 8.82 13.01 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 125.381 1.472 . . . . 0.0 113.572 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 67.7 mt -128.43 144.64 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 126.15 1.78 . . . . 0.0 109.215 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -138.92 150.32 45.79 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 125.816 1.646 . . . . 0.0 111.063 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.38 132.16 45.21 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.3 ptp -69.53 152.98 96.13 Favored Pre-proline 0 CA--C 1.55 0.947 0 O-C-N 121.784 -0.572 . . . . 0.0 111.779 176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -72.64 164.03 36.78 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 123.519 2.813 . . . . 0.0 111.743 178.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 28.3 mp0 -57.71 -33.04 68.0 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.34 -0.85 . . . . 0.0 112.184 172.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -61.82 -22.39 65.44 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.111 1.364 . . . . 0.0 114.112 175.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -85.77 -1.74 57.52 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.562 1.145 . . . . 0.0 113.656 176.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -131.24 -40.37 1.14 Allowed 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.378 1.471 . . . . 0.0 112.782 -174.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 79.3 179.0 51.7 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.332 1.444 . . . . 0.0 114.627 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.3 mt-30 51.39 29.64 5.38 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.15 1.78 . . . . 0.0 114.667 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -72.36 173.07 9.24 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.476 1.51 . . . . 0.0 113.621 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -129.95 18.24 5.59 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.603 1.561 . . . . 0.0 113.423 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 45.3 mm -59.61 125.97 16.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.485 0 C-N-CA 124.527 1.131 . . . . 0.0 109.726 174.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 54.96 31.41 15.92 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.213 1.805 . . . . 0.0 115.126 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.82 35.59 4.84 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 126.138 1.775 . . . . 0.0 111.767 178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 26.9 m -57.87 152.8 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.201 1.4 . . . . 0.0 113.266 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -67.98 167.11 14.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.799 1.239 . . . . 0.0 113.464 175.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.328 0 C-N-CA 126.409 1.884 . . . . 0.0 111.749 176.76 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.446 0 N-CA-C 111.246 -0.741 . . . . 0.0 111.246 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.6 m -61.28 151.4 31.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.696 1.198 . . . . 0.0 113.37 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.1 m -70.04 -15.89 63.07 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.215 1.561 . . . . 0.0 115.215 -176.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.98 13.77 72.82 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 124.579 1.085 . . . . 0.0 114.668 -176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 26.1 p -71.11 167.61 18.93 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.366 1.867 . . . . 0.0 113.872 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.2 t -147.56 166.61 26.82 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 125.907 1.683 . . . . 0.0 110.922 174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.55 32.24 59.82 Favored Glycine 0 CA--C 1.54 1.655 0 C-N-CA 123.787 0.708 . . . . 0.0 113.88 -178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -78.14 117.33 19.32 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.573 1.149 . . . . 0.0 112.515 -178.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -157.72 157.37 33.33 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.818 1.647 . . . . 0.0 111.488 170.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -72.73 153.3 41.21 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.396 1.078 . . . . 0.0 113.117 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 63.4 mttt -138.0 148.07 44.81 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.014 0.926 . . . . 0.0 113.166 -168.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.24 132.59 54.48 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.57 -0.706 . . . . 0.0 111.723 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.77 6.15 66.32 Favored Glycine 0 CA--C 1.54 1.62 0 N-CA-C 115.837 1.095 . . . . 0.0 115.837 -178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.73 141.47 48.15 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 119.185 1.492 . . . . 0.0 111.839 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -77.32 132.27 38.53 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.005 0.922 . . . . 0.0 111.669 171.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.3 m -148.16 175.62 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 125.506 1.522 . . . . 0.0 111.918 -168.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -116.3 151.63 35.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.406 1.483 . . . . 0.0 108.971 169.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.67 154.82 36.06 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 121.207 -0.933 . . . . 0.0 112.255 169.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 55.9 ttp85 -72.01 156.85 38.78 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.022 1.329 . . . . 0.0 110.236 173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 12.0 t-105 -136.91 -150.09 0.35 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.53 0.732 . . . . 0.0 112.274 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 41.2 p -62.54 -3.0 1.23 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.792 1.637 . . . . 0.0 114.735 171.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -129.24 161.76 29.43 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 126.811 2.045 . . . . 0.0 110.543 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 27.9 p -64.6 -21.69 66.78 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -66.33 147.05 53.87 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.315 1.446 . . . . 0.0 112.259 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.2 m-85 -86.55 152.76 22.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.111 0.564 . . . . 0.0 109.622 167.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -139.76 152.15 67.6 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.462 1.105 . . . . 0.0 111.805 -179.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.61 137.33 38.72 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.302 2.668 . . . . 0.0 112.319 -177.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.81 176.83 10.69 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.274 1.43 . . . . 0.0 111.715 -175.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -135.25 139.94 44.83 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.954 1.702 . . . . 0.0 109.578 174.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.0 mm -61.49 134.78 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 123.501 0.721 . . . . 0.0 110.251 173.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -106.75 -29.99 9.22 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 126.214 1.806 . . . . 0.0 112.106 171.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.38 148.18 27.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.989 0.916 . . . . 0.0 113.154 175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 31.8 mm -120.44 147.37 24.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 127.709 2.404 . . . . 0.0 108.246 176.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 34.0 m120 51.41 40.84 27.5 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.905 1.282 . . . . 0.0 113.533 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.7 tptt -60.41 166.27 3.16 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.615 1.166 . . . . 0.0 109.804 168.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -44.47 -31.43 1.09 Allowed 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 116.253 1.945 . . . . 0.0 116.253 -171.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -167.92 34.59 0.2 Allowed Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.977 1.275 . . . . 0.0 112.949 169.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.7 t -162.36 -169.19 2.06 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.746 1.218 . . . . 0.0 112.975 -167.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -130.08 143.46 50.8 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 128.177 2.591 . . . . 0.0 108.15 169.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.4 m -111.93 140.17 46.82 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.736 -0.602 . . . . 0.0 109.561 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.9 m -140.67 151.77 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 124.763 1.225 . . . . 0.0 112.207 -172.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -112.72 124.07 51.74 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.84 1.656 . . . . 0.0 108.87 170.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.72 163.58 27.14 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.561 0.745 . . . . 0.0 112.24 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.0 p90 -54.17 -29.75 46.84 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.652 1.181 . . . . 0.0 114.008 173.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -70.72 -21.09 62.59 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.478 1.511 . . . . 0.0 113.794 175.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.45 -17.25 37.02 Favored Glycine 0 CA--C 1.537 1.444 0 C-N-CA 125.844 1.688 . . . . 0.0 114.419 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -62.28 148.96 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 124.982 1.313 . . . . 0.0 112.218 175.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 90.7 mt -128.85 129.08 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 125.606 1.562 . . . . 0.0 109.834 -177.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -145.63 177.37 8.94 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 127.038 2.135 . . . . 0.0 110.142 173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 28.0 p -125.52 148.16 48.99 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.366 1.066 . . . . 0.0 111.754 174.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 87.5 mt -147.82 144.03 27.89 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.665 1.586 . . . . 0.0 111.414 -169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -65.94 151.3 47.06 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.989 0.916 . . . . 0.0 111.076 170.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.46 -30.53 12.87 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 175.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 47.9 tpp -66.59 -12.44 57.9 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.782 1.633 . . . . 0.0 113.744 177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -117.0 15.0 15.13 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.713 1.605 . . . . 0.0 112.418 -179.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 63.7 mt -127.64 151.36 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.653 0 C-N-CA 127.013 2.125 . . . . 0.0 109.866 -171.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -140.18 155.23 47.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.702 2.001 . . . . 0.0 111.497 -176.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -84.24 152.43 24.2 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.039 0.936 . . . . 0.0 111.657 175.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.8 tpp -66.79 120.56 72.24 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 123.921 0.888 . . . . 0.0 110.592 172.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -72.85 162.62 40.63 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.671 2.247 . . . . 0.0 113.016 -177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -57.0 113.67 1.79 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 126.704 2.001 . . . . 0.0 112.137 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.1 t0 51.37 51.45 16.81 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.623 1.969 . . . . 0.0 112.87 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -44.77 121.47 2.74 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.257 1.823 . . . . 0.0 114.389 -174.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -65.03 -9.64 23.61 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.452 1.649 . . . . 0.0 115.452 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.66 46.35 0.89 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 126.325 1.916 . . . . 0.0 114.591 173.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 52.85 40.31 30.53 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.768 2.027 . . . . 0.0 114.338 -179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.1 t0 -68.71 122.51 18.69 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.939 -1.101 . . . . 0.0 112.401 172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 86.2 m95 -132.96 6.41 3.94 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.052 1.741 . . . . 0.0 111.728 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.5 mm -74.86 -36.63 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 125.163 1.385 . . . . 0.0 112.037 -169.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -94.71 -3.86 48.53 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 81.2 mt -84.76 142.06 30.09 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.441 1.096 . . . . 0.0 112.126 -176.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 p -158.3 159.33 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 125.715 1.606 . . . . 0.0 111.008 -178.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -55.75 135.23 51.74 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.124 1.37 . . . . 0.0 111.759 172.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.248 0 C-N-CA 125.694 1.598 . . . . 0.0 113.514 177.843 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 69.0 p -76.12 7.03 4.53 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 125.883 1.673 . . . . 0.0 115.511 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.6 t -60.58 -18.12 50.69 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.701 1.6 . . . . 0.0 114.558 179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -150.6 178.05 28.28 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 125.775 1.655 . . . . 0.0 112.633 174.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 5.3 t -61.16 -28.97 69.51 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.6 t 48.26 31.96 2.9 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.696 1.998 . . . . 0.0 115.75 170.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.27 29.69 0.23 Allowed Glycine 0 CA--C 1.535 1.308 0 O-C-N 121.422 -0.799 . . . . 0.0 114.992 -170.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -68.17 141.7 55.93 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.794 0.838 . . . . 0.0 111.595 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -150.05 142.22 24.08 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 111.577 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -77.17 158.78 30.18 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.927 0.891 . . . . 0.0 111.698 169.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 44.4 mmtm -82.99 155.81 23.77 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 125.154 1.382 . . . . 0.0 111.196 169.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.74 135.81 41.77 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 121.613 -0.68 . . . . 0.0 109.492 167.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.13 5.84 77.6 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.653 1.12 . . . . 0.0 114.88 -174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -65.65 131.93 47.56 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.119 1.46 . . . . 0.0 111.782 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -76.22 130.06 37.63 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.285 0.564 . . . . 0.0 110.159 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.9 m -144.61 177.28 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 126.229 1.812 . . . . 0.0 111.31 -169.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.5 mt -114.26 133.8 55.39 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.387 1.475 . . . . 0.0 109.766 174.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.98 155.91 42.07 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.6 ttt-85 -75.76 148.35 38.58 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.028 1.331 . . . . 0.0 111.555 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 21.1 t-105 -144.92 -36.13 0.31 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.708 1.373 . . . . 0.0 114.708 174.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.3 p -139.22 -28.67 0.78 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -175.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -148.81 178.41 8.69 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.768 1.627 . . . . 0.0 110.787 -169.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 83.5 m -61.53 -17.55 55.29 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 113.839 1.052 . . . . 0.0 113.839 172.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -73.05 114.24 10.99 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 124.823 1.249 . . . . 0.0 110.477 170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 42.6 m-85 -72.33 152.27 42.2 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.301 0.641 . . . . 0.0 110.092 169.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -129.97 156.2 79.46 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 124.567 1.147 . . . . 0.0 110.909 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.52 139.29 37.26 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.603 2.202 . . . . 0.0 113.029 -176.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.47 172.58 14.75 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.702 1.601 . . . . 0.0 111.404 177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -119.92 141.48 49.58 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.852 1.661 . . . . 0.0 110.088 171.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 89.3 mt -80.16 110.3 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 123.658 0.783 . . . . 0.0 109.833 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -83.03 -31.35 27.46 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.447 1.099 . . . . 0.0 113.106 178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.16 163.97 37.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.929 1.292 . . . . 0.0 112.14 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 57.6 mt -134.09 143.84 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.781 1.632 . . . . 0.0 109.676 -171.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -135.42 134.63 39.87 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.472 1.509 . . . . 0.0 111.504 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 tmtt? -29.62 89.22 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 130.497 3.519 . . . . 0.0 115.211 -170.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 38.39 40.33 0.35 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 127.872 2.469 . . . . 0.0 115.36 -175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -147.2 -30.74 0.07 OUTLIER Glycine 0 N--CA 1.472 1.087 0 N-CA-C 117.094 1.597 . . . . 0.0 117.094 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -152.47 156.41 39.38 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 119.919 1.859 . . . . 0.0 112.753 -175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -143.48 127.36 17.28 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.455 1.502 . . . . 0.0 109.322 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 53.8 m -82.47 134.68 35.22 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 169.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.44 144.31 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 124.117 0.967 . . . . 0.0 112.257 -169.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -119.36 110.19 16.66 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 125.598 1.559 . . . . 0.0 109.62 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.3 m-85 -75.73 164.17 26.54 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.046 0.938 . . . . 0.0 111.781 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -54.21 -26.34 27.86 Favored 'General case' 0 CA--C 1.546 0.82 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.73 -22.08 64.35 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.094 1.358 . . . . 0.0 113.874 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.76 -15.61 44.7 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 126.005 1.764 . . . . 0.0 114.083 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.0 p -60.43 148.23 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.655 1.582 . . . . 0.0 112.274 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.3 mt -129.92 127.59 64.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 125.147 1.379 . . . . 0.0 110.003 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -143.29 -171.05 3.41 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.276 2.231 . . . . 0.0 109.307 173.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.6 p -129.77 151.2 50.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.732 0.813 . . . . 0.0 112.005 171.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 74.5 mt -142.15 160.22 40.67 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.11 1.764 . . . . 0.0 110.882 -174.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -87.58 161.6 17.64 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.633 1.173 . . . . 0.0 111.246 172.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 27.6 ptt85 -55.42 -20.9 13.62 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 169.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 36.7 mmt -63.87 -13.37 44.53 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.828 1.251 . . . . 0.0 113.97 170.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -128.28 10.9 6.35 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.376 1.47 . . . . 0.0 113.633 -171.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.26 140.3 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.494 1.518 . . . . 0.0 110.039 -174.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -141.18 152.79 44.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.172 1.789 . . . . 0.0 110.927 173.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.05 139.98 58.23 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.706 -0.621 . . . . 0.0 109.861 169.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.9 ptp -67.13 153.81 93.88 Favored Pre-proline 0 CA--C 1.55 0.968 0 O-C-N 121.716 -0.615 . . . . 0.0 111.553 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.51 165.08 31.89 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.204 2.602 . . . . 0.0 113.325 -176.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -55.62 110.46 0.71 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.396 1.878 . . . . 0.0 111.088 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 53.1 56.11 7.96 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.335 1.854 . . . . 0.0 112.992 -174.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -49.28 153.86 0.95 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.831 1.652 . . . . 0.0 114.401 176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 5.5 tmmm? -61.8 -35.52 78.42 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 125.053 1.341 . . . . 0.0 113.913 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -67.91 159.57 50.94 Favored Glycine 0 CA--C 1.537 1.416 0 C-N-CA 124.049 0.833 . . . . 0.0 113.9 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.403 ' NE2' ' HE1' ' A' ' 145' ' ' TRP . 13.7 mm100 -63.4 141.02 58.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.842 0.857 . . . . 0.0 111.471 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -148.95 36.47 0.77 Allowed 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.678 1.191 . . . . 0.0 113.795 -168.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.403 ' HE1' ' NE2' ' A' ' 143' ' ' GLN . 85.0 m95 -69.23 46.67 0.06 Allowed 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 127.279 2.232 . . . . 0.0 115.557 -175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.8 pp -127.34 155.07 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.94 2.096 . . . . 0.0 111.018 176.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 50.99 23.2 1.4 Allowed 'General case' 0 CA--C 1.555 1.141 0 N-CA-C 115.926 1.825 . . . . 0.0 115.926 -176.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 57.1 mt -79.9 32.39 0.26 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.804 1.641 . . . . 0.0 113.534 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.2 t -137.0 136.63 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 125.958 1.703 . . . . 0.0 109.625 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -57.61 136.28 56.78 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.282 1.433 . . . . 0.0 111.993 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.232 0 C-N-CA 126.28 1.832 . . . . 0.0 114.429 -176.417 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.8 p -73.6 -27.32 61.23 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.18 1.178 . . . . 0.0 114.18 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.1 t -70.96 153.72 42.43 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.345 1.058 . . . . 0.0 111.905 173.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.21 144.59 43.1 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 123.636 0.636 . . . . 0.0 113.646 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 21.5 p -58.86 129.99 44.82 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 124.0 0.92 . . . . 0.0 111.568 175.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.9 m -132.63 -10.14 3.16 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 114.685 1.365 . . . . 0.0 114.685 -169.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 55.91 33.77 60.71 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 125.091 1.329 . . . . 0.0 116.353 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -56.35 145.47 27.03 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.445 1.123 . . . . 0.0 113.147 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -151.67 139.62 20.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.836 1.254 . . . . 0.0 112.146 -177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -76.7 159.41 30.22 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.78 0.832 . . . . 0.0 111.623 169.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -116.36 157.55 24.87 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.626 1.57 . . . . 0.0 111.699 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.48 133.69 46.02 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.35 0.66 . . . . 0.0 110.793 173.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.8 3.05 58.47 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 124.608 1.099 . . . . 0.0 114.849 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -66.7 129.41 39.77 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.786 1.293 . . . . 0.0 111.164 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -74.95 134.58 41.5 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-O 121.436 0.636 . . . . 0.0 110.778 170.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 30.9 m -145.89 179.43 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.501 1.921 . . . . 0.0 111.023 -169.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 87.5 mt -117.75 146.59 43.67 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 125.336 1.454 . . . . 0.0 108.909 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -155.08 149.6 26.3 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.296 -0.877 . . . . 0.0 112.979 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -80.61 110.13 15.79 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.252 1.421 . . . . 0.0 110.348 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 11.4 t-105 -85.71 -160.06 0.5 Allowed 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.111 0.965 . . . . 0.0 112.063 177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 m -56.4 -35.14 67.43 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.767 1.227 . . . . 0.0 112.458 171.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -85.75 153.42 22.31 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.808 1.243 . . . . 0.0 111.957 170.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 82.7 m -77.24 50.85 0.8 Allowed 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.289 1.436 . . . . 0.0 112.74 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 41.6 mmt180 -134.41 163.22 30.17 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 127.526 2.331 . . . . 0.0 110.607 -176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -121.96 70.7 0.97 Allowed 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.395 1.478 . . . . 0.0 110.493 -174.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -67.54 157.39 86.08 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.429 1.092 . . . . 0.0 112.442 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -67.22 138.58 47.48 Favored 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.808 2.338 . . . . 0.0 111.965 172.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.17 179.57 7.8 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.175 1.79 . . . . 0.0 110.619 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 6.7 ptpp? -142.55 152.76 42.93 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.633 1.173 . . . . 0.0 111.987 169.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 91.0 mt -83.33 113.2 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 124.259 1.024 . . . . 0.0 110.108 -179.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -80.65 -33.44 35.64 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.668 1.187 . . . . 0.0 112.787 177.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.66 160.76 38.33 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.461 1.104 . . . . 0.0 112.546 177.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 64.0 mt -127.47 138.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 126.111 1.764 . . . . 0.0 109.118 -174.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.9 t-20 -128.77 126.19 39.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.456 1.102 . . . . 0.0 110.368 177.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 2.9 mppt? -62.24 -17.61 58.82 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.657 1.583 . . . . 0.0 113.613 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -64.56 -21.41 66.69 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.346 1.058 . . . . 0.0 113.628 169.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 124.54 -12.15 7.91 Favored Glycine 0 CA--C 1.537 1.426 0 C-N-CA 125.591 1.567 . . . . 0.0 114.957 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -85.56 157.71 20.32 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.232 1.413 . . . . 0.0 111.765 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -138.51 130.21 27.84 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.515 1.526 . . . . 0.0 110.175 178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 26.5 m -86.93 135.76 33.19 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.722 0.809 . . . . 0.0 108.926 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.4 m -138.84 148.5 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.591 1.156 . . . . 0.0 112.111 -171.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -119.7 123.82 44.72 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 125.275 1.43 . . . . 0.0 109.593 173.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -87.42 164.77 16.02 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.213 1.005 . . . . 0.0 111.548 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 27.3 p90 -52.7 -28.45 21.91 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -67.98 -21.95 65.04 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.263 1.425 . . . . 0.0 113.733 175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.44 -20.15 32.9 Favored Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.206 1.86 . . . . 0.0 114.068 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.7 p -57.48 145.95 7.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.856 1.662 . . . . 0.0 112.749 176.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 23.4 mt -129.61 125.05 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 125.241 1.416 . . . . 0.0 109.892 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 -142.62 -172.68 3.68 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 127.153 2.181 . . . . 0.0 109.636 172.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 32.1 p -130.3 154.5 47.56 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.381 -0.824 . . . . 0.0 112.261 172.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.7 mt -143.4 157.95 44.04 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.025 1.73 . . . . 0.0 111.088 -172.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -73.05 156.64 38.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.197 0.999 . . . . 0.0 110.447 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.0 ptt180 -54.54 -25.4 25.63 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 169.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 54.9 ttm -60.61 -19.56 58.19 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.355 1.862 . . . . 0.0 114.139 173.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -120.26 12.23 11.72 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.137 1.375 . . . . 0.0 113.394 -173.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 61.2 mt -128.38 142.28 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.01 1.724 . . . . 0.0 108.854 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -135.69 145.76 47.06 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.053 1.741 . . . . 0.0 110.254 -177.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.52 139.27 58.46 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.028 170.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 51.3 ttm -64.3 125.56 88.59 Favored Pre-proline 0 CA--C 1.549 0.907 0 CA-C-O 118.834 -0.603 . . . . 0.0 109.893 174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.57 160.61 43.88 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 122.828 2.352 . . . . 0.0 113.14 -169.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -65.52 -10.6 36.14 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.288 1.435 . . . . 0.0 114.434 -179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -106.75 -10.2 16.18 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.478 1.511 . . . . 0.0 113.593 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -73.3 141.17 47.15 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.013 -1.054 . . . . 0.0 111.754 172.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -76.95 153.56 34.49 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.138 0.975 . . . . 0.0 111.82 174.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.5 -24.8 1.68 Allowed Glycine 0 CA--C 1.535 1.316 0 C-N-CA 125.228 1.394 . . . . 0.0 113.952 176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -148.63 161.58 41.43 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.724 2.01 . . . . 0.0 109.915 179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -132.74 168.76 17.75 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.368 1.467 . . . . 0.0 112.8 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -141.59 13.81 2.14 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.268 1.427 . . . . 0.0 114.148 -168.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.4 pp -49.26 121.03 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.818 1.247 . . . . 0.0 113.055 178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 46.11 43.87 11.3 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 126.274 1.83 . . . . 0.0 114.731 -176.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.4 pp -47.13 143.81 2.97 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.701 1.6 . . . . 0.0 114.673 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.8 p -72.01 144.78 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.669 1.188 . . . . 0.0 112.022 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 64.5 pttt -151.45 167.93 26.45 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.891 1.676 . . . . 0.0 112.032 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.319 0 C-N-CA 126.201 1.8 . . . . 0.0 111.882 179.568 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.396 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 60.1 p -154.66 172.03 18.55 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.299 1.44 . . . . 0.0 112.365 -178.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 54.7 m -154.85 153.0 30.46 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.474 1.51 . . . . 0.0 111.214 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.92 59.56 0.03 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 123.916 0.769 . . . . 0.0 112.98 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 m -48.43 135.62 13.77 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.86 1.664 . . . . 0.0 114.22 -173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.1 t -63.73 146.21 54.28 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.245 1.018 . . . . 0.0 112.363 177.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.59 52.83 0.02 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 124.121 0.867 . . . . 0.0 113.24 -175.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -51.46 -44.87 62.54 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.972 1.309 . . . . 0.0 114.209 -171.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -153.89 148.97 26.83 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.047 1.739 . . . . 0.0 110.879 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 8.1 m-30 -80.97 155.87 26.22 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.655 0.782 . . . . 0.0 110.564 168.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.04 152.12 34.35 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.39 1.476 . . . . 0.0 111.706 177.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.38 141.29 57.72 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.012 0.525 . . . . 0.0 111.326 174.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.32 -9.36 73.39 Favored Glycine 0 CA--C 1.538 1.492 0 C-N-CA 125.17 1.367 . . . . 0.0 114.626 -174.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -81.38 145.06 31.01 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 119.16 1.48 . . . . 0.0 111.974 176.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -92.87 143.78 25.92 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.53 1.132 . . . . 0.0 112.05 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -146.93 170.55 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 C-N-CA 126.438 1.895 . . . . 0.0 111.008 -170.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 45.9 mt -109.72 133.39 53.19 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.6 1.16 . . . . 0.0 108.889 169.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.21 153.28 38.54 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 78.1 ttt-85 -74.66 150.38 39.58 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.138 1.375 . . . . 0.0 111.573 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.9 t-105 -140.23 -44.13 0.42 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.2 m -139.63 -21.77 0.9 Allowed 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 -171.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -142.76 -178.61 5.88 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.679 1.592 . . . . 0.0 110.721 -171.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.4 m -65.47 -14.07 60.18 Favored 'General case' 0 CA--C 1.549 0.942 0 O-C-N 120.816 -1.178 . . . . 0.0 113.768 170.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -73.89 133.58 43.13 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.8 1.24 . . . . 0.0 110.571 173.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -89.06 152.3 21.75 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.577 0.751 . . . . 0.0 109.255 168.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 56.8 m-85 -134.47 155.84 79.34 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.118 1.367 . . . . 0.0 110.859 -176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -68.52 137.17 38.58 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.679 2.253 . . . . 0.0 112.732 -176.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.41 174.6 12.28 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.818 1.647 . . . . 0.0 111.482 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -136.39 138.3 41.42 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.898 1.679 . . . . 0.0 110.052 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.11 130.8 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.343 0.657 . . . . 0.0 109.586 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -107.84 -31.51 7.99 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.764 1.226 . . . . 0.0 112.53 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.14 165.5 33.61 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.092 1.757 . . . . 0.0 110.749 174.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 12.8 mt -135.21 148.12 28.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.849 1.26 . . . . 0.0 110.521 -169.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -127.63 144.46 51.07 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.116 1.366 . . . . 0.0 110.719 172.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.2 mtpp -68.15 -27.87 66.8 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -170.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -142.91 35.43 1.39 Allowed 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.51 -43.84 0.07 OUTLIER Glycine 0 N--CA 1.476 1.362 0 N-CA-C 118.458 2.143 . . . . 0.0 118.458 169.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 30.0 p -137.82 166.6 23.62 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -167.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -132.64 134.78 45.3 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.78 1.632 . . . . 0.0 108.895 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.1 m -81.69 130.45 35.06 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.954 0.902 . . . . 0.0 108.612 172.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.2 m -141.62 142.43 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 124.434 1.094 . . . . 0.0 112.027 -169.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -110.78 129.51 55.83 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.679 1.592 . . . . 0.0 109.473 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.5 m-85 -94.22 168.01 11.19 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.951 0.9 . . . . 0.0 111.756 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.82 -27.05 27.21 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.069 1.348 . . . . 0.0 113.841 175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.01 -17.99 37.33 Favored Glycine 0 CA--C 1.537 1.455 0 C-N-CA 126.123 1.821 . . . . 0.0 114.193 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.8 p -63.11 147.0 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 125.789 1.636 . . . . 0.0 112.439 175.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 mp -126.53 129.53 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.691 1.596 . . . . 0.0 110.136 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -143.09 -166.72 2.37 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 127.142 2.177 . . . . 0.0 109.351 173.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.13 155.45 46.96 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 121.228 -0.92 . . . . 0.0 111.564 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 97.4 mt -140.42 152.79 45.98 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.242 1.417 . . . . 0.0 110.753 -174.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm -66.27 153.38 42.73 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.303 1.041 . . . . 0.0 110.957 171.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.33 18.56 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 169.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.0 tpt -65.33 -13.98 59.75 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.44 1.896 . . . . 0.0 113.804 176.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -120.79 13.35 11.51 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.492 1.517 . . . . 0.0 113.603 -170.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 45.9 mt -134.3 144.41 35.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 126.035 1.734 . . . . 0.0 109.455 -178.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -136.61 149.32 47.95 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 127.063 2.145 . . . . 0.0 110.271 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.5 157.24 30.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.58 0.752 . . . . 0.0 111.229 172.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 4.1 tpt -63.87 120.51 64.25 Favored Pre-proline 0 CA--C 1.55 0.962 0 O-C-N 121.964 -0.46 . . . . 0.0 110.306 177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.86 164.44 34.61 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 123.298 2.665 . . . . 0.0 114.127 -168.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.25 -20.81 63.27 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.426 1.091 . . . . 0.0 113.248 172.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.88 -21.66 62.38 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.361 1.464 . . . . 0.0 113.767 174.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -69.22 158.81 34.21 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.786 0.834 . . . . 0.0 112.522 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 157.23 15.81 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.281 1.032 . . . . 0.0 112.598 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 69.18 -148.85 48.19 Favored Glycine 0 CA--C 1.536 1.39 0 C-N-CA 123.241 0.448 . . . . 0.0 112.808 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 65.58 15.13 9.89 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.66 1.584 . . . . 0.0 113.932 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -80.41 62.94 4.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 126.201 1.8 . . . . 0.0 112.181 179.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 1.1 p90 -69.95 31.77 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.505 1.522 . . . . 0.0 114.958 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.8 pt -63.44 157.58 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 O-C-N 120.35 -1.469 . . . . 0.0 111.608 172.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.01 34.69 4.35 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 126.464 1.906 . . . . 0.0 114.903 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.6 0.75 2.87 Favored 'General case' 0 CA--C 1.55 0.97 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 -178.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.2 p -145.19 154.22 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.817 0 C-N-CA 126.075 1.75 . . . . 0.0 110.688 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -54.2 125.0 17.48 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 125.496 1.518 . . . . 0.0 112.245 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.304 0 C-N-CA 125.614 1.566 . . . . 0.0 112.99 174.806 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.369 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 39.9 m -63.2 157.33 22.82 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.693 1.197 . . . . 0.0 113.623 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -106.21 163.61 12.67 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.367 1.467 . . . . 0.0 111.695 175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 174.69 -53.84 0.13 Allowed Glycine 0 N--CA 1.472 1.035 0 C-N-CA 123.719 0.676 . . . . 0.0 112.993 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 67.0 m -82.71 60.9 5.52 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.666 1.186 . . . . 0.0 109.107 168.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.7 m -136.57 130.28 32.13 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.423 1.489 . . . . 0.0 110.958 -167.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.03 -8.0 68.62 Favored Glycine 0 CA--C 1.54 1.613 0 C-N-CA 124.576 1.084 . . . . 0.0 114.484 -172.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 32.8 p90 -153.87 161.75 41.78 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.194 1.798 . . . . 0.0 111.271 176.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -149.45 143.84 25.95 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.613 1.565 . . . . 0.0 110.557 172.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 16.7 m-30 -75.17 156.41 35.91 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.346 0.658 . . . . 0.0 111.414 169.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.27 164.26 30.7 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.925 1.69 . . . . 0.0 111.779 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.89 132.32 53.47 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-O 120.942 0.401 . . . . 0.0 110.421 169.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.78 -4.52 85.71 Favored Glycine 0 CA--C 1.538 1.488 0 C-N-CA 125.087 1.327 . . . . 0.0 115.054 -175.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -65.88 132.68 49.23 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 119.519 1.66 . . . . 0.0 111.776 177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 25.8 mp0 -77.81 133.82 38.13 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.621 0.769 . . . . 0.0 110.792 171.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.6 m -143.34 167.05 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 125.715 1.606 . . . . 0.0 111.171 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -95.17 140.7 29.73 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 169.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.26 160.08 44.01 Favored 'General case' 0 CA--C 1.54 0.563 0 O-C-N 121.717 -0.614 . . . . 0.0 112.225 177.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -97.52 145.52 26.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.827 1.251 . . . . 0.0 111.258 -175.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.89 -48.02 0.5 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 10.0 m -140.27 -14.55 1.0 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -169.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -140.25 179.14 6.81 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 125.209 1.404 . . . . 0.0 111.6 -169.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 72.6 m -73.13 -20.49 60.91 Favored 'General case' 0 CA--C 1.546 0.826 0 O-C-N 121.762 -0.587 . . . . 0.0 111.59 167.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 38.4 mmt180 -71.81 131.38 42.98 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.581 1.552 . . . . 0.0 110.357 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -80.76 161.91 24.33 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 122.895 0.478 . . . . 0.0 110.145 168.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -136.48 154.56 76.94 Favored Pre-proline 0 CA--C 1.542 0.661 0 C-N-CA 125.51 1.524 . . . . 0.0 110.529 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -70.49 139.44 37.72 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.364 2.043 . . . . 0.0 112.101 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.5 173.5 12.24 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.127 1.771 . . . . 0.0 110.736 177.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -125.06 140.42 52.92 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.485 1.514 . . . . 0.0 109.533 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 66.4 mt -73.53 121.34 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.323 0.649 . . . . 0.0 109.736 175.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -90.36 -33.97 15.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.284 1.034 . . . . 0.0 112.379 175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.6 159.58 35.61 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.549 1.14 . . . . 0.0 112.702 176.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 62.6 mt -131.58 156.28 42.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.797 2.039 . . . . 0.0 109.187 -172.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 57.42 43.35 23.26 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.502 1.521 . . . . 0.0 113.536 177.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -67.24 -175.86 0.5 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.617 1.167 . . . . 0.0 110.902 168.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -54.78 -28.59 50.08 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.373 1.069 . . . . 0.0 113.838 178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -173.24 24.4 0.07 OUTLIER Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.299 0.952 . . . . 0.0 115.14 171.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 41.4 p -148.91 179.84 7.56 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.615 1.566 . . . . 0.0 112.775 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.44 126.5 48.05 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.974 2.11 . . . . 0.0 108.006 169.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 7.8 m -77.37 135.9 38.39 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.0 m -143.02 151.53 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 124.564 1.146 . . . . 0.0 112.275 -171.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -122.31 112.86 18.64 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.949 1.7 . . . . 0.0 109.445 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -76.17 164.17 26.35 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.636 0.774 . . . . 0.0 111.614 176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -58.02 -21.79 46.82 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 -177.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -69.96 -16.03 63.13 Favored 'General case' 0 CA--C 1.548 0.865 0 C-N-CA 124.709 1.203 . . . . 0.0 114.032 172.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.52 -11.46 64.97 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 125.805 1.669 . . . . 0.0 114.542 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.5 p -63.51 148.19 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 125.4 1.48 . . . . 0.0 112.095 174.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 45.6 mt -130.23 126.14 61.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 125.214 1.405 . . . . 0.0 110.099 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.5 mmm180 -144.6 -167.42 2.64 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 127.481 2.312 . . . . 0.0 109.249 172.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 30.0 p -131.34 153.98 49.05 Favored 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.26 -0.9 . . . . 0.0 112.067 170.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 82.1 mt -138.69 156.83 47.08 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.214 1.406 . . . . 0.0 111.816 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -77.99 158.39 29.3 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.7 1.2 . . . . 0.0 110.569 169.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -57.74 -26.45 61.84 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.2 mpp? -67.01 -11.63 57.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.146 1.378 . . . . 0.0 113.91 174.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 42.4 m80 -115.51 14.82 16.68 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.767 1.627 . . . . 0.0 112.817 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 76.4 mt -134.25 145.79 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 126.47 1.908 . . . . 0.0 109.446 -176.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -138.86 150.03 45.54 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 126.526 1.931 . . . . 0.0 111.36 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.42 144.52 48.12 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.006 174.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 48.2 tpp -62.78 125.57 86.71 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 124.134 0.974 . . . . 0.0 110.785 176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -73.67 159.67 45.31 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 123.041 2.494 . . . . 0.0 112.572 -175.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 35.0 mp0 -62.56 -22.17 66.14 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.784 1.234 . . . . 0.0 113.377 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -69.64 -25.25 63.83 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.945 1.298 . . . . 0.0 113.704 175.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -74.79 138.44 42.61 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.856 . . . . 0.0 112.572 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -71.1 162.05 30.09 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.63 1.172 . . . . 0.0 112.66 170.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 171.05 179.69 42.37 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.224 0.916 . . . . 0.0 114.145 176.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.28 157.64 22.28 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.088 1.355 . . . . 0.0 111.86 171.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -131.03 146.72 52.48 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.959 1.304 . . . . 0.0 111.057 173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -78.13 36.06 0.23 Allowed 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.466 1.907 . . . . 0.0 115.071 -169.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 67.9 mt -54.87 -33.14 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 125.894 1.678 . . . . 0.0 112.151 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -71.48 -12.38 61.36 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.172 1.545 . . . . 0.0 115.172 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 54.0 mt -103.37 91.33 4.02 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.904 1.282 . . . . 0.0 110.888 -173.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 38.6 t -136.51 143.82 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 125.765 1.626 . . . . 0.0 109.975 -175.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.3 ttpm? -59.71 150.56 27.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.252 1.421 . . . . 0.0 112.701 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.197 0 C-N-CA 125.061 1.344 . . . . 0.0 112.664 169.089 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.4 0 N-CA-C 111.624 -0.59 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 t 48.34 39.98 13.54 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.254 1.822 . . . . 0.0 114.858 177.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.5 t -153.56 153.38 32.26 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 124.689 1.196 . . . . 0.0 112.349 -177.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 172.05 154.55 10.15 Favored Glycine 0 CA--C 1.537 1.44 0 C-N-CA 125.814 1.673 . . . . 0.0 112.619 174.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 70.2 m -149.27 149.02 30.26 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.185 1.394 . . . . 0.0 111.98 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.6 t -161.35 162.27 30.74 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.366 1.467 . . . . 0.0 111.414 174.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.36 28.16 72.67 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 116.018 1.167 . . . . 0.0 116.018 170.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -64.41 156.12 30.35 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 118.284 1.042 . . . . 0.0 113.238 178.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -148.53 141.98 25.31 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.865 1.666 . . . . 0.0 110.513 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -126.14 137.56 53.59 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.146 1.779 . . . . 0.0 109.268 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -143.46 146.14 33.18 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 111.571 -170.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.49 131.44 50.95 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 122.021 -0.425 . . . . 0.0 111.154 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.78 -13.5 52.82 Favored Glycine 0 CA--C 1.539 1.533 0 C-N-CA 125.531 1.538 . . . . 0.0 115.371 -177.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -71.45 149.46 45.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.356 1.578 . . . . 0.0 111.488 174.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -90.21 143.94 26.31 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.2 1.4 . . . . 0.0 112.127 -178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -145.72 164.62 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.599 1.96 . . . . 0.0 111.142 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 44.4 mt -108.71 125.25 51.71 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.091 1.756 . . . . 0.0 109.208 176.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.37 152.72 41.93 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -169.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 37.8 ttt180 -92.33 72.25 5.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.75 1.62 . . . . 0.0 112.508 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.424 ' CE3' ' CE1' ' A' ' 120' ' ' PHE . 50.8 t-105 -62.33 -37.13 84.45 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -176.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -155.25 -29.17 0.1 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.655 0.984 . . . . 0.0 113.655 -175.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -136.46 163.04 31.41 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.103 1.361 . . . . 0.0 111.792 -174.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 70.9 m -59.53 -20.34 54.77 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 124.892 1.277 . . . . 0.0 114.418 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.67 96.44 2.49 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.308 1.043 . . . . 0.0 108.918 168.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -55.49 143.21 30.13 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.386 0.675 . . . . 0.0 111.419 175.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -121.89 150.87 56.88 Favored Pre-proline 0 CA--C 1.54 0.576 0 C-N-CA 124.955 1.302 . . . . 0.0 111.522 -174.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -72.68 137.77 28.0 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.667 2.245 . . . . 0.0 112.193 -177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.99 167.18 24.66 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.008 1.723 . . . . 0.0 110.954 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -113.01 142.29 45.87 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 125.151 1.38 . . . . 0.0 109.996 169.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 58.8 mt -72.83 120.61 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.91 0.884 . . . . 0.0 109.383 175.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -92.79 -31.47 15.02 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.124 0.969 . . . . 0.0 112.561 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.03 158.68 36.95 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.357 1.063 . . . . 0.0 112.446 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.7 mt -134.5 143.82 36.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 C-N-CA 126.564 1.946 . . . . 0.0 108.408 -177.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -134.06 140.61 46.76 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.611 1.164 . . . . 0.0 110.811 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -68.7 -29.5 67.95 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.538 1.135 . . . . 0.0 113.249 -175.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -140.63 24.33 2.24 Favored 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.636 1.574 . . . . 0.0 112.313 -172.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.53 -111.7 1.21 Allowed Glycine 0 CA--C 1.532 1.135 0 C-N-CA 124.776 1.179 . . . . 0.0 113.452 -172.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 10.7 t -143.64 -177.63 5.5 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.027 1.331 . . . . 0.0 112.56 -172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -122.7 106.47 10.97 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 126.4 1.88 . . . . 0.0 109.896 -177.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 10.2 m -72.4 134.8 45.6 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.52 0.728 . . . . 0.0 109.506 172.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 m -143.31 147.26 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.027 1.331 . . . . 0.0 111.751 -171.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -123.22 118.27 27.23 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.547 1.539 . . . . 0.0 109.954 178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.424 ' CE1' ' CE3' ' A' ' 97' ' ' TRP . 33.2 m-85 -85.91 172.05 11.01 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.709 1.203 . . . . 0.0 111.872 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -57.87 -21.75 44.55 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -70.78 -14.03 62.27 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.923 1.289 . . . . 0.0 114.12 171.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 90.61 -16.31 58.29 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 125.641 1.591 . . . . 0.0 114.883 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.8 p -64.47 148.56 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 125.689 1.596 . . . . 0.0 112.326 174.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.36 124.22 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.522 1.529 . . . . 0.0 110.368 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 57.8 mmm-85 -142.57 -162.46 1.42 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 127.295 2.238 . . . . 0.0 108.888 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.6 p -135.52 155.29 50.74 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.134 -0.979 . . . . 0.0 112.492 176.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 51.6 mt -142.25 149.97 40.29 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.314 1.446 . . . . 0.0 111.192 -179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 59.1 mtmt -68.71 159.54 32.01 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.631 1.172 . . . . 0.0 111.329 174.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -58.27 -20.47 42.75 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 171.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 89.9 mmm -67.89 -12.91 61.62 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.915 1.286 . . . . 0.0 113.661 171.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.6 m80 -130.8 13.51 5.33 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.355 1.862 . . . . 0.0 112.871 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 26.3 mt -138.83 136.22 43.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.791 1.636 . . . . 0.0 109.422 174.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -140.53 157.61 45.24 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 126.063 1.745 . . . . 0.0 111.287 176.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.55 174.52 5.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.211 0.604 . . . . 0.0 111.0 168.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -56.59 141.96 71.51 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.201 -0.937 . . . . 0.0 111.318 169.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -67.25 135.18 36.12 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.836 2.357 . . . . 0.0 110.168 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 46.91 30.04 1.15 Allowed 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 125.257 1.423 . . . . 0.0 114.123 -171.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 t0 47.49 49.53 15.86 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.314 1.846 . . . . 0.0 113.953 -171.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -55.92 -24.6 38.76 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 116.759 2.133 . . . . 0.0 116.759 -174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -68.19 159.62 30.76 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.826 1.194 . . . . 0.0 112.795 175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 88.01 55.79 2.19 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 123.355 0.502 . . . . 0.0 112.545 -175.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.9 pp0? -59.61 1.21 0.1 Allowed 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 -175.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -61.9 -46.89 87.38 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.872 1.269 . . . . 0.0 112.937 170.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . 0.255 11.5 p-90 44.86 7.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 119.532 3.16 . . . . 0.0 119.532 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 50.1 mm -58.92 -30.92 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 CA-C-N 120.977 1.717 . . . . 0.0 112.992 -177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -144.73 144.05 31.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.162 . . . . 0.0 111.688 172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 1.9 pp -156.99 168.49 27.32 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.509 1.924 . . . . 0.0 111.325 176.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 15.2 m -80.6 130.24 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 123.7 0.8 . . . . 0.0 111.406 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -156.9 150.97 24.93 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 125.449 1.5 . . . . 0.0 110.973 178.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.317 0 C-N-CA 125.391 1.477 . . . . 0.0 113.272 175.409 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.4 m -160.47 158.72 29.83 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.613 1.565 . . . . 0.0 111.579 174.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.7 t -155.26 167.89 28.88 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.426 1.49 . . . . 0.0 111.233 174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -171.14 29.86 0.12 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 124.184 0.897 . . . . 0.0 114.815 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 61.1 m -139.59 144.69 37.87 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.731 1.212 . . . . 0.0 112.408 -173.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.4 p -160.66 166.98 27.9 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.168 1.787 . . . . 0.0 111.336 177.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.54 23.7 0.43 Allowed Glycine 0 CA--C 1.534 1.256 0 N-CA-C 115.093 0.797 . . . . 0.0 115.093 -178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -74.39 148.05 41.57 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.357 1.063 . . . . 0.0 112.387 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -145.09 126.38 14.83 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.697 1.599 . . . . 0.0 109.366 169.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -127.8 150.68 49.71 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.626 1.57 . . . . 0.0 110.446 -176.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.8 142.71 30.19 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.928 1.291 . . . . 0.0 112.566 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.89 135.96 57.78 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 121.831 -0.543 . . . . 0.0 110.834 174.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.04 -12.88 69.01 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.105 1.336 . . . . 0.0 114.631 -174.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -69.26 162.17 27.71 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 119.4 1.6 . . . . 0.0 112.375 173.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -101.41 142.79 32.28 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.833 0.853 . . . . 0.0 112.175 170.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.7 m -144.95 162.98 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.838 2.055 . . . . 0.0 110.806 -174.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.8 137.43 32.42 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 168.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.55 152.06 33.58 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.522 0.601 . . . . 0.0 112.379 175.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -84.95 150.01 25.23 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.846 1.258 . . . . 0.0 111.519 -177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 22.7 t-105 -151.42 -39.77 0.12 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -132.73 -32.68 1.25 Allowed 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -169.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -144.62 178.83 7.69 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.146 1.778 . . . . 0.0 110.528 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 79.2 m -61.17 -22.45 64.73 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 114.22 1.192 . . . . 0.0 114.22 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.93 122.78 22.22 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.647 1.179 . . . . 0.0 111.096 171.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -70.64 155.69 40.42 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.009 0.924 . . . . 0.0 110.745 169.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -129.29 157.34 76.47 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.435 1.494 . . . . 0.0 110.579 178.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -67.44 135.08 35.27 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.135 1.89 . . . . 0.0 111.564 175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.16 174.14 11.14 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.722 2.009 . . . . 0.0 110.145 177.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.4 ttpt -127.34 134.99 49.92 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.528 1.531 . . . . 0.0 110.098 -178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 21.5 mt -72.31 121.95 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 123.02 0.528 . . . . 0.0 110.007 176.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -87.47 -37.45 16.95 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.526 1.131 . . . . 0.0 111.858 170.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.1 162.11 38.01 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.571 1.148 . . . . 0.0 113.002 177.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 71.8 mt -127.65 131.24 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.885 1.674 . . . . 0.0 109.242 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 53.35 11.32 0.25 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.233 2.213 . . . . 0.0 116.581 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -56.75 -32.08 65.22 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.566 1.546 . . . . 0.0 113.585 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -142.09 49.77 1.54 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.427 1.491 . . . . 0.0 110.219 173.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 60.46 18.24 50.16 Favored Glycine 0 CA--C 1.54 1.619 0 C-N-CA 125.001 1.286 . . . . 0.0 114.859 -176.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.1 p -149.25 170.1 19.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.458 2.303 . . . . 0.0 110.617 -169.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -98.92 112.32 24.46 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 124.509 1.124 . . . . 0.0 109.575 175.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 6.9 m -73.64 131.34 41.56 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 170.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.3 m -140.92 149.76 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.467 1.107 . . . . 0.0 112.018 -170.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 47.7 tt0 -120.84 127.92 52.35 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.034 1.733 . . . . 0.0 109.368 176.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -93.46 168.18 11.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.659 0.784 . . . . 0.0 111.488 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -59.77 -20.43 56.6 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -176.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -73.22 -14.01 61.26 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.551 1.14 . . . . 0.0 113.994 171.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.94 -12.08 67.36 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.935 1.731 . . . . 0.0 114.53 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -63.9 149.18 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 125.643 1.577 . . . . 0.0 112.301 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 42.8 mt -131.6 130.27 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 125.308 1.443 . . . . 0.0 110.263 -176.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -145.81 -169.8 3.32 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.429 2.292 . . . . 0.0 109.661 173.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.9 p -129.59 151.33 50.32 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.403 1.081 . . . . 0.0 111.816 171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 75.3 mt -139.2 159.39 42.27 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.231 1.412 . . . . 0.0 112.21 -174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -82.98 155.62 23.89 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.288 1.435 . . . . 0.0 110.979 171.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -53.98 -25.72 22.27 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 171.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.3 ttt -61.84 -20.56 63.8 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.788 1.635 . . . . 0.0 113.928 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -120.89 17.63 11.8 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.274 1.43 . . . . 0.0 112.913 -170.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 64.1 mt -136.28 145.53 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.053 2.141 . . . . 0.0 108.929 -175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -133.42 144.84 49.78 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.144 1.378 . . . . 0.0 110.781 171.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.07 152.66 42.92 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 167.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.5 mmt -61.87 148.18 88.24 Favored Pre-proline 0 CA--C 1.547 0.856 0 O-C-N 121.499 -0.751 . . . . 0.0 112.397 176.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -71.38 169.49 20.69 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.784 2.99 . . . . 0.0 112.847 -178.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -59.34 -23.6 62.64 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.602 1.161 . . . . 0.0 113.929 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 28.2 m-20 -80.99 -14.26 58.11 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.007 1.323 . . . . 0.0 114.164 178.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.63 152.69 41.62 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -155.67 150.58 26.45 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 126.449 1.9 . . . . 0.0 110.342 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -178.35 -44.99 0.07 OUTLIER Glycine 0 CA--C 1.534 1.236 0 N-CA-C 114.482 0.553 . . . . 0.0 114.482 176.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -74.76 171.28 14.22 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 118.056 0.928 . . . . 0.0 111.323 169.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -136.09 -179.78 5.88 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.966 1.706 . . . . 0.0 110.501 172.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 51.0 p-90 -142.51 -12.14 0.8 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.835 1.654 . . . . 0.0 114.223 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.27 -22.57 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.45 1.1 . . . . 0.0 110.708 168.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -125.45 179.67 5.01 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 127.544 2.337 . . . . 0.0 110.175 172.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.9 mp 56.28 24.44 8.23 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 125.552 1.541 . . . . 0.0 113.43 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 32.7 t -63.29 123.16 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 125.375 1.47 . . . . 0.0 111.238 -174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' H ' ' HD2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -69.94 162.53 27.88 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.185 1.394 . . . . 0.0 113.478 178.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.305 0 C-N-CA 125.414 1.485 . . . . 0.0 113.194 174.428 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.332 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 48.9 m -142.98 165.29 27.75 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 125.367 1.467 . . . . 0.0 111.92 -175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 39.4 m -158.39 164.36 36.36 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 125.65 1.58 . . . . 0.0 111.686 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -177.12 -175.75 44.67 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.782 1.182 . . . . 0.0 113.313 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.9 t -64.12 138.39 58.43 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.937 0.895 . . . . 0.0 112.195 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 74.5 m -149.85 170.06 19.65 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.412 1.885 . . . . 0.0 111.429 -174.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 94.59 34.37 6.34 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 123.714 0.673 . . . . 0.0 114.573 172.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -143.3 161.58 37.93 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.232 1.413 . . . . 0.0 112.38 -178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -159.06 155.01 26.61 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.799 1.64 . . . . 0.0 111.695 -178.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.5 m-30 -76.08 149.83 37.39 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.237 1.015 . . . . 0.0 112.75 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -143.44 165.15 28.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.313 1.845 . . . . 0.0 111.477 174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.61 130.06 45.02 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.859 0.464 . . . . 0.0 110.668 170.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 85.03 -2.48 88.27 Favored Glycine 0 CA--C 1.537 1.425 0 C-N-CA 124.907 1.241 . . . . 0.0 115.13 -176.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -68.35 146.04 53.62 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.758 1.779 . . . . 0.0 112.256 176.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -95.37 131.12 41.83 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.044 1.338 . . . . 0.0 110.635 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.3 m -144.64 177.67 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 126.138 1.775 . . . . 0.0 111.666 -168.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 72.6 mt -108.3 140.33 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.449 1.1 . . . . 0.0 108.434 168.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -139.93 137.39 34.74 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 123.555 0.742 . . . . 0.0 111.798 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 38.5 ttm105 -77.67 129.12 35.16 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.903 1.281 . . . . 0.0 109.767 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.4 t-105 -93.36 -160.35 0.75 Allowed 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.551 0.741 . . . . 0.0 111.928 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.0 t -61.99 -28.5 69.61 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 121.167 -0.958 . . . . 0.0 112.222 169.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 31.2 m-20 -76.87 155.45 32.89 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.043 1.337 . . . . 0.0 112.174 169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.2 m -74.04 34.78 0.09 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.887 1.675 . . . . 0.0 114.262 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.4 mmt180 -138.46 145.47 40.9 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.58 1.952 . . . . 0.0 111.488 -172.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -85.41 148.51 25.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.499 1.119 . . . . 0.0 111.432 169.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -142.38 155.45 64.34 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 125.995 1.718 . . . . 0.0 111.185 -177.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.62 134.44 32.84 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.023 2.482 . . . . 0.0 111.739 176.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -149.88 172.51 15.06 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 125.227 1.411 . . . . 0.0 111.933 -177.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -134.1 130.86 38.02 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.537 1.535 . . . . 0.0 110.054 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.14 118.39 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.044 0.938 . . . . 0.0 110.536 -178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -91.5 -31.84 15.8 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.14 1.376 . . . . 0.0 112.474 175.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.65 160.67 38.27 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.716 1.206 . . . . 0.0 112.523 176.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 26.5 mt -133.49 133.64 57.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 C-N-CA 126.017 1.727 . . . . 0.0 108.905 -177.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -140.05 99.36 3.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.727 1.211 . . . . 0.0 110.753 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -51.72 148.18 5.84 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.945 1.298 . . . . 0.0 113.469 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 50.96 34.94 11.46 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 125.507 1.523 . . . . 0.0 113.798 -176.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.0 -93.49 0.1 OUTLIER Glycine 0 CA--C 1.532 1.12 0 O-C-N 121.09 -1.006 . . . . 0.0 114.636 -176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 34.2 p -148.38 175.36 11.18 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 125.003 1.321 . . . . 0.0 113.327 -168.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -131.94 139.84 48.82 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.877 1.671 . . . . 0.0 108.475 172.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 34.7 m -98.88 134.7 41.38 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.747 0.819 . . . . 0.0 108.982 178.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.2 m -136.91 140.73 42.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 124.34 1.056 . . . . 0.0 111.953 -173.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -99.65 128.46 45.75 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.857 1.263 . . . . 0.0 109.469 169.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -84.73 165.16 18.08 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.305 1.042 . . . . 0.0 112.444 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -53.31 -29.7 34.98 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.302 1.441 . . . . 0.0 114.266 173.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.94 -20.03 61.13 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 125.285 1.434 . . . . 0.0 113.797 176.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.49 -20.88 31.6 Favored Glycine 0 CA--C 1.536 1.388 0 C-N-CA 126.104 1.811 . . . . 0.0 114.278 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 150.14 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.56 1.544 . . . . 0.0 112.457 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.6 mt -132.61 126.39 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.283 1.433 . . . . 0.0 109.896 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 5.6 mmp_? -142.83 177.93 8.0 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.168 2.187 . . . . 0.0 110.036 173.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 29.1 p -121.95 154.05 37.68 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.134 0.974 . . . . 0.0 112.522 174.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 96.1 mt -143.41 157.22 44.64 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.621 1.569 . . . . 0.0 112.059 -169.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -72.2 158.59 35.6 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.087 1.355 . . . . 0.0 111.497 169.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 29.7 ttm180 -52.34 -39.14 60.3 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.293 1.437 . . . . 0.0 113.657 174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -69.16 2.61 2.68 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 126.69 1.996 . . . . 0.0 114.238 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -122.91 13.33 9.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.888 1.675 . . . . 0.0 112.654 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 25.8 mt -135.7 141.63 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 124.873 1.269 . . . . 0.0 110.025 -177.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -138.12 152.28 48.59 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.509 1.924 . . . . 0.0 110.662 -179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.27 135.95 55.16 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 122.812 0.445 . . . . 0.0 110.416 170.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 54.7 ttm -67.87 129.83 93.08 Favored Pre-proline 0 CA--C 1.548 0.882 0 CA-C-O 118.857 -0.592 . . . . 0.0 109.864 172.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.21 163.51 38.46 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.645 2.23 . . . . 0.0 113.351 -171.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -70.8 6.06 1.67 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 126.379 1.872 . . . . 0.0 114.094 177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -133.82 27.85 3.92 Favored 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 126.52 1.928 . . . . 0.0 112.374 -173.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -134.78 157.78 45.86 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.621 1.569 . . . . 0.0 112.105 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 2.2 tpmt? -66.57 104.97 1.38 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.073 1.349 . . . . 0.0 111.164 179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 168.3 -149.83 14.99 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 124.95 1.262 . . . . 0.0 112.528 -174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -126.42 158.26 36.44 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 124.945 1.298 . . . . 0.0 113.028 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -151.73 160.98 43.4 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.074 1.75 . . . . 0.0 110.533 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 76.7 m95 -138.26 23.92 2.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 124.463 1.105 . . . . 0.0 112.497 -171.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 30.3 mm -60.7 140.43 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 125.899 1.679 . . . . 0.0 110.582 179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 51.69 40.38 27.3 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 126.449 1.9 . . . . 0.0 114.709 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.53 2.84 0.82 Allowed 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.0 p -144.8 159.95 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.064 1.746 . . . . 0.0 111.145 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 59.5 tptt -137.31 142.36 41.87 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.232 1.813 . . . . 0.0 110.966 -176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.255 0 C-N-CA 125.796 1.639 . . . . 0.0 113.59 178.41 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.467 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.7 t -152.09 148.55 27.8 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.816 1.247 . . . . 0.0 111.607 177.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 28.6 m -80.61 42.6 0.62 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 126.268 1.827 . . . . 0.0 113.614 -176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -54.64 138.78 40.57 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.702 1.144 . . . . 0.0 113.798 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 43.9 p -74.71 154.4 38.44 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.585 1.154 . . . . 0.0 113.71 -176.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.4 t -75.09 148.45 39.72 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.115 0.966 . . . . 0.0 111.742 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 136.76 -26.08 3.04 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.322 1.439 . . . . 0.0 114.006 175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -84.46 143.93 29.07 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.842 1.257 . . . . 0.0 111.88 178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -150.17 147.62 27.96 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.687 1.595 . . . . 0.0 110.866 175.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 12.0 m-30 -72.42 156.29 39.22 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.39 0.676 . . . . 0.0 111.053 169.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.6 pttt -144.46 151.61 39.44 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.648 1.579 . . . . 0.0 111.458 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.74 139.69 58.29 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-O 121.042 0.449 . . . . 0.0 110.927 172.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.13 -18.34 54.24 Favored Glycine 0 CA--C 1.538 1.51 0 C-N-CA 125.287 1.423 . . . . 0.0 114.384 -174.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -72.02 147.28 47.0 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 118.591 1.196 . . . . 0.0 111.755 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -93.49 141.34 28.57 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 122.024 0.916 . . . . 0.0 112.148 170.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.0 m -145.53 166.87 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 126.826 2.05 . . . . 0.0 110.46 -174.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.5 mt -93.55 137.75 32.52 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.869 0.868 . . . . 0.0 109.037 171.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.31 153.37 38.56 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 121.527 -0.733 . . . . 0.0 112.488 177.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -82.77 148.03 28.07 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.795 1.238 . . . . 0.0 110.994 -178.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 39.4 t-105 -142.74 -42.51 0.31 Allowed 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.579 1.696 . . . . 0.0 115.579 -176.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 24.2 m -134.55 -29.11 1.22 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -169.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -149.85 -161.93 1.45 Allowed 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.348 1.459 . . . . 0.0 110.955 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 34.1 t -67.2 -32.24 73.18 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 18.0 mmm180 -63.78 153.27 37.02 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.78 1.232 . . . . 0.0 112.582 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -101.27 157.43 16.79 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.263 1.025 . . . . 0.0 110.387 168.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -138.26 153.0 72.65 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 125.644 1.577 . . . . 0.0 110.092 -179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -71.56 137.79 31.05 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.518 2.145 . . . . 0.0 112.499 -175.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -146.81 160.25 42.51 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 125.36 1.464 . . . . 0.0 111.842 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -108.14 127.79 54.12 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.553 1.941 . . . . 0.0 109.555 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.74 135.68 27.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.031 0.532 . . . . 0.0 109.686 175.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -115.78 -26.33 7.44 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.656 1.182 . . . . 0.0 113.008 176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.0 153.41 30.96 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.713 1.205 . . . . 0.0 111.377 175.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.5 mt -132.09 119.46 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 125.591 1.556 . . . . 0.0 109.064 -174.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 59.8 t30 51.51 18.51 0.69 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.731 2.012 . . . . 0.0 115.507 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.59 -35.58 72.64 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.731 1.612 . . . . 0.0 113.539 -172.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.1 mm-40 -131.76 21.87 4.62 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 126.296 1.838 . . . . 0.0 111.37 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.11 12.3 61.98 Favored Glycine 0 CA--C 1.538 1.518 0 C-N-CA 124.841 1.21 . . . . 0.0 114.221 -172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.1 m -147.85 159.62 43.65 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 126.106 1.763 . . . . 0.0 110.501 -171.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -96.65 138.86 33.58 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.961 1.305 . . . . 0.0 109.327 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 52.6 m -110.29 135.76 50.52 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.872 0.869 . . . . 0.0 109.354 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 14.8 m -141.82 151.26 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.19 0.996 . . . . 0.0 112.669 -169.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -121.11 111.36 17.34 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.829 1.652 . . . . 0.0 109.114 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -73.16 161.33 30.71 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.25 0.62 . . . . 0.0 111.806 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -55.15 -26.1 36.38 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -68.7 -21.88 64.39 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.135 1.374 . . . . 0.0 113.762 174.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 108.51 -12.95 36.08 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 126.183 1.849 . . . . 0.0 114.232 -179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 11.9 p -65.63 149.15 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 125.453 1.501 . . . . 0.0 112.407 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 66.6 mt -131.83 124.55 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 125.466 1.506 . . . . 0.0 109.952 -174.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.1 mmp_? -144.17 -174.93 4.42 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.171 2.188 . . . . 0.0 109.883 170.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 27.1 p -125.17 151.35 45.91 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.723 1.209 . . . . 0.0 111.732 174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 93.6 mt -143.18 152.54 41.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.815 1.646 . . . . 0.0 111.704 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -70.09 151.49 45.42 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.53 0.732 . . . . 0.0 109.338 167.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.1 tpt180 -57.88 -29.59 65.17 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.881 0.873 . . . . 0.0 113.121 176.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -59.31 -7.33 1.24 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.504 1.922 . . . . 0.0 114.488 173.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 39.3 m-70 -115.97 10.72 15.23 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.079 1.752 . . . . 0.0 112.626 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 33.4 mt -131.53 143.73 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.842 1.657 . . . . 0.0 109.625 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -139.16 152.6 47.55 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 127.155 2.182 . . . . 0.0 111.05 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.85 159.19 25.97 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.294 0.638 . . . . 0.0 111.712 170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 14.9 mmt -62.11 157.68 50.84 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 123.706 0.802 . . . . 0.0 112.32 170.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.11 9.21 1.8 Allowed 'Trans proline' 0 CA--C 1.545 1.05 0 C-N-CA 124.35 3.367 . . . . 0.0 116.302 -170.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 64.34 28.2 13.74 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 126.665 1.986 . . . . 0.0 112.577 -172.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -136.02 -28.61 1.05 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 126.081 1.753 . . . . 0.0 112.857 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.43 122.67 18.07 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.229 1.012 . . . . 0.0 111.208 169.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -153.62 153.45 32.34 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 125.596 1.558 . . . . 0.0 110.981 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -167.93 -151.06 6.84 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 124.306 0.955 . . . . 0.0 112.988 -177.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -71.18 105.84 3.56 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 122.075 -0.662 . . . . 0.0 109.246 169.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.3 p30 -148.62 -177.5 5.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.035 1.334 . . . . 0.0 113.029 -171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -130.96 38.08 3.71 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.544 1.538 . . . . 0.0 112.282 -169.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.2 pt -58.53 -20.16 15.66 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 176.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -146.96 137.1 23.43 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.028 1.731 . . . . 0.0 110.072 169.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -152.24 23.24 0.64 Allowed 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.293 1.437 . . . . 0.0 113.235 -173.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.97 155.23 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 125.58 1.552 . . . . 0.0 111.783 -169.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -55.52 141.3 37.55 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.855 1.662 . . . . 0.0 112.566 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.339 0 C-N-CA 126.394 1.877 . . . . 0.0 111.782 178.752 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.334 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 52.0 m -143.94 163.48 33.34 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.802 1.641 . . . . 0.0 111.619 -177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 40.6 m -59.44 148.7 31.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.56 1.144 . . . . 0.0 112.987 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.04 -12.64 84.47 Favored Glycine 0 CA--C 1.538 1.495 0 C-N-CA 124.197 0.904 . . . . 0.0 114.947 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 72.1 p -151.97 165.83 33.42 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.996 1.718 . . . . 0.0 112.032 178.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 65.4 p -70.59 167.22 18.98 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.905 1.282 . . . . 0.0 113.433 175.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -178.11 -138.93 3.24 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.098 1.332 . . . . 0.0 112.001 -175.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.24 159.68 5.79 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.827 0.851 . . . . 0.0 112.799 169.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -141.56 144.44 34.27 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.49 1.516 . . . . 0.0 110.932 172.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -69.83 160.58 31.51 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.85 0.86 . . . . 0.0 112.206 170.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.01 159.81 43.88 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 125.86 1.664 . . . . 0.0 111.273 173.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.12 128.55 37.37 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 122.692 0.397 . . . . 0.0 110.989 176.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 93.36 -10.72 72.82 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 125.474 1.511 . . . . 0.0 114.559 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -66.11 132.04 47.57 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 119.133 1.466 . . . . 0.0 111.61 176.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -80.65 143.4 33.11 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.039 0.936 . . . . 0.0 111.264 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.7 m -149.34 169.5 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 C-N-CA 125.855 1.662 . . . . 0.0 111.645 -171.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 32.2 mt -112.3 141.72 45.68 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.396 1.478 . . . . 0.0 108.325 168.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -152.99 151.32 30.16 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.51 -0.744 . . . . 0.0 112.886 -177.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 54.0 ttt85 -81.4 113.22 19.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.938 1.295 . . . . 0.0 110.247 -179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 14.0 t-105 -93.75 -159.7 0.71 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.347 1.059 . . . . 0.0 112.044 -177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 t -61.14 -12.17 11.5 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.538 1.135 . . . . 0.0 113.712 171.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -122.16 149.7 43.25 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.423 2.289 . . . . 0.0 110.055 174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 29.9 p -67.34 -17.24 64.67 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 -169.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -68.71 155.98 39.1 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 119.254 0.934 . . . . 0.0 111.682 175.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -101.52 80.92 2.12 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.195 1.398 . . . . 0.0 110.25 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -71.62 153.66 93.43 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 124.476 1.11 . . . . 0.0 112.085 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -70.75 137.78 33.3 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.132 2.555 . . . . 0.0 112.447 179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.03 -178.32 6.42 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.568 1.547 . . . . 0.0 111.606 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 ptpp? -143.32 154.41 43.74 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.354 1.462 . . . . 0.0 111.255 169.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.5 mt -82.6 133.27 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 C-N-CA 124.157 0.983 . . . . 0.0 109.743 177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 25.3 mm-40 -104.38 -30.16 10.27 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.446 1.499 . . . . 0.0 112.794 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.32 154.44 32.07 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.609 1.164 . . . . 0.0 112.301 177.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 56.0 mt -141.97 141.73 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 126.044 1.738 . . . . 0.0 110.085 -172.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -152.71 157.71 41.28 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.959 0.904 . . . . 0.0 111.459 168.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -67.1 -26.14 66.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.522 1.129 . . . . 0.0 112.95 171.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -136.31 63.53 1.58 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.663 1.985 . . . . 0.0 109.968 -176.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 171.98 120.64 0.56 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 125.241 1.4 . . . . 0.0 110.266 -172.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 6.9 p -44.07 146.99 0.55 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 126.129 1.772 . . . . 0.0 113.883 174.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -73.36 111.09 8.16 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 124.582 1.153 . . . . 0.0 109.929 178.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 18.7 m -68.4 135.84 52.38 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 169.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.0 m -139.62 150.1 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.694 1.197 . . . . 0.0 111.5 -173.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -126.86 125.58 41.87 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.129 1.371 . . . . 0.0 110.233 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -87.95 162.29 16.96 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 124.013 0.925 . . . . 0.0 111.672 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -52.39 -29.44 24.18 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -76.0 -20.15 58.09 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 114.457 1.281 . . . . 0.0 114.457 178.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.41 -22.91 8.2 Favored Glycine 0 CA--C 1.537 1.467 0 C-N-CA 125.694 1.616 . . . . 0.0 115.472 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.31 148.0 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 CA-C-N 119.109 1.454 . . . . 0.0 113.176 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 28.5 mt -130.2 127.84 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 125.214 1.405 . . . . 0.0 110.225 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -143.7 -169.03 2.99 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 127.413 2.285 . . . . 0.0 109.436 171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 25.5 p -127.77 150.81 49.64 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.413 1.085 . . . . 0.0 112.133 173.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.7 mt -141.21 163.09 33.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.555 1.542 . . . . 0.0 111.557 -178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -89.0 155.89 19.21 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.138 1.375 . . . . 0.0 110.715 173.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.99 -28.7 10.5 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 171.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.3 ttt -63.94 -12.83 40.92 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.942 1.697 . . . . 0.0 113.811 175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 52.2 m80 -128.18 13.36 6.68 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.049 1.74 . . . . 0.0 113.354 -172.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 65.6 mt -131.56 143.58 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 126.458 1.903 . . . . 0.0 109.148 -178.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -137.21 149.89 47.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 126.637 1.975 . . . . 0.0 110.521 178.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.92 150.14 48.39 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.304 0.642 . . . . 0.0 111.094 173.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 6.2 tpt -63.43 119.32 52.37 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 123.464 0.706 . . . . 0.0 110.821 179.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -75.22 168.83 23.82 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.807 2.338 . . . . 0.0 113.57 -172.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -56.58 118.49 4.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.141 1.776 . . . . 0.0 111.291 174.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 8.0 t70 57.76 36.54 26.6 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.529 1.932 . . . . 0.0 113.605 176.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -46.84 89.79 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 127.886 2.474 . . . . 0.0 115.212 -176.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 9.0 tppt? 45.81 27.24 0.44 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 127.497 2.319 . . . . 0.0 114.65 -174.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 161.82 179.4 36.46 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 125.429 1.49 . . . . 0.0 113.178 -173.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -129.98 133.57 46.87 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.826 1.25 . . . . 0.0 111.468 -173.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -146.4 156.91 43.66 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 125.947 1.699 . . . . 0.0 110.796 176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -81.78 38.92 0.53 Allowed 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.721 1.609 . . . . 0.0 114.251 -170.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.462 HG22 ' H ' ' A' ' 147' ' ' ALA . 2.8 mm -85.93 -149.06 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.096 0 C-N-CA 125.883 1.673 . . . . 0.0 109.936 -177.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' H ' HG22 ' A' ' 146' ' ' ILE . . . -72.02 48.32 0.16 Allowed 'General case' 0 CA--C 1.554 1.108 0 C-N-CA 127.369 2.268 . . . . 0.0 114.37 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.29 -6.43 9.76 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 126.877 2.071 . . . . 0.0 115.307 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 12.6 p -148.43 162.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.914 2.086 . . . . 0.0 110.475 177.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -129.33 144.84 51.39 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.081 1.752 . . . . 0.0 111.103 -178.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.266 0 C-N-CA 125.623 1.569 . . . . 0.0 113.361 176.042 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.388 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 8.8 t -152.12 168.44 25.3 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.459 1.504 . . . . 0.0 111.452 178.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 77.2 p -149.73 80.6 1.39 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.379 1.472 . . . . 0.0 112.54 -174.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.76 169.55 42.68 Favored Glycine 0 CA--C 1.534 1.272 0 C-N-CA 124.571 1.081 . . . . 0.0 113.586 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.5 m -163.17 160.05 23.69 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 126.181 1.793 . . . . 0.0 111.212 176.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 71.7 m -66.65 136.57 55.76 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.424 0.689 . . . . 0.0 111.587 172.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 149.65 -33.84 1.07 Allowed Glycine 0 CA--C 1.534 1.233 0 C-N-CA 124.968 1.27 . . . . 0.0 113.283 177.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -81.19 144.07 31.89 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.501 1.12 . . . . 0.0 111.301 171.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -148.21 137.67 22.18 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.214 1.406 . . . . 0.0 110.927 176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -77.91 166.72 22.53 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.807 0.843 . . . . 0.0 112.036 169.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 26.5 mtmt -126.35 152.67 45.96 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 126.006 1.722 . . . . 0.0 111.795 -177.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -68.9 137.85 54.18 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.173 0.589 . . . . 0.0 111.051 173.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.18 72.33 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.77 1.176 . . . . 0.0 114.886 -177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -86.51 142.45 28.33 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 118.738 1.269 . . . . 0.0 112.199 -176.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -85.38 141.13 30.22 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.175 0.99 . . . . 0.0 111.849 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.2 m -146.39 170.16 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.185 1.794 . . . . 0.0 111.061 -171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 93.9 mt -108.73 133.54 52.67 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.533 1.133 . . . . 0.0 107.998 169.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.42 159.04 44.76 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.4 -0.813 . . . . 0.0 112.526 -176.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.64 139.61 35.04 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.211 1.004 . . . . 0.0 111.549 -173.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 30.5 t-105 -135.72 -29.24 1.05 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 -176.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 16.2 m -142.41 -56.5 0.44 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.063 0.847 . . . . 0.0 112.19 -172.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -119.28 176.97 5.07 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.015 1.326 . . . . 0.0 111.814 -177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 81.8 m -60.74 -20.74 61.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.44 128.02 33.99 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 124.655 1.182 . . . . 0.0 110.508 173.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -68.37 161.02 28.39 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.759 168.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -131.4 156.42 80.15 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 125.751 1.621 . . . . 0.0 110.37 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.57 135.52 36.38 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.407 2.071 . . . . 0.0 111.64 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -147.24 173.87 12.15 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.846 1.658 . . . . 0.0 111.093 -178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -144.15 133.12 22.72 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.065 1.346 . . . . 0.0 110.457 179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 87.7 mt -70.6 117.86 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.991 0.917 . . . . 0.0 110.15 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -84.03 -37.28 22.34 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.087 1.355 . . . . 0.0 112.167 173.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.45 160.82 38.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.788 1.235 . . . . 0.0 112.347 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 20.3 mt -129.64 143.21 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.799 1.64 . . . . 0.0 109.246 -174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 -132.47 -50.93 0.93 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.857 0.863 . . . . 0.0 112.57 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -159.47 163.39 35.36 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.532 1.533 . . . . 0.0 110.283 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -55.67 -13.73 1.82 Allowed 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 174.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.95 -11.59 39.5 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.296 1.427 . . . . 0.0 115.396 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.6 p -149.61 127.81 12.07 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 120.124 1.962 . . . . 0.0 113.535 -175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -135.25 144.34 46.8 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.861 1.664 . . . . 0.0 110.109 179.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 23.4 m -97.89 126.1 43.1 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.843 0.857 . . . . 0.0 109.121 178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -136.28 130.81 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.052 0.941 . . . . 0.0 112.449 -169.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -89.77 140.87 29.16 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.08 1.352 . . . . 0.0 109.529 169.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -108.58 168.25 9.46 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.659 1.184 . . . . 0.0 111.43 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -58.17 -22.88 53.28 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -175.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -73.53 -13.54 61.05 Favored 'General case' 0 CA--C 1.548 0.888 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.24 -14.12 63.92 Favored Glycine 0 CA--C 1.537 1.469 0 C-N-CA 126.0 1.762 . . . . 0.0 114.258 -176.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.7 p -64.65 151.99 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.735 1.614 . . . . 0.0 112.182 175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 15.6 mt -137.32 129.93 42.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.504 1.521 . . . . 0.0 109.993 -175.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 62.5 mtm180 -146.45 167.7 23.0 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.015 1.726 . . . . 0.0 111.515 172.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 79.0 m -82.65 145.43 29.65 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 122.935 0.494 . . . . 0.0 110.346 167.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 37.3 mt -139.25 157.15 46.41 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.541 1.536 . . . . 0.0 111.252 172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -81.49 155.65 25.7 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.906 1.282 . . . . 0.0 111.268 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 78.8 ttt-85 -56.37 -29.3 61.26 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.859 1.264 . . . . 0.0 113.365 169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 21.9 ttt -59.0 -14.85 10.56 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 125.707 1.603 . . . . 0.0 114.157 171.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 68.1 m80 -130.35 16.19 5.51 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.306 1.842 . . . . 0.0 112.805 -173.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 74.4 mt -132.43 143.01 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 126.676 1.99 . . . . 0.0 108.825 177.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 10.4 mmmm -136.87 149.2 47.52 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 127.227 2.211 . . . . 0.0 110.07 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.12 155.83 38.76 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.172 0.589 . . . . 0.0 111.114 170.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 16.1 mmt -64.47 145.67 98.37 Favored Pre-proline 0 CA--C 1.547 0.85 0 O-C-N 121.949 -0.469 . . . . 0.0 111.824 171.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.14 169.03 20.35 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.649 2.899 . . . . 0.0 113.281 177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -60.44 -17.81 46.96 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.964 1.706 . . . . 0.0 114.337 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -114.84 13.35 17.15 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.01 1.724 . . . . 0.0 113.886 -175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.68 37.52 0.06 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.504 1.922 . . . . 0.0 115.051 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.9 139.67 26.64 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.707 1.603 . . . . 0.0 114.149 -174.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.66 143.48 3.71 Favored Glycine 0 CA--C 1.535 1.285 0 C-N-CA 125.633 1.587 . . . . 0.0 111.997 176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 38.13 42.52 0.49 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.964 2.106 . . . . 0.0 115.194 -175.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -82.18 77.19 9.01 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.54 1.536 . . . . 0.0 112.569 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -122.59 15.03 10.27 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.635 1.574 . . . . 0.0 113.958 -179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 48.2 pt -110.06 168.47 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 126.591 1.956 . . . . 0.0 111.366 175.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 51.44 26.11 3.0 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 126.567 1.947 . . . . 0.0 115.267 -179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 148' ' ' LEU . 2.2 pt? -74.85 29.98 0.09 Allowed 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 127.899 2.48 . . . . 0.0 114.913 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 35.4 m -63.29 155.59 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.289 1.436 . . . . 0.0 113.445 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.58 14.71 1.41 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 125.508 1.523 . . . . 0.0 114.062 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 126.471 1.908 . . . . 0.0 111.863 -178.379 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.363 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 84.7 p -152.88 163.49 39.67 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.909 1.284 . . . . 0.0 112.241 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 1.5 t 52.48 29.69 7.38 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.744 1.618 . . . . 0.0 114.593 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -77.64 160.24 48.8 Favored Glycine 0 CA--C 1.535 1.284 0 O-C-N 121.085 -1.01 . . . . 0.0 114.571 -175.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 23.0 t -81.61 160.12 23.87 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.986 1.314 . . . . 0.0 112.483 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.5 t -74.0 -9.94 59.14 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.321 1.048 . . . . 0.0 113.568 169.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -176.02 169.37 41.99 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 126.006 1.765 . . . . 0.0 112.424 177.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -59.96 -38.31 82.11 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 -174.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -162.89 165.34 25.29 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.006 1.722 . . . . 0.0 110.908 176.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.12 176.61 3.72 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 124.684 1.194 . . . . 0.0 111.768 168.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -122.89 128.08 49.84 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.624 1.57 . . . . 0.0 110.475 -174.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.96 134.54 54.16 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.148 0.579 . . . . 0.0 111.528 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 77.23 -7.74 35.78 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.784 1.659 . . . . 0.0 115.178 -176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -79.12 146.82 32.98 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.776 1.288 . . . . 0.0 112.599 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -80.43 138.92 36.67 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 124.811 1.245 . . . . 0.0 111.807 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 31.1 m -146.6 174.23 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 127.174 2.19 . . . . 0.0 110.896 -170.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -107.26 136.45 47.07 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.656 1.182 . . . . 0.0 107.98 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -145.81 146.41 31.16 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.597 -0.689 . . . . 0.0 112.324 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -72.97 142.68 47.79 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.962 0.905 . . . . 0.0 110.518 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.0 t-105 -146.72 -44.23 0.18 Allowed 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 115.653 1.723 . . . . 0.0 115.653 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 34.4 m -136.51 -16.7 1.55 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 113.828 1.047 . . . . 0.0 113.828 -171.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -147.97 -176.24 5.2 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.428 1.491 . . . . 0.0 111.228 -169.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 77.3 m -67.89 -24.16 65.19 Favored 'General case' 0 CA--C 1.549 0.929 0 O-C-N 121.142 -0.974 . . . . 0.0 111.439 166.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -68.31 141.7 55.75 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 126.229 1.812 . . . . 0.0 111.953 170.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -81.47 163.87 22.43 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.563 0.745 . . . . 0.0 110.593 168.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 81.0 m-85 -134.79 153.26 78.67 Favored Pre-proline 0 CA--C 1.543 0.685 0 C-N-CA 126.191 1.796 . . . . 0.0 110.669 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -71.57 135.1 25.56 Favored 'Trans proline' 0 CA--C 1.535 0.57 0 C-N-CA 122.683 2.256 . . . . 0.0 111.825 -177.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.52 177.69 9.78 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.559 1.543 . . . . 0.0 110.581 178.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -133.92 151.71 51.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.133 0.973 . . . . 0.0 110.819 168.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.6 mt -81.14 113.68 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.675 0.79 . . . . 0.0 109.922 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -80.4 -32.83 37.46 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.525 1.13 . . . . 0.0 112.747 176.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.3 157.77 36.3 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.064 0.946 . . . . 0.0 113.177 177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 69.5 mt -130.79 133.31 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 126.424 1.89 . . . . 0.0 108.609 -177.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 47.64 16.1 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 127.96 2.504 . . . . 0.0 117.288 -177.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 52.7 tttm -60.97 -40.53 93.78 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.581 1.552 . . . . 0.0 113.26 -174.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -137.45 17.57 2.93 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 125.739 1.616 . . . . 0.0 112.428 -171.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.59 -1.87 64.32 Favored Glycine 0 CA--C 1.538 1.529 0 C-N-CA 125.249 1.404 . . . . 0.0 114.5 -178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 14.5 p -144.72 160.95 40.38 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 126.759 2.024 . . . . 0.0 110.973 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -70.41 148.2 48.63 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.285 0.634 . . . . 0.0 110.468 169.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 20.5 m -115.48 136.61 52.91 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 124.646 1.178 . . . . 0.0 108.392 171.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.5 m -135.95 156.15 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 C-N-CA 123.949 0.899 . . . . 0.0 112.15 -173.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -125.0 117.29 23.69 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.274 1.43 . . . . 0.0 109.473 172.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -79.71 165.39 22.88 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.119 0.968 . . . . 0.0 112.174 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 36.3 p90 -54.0 -27.03 29.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.872 1.269 . . . . 0.0 114.367 175.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -68.94 -21.88 64.17 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.386 1.475 . . . . 0.0 113.863 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 102.53 -13.14 56.78 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 125.668 1.604 . . . . 0.0 114.766 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.1 p -59.51 144.65 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 125.239 1.416 . . . . 0.0 112.179 173.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 36.3 mt -129.78 109.61 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.038 1.335 . . . . 0.0 109.515 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -138.51 175.58 9.44 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.978 1.711 . . . . 0.0 111.644 175.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.5 m -104.56 155.6 18.69 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.326 1.05 . . . . 0.0 112.199 178.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.2 mt -144.77 156.91 44.3 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -73.11 156.32 38.8 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.417 1.087 . . . . 0.0 110.732 169.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.7 ptm180 -57.12 -24.83 56.87 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 169.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 75.6 mtm -66.05 -12.16 53.42 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 126.001 1.72 . . . . 0.0 114.126 172.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 m170 -120.86 12.04 11.21 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.727 1.611 . . . . 0.0 113.109 -173.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 51.3 mt -132.67 143.2 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.667 1.587 . . . . 0.0 109.565 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 29.2 mmmt -134.72 147.29 50.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.765 2.026 . . . . 0.0 110.697 175.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.45 141.63 48.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.929 0.892 . . . . 0.0 110.959 174.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 56.2 tpp -64.98 122.32 78.86 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 123.663 0.785 . . . . 0.0 110.437 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.04 168.13 24.84 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.584 2.19 . . . . 0.0 113.092 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 27.0 mp0 -51.57 106.39 0.14 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.852 2.461 . . . . 0.0 112.54 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.3 t70 51.71 44.44 29.23 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 126.684 1.994 . . . . 0.0 113.573 179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -51.49 -34.87 37.65 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 125.652 1.581 . . . . 0.0 115.038 -176.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -153.71 151.87 30.13 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.629 1.972 . . . . 0.0 110.209 176.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.82 -156.26 4.15 Favored Glycine 0 CA--C 1.537 1.441 0 C-N-CA 124.866 1.222 . . . . 0.0 113.539 171.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 62.36 16.41 8.52 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.712 1.605 . . . . 0.0 114.375 178.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -151.7 153.44 34.38 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 126.078 1.751 . . . . 0.0 111.53 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 81.6 m95 -140.98 -21.16 0.79 Allowed 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 -173.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.82 -13.48 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -171.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.56 -19.76 65.85 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.597 1.159 . . . . 0.0 113.593 171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 78.1 mt -80.76 61.96 4.62 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.902 1.681 . . . . 0.0 111.398 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.0 p -134.26 142.21 41.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.293 1.437 . . . . 0.0 111.926 -173.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -70.21 151.24 45.59 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.422 1.489 . . . . 0.0 112.239 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.307 0 C-N-CA 126.257 1.823 . . . . 0.0 111.614 176.645 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 N-CA-C 111.741 -0.544 . . . . 0.0 111.741 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 18.8 t -151.27 141.69 22.48 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.841 1.256 . . . . 0.0 111.113 177.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 66.4 m -148.24 162.67 39.02 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.68 1.592 . . . . 0.0 111.994 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -176.27 169.99 42.71 Favored Glycine 0 CA--C 1.534 1.267 0 C-N-CA 124.698 1.142 . . . . 0.0 113.18 174.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 t -156.16 148.56 23.6 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.732 1.213 . . . . 0.0 111.534 178.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.7 m -147.22 154.68 41.32 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.894 1.678 . . . . 0.0 111.143 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.08 172.63 45.85 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 123.819 0.723 . . . . 0.0 113.273 171.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -138.11 147.37 43.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.391 1.477 . . . . 0.0 110.521 177.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -141.33 54.66 1.54 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.065 1.346 . . . . 0.0 111.279 -169.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -49.01 144.2 4.96 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.074 1.349 . . . . 0.0 112.575 175.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.93 154.81 43.71 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.864 1.266 . . . . 0.0 112.428 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.52 130.23 43.48 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.367 0.667 . . . . 0.0 111.547 179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 95.61 -8.71 68.81 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 125.463 1.506 . . . . 0.0 114.371 -176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -75.24 132.52 41.13 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 119.018 1.409 . . . . 0.0 112.5 178.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -78.45 135.65 37.43 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.425 1.09 . . . . 0.0 111.64 172.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.4 m -147.35 -176.77 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 127.418 2.287 . . . . 0.0 111.009 -169.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 88.7 mt -111.39 145.09 39.54 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.132 0.973 . . . . 0.0 109.247 168.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.67 150.43 35.41 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 121.443 0.64 . . . . 0.0 112.46 179.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 67.2 ttt180 -80.72 154.29 27.36 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 125.543 1.537 . . . . 0.0 110.638 174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 20.3 t-105 -138.39 -47.51 0.52 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -142.95 -29.36 0.55 Allowed 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 114.159 1.17 . . . . 0.0 114.159 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -138.58 -169.51 2.62 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.095 1.758 . . . . 0.0 110.301 -173.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 28.0 p -62.17 -15.56 47.06 Favored 'General case' 0 CA--C 1.548 0.903 0 O-C-N 120.631 -1.293 . . . . 0.0 114.415 172.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 36.1 mmt180 -62.8 145.4 55.04 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.554 1.541 . . . . 0.0 111.979 175.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -117.29 154.34 31.38 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.926 1.29 . . . . 0.0 109.444 169.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -138.64 152.8 71.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.677 1.191 . . . . 0.0 111.332 -171.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -66.78 130.9 24.32 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.783 2.322 . . . . 0.0 110.852 175.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -145.2 172.76 12.66 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.242 1.417 . . . . 0.0 110.859 -176.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -132.71 132.18 42.05 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.293 1.437 . . . . 0.0 109.458 176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 59.5 mt -71.45 121.47 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 C-N-CA 123.111 0.564 . . . . 0.0 109.623 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -95.23 -32.25 13.11 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.754 1.222 . . . . 0.0 112.343 176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.48 160.99 40.07 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.841 1.257 . . . . 0.0 112.143 176.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 74.1 mt -135.2 117.02 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.199 1.399 . . . . 0.0 109.084 -172.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 51.71 14.52 0.29 Allowed 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 127.078 2.151 . . . . 0.0 116.156 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -56.61 -34.12 66.92 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.025 1.73 . . . . 0.0 113.809 -173.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -129.61 29.92 4.98 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 126.064 1.745 . . . . 0.0 111.012 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 84.95 2.67 88.33 Favored Glycine 0 CA--C 1.539 1.575 0 C-N-CA 124.969 1.271 . . . . 0.0 114.571 -176.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.5 p -144.43 162.82 35.55 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 126.886 2.074 . . . . 0.0 111.066 -179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -75.96 160.39 29.91 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.443 0.697 . . . . 0.0 110.056 168.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 25.4 m -131.27 134.37 46.33 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.883 1.273 . . . . 0.0 108.727 173.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.9 m -136.35 150.99 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 124.407 1.083 . . . . 0.0 111.71 -175.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -118.29 134.15 55.28 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.581 1.552 . . . . 0.0 109.651 174.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -93.28 167.55 11.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.443 1.097 . . . . 0.0 112.156 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -53.7 -28.74 35.47 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 125.602 1.561 . . . . 0.0 114.463 176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.42 -18.93 61.09 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.11 1.364 . . . . 0.0 113.797 175.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 104.92 -15.9 47.53 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 125.886 1.708 . . . . 0.0 114.317 -179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.7 p -62.34 146.12 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 125.393 1.477 . . . . 0.0 112.347 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 132.02 70.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 125.788 1.635 . . . . 0.0 109.986 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -143.71 168.73 19.23 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 125.948 1.699 . . . . 0.0 111.461 177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.1 m -107.64 149.96 27.46 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.289 1.036 . . . . 0.0 111.712 176.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 55.0 mt -148.11 158.65 44.19 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.348 1.459 . . . . 0.0 112.458 -171.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -76.35 159.79 30.2 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.752 0.821 . . . . 0.0 109.534 167.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -56.58 -35.01 67.71 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.055 0.942 . . . . 0.0 112.472 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 62.8 mtt -64.52 -1.17 1.64 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.734 1.614 . . . . 0.0 114.729 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 24.6 m170 -120.42 7.59 10.68 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.733 1.613 . . . . 0.0 113.193 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 55.5 mt -130.27 139.66 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 125.989 1.716 . . . . 0.0 108.822 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -136.72 147.09 46.54 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.468 1.507 . . . . 0.0 110.669 -176.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.78 135.11 55.45 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.229 -0.442 . . . . 0.0 109.857 169.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 55.7 ttm -66.01 128.81 94.07 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.787 -0.625 . . . . 0.0 109.786 173.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.28 159.04 53.02 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.776 2.317 . . . . 0.0 112.06 -174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 24.7 mm-40 -60.93 -19.15 60.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.134 0.974 . . . . 0.0 113.492 177.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -72.72 -9.74 58.99 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.471 1.508 . . . . 0.0 114.156 172.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -135.31 -34.46 0.86 Allowed 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.078 1.351 . . . . 0.0 114.001 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -62.73 127.5 31.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.436 1.494 . . . . 0.0 109.621 172.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -52.5 141.13 27.73 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.539 1.066 . . . . 0.0 114.566 -175.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -61.33 129.92 43.61 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.771 1.228 . . . . 0.0 111.764 -176.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . 0.321 2.3 p30 53.65 12.65 0.41 Allowed 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 118.194 2.665 . . . . 0.0 118.194 -176.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -60.87 -11.24 7.21 Favored 'General case' 0 N--CA 1.483 1.175 0 O-C-N 120.681 -1.262 . . . . 0.0 114.083 169.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.7 mm -56.76 -23.64 17.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.292 1.837 . . . . 0.0 112.736 170.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -132.24 138.19 47.82 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.136 1.374 . . . . 0.0 111.656 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.43 173.27 17.14 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.71 1.604 . . . . 0.0 112.133 -173.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 8.1 p -146.45 160.63 10.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.711 1.604 . . . . 0.0 110.999 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.68 165.06 29.12 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.829 1.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.322 0 C-N-CA 125.729 1.611 . . . . 0.0 113.488 178.319 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.405 0 N-CA-C 111.406 -0.678 . . . . 0.0 111.406 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 53.6 m -142.43 164.13 30.96 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.7 1.6 . . . . 0.0 111.654 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -151.61 163.64 38.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.53 1.132 . . . . 0.0 112.878 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.85 162.72 25.88 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 125.207 1.384 . . . . 0.0 113.984 -176.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.7 m -72.74 155.6 39.79 Favored 'General case' 0 N--CA 1.476 0.854 0 O-C-N 121.943 -0.739 . . . . 0.0 111.45 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.5 m -149.98 158.3 44.02 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.931 1.292 . . . . 0.0 112.094 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -73.97 70.84 1.47 Allowed Glycine 0 CA--C 1.536 1.356 0 C-N-CA 125.881 1.705 . . . . 0.0 113.738 176.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -57.63 -20.95 36.6 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.461 1.505 . . . . 0.0 114.212 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -128.57 145.75 51.04 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.206 1.802 . . . . 0.0 111.48 179.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -119.55 151.08 39.22 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.809 1.644 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.63 162.68 40.57 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.332 1.853 . . . . 0.0 110.491 179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -58.22 123.83 17.37 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 121.992 -0.443 . . . . 0.0 111.453 177.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 92.4 -7.16 78.1 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.289 1.423 . . . . 0.0 114.877 -175.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -63.92 135.52 56.59 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.27 1.535 . . . . 0.0 111.619 175.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.12 138.81 31.64 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.777 0.831 . . . . 0.0 112.092 175.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.34 167.04 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 126.071 1.748 . . . . 0.0 111.03 -171.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 49.9 mt -95.08 148.45 22.34 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 167.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.3 144.16 28.6 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.439 0.696 . . . . 0.0 111.571 173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -72.62 152.84 41.54 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.149 0.98 . . . . 0.0 110.015 170.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 13.1 t-105 -131.67 -160.28 1.03 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.156 0.982 . . . . 0.0 112.152 -178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.5 m -55.24 -36.56 66.16 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.155 0.982 . . . . 0.0 111.382 169.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -84.07 139.59 32.38 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 125.021 1.329 . . . . 0.0 109.747 168.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.41 -21.46 65.4 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -64.67 158.51 24.37 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 120.008 1.276 . . . . 0.0 112.199 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -88.84 149.09 23.55 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.688 0.795 . . . . 0.0 110.263 168.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -139.65 152.77 69.3 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.257 1.423 . . . . 0.0 111.29 -175.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 136.56 29.25 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.999 2.466 . . . . 0.0 112.141 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.75 173.13 13.56 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.736 1.615 . . . . 0.0 111.221 -179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -128.82 141.15 51.39 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.86 1.264 . . . . 0.0 110.862 169.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 79.1 mt -77.02 124.98 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 124.155 0.982 . . . . 0.0 109.58 178.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -95.57 -30.51 13.77 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.885 0.874 . . . . 0.0 112.894 174.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.76 153.22 32.74 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 81.6 mt -137.64 149.89 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 127.645 2.378 . . . . 0.0 108.467 -171.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.38 44.99 29.32 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 125.168 1.387 . . . . 0.0 113.571 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 8.8 mmmm -70.34 -154.5 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.099 1.76 . . . . 0.0 110.012 168.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -57.91 -16.35 11.79 Favored 'General case' 0 N--CA 1.48 1.031 0 O-C-N 120.46 -1.4 . . . . 0.0 114.569 175.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 161.81 -30.93 0.31 Allowed Glycine 0 CA--C 1.536 1.404 0 C-N-CA 126.528 2.013 . . . . 0.0 112.51 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.18 171.8 13.52 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.784 2.434 . . . . 0.0 112.057 173.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -113.4 162.98 15.45 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.891 1.676 . . . . 0.0 108.714 168.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 32.3 m -122.06 133.33 54.79 Favored 'General case' 0 N--CA 1.478 0.972 0 O-C-N 121.204 -0.935 . . . . 0.0 109.875 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 28.5 m -138.94 157.07 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 124.415 1.086 . . . . 0.0 112.421 -170.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -128.41 128.6 44.78 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.154 1.382 . . . . 0.0 110.145 173.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -81.74 162.63 22.87 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.422 1.089 . . . . 0.0 112.485 179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -52.96 -31.74 42.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.339 1.456 . . . . 0.0 114.814 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -80.35 -17.33 52.3 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 120.53 -21.17 8.66 Favored Glycine 0 CA--C 1.536 1.383 0 C-N-CA 125.277 1.418 . . . . 0.0 115.449 175.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 9.2 p -60.42 146.83 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-N 119.289 1.544 . . . . 0.0 112.857 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.9 mt -124.78 128.87 73.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.988 1.715 . . . . 0.0 109.215 -176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 -143.95 175.07 10.3 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.173 1.789 . . . . 0.0 110.922 173.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 74.7 m -113.68 141.73 46.87 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.135 0.974 . . . . 0.0 110.523 171.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 81.4 mt -144.07 146.44 32.83 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.404 1.882 . . . . 0.0 109.731 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.4 160.86 30.45 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 121.409 -0.807 . . . . 0.0 110.978 171.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.32 -24.95 8.37 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.804 1.242 . . . . 0.0 113.916 168.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 91.4 mtp -63.67 -12.54 34.9 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 126.541 1.936 . . . . 0.0 113.892 174.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -128.41 9.51 6.09 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.3 1.84 . . . . 0.0 113.157 -173.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 88.3 mt -126.25 143.42 39.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 127.15 2.18 . . . . 0.0 108.18 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -135.31 148.69 49.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.55 1.54 . . . . 0.0 110.854 -176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.51 145.47 48.4 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.703 0.801 . . . . 0.0 111.028 172.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 7.0 tpt -62.54 131.12 93.94 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-O 118.814 -0.612 . . . . 0.0 110.857 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.71 172.09 15.95 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.581 2.854 . . . . 0.0 113.941 -171.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -60.81 -18.61 56.53 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 114.989 1.477 . . . . 0.0 114.989 179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -148.27 133.36 18.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.299 1.44 . . . . 0.0 111.292 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -159.61 -38.67 0.06 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.798 1.639 . . . . 0.0 112.362 176.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -147.21 141.54 26.3 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.029 2.132 . . . . 0.0 109.196 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -61.39 113.38 5.63 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.669 1.128 . . . . 0.0 113.766 -176.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -156.02 170.55 21.9 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.973 1.309 . . . . 0.0 112.605 -175.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 55.06 31.62 16.58 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 126.511 1.924 . . . . 0.0 115.498 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -73.32 26.67 0.06 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.893 1.677 . . . . 0.0 114.007 172.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mm -123.04 131.8 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 126.631 1.972 . . . . 0.0 109.123 -170.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 48.48 33.13 3.75 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.56 1.544 . . . . 0.0 114.218 -173.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.2 pp -62.46 165.85 5.76 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.674 1.59 . . . . 0.0 114.218 -178.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.72 129.81 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.744 1.218 . . . . 0.0 111.272 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -60.31 156.66 15.18 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.172 1.389 . . . . 0.0 114.026 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.298 0 C-N-CA 125.452 1.501 . . . . 0.0 113.128 174.669 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.418 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 20.3 m -64.41 -25.63 68.1 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.399 1.629 . . . . 0.0 115.399 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.7 m -136.7 -7.39 1.91 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -171.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 70.09 172.66 10.75 Favored Glycine 0 CA--C 1.541 1.659 0 C-N-CA 124.778 1.18 . . . . 0.0 114.658 -175.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 3.2 t -158.55 38.88 0.24 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 125.109 1.364 . . . . 0.0 111.762 179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 19.0 m -57.21 -31.8 65.85 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -169.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.24 165.57 17.37 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 124.664 1.126 . . . . 0.0 113.987 172.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -86.37 88.03 7.55 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 170.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -139.99 158.53 43.92 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.516 1.527 . . . . 0.0 111.474 -174.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -138.45 -178.46 5.3 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 126.511 1.924 . . . . 0.0 111.479 -177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -119.17 128.02 53.85 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.982 1.713 . . . . 0.0 109.911 -177.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.92 133.76 52.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.146 0.578 . . . . 0.0 111.34 177.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.24 3.07 75.34 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 124.884 1.23 . . . . 0.0 115.061 -177.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -89.47 154.09 20.3 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.908 1.354 . . . . 0.0 112.411 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -90.36 142.55 27.62 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.175 0.99 . . . . 0.0 112.533 179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.0 m -146.24 174.79 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.911 2.084 . . . . 0.0 110.86 -170.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -110.0 124.99 52.43 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 124.724 1.21 . . . . 0.0 109.32 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -143.14 154.84 44.31 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -174.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -88.66 147.1 24.7 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.043 1.337 . . . . 0.0 111.674 -174.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 26.7 t-105 -143.73 -30.53 0.49 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.97 1.841 . . . . 0.0 115.97 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.3 p -139.11 -28.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 115.875 1.805 . . . . 0.0 115.875 -169.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -147.55 -167.81 2.89 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.027 1.731 . . . . 0.0 110.064 -170.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 85.7 m -66.73 -13.89 61.9 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 120.836 -1.165 . . . . 0.0 113.727 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 83.7 mtp180 -69.18 166.55 18.08 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.189 1.796 . . . . 0.0 113.378 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -129.13 152.01 49.19 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.883 1.673 . . . . 0.0 109.991 173.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -139.12 156.01 72.4 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.48 1.512 . . . . 0.0 110.738 -171.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -66.41 132.08 28.25 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.428 2.085 . . . . 0.0 111.881 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -144.86 172.02 13.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.798 1.639 . . . . 0.0 110.59 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -128.75 129.26 45.48 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.211 1.804 . . . . 0.0 109.605 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.5 mt -76.62 120.94 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 123.367 0.667 . . . . 0.0 109.625 178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -96.29 -27.37 15.01 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.879 0.872 . . . . 0.0 112.69 -177.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.69 156.44 29.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.235 1.414 . . . . 0.0 111.603 174.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 86.2 mt -132.48 127.75 57.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.736 1.615 . . . . 0.0 108.936 -174.158 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 56.8 t-20 -153.0 114.67 4.27 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.783 0.833 . . . . 0.0 111.697 174.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -63.12 -7.63 6.09 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -53.89 -28.88 39.24 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.399 1.48 . . . . 0.0 113.509 171.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 170.28 -22.45 0.08 OUTLIER Glycine 0 CA--C 1.533 1.172 0 N-CA-C 117.991 1.957 . . . . 0.0 117.991 169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.93 153.04 37.42 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-N 120.03 1.915 . . . . 0.0 113.111 -169.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -115.44 124.92 52.39 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.786 1.634 . . . . 0.0 109.839 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 17.7 m -80.72 132.23 35.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.69 0.796 . . . . 0.0 110.403 -178.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 3.7 m -140.17 146.21 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.056 1.342 . . . . 0.0 112.438 -172.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.14 119.61 29.93 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.317 1.847 . . . . 0.0 109.223 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -89.67 165.58 14.13 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.121 0.968 . . . . 0.0 111.005 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -58.94 -18.8 36.99 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 115.293 1.59 . . . . 0.0 115.293 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -69.09 -15.72 63.51 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.74 1.216 . . . . 0.0 113.928 170.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.95 -15.49 61.57 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 126.248 1.88 . . . . 0.0 114.321 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.6 p -61.26 146.39 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 125.84 1.656 . . . . 0.0 112.231 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mp -126.42 126.42 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 125.418 1.487 . . . . 0.0 110.125 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.3 mmt180 -140.71 -162.57 1.38 Allowed 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.945 2.098 . . . . 0.0 109.236 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.4 p -138.53 151.93 47.78 Favored 'General case' 0 CA--C 1.539 0.521 0 O-C-N 121.164 -0.96 . . . . 0.0 112.138 175.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.6 mt -139.13 158.12 44.75 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.54 1.536 . . . . 0.0 111.904 -174.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -72.13 158.01 36.71 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.65 1.18 . . . . 0.0 110.756 170.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -61.68 -17.86 57.25 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 169.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.7 mmt -68.97 -12.24 61.47 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.14 1.376 . . . . 0.0 113.427 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -127.03 9.88 6.88 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.982 1.713 . . . . 0.0 113.321 -173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 53.1 mt -132.66 136.83 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 126.55 1.94 . . . . 0.0 108.243 174.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -134.48 148.74 50.62 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 126.175 1.79 . . . . 0.0 110.281 177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.3 138.24 58.33 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.228 0.611 . . . . 0.0 110.549 175.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 44.7 ttm -64.92 127.04 92.32 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 118.866 -0.588 . . . . 0.0 110.12 175.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.47 162.11 40.85 Favored 'Trans proline' 0 CA--C 1.537 0.634 0 C-N-CA 123.063 2.509 . . . . 0.0 113.704 -169.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.87 -19.79 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 174.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -73.32 -23.05 60.2 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.773 1.229 . . . . 0.0 113.361 173.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -81.19 173.59 12.38 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.653 1.181 . . . . 0.0 112.933 178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 35.8 tptt -72.37 30.77 0.06 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 127.144 2.177 . . . . 0.0 114.092 179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.12 51.22 0.19 Allowed Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.627 1.108 . . . . 0.0 114.361 -169.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 24.6 pt20 -56.13 155.21 6.8 Favored 'General case' 0 CA--C 1.546 0.823 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 174.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -93.78 162.29 13.98 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.631 1.172 . . . . 0.0 113.188 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 99.5 m95 -73.23 54.34 0.41 Allowed 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 127.993 2.517 . . . . 0.0 113.248 175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 1.7 pp -59.81 -5.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.108 2.262 . . . . 0.0 117.108 -173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -128.68 18.93 6.21 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.381 1.872 . . . . 0.0 113.406 -178.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 4.4 pp -57.73 159.68 5.08 Favored 'General case' 0 CA--C 1.548 0.878 0 N-CA-C 114.599 1.333 . . . . 0.0 114.599 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 11.6 p -63.83 146.12 13.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 125.143 1.377 . . . . 0.0 112.753 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -139.74 137.87 35.46 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.394 1.478 . . . . 0.0 110.948 -177.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.203 1.801 . . . . 0.0 111.829 -179.302 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.39 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.1 m 57.68 20.89 6.74 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 126.083 1.753 . . . . 0.0 115.718 177.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 7.6 t -73.58 175.06 7.43 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.706 1.202 . . . . 0.0 112.598 175.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -172.93 -35.2 0.03 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.612 1.101 . . . . 0.0 114.092 176.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 36.8 p -157.36 141.64 16.32 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.818 1.247 . . . . 0.0 111.799 174.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.1 p -142.11 1.02 1.41 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -178.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 168.79 35.27 0.02 OUTLIER Glycine 0 CA--C 1.535 1.329 0 C-N-CA 124.037 0.827 . . . . 0.0 114.609 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -138.77 131.32 28.9 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.451 1.1 . . . . 0.0 112.059 -170.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -159.64 159.51 33.19 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.405 1.882 . . . . 0.0 110.254 174.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -60.11 150.23 30.22 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.777 0.831 . . . . 0.0 112.26 172.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.63 160.18 39.92 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 176.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -64.25 143.58 57.78 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 121.728 -0.607 . . . . 0.0 112.109 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 81.58 -11.57 45.04 Favored Glycine 0 CA--C 1.539 1.538 0 C-N-CA 125.92 1.724 . . . . 0.0 114.85 -177.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -69.23 131.15 44.46 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 125.241 1.416 . . . . 0.0 112.701 -176.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -77.21 140.18 40.06 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.557 1.143 . . . . 0.0 112.449 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.84 171.68 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 126.685 1.994 . . . . 0.0 111.322 -169.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -103.42 139.32 38.95 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.18 155.4 40.6 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 26.1 ttm180 -87.02 150.14 24.25 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.122 1.369 . . . . 0.0 111.312 -176.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 18.5 t-105 -143.83 -44.46 0.27 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.2 -5.15 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -170.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -156.55 177.01 11.95 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.29 1.436 . . . . 0.0 111.082 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 -30.09 68.4 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 121.076 -1.015 . . . . 0.0 112.863 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -56.71 156.78 6.01 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 125.843 1.657 . . . . 0.0 113.275 172.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -119.23 155.23 32.1 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.255 1.422 . . . . 0.0 109.596 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -136.5 155.51 76.93 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.693 1.197 . . . . 0.0 111.28 -170.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.03 132.33 27.79 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.778 2.319 . . . . 0.0 111.916 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.02 179.35 8.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.19 1.796 . . . . 0.0 110.349 -179.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -141.86 151.8 43.04 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.105 0.962 . . . . 0.0 112.223 168.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 72.9 mt -75.06 122.52 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.564 1.146 . . . . 0.0 110.093 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -93.67 -31.53 14.42 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.803 1.241 . . . . 0.0 112.404 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.69 156.28 34.66 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.256 1.022 . . . . 0.0 112.937 176.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 58.8 mt -133.13 131.13 58.46 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 126.563 1.945 . . . . 0.0 108.345 -177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 6.4 p30 50.33 -5.44 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 119.4 3.111 . . . . 0.0 119.4 -178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.46 -18.67 41.6 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 120.76 1.618 . . . . 0.0 114.903 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -131.61 19.92 4.7 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.019 1.727 . . . . 0.0 111.015 173.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 75.07 -50.81 2.35 Favored Glycine 0 CA--C 1.534 1.259 0 C-N-CA 126.733 2.111 . . . . 0.0 112.311 -169.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 1.9 m -71.19 158.78 35.82 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.652 1.981 . . . . 0.0 111.343 170.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -81.0 160.31 24.62 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.888 0.875 . . . . 0.0 110.407 169.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 22.0 m -126.21 137.89 53.59 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.299 1.04 . . . . 0.0 109.123 172.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.1 m -139.65 152.66 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.624 1.169 . . . . 0.0 111.926 -173.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -120.82 130.23 53.88 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.687 1.595 . . . . 0.0 109.794 175.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -95.1 169.67 9.95 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.759 1.223 . . . . 0.0 112.206 -176.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -57.3 -24.22 53.57 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -73.44 -12.82 60.93 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.554 1.141 . . . . 0.0 113.95 172.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.26 -14.15 65.64 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.898 1.713 . . . . 0.0 114.493 -178.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.5 p -65.42 148.28 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 125.728 1.611 . . . . 0.0 112.503 176.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.3 mp -126.97 130.63 71.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.914 1.686 . . . . 0.0 110.267 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -146.43 163.25 36.25 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.754 1.622 . . . . 0.0 111.859 175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 75.9 m -82.13 145.13 30.29 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.5 0.72 . . . . 0.0 110.705 168.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.6 mt -146.14 144.8 30.2 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 125.106 1.362 . . . . 0.0 110.835 173.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -69.52 158.85 34.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 123.349 0.66 . . . . 0.0 111.337 171.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -57.08 -21.57 32.74 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -66.13 -12.88 58.61 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.608 1.563 . . . . 0.0 113.889 171.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -127.11 11.52 7.04 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.954 1.702 . . . . 0.0 113.354 -173.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.58 139.54 50.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 126.593 1.957 . . . . 0.0 108.484 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -137.09 145.79 44.33 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.033 1.733 . . . . 0.0 110.883 -177.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.44 149.26 50.47 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 123.163 0.585 . . . . 0.0 110.758 169.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 30.5 mtt -65.1 145.53 99.08 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 123.092 0.557 . . . . 0.0 112.332 174.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -71.82 166.75 28.57 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.332 2.688 . . . . 0.0 112.425 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -58.25 -31.91 67.87 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.606 1.162 . . . . 0.0 113.923 -174.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -81.48 -15.76 54.01 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 45.82 1.03 Allowed 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.236 1.414 . . . . 0.0 112.749 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -61.07 160.19 10.46 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.939 1.696 . . . . 0.0 112.863 178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -177.45 -35.12 0.05 OUTLIER Glycine 0 CA--C 1.536 1.355 0 C-N-CA 124.137 0.875 . . . . 0.0 114.375 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -143.39 168.32 20.09 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.031 1.732 . . . . 0.0 111.042 173.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -142.74 132.04 23.43 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.081 1.352 . . . . 0.0 110.781 170.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -151.75 107.04 3.3 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.736 1.615 . . . . 0.0 109.872 -171.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 57.6 mt -136.16 141.67 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.757 1.623 . . . . 0.0 109.343 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 52.75 22.48 2.31 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 126.668 1.987 . . . . 0.0 115.982 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 148' ' ' LEU . 2.7 pt? -74.07 -1.4 19.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.937 1.695 . . . . 0.0 115.106 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 27.2 m -59.84 151.07 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 124.769 1.228 . . . . 0.0 113.129 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.2 22.33 3.55 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 126.492 1.917 . . . . 0.0 115.374 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.31 0 C-N-CA 125.367 1.467 . . . . 0.0 113.18 173.153 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.398 0 N-CA-C 110.785 -0.926 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 27.3 t -59.87 152.21 23.89 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.03 0.932 . . . . 0.0 112.39 173.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 73.1 p -68.71 -17.99 64.16 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.09 1.144 . . . . 0.0 114.09 171.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 167.43 -162.2 36.0 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 124.655 1.121 . . . . 0.0 113.813 -178.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 1.7 t 53.98 36.77 25.25 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 126.154 1.782 . . . . 0.0 114.556 176.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.4 m -56.11 124.77 18.97 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.15 1.38 . . . . 0.0 112.347 178.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -134.05 -15.94 1.14 Allowed Glycine 0 CA--C 1.535 1.323 0 C-N-CA 124.531 1.063 . . . . 0.0 115.262 -177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 35.2 p90 47.61 14.73 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 118.611 2.819 . . . . 0.0 118.611 170.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -149.47 143.12 25.47 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.227 1.411 . . . . 0.0 111.331 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -83.2 170.3 14.85 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.02 1.328 . . . . 0.0 113.636 -176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -138.46 157.43 46.21 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.738 2.015 . . . . 0.0 111.249 175.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.75 136.38 58.05 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.927 -0.483 . . . . 0.0 111.326 175.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 82.14 -1.34 87.22 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.645 1.117 . . . . 0.0 114.988 -176.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -69.97 142.2 52.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 119.359 1.58 . . . . 0.0 111.877 175.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -91.17 145.32 24.77 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.924 0.89 . . . . 0.0 111.714 177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.0 m -148.41 162.28 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.558 1.543 . . . . 0.0 112.022 -169.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -105.05 118.25 36.07 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.876 1.671 . . . . 0.0 107.245 169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.62 144.9 48.15 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.219 0.608 . . . . 0.0 112.142 -172.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 -74.71 150.21 39.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.723 1.209 . . . . 0.0 110.992 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 37.8 t-105 -134.05 -40.39 0.84 Allowed 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.3 m -159.36 -51.0 0.06 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 124.401 1.081 . . . . 0.0 111.282 176.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.0 t0 -74.95 170.59 15.67 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.113 0.965 . . . . 0.0 112.039 175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 76.7 m -73.38 43.54 0.14 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 126.234 1.814 . . . . 0.0 112.56 171.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -140.75 162.44 35.41 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 127.778 2.431 . . . . 0.0 110.77 -171.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.431 ' CD2' ' HE2' ' A' ' 134' ' ' LYS . 53.2 m-85 -124.0 145.73 49.0 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 124.967 1.307 . . . . 0.0 109.701 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -135.85 154.31 77.75 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 124.626 1.17 . . . . 0.0 111.117 -170.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -66.68 131.27 25.47 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.625 2.217 . . . . 0.0 112.016 -177.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.69 174.6 12.0 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 126.189 1.796 . . . . 0.0 110.904 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -138.4 133.81 33.32 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.313 1.445 . . . . 0.0 110.686 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 78.1 mt -72.26 120.49 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.166 0.986 . . . . 0.0 110.582 -178.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -95.14 -30.01 14.25 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.416 1.486 . . . . 0.0 112.488 176.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.64 161.93 39.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.528 1.131 . . . . 0.0 112.803 176.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 51.8 mt -137.37 148.62 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 126.19 1.796 . . . . 0.0 109.733 -171.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 58.5 t30 62.82 6.4 2.13 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 127.501 2.32 . . . . 0.0 116.462 174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -59.85 110.54 1.19 Allowed 'General case' 0 N--CA 1.477 0.892 0 O-C-N 120.721 -1.237 . . . . 0.0 110.373 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . 0.254 4.3 pm0 39.28 43.6 0.94 Allowed 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 125.897 1.679 . . . . 0.0 114.785 -169.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 70.55 30.71 68.54 Favored Glycine 0 CA--C 1.537 1.413 0 O-C-N 121.181 -0.949 . . . . 0.0 114.238 -179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 2.5 m -138.98 162.74 34.15 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 126.907 2.083 . . . . 0.0 109.857 -172.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -111.6 159.63 17.98 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 125.482 1.513 . . . . 0.0 109.856 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 41.3 m -125.19 133.15 52.87 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.629 1.172 . . . . 0.0 108.635 175.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.45 133.3 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.134 0.974 . . . . 0.0 111.978 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -93.12 125.19 37.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.887 1.275 . . . . 0.0 109.5 169.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -88.66 165.63 14.64 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.912 0.885 . . . . 0.0 111.561 176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -54.5 -26.92 34.37 Favored 'General case' 0 CA--C 1.547 0.834 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -71.61 -20.11 62.03 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.023 1.329 . . . . 0.0 113.778 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 106.51 -17.14 40.2 Favored Glycine 0 CA--C 1.538 1.472 0 C-N-CA 126.169 1.842 . . . . 0.0 114.075 -178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 12.0 p -62.63 150.39 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.778 1.631 . . . . 0.0 112.226 175.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.1 mt -133.66 127.48 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.38 1.472 . . . . 0.0 109.819 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -143.86 175.83 9.71 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 126.233 1.813 . . . . 0.0 110.853 173.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 72.5 m -107.4 146.03 32.19 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.503 1.121 . . . . 0.0 111.738 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 72.9 mt -147.42 152.97 39.01 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.093 1.757 . . . . 0.0 111.415 -177.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -78.96 158.99 27.88 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.97 0.908 . . . . 0.0 110.872 169.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -57.91 -26.1 61.73 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.911 1.284 . . . . 0.0 113.661 173.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 57.9 ttm -54.78 -18.88 5.3 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.352 1.861 . . . . 0.0 114.116 169.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -123.75 13.17 9.25 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.9 1.68 . . . . 0.0 113.127 -173.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 69.6 mt -134.59 136.62 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.493 1.917 . . . . 0.0 109.093 -177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.431 ' HE2' ' CD2' ' A' ' 102' ' ' TYR . 55.4 mtmt -132.87 150.41 52.16 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.918 1.687 . . . . 0.0 110.376 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.95 152.85 35.47 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.288 0.635 . . . . 0.0 111.789 176.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 5.4 tpt -59.21 125.93 80.21 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 123.54 0.736 . . . . 0.0 110.461 174.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.65 153.05 65.07 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.431 2.088 . . . . 0.0 112.117 -176.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -61.5 -27.24 68.45 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.74 0.816 . . . . 0.0 112.78 176.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -84.47 1.58 44.9 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.669 1.588 . . . . 0.0 114.194 178.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -56.58 137.45 53.64 Favored 'General case' 0 CA--C 1.546 0.817 0 O-C-N 121.074 -1.016 . . . . 0.0 112.861 178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -69.69 140.33 53.56 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.781 1.232 . . . . 0.0 111.766 178.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 81.0 164.19 31.62 Favored Glycine 0 CA--C 1.538 1.521 0 C-N-CA 125.308 1.432 . . . . 0.0 114.535 177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -159.59 176.94 11.44 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.886 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -130.94 86.55 2.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.792 1.637 . . . . 0.0 109.569 175.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 58.2 p-90 -54.01 -23.59 13.98 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.523 1.529 . . . . 0.0 114.894 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . 0.598 HD12 ' H ' ' A' ' 146' ' ' ILE . 5.0 mp -59.26 -27.68 37.24 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 C-N-CA 125.912 1.685 . . . . 0.0 111.923 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -88.17 21.02 2.94 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 125.778 1.631 . . . . 0.0 114.095 -177.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.13 151.38 40.3 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 120.846 -1.159 . . . . 0.0 113.682 -177.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 46.6 t -143.96 147.58 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.338 1.855 . . . . 0.0 109.154 179.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.1 ttpm? -137.0 45.49 2.25 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.547 1.539 . . . . 0.0 111.968 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.354 0 C-N-CA 126.555 1.942 . . . . 0.0 111.772 -176.751 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.441 0 N-CA-C 111.765 -0.534 . . . . 0.0 111.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 31.4 t -154.06 153.98 32.86 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.25 1.42 . . . . 0.0 111.424 178.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -66.91 -24.29 66.08 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.356 1.062 . . . . 0.0 113.436 171.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 72.72 -53.61 1.64 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.329 1.919 . . . . 0.0 114.388 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 7.1 t -75.96 174.35 10.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.509 1.524 . . . . 0.0 112.179 170.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 8.0 t -59.04 150.32 25.17 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.57 1.148 . . . . 0.0 112.134 172.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.56 158.76 19.27 Favored Glycine 0 CA--C 1.535 1.284 0 C-N-CA 124.422 1.01 . . . . 0.0 113.871 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -145.64 157.94 43.91 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.627 1.571 . . . . 0.0 111.144 -176.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -144.47 137.56 27.02 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.299 1.44 . . . . 0.0 110.64 177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -74.0 168.09 20.19 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.59 0.756 . . . . 0.0 112.447 171.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -140.33 160.1 40.72 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 125.884 1.674 . . . . 0.0 111.956 173.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.51 141.2 58.85 Favored 'General case' 0 CA--C 1.547 0.842 0 O-C-N 121.854 -0.529 . . . . 0.0 111.775 174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 83.32 -12.81 49.15 Favored Glycine 0 CA--C 1.538 1.514 0 C-N-CA 125.786 1.66 . . . . 0.0 114.885 -177.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -74.0 138.47 44.13 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.658 1.183 . . . . 0.0 112.277 -179.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -80.52 141.79 34.81 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.461 1.104 . . . . 0.0 112.611 175.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 23.0 m -151.88 168.09 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.372 1.869 . . . . 0.0 111.023 -171.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.03 129.84 44.87 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.09 133.41 41.1 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.998 0.919 . . . . 0.0 111.187 -176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -67.77 161.21 26.6 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.868 1.267 . . . . 0.0 110.994 173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 5.9 t-105 -135.56 -163.79 1.44 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.454 1.102 . . . . 0.0 111.238 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.9 t -62.28 -29.91 70.76 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 121.49 -0.757 . . . . 0.0 112.602 171.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.03 154.48 28.14 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.558 1.143 . . . . 0.0 112.005 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 31.0 p -72.57 33.8 0.07 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.165 1.786 . . . . 0.0 115.579 -176.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 39.3 mmt180 -137.69 157.22 46.94 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 126.472 1.909 . . . . 0.0 111.77 -175.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -99.3 148.58 24.01 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.033 1.333 . . . . 0.0 110.215 170.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -140.04 154.32 70.24 Favored Pre-proline 0 CA--C 1.541 0.625 0 C-N-CA 125.82 1.648 . . . . 0.0 111.222 -172.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -66.85 129.45 20.9 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.538 2.159 . . . . 0.0 111.358 175.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -148.86 175.29 11.39 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.7 1.6 . . . . 0.0 111.247 -176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -132.11 136.85 47.44 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.09 1.356 . . . . 0.0 110.654 172.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 75.7 mt -74.37 140.74 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.692 0.797 . . . . 0.0 109.534 175.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -116.6 -27.99 6.55 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.539 1.136 . . . . 0.0 113.173 177.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.09 155.34 33.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.65 1.18 . . . . 0.0 111.286 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 68.1 mt -136.02 138.87 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 125.661 1.584 . . . . 0.0 108.592 -170.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.1 t30 -134.87 130.29 35.74 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.7 1.2 . . . . 0.0 111.57 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -42.31 101.6 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 128.251 2.621 . . . . 0.0 114.409 -169.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 54.31 17.26 1.47 Allowed 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 127.011 2.124 . . . . 0.0 115.293 178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.16 -61.14 0.21 Allowed Glycine 0 N--CA 1.469 0.874 0 O-C-N 120.991 -1.068 . . . . 0.0 114.729 -169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 17.7 p -146.8 162.68 38.08 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 113.981 1.104 . . . . 0.0 113.981 -171.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -137.86 124.62 21.1 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 126.921 2.089 . . . . 0.0 108.711 179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 90.2 m -87.74 135.42 33.39 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.657 0.783 . . . . 0.0 109.056 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 26.6 m -136.63 156.52 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 C-N-CA 124.583 1.153 . . . . 0.0 112.156 -175.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -124.5 131.01 53.49 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.22 1.408 . . . . 0.0 109.795 170.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -90.56 167.59 12.45 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.721 1.209 . . . . 0.0 111.676 179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -59.07 -23.38 62.0 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 176.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -72.33 -14.01 61.63 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.655 1.182 . . . . 0.0 113.87 171.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 95.62 -15.65 62.76 Favored Glycine 0 CA--C 1.536 1.384 0 C-N-CA 125.677 1.608 . . . . 0.0 114.329 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 13.8 p -60.54 146.46 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 125.446 1.498 . . . . 0.0 112.477 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 68.7 mt -127.84 128.07 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 125.769 1.628 . . . . 0.0 109.387 -175.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -144.96 178.18 8.22 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.635 1.974 . . . . 0.0 110.508 174.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 26.7 p -122.76 152.37 40.7 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.177 0.991 . . . . 0.0 111.936 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 94.8 mt -139.72 165.36 27.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.55 1.94 . . . . 0.0 110.937 -169.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -79.8 159.03 26.68 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.572 0.749 . . . . 0.0 110.68 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 38.5 ptt85 -55.94 -29.33 59.97 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 174.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 24.8 mmt -70.97 -21.01 62.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.421 1.088 . . . . 0.0 113.638 175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 27.7 m170 -86.08 4.63 37.32 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.72 1.208 . . . . 0.0 113.578 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 13.5 mt -131.93 140.34 48.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.372 1.069 . . . . 0.0 110.522 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -137.71 153.11 49.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.974 2.11 . . . . 0.0 110.817 -178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.92 165.63 22.92 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.08 0.552 . . . . 0.0 111.236 169.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.61 146.91 72.23 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.185 0.594 . . . . 0.0 111.941 170.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -68.43 163.62 35.86 Favored 'Trans proline' 0 CA--C 1.542 0.888 0 C-N-CA 123.164 2.576 . . . . 0.0 113.402 -177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -65.25 -9.34 23.1 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.485 1.514 . . . . 0.0 114.745 -176.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -133.38 26.31 4.13 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 126.651 1.981 . . . . 0.0 112.978 -175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -60.82 72.88 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 127.373 2.269 . . . . 0.0 114.542 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 67.0 tttt 51.59 28.42 4.66 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 127.11 2.164 . . . . 0.0 113.472 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 157.28 -167.65 33.97 Favored Glycine 0 CA--C 1.533 1.201 0 C-N-CA 126.125 1.821 . . . . 0.0 112.062 -171.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 23.9 pt20 -144.41 171.01 14.94 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.521 1.528 . . . . 0.0 111.363 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -145.6 128.88 16.78 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.258 1.023 . . . . 0.0 112.116 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -144.39 16.59 1.68 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.651 1.58 . . . . 0.0 113.365 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 34.7 pt -56.14 131.26 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 O-C-N 120.728 -1.233 . . . . 0.0 111.501 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 40.58 48.8 2.6 Favored 'General case' 0 CA--C 1.553 1.075 0 C-N-CA 126.686 1.994 . . . . 0.0 114.433 -176.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.94 162.73 2.29 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.062 1.345 . . . . 0.0 114.07 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 29.3 m -125.45 175.65 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.759 1.624 . . . . 0.0 112.681 -169.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.83 56.39 0.73 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.797 2.039 . . . . 0.0 112.429 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.227 0 C-N-CA 126.534 1.934 . . . . 0.0 113.306 176.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.484 0 N-CA-C 111.276 -0.729 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 42.7 m -70.02 98.36 1.29 Allowed 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.985 1.314 . . . . 0.0 112.512 179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 46.0 m -73.42 46.62 0.2 Allowed 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.689 1.996 . . . . 0.0 113.853 178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -148.79 29.25 1.28 Allowed Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.131 1.824 . . . . 0.0 113.313 -176.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.2 p -74.93 4.88 5.8 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.693 1.997 . . . . 0.0 115.488 -176.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 78.7 p -141.86 166.84 23.61 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.229 1.412 . . . . 0.0 113.034 -176.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -177.91 -133.76 1.93 Allowed Glycine 0 CA--C 1.533 1.201 0 C-N-CA 125.208 1.385 . . . . 0.0 111.948 -172.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -130.99 139.38 49.99 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.98 1.312 . . . . 0.0 111.347 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -157.15 157.76 35.04 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.287 1.435 . . . . 0.0 111.101 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -81.25 179.15 7.98 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 125.105 1.362 . . . . 0.0 112.37 173.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 8.5 ptpp? -133.18 160.04 38.4 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.376 1.871 . . . . 0.0 111.488 173.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.05 129.0 38.82 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 121.773 -0.58 . . . . 0.0 110.062 169.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.18 2.07 83.67 Favored Glycine 0 CA--C 1.536 1.378 0 CA-C-O 118.55 -1.139 . . . . 0.0 115.365 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.04 140.13 58.84 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 120.041 1.921 . . . . 0.0 111.155 172.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -97.85 121.0 39.25 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.526 1.13 . . . . 0.0 109.028 174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.9 m -136.09 174.59 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 125.349 1.46 . . . . 0.0 112.181 -166.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.9 mt -107.09 141.48 38.27 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.521 1.128 . . . . 0.0 108.967 169.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -154.66 156.03 35.72 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 178.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 58.7 ttt-85 -71.74 151.82 43.26 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 125.068 1.347 . . . . 0.0 111.04 176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 38.1 t-105 -132.99 -38.89 0.96 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 11.7 t -157.6 -32.03 0.08 Allowed 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -176.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -128.71 -176.87 3.97 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.52 1.528 . . . . 0.0 112.612 -173.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' CYS . . . . . . . . . . . . . 8.3 t -73.22 39.77 0.1 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.103 1.761 . . . . 0.0 114.49 -175.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -138.22 165.86 25.63 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 127.416 2.286 . . . . 0.0 111.021 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -118.48 153.57 33.93 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.417 1.087 . . . . 0.0 110.269 170.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -137.39 154.14 75.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.053 1.341 . . . . 0.0 110.796 -174.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -67.3 136.47 40.33 Favored 'Trans proline' 0 CA--C 1.536 0.599 0 C-N-CA 122.852 2.368 . . . . 0.0 112.523 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -150.09 174.69 12.47 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.953 1.701 . . . . 0.0 111.467 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -134.68 135.46 42.05 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.377 1.471 . . . . 0.0 109.933 173.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 97.8 mt -74.26 120.07 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 124.053 0.941 . . . . 0.0 109.956 178.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.2 mm-40 -84.38 -36.86 22.16 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.857 1.263 . . . . 0.0 112.314 176.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -158.78 160.32 36.17 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.768 1.227 . . . . 0.0 112.43 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 55.2 mt -134.55 130.88 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 125.674 1.589 . . . . 0.0 109.7 -175.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -163.65 110.86 1.15 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.653 1.181 . . . . 0.0 111.358 171.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -58.55 -24.08 59.88 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.749 1.22 . . . . 0.0 113.078 172.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -63.81 -8.94 12.23 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 125.744 1.618 . . . . 0.0 114.368 172.161 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.24 -84.61 0.05 OUTLIER Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.318 -0.864 . . . . 0.0 113.532 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 12.7 p -154.41 158.83 40.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.948 1.299 . . . . 0.0 112.917 -169.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -84.26 112.48 20.34 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 126.053 1.741 . . . . 0.0 109.296 169.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 11.3 m -74.59 134.69 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 121.507 -0.745 . . . . 0.0 109.425 172.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.4 m -142.44 141.14 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.69 1.196 . . . . 0.0 111.825 -170.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -115.82 125.22 52.41 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.403 1.481 . . . . 0.0 109.278 175.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -92.91 167.33 11.9 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.002 0.921 . . . . 0.0 111.875 -176.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -52.76 -28.76 23.72 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -176.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -71.96 -18.71 61.98 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 124.833 1.253 . . . . 0.0 113.693 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 107.07 -16.95 38.55 Favored Glycine 0 CA--C 1.538 1.496 0 C-N-CA 126.3 1.905 . . . . 0.0 113.995 -179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 14.2 p -62.82 147.5 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 126.088 1.755 . . . . 0.0 112.659 176.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.1 mp -125.46 130.34 72.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 125.629 1.572 . . . . 0.0 110.391 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -142.66 -163.59 1.65 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 127.287 2.235 . . . . 0.0 109.56 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 31.3 p -140.35 156.97 46.23 Favored 'General case' 0 CA--C 1.541 0.626 0 O-C-N 121.202 -0.936 . . . . 0.0 112.647 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 79.0 mt -145.04 171.62 14.22 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 126.292 1.837 . . . . 0.0 111.776 -171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 13.5 mptt -101.09 158.3 16.12 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.139 1.376 . . . . 0.0 109.461 168.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -53.19 -28.88 28.85 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 4.4 mpp? -65.31 -14.44 60.77 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.215 1.406 . . . . 0.0 114.217 176.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -108.9 9.14 26.69 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.465 1.506 . . . . 0.0 112.985 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 62.1 mt -128.38 145.38 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 126.105 1.762 . . . . 0.0 109.694 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -139.7 151.23 45.72 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 127.242 2.217 . . . . 0.0 111.0 -177.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.54 162.8 26.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.575 0.75 . . . . 0.0 111.63 169.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' MET . . . . . . . . . . . . . 15.9 mmt -64.34 149.27 94.99 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 123.188 0.595 . . . . 0.0 112.429 171.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.12 175.64 10.62 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 124.192 3.262 . . . . 0.0 113.239 -179.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -62.8 -13.31 31.81 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.968 1.307 . . . . 0.0 114.07 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.25 -7.53 59.59 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.187 1.395 . . . . 0.0 113.532 171.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -138.05 47.49 2.02 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 126.76 2.024 . . . . 0.0 111.174 -170.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -57.46 -23.35 49.25 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 126.802 2.041 . . . . 0.0 115.87 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 78.44 -162.59 49.5 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.962 0.792 . . . . 0.0 113.715 -175.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -132.79 29.49 4.14 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.807 1.643 . . . . 0.0 111.896 -174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -69.0 -31.16 69.79 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . . . . . . . . . 84.9 m95 40.5 44.89 1.82 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.822 2.049 . . . . 0.0 114.762 179.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -68.04 -177.65 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.826 0 C-N-CA 125.69 1.596 . . . . 0.0 110.009 170.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -50.87 119.24 3.73 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.564 1.145 . . . . 0.0 111.408 173.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.7 pp -130.8 -0.79 4.26 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.801 1.24 . . . . 0.0 114.291 -169.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . . . . . . . . . 56.7 t -77.85 145.75 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 125.294 1.438 . . . . 0.0 110.435 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -146.76 168.07 22.27 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.594 1.558 . . . . 0.0 112.459 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.241 0 C-N-CA 126.324 1.849 . . . . 0.0 111.742 179.833 . . . . . . . . 0 0 . 1 stop_ save_